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Abstract 
The progression of cardiovascular disease (CVD) is largely modifiable through lifestyle behaviours. UK 
pharmacists are contractually obliged to facilitate patient self-management of chronic conditions 
such as CVD. Pharmacists are easily accessible health professionals who are well placed to identify 
“at risk” patients through medication regimes. Research has identified varying attitudes towards and 
levels of involvement in pharmacist-led health promotion activity. Given the diverse and exploratory 
nature of the work, a pragmatic, mixed methods approach was used to explore community 
pharmacists’ role in facilitating patient self-management of CVD. The thesis presents four studies: a 
qualitative study with pharmacists; a cross sectional questionnaire of community pharmacists; a 
systematic review and a qualitative study with patients with CVD. The qualitative study with 
pharmacists gave an insight into pharmacists’ experiences of giving patients with CVD lifestyle advice 
and the factors underpinning commonly cited barriers to providing public health services. This 
informed the development of the cross-sectional questionnaire which identified the predictors of 
pharmacists’ intentions to give two different types of advice to facilitate patient self-management.  
The systematic review identified a small number of interventions to prepare pharmacists to facilitate 
patient lifestyle behaviour change and evaluated the theories and behaviour change techniques used 
in successful interventions; however due to poor study quality and poor reporting of the 
interventions limited conclusions about the efficacy of the interventions could reliably be drawn. 
Finally, the qualitative study gave an insight into the experiences of patients with CVD using 
community pharmacy services and their expectations of the service they receive from community 
pharmacists. Recommendations about changes to pharmacy policy and practice in order to support 
pharmacists’ provision of CVD self-management advice are made. 
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1 Chapter One: General Introduction 
1.1 Introduction and Literature Review 
Cardiovascular disease (CVD) is the leading cause of death worldwide (WHO, 2011). In 2013, 28% of 
deaths in England and Wales were from circulatory diseases such as heart disease and stroke, and 
CVD was the leading cause of death in women (ONS, 2014). The development and progression of 
CVD is largely modifiable through lifestyle-related health behaviours such as eating a healthy diet, 
consuming alcohol in moderation, smoking cessation and engaging in regular physical activity (WHO, 
2011). UK community pharmacists are easily accessible health professionals who are well placed to 
identify “at risk” patients through medication regimes. Furthermore, UK community pharmacists are 
contractually obliged to facilitate patient self-management of chronic conditions such as CVD (DoH, 
2005). Research has examined the efficacy of public health interventions delivered by pharmacists, 
with some studies concluding that pharmacist-led public health services resulted in improvements in 
patients’ cardiovascular health (Blenkinsopp, Anderson, & Armstrong, 2003; Machado, Bajcar, Guzzo, 
& Einarson, 2007; Santschi, Chiolero, Burnand, Colosimo, & Paradis, 2011; Tsuyuki, 2002). 
Furthermore, varying attitudes of both patients and pharmacists regarding pharmacist-led public 
health services and varying levels of pharmacist involvement in public-health related activities have 
been identified (Anderson, Blenkinsopp, & Armstrong, 2003, 2004b; Bush, Langley, & Wilson, 2009; 
Eades, Ferguson, & O'Carroll, 2011; Laliberte, Perreault, Damestoy, & Lalonde, 2012; Maunder & 
Landes, 2005; O'Loughlin, Masson, Déry, & Fagnan, 1999). This introductory chapter will review the 
literature relating to pharmacy practice and cardiovascular disease and the contribution the field of 
health psychology can make to understanding pharmacists’ behaviour. Previous research and policy 
will be summarised, gaps in knowledge will be identified and the programme of work conducted to 
address these gaps will be outlined. 
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1.2 Focus on cardiovascular disease 
Cardiovascular disease (CVD) is an umbrella term used to describe diseases of the heart, vascular 
diseases of the brain and diseases of blood vessels. CVDs can be further categorised into those 
caused by atherosclerosis (see below for an explanation) and those caused by other factors (WHO, 
2011). CVDs which are not caused by atherosclerosis are less common and include congenital heart 
disease (abnormalities in heart structure which are present from birth), rheumatic heart disease 
(damaged heart muscle and valves as a result of rheumatic fever), cardiomyopathies (disorders of the 
heart muscle) and cardiac arrhythmias (disorders of the electrical conduction system in the heart) 
(WHO, 2011). 
The work presented in this thesis focuses on how pharmacists can support patients with CVDs caused 
by atherosclerosis to self-manage their condition. Atherosclerosis is a complex disease process which 
occurs in the blood vessels. Fats and cholesterol are deposited inside arteries over a number of years. 
This build up (referred to as a plaque) causes the inner surface of the blood vessels to become 
irregular, in turn narrowing the space the blood has to pass through and consequently making it 
more difficult for blood to flow. Over time, the build-up of the plaque can rupture, triggering the 
formation of a blood clot. If the blood clot forms in a coronary artery (an artery leading to the heart) 
it can cause coronary heart disease which can lead to angina (chest pain) or myocardial infarction 
(heart attack). If the blood clot forms in the brain it can result in cerebrovascular disease, the most 
common types being stroke (disrupted blood supply to the brain) and transient ischemic attack 
(temporary lack of oxygen to the brain) (WHO, 2011). Factors which predispose an individual to 
atherosclerosis include: high blood pressure (hypertension), high cholesterol (hypercholesterolemia), 
diabetes, diet, being overweight or obese, physical inactivity, smoking, and a variety of psychosocial 
factors (WHO, 2011). The majority of the aforementioned risk factors are modifiable and therefore 
both the development and progression of CVD can be prevented through engaging in healthy 
lifestyle behaviours(WHO, 2011).  
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As previously highlighted, CVDs are the leading global cause of death (WHO, 2011). It is estimated 
that in 2008, 17.3 million people died from CVDs, accounting for 30% of deaths worldwide.  The 
incidence of CVD is on the increase, and the WHO (2011) estimate that by 2030 nearly 23.6 million 
people will die from CVDs. The majority of such deaths will be from heart disease and stroke, and 
consequently the WHO projects that heart disease and stroke will continue to remain the leading 
global causes of death. CVD is regularly implicated in premature death, defined as death before 
reaching 75 years of age. More than three million of the 17.3 million worldwide deaths attributable 
to CVD in 2008 occurred in individuals aged less than 60 years (WHO, 2011) whilst in 2010 CVD 
accounted for 22% of deaths in individuals aged under 75 living in England (DoH, 2014).  
1.3 CVD self-management  
Effective self-management of chronic conditions has been shown to improve patient outcome (Lorig 
& Holman, 2003). At present, there is no ‘gold standard’ definition of the term ‘self-management’. 
Barlow, Wright, Sheasby, Turner, and Hainsworth (2002)defined self-management as an individual’s 
ability to manage symptoms, treatment and the psychological and social consequences associated 
with living with a chronic condition. The authors stated that successful self-management is 
dependent on an individual’s ability to monitor their condition and orchestrate the cognitive, 
behavioural and emotional responses required to enjoy a satisfactory quality of life, emphasising that 
this is a dynamic, ongoing process of self-regulation.  
Effective self-management is crucial for patients with CVD in order to prevent further progression of 
the condition. The recommended treatment for CVD is a combination of lifestyle behaviours, and for 
some patients, taking medication. Recent NICE guidelines issued for primary and secondary 
prevention of CVD state that patients should be advised to eat a ‘cardioprotective diet’ (consisting of 
a total fat intake of 30% or less of total energy intake, saturated fats 7% or less of total energy intake, 
dietary cholesterol intake less than 300 mg/day and where possible  replacing saturated fats with 
mono-unsaturated and polyunsaturated fats); engage in 75 minutes of vigorous aerobic activity or 
150 minutes of moderate intensity aerobic activity a week; lose weight if overweight or obese; stop 
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smoking if they smoke and reduce their alcohol consumption (a maximum of 3-4 units daily if male 
and 2-3 units daily if female) (NICE, 2014). The guidance states that patients should be encouraged to 
make the above lifestyle changes and given a CVD risk assessment before being prescribed statins (to 
lower cholesterol levels). Patients with hypertension should be prescribed antihypertensive 
medication and be given the lifestyle advice described above periodically (NICE, 2011). In addition to 
this, treatment guidelines also state that relaxation therapies may be beneficial for patients with 
hypertension (NICE, 2011). 
Hypertension (high blood pressure) and hyperlipidaemia (an umbrella term for raised blood lipids 
which includes high cholesterol, also known as hypercholesterolemia) are major risk factors for the 
development of CVD (WHO, 2012). It has been estimated that people with hypertension are almost 
twice as likely to have a heart attack as those with normal blood pressure, whilst those with 
hyperlipidaemia are three times more likely to have a heart attack than those with normal blood 
lipids (Yusuf et al. 2004). Hypertension is a common condition; at least 25% of adults under 60 and 
more than half of adults aged over 60 have hypertension (NICE, 2O11). Untreated hypertension is 
associated with a progressive rise in blood pressure, and with each 2mmHg rise in systolic blood 
pressure there is a 7% increased risk of dying from ischaemic heart disease and a 10% increased risk 
of mortality from stroke. (NICE, 2011). Raised cholesterol is also a common condition; in England in 
2008 the prevalence of high cholesterol levels (>5.0 mmol/l total cholesterol) was 61% in women and 
58% in men (Scarborough et al., 2010). 
Therefore in order to effectively self-manage the condition, patients with CVD must engage in a 
number of self-management behaviours including engaging in lifestyle behaviours and, for many 
patients with CVD, adhering to prescribed medication. Adherence has been defined by Horne (2005) 
as: 
‘the extent to which the patient’s behaviour matches agreed recommendations from the 
prescriber’ (p33) 
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This definition acknowledges that, for many patients, not taking medicines as prescribed is a rational 
response to their perceptions of illness and treatment (Horne, 2005). Adherence is normally 
considered in relation to medication taking, however adherence also relates to other non-
pharmacological treatment including lifestyle behaviours. Pharmacological treatment is 
recommended for patients at increased risk of cardiovascular disease, and patients with a number of 
risk factors may be prescribed multiple medications to decrease their risk of having/having further 
cardiovascular events (van Geffen et al. 2011). Adherence to medication, including that prescribed 
for CVD is problematic. A recent meta-analysis of studies examining patient adherence to drugs used 
in primary and secondary prevention of CVD, totalling 376,162 participants, found that 
approximately one third of patients who had experienced a heart attack and approximately one half 
who had never experienced a heart attack did not adhere to cardiovascular preventive treatment 
(Naderi, Bestwick, & Wald, 2012). 
The Perceptions and Practicalities Approach (PPA) was developed by Horne (2001) to provide a 
framework for developing interventions to improve adherence. The PPA classifies non-adherent 
behaviour as ‘intentional’ or unintentional’. Horne (2001) suggests that unintentional non-adherence 
is the result of capacity and resource limitations and practical barriers affecting an individual’s 
intentions to adhere to treatment.  Examples of unintentional non-adherence include: forgetting or 
misunderstanding treatment instructions; problems administering treatment; the cost of treatment 
and forgetting to take the treatment. Conversely, intentional non-adherence refers to a conscious 
decision not to adhere to treatment influenced by the individual’s beliefs about treatment.  Horne, 
Weinman and Hankins (1999) used principal components analysis to assess statements of 
participants’ beliefs about prescription medicines, finding that the responses could be grouped into 
“necessity beliefs” and “concerns”. 
Necessity beliefs are defined as an individual’s beliefs concerning their perceived need for treatment 
whilst concerns are the worries individuals have about taking treatment (commonly relating to 
adverse effects and dependency). The Necessity Concerns Framework (Horne, 2003) posits that 
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adherence is determined by individuals weighing up the extent to which they believe they need 
treatment with concerns about adverse effects.  According to the Necessity Concerns Framework, 
non-adherence may be a common sense response to a necessity-concerns dilemma. A more recent 
meta-analytic review of the Necessity Concerns Framework of 94 studies (n= 25,072) found that 
higher adherence was associated with stronger perceptions of necessity of treatment (p<0.0001) and 
fewer concerns about treatment (p<0.0001) (Horne et al., 2013). This relationship remained 
significant when stratified by study size, country the research was conducted in and the type of 
adherence measures used.  
The Common Sense Self-Regulation Model (Leventhal et al., 1980) can be applied to understand the 
self-management behaviours of patients with hypertension and hyperlipidaemia. Leventhal and 
colleagues posit that people cope with symptoms or illnesses in the same way they deal with other 
problems. The CS-SRM assumes that people are motivated to maintain equilibrium (health) and if the 
person encounters a change or problem (such as symptoms or illness) they will be motivated to solve 
the problem and return to their usual state of health. The CS-SRM proposes that this occurs in three 
stages: interpretation, coping and appraisal.  The interpretation stage describes when an individual is 
presented with the problem of potential illness through symptom perception or social messages 
(such as diagnosis from a health professional). Leventhal et al. (1980) suggest that the individual is 
motivated to return to their status quo (health) and need to assign meaning to the problem in order 
to do so. The CS-SRM suggests that this occurs through individuals assessing their existing illness 
cognitions and/or developing new illness cognitions.  
Leventhal et al. (1991) suggest that illness cognitions give patients a framework for understanding 
their illness, telling them what to watch out for and give an indication that they are getting ill.  The 
CS-SRM posits that illness cognitions are developed in five domains: identity, cause, consequences, 
timeline and cure/control. Identity refers to the label given to the illness and the symptoms 
experienced whilst ‘cause’ describes the patients’ perception of what caused the illness. This includes 
both biological and psychological causes such as a virus or stress. ‘Consequences’ describes the effect 
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patients perceive that an illness will have on their lives. This can refer to physical effects such as lack 
of function or mobility, emotional consequences such as loneliness due to lack of social contact as a 
result of illness, or a combination of both physical and psychological consequences. ‘Timeline’ refers 
to patients’ beliefs about how long an illness will last and patients may have an acute or a chronic 
model of their illness. Finally, ‘curability/control’ concerns patients’ perceptions of whether their 
illness can be treated and cured. It also incorporates the extent to which patients feel they have 
control over their illness.   
In addition to illness cognitions, the CS-SRM posits that patients also form emotional representations 
which identify if the illness will result in changes to the individual’s emotional state. The CS-SRM 
states that both illness cognitions and emotional representations inform the identification of 
previous successful coping strategies or the development of new coping strategies to return the 
patient to equilibrium (health). The third stage of the model, the appraisal stage, involves the patient 
evaluating the coping strategy they have selected. If deemed successful, the individual will continue 
with their original coping strategy. If the individual believes that the coping strategy is not effective 
they will select a new coping strategy and/or update their illness cognitions accordingly. This process 
is dynamic and iterative, with the three components interrelating with each other. Individuals will 
move back and forth through the stages until they return to a state of equilibrium.  
Unlike the other CVD risk factors, hyperlipidaemia and hypertension are largely asymptomatic. 
Therefore patients with hypertension and/ or hyperlipidaemia need to engage in self-management 
behaviours to control their condition (objectively measured cholesterol levels/ blood pressure) but 
subjectively will not experience symptoms because hypertension and hyperlipidaemia are 
asymptomatic conditions. As described above, according to the CS-SRM, coping behaviours are 
guided by illness representations which are activated in response to the patient’s interpretation of a 
symptom and social cues. The absence of symptoms associated with hypertension and 
hyperlipidaemia has been found to affect patients’ self-management of the condition. This may 
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mean that patients with hypertension or hyperlipidaemia may need different support to self-manage 
the conditions compared to patients with a symptomatic chronic condition. 
A recent synthesis of qualitative studies examining patients’ perceptions of hypertension found that 
despite hypertension being an asymptomatic condition, a large proportion of patients believed that 
hypertension produced symptoms of dizziness, headaches and sweating (Marshall, Wolfe, & 
McKevitt, 2012). Marshall et al. (2012) found patients commonly believed that stress caused their 
hypertension, perceiving their blood pressure to have improved when they were not stressed or did 
not experience perceived symptoms, reporting that they did not need to take antihypertensive 
medications at these times. Furthermore a study examining the relationship between illness 
cognitions and medication adherence in patients with hypercholesterolaemia(high cholesterol) 
(Brewer, Chapman, Brownlee, & Leventhal, 2002) found that patients who believed that 
hypercholesterolaemia was a stable, asymptomatic condition had better cholesterol control and self-
reported medication adherence than patients who believed  hypercholesterolaemia produced 
physical symptoms. The work in this thesis focused on pharmacists facilitating patient self-
management of patients with diagnosed with and taking medication for hypertension and/or 
hyperlipidaemia, given the particular importance of lifestyle behaviours in preventing the 
progression of the condition. 
1.4  The Role of UK community pharmacists in public health 
Community pharmacists are frequently described as the most accessible health professionals in the 
UK. Pharmacists regularly interact with patients on a one-to-one basis, operating in pharmacies 
which are geographically well-placed to provide local services (Holland, Brooksby, Ashton, et al., 
2007). Members of the public do not require an appointment to seek advice from a community 
pharmacist and pharmacies are accessed by people with both good and poor health, and those who 
may not otherwise interact with health professionals (Eades et al., 2011). Anderson et al. (2003) 
suggest that the dual health and commercial roles of pharmacies offer the opportunity to target 
services at healthy people as well as those with health problems, presenting pharmacists and their 
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staff with the chance to give advice on health and/or medicines to a large proportion of the 
population on a regular or ad hoc basis.  
Usage of community pharmacy is reportedly high, however statistics on pharmacy usage in the UK 
are difficult to access. A survey of pharmacy usage in the UK in 1996 found that 94% of the 
population visits a pharmacy at least once a year, with each adult making an average of 12 visits a 
year. Of the 1.8 million visits to community pharmacies every day, 260,000 of them (14%) are 
specifically to seek health advice (Royal Pharmaceutical Society of Great Britain, 1996). A later study 
which examined data from a stratified sample of 6322 UK adults aged 35 years or above found that 
59% cent of respondents had collected a prescription medicine and 40 per cent had purchased an 
over-the-counter medicine from a pharmacy in the last month, whereas only 12 per cent had asked 
for advice (Boardman, Lewis, Croft, Trinder, & Rajaratnam, 2005). Specifically in relation to 
cardiovascular health, around 266 million prescriptions were issued for CVDs in England in 2008 
(British Heart Foundation Statistics Database, 2010). Patients collecting prescriptions for medicines 
to treat CVD present potential opportunities for pharmacists to facilitate patient self-management 
through the provision of advice on healthy lifestyles and the importance of adhering to medication. 
The landscape of community pharmacy has changed dramatically in the past 40 years. The pattern of 
pharmacy ownership has changed, with increasing numbers of pharmacists now employed by 
multiple pharmacy chains as opposed to working as independent pharmacists who own their own 
pharmacy business. Traditionally the role of pharmacists centred on compounding medicines from 
constituent ingredients and subsequently dispensing the medicine (Harding & Taylor, 1997; Taylor & 
Harding, 2003). The expansion of the pharmaceutical industry arguably threatened the professional 
status of pharmacy, (Harding & Taylor, 1997; Taylor & Harding, 2003) with the development of pre-
packaged medicines containing information leaflets about medicine dosage, frequency and possible 
adverse effects reducing the pharmacists’ input in the supply process. Similarly, technological 
advances such as software in GPs surgeries and pharmacies which identify drug interactions and 
inappropriate prescription doses and produce medicine labels with directions and warnings arguably 
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reduce the need for pharmacists’ input based on their knowledge and expertise in medicine (Roberts, 
1988). Medicines have also increasingly become available from non-pharmacy outlets such as petrol 
stations, with which comes the association that the no "expert" supervision or advice is required to 
sell these drugs (Harding & Taylor, 1996).  
This has led to debate regarding the professional role of pharmacists, with some questioning 
whether pharmacy should be considered a profession at all. There are a number of theories 
concerning the attributes which make a profession a profession. Traulsen and Bissel (2004) applied 
the trait theory of professions, suggesting that pharmacy has a number of the characteristics which 
distinguish a profession according to the theory. Examples of these include: a monopoly over 
compounding and medicines (with few exceptions); a monopoly on the sale of pharmacy medicines 
in the UK; having specialised knowledge and completing lengthy training and pharmacists regulating 
their own professional conduct. However this notion has been contested, with Denzin and Metlin 
(1966) arguing that pharmacy is not a “true” profession, asserting that pharmacists do not have 
social control over the object of their practice (medicines). They also suggested that pharmacists are 
motivated by commercial interests which arguably conflicts with the altruistic, service oriented 
nature of professions. This was supported by Knapp and Knapp (1968) who argued that pharmacy 
had not clearly defined its professional function and role, positing that medicines were controlled by 
the medical profession and community pharmacists were caught between professionalism and 
commercialism. 
Sociologists have cited the process of the pharmacy profession losing activities that were considered 
as core to its professional status as an example of ‘de-professionalisation’, arguing that the increasing 
automisation of tasks traditionally associated with the pharmacists’ role undermined the basis for 
pharmacy’s claim to professional status (Jiwa et al., 2014). It has been suggested that community 
pharmacists underwent a process coined ‘re-professionalisation’ in response to role ambiguity 
caused by the loss of the aforementioned activities which were traditionally the associated with the 
role of the pharmacist (Bush et al., 2009), promoting the pharmacy profession as the providers of a 
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wider range of services (Harding & Taylor, 2008). Anderson and Rajyaguru (2002) describe UK 
pharmacists as having reclaimed their traditional role in health promotion, expanding the role 
beyond the provision of medicines by moving to a disease and patient centred approach to making 
pharmaceutical decisions which includes chronic condition self-management support and 
opportunistic lifestyle advice.  
Pharmacy In A New Age (PIANA) was a project conducted by the Royal Pharmaceutical Society of 
Great Britain (the former regulatory and professional body for pharmacists and pharmacy technicians 
in England, Scotland and Wales) between 1995 and 1999 which created a strategy to achieve a vision 
for the future of pharmacy. It was adopted by subsequent governments and shaped future 
government policy (Wilcock et al., 2013). The functions and aims for pharmacists outlined in PIANA 
are as follows: for pharmacists to be involved in and provide advice about the management of long 
term conditions; for pharmacists to be seen as the primary source of advice on common ailments; for 
pharmacists to have a role as advisors on healthy lifestyles which was fully recognised and integrated 
into NHS services and for pharmacists to advise and support other health care professionals. The 
vision outlined in PIANA was adopted by the Labour government and in 2003 the Department of 
Health published ‘A vision for Pharmacy in the New NHS’ which described pharmacists as “an integral 
part of the NHS family”. The Chief Pharmaceutical Officer at the time (Jim Smith) highlighted the 
importance of the pharmacist’s traditional role, but argued that changes in patient needs, technology 
and scientific advancements meant that pharmacists needed to change their contribution and 
provide a wider range of pharmacy services. The report suggested that UK pharmacists are well 
placed to make an important contribution to improving public health and the promotion of health in 
areas such as smoking cessation, sexual health, reducing obesity and minimising health inequalities.  
The NHS pharmacy contract (DoH, 2005) implemented objectives set out in A vision for pharmacy in 
the new NHS (DoH, 2003). The contractual framework is comprised of three service types: essential 
services (which all pharmacists must provide, commissioned by NHS England); advanced services 
(which requires accreditation of the pharmacist providing the service and/or the pharmacy premises 
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meeting specific requirements, commissioned by NHS England) and enhanced services (which are 
commissioned and funded by Care Commissioning Groups (CCGs), local authorities and NHS England 
in response to the needs of the local population). These were formally funded by Primary Care Trusts 
until they were dissolved. The services associated with each category are outlined in table 1.1. 
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Table 1.1: Pharmacy services in NHS contractual framework 
Service Level Description 
Essential Public Health (Promotion of healthy lifestyles) 
 signposting to health promotion and education services 
 proactively participating in six public health campaigns a year  
 promoting healthy lifestyles to people who present prescriptions for 
diabetes, coronary heart disease and those who smoke or are 
overweight through discussion about smoking cessation, appropriate 
alcohol intake, diet and exercise 
Dispensing medicines, appliances and repeat dispensing 
Clinical Governance 
Disposal of unwanted medicines 
Signposting patients to other health and social care providers 
 Support for self-care 
 advice to help patients and carers manage long term conditions 
 opportunistic health promotion advice 
 advice on non-prescription medications used for self-care of minor 
illnesses and long term conditions. 
Advanced Medicines Use Reviews  
 discussion of patient’s use of medicines to improve adherence and 
reduce medicines wastage 
New Medicines Service 
Appliance Use Reviews 
Stoma Appliance Customisation 
Enhanced  Substance Misuse 
Weight management services 
Supplementary prescribing 
Smoking cessation services 
Sexual health services 
NHS Health Checks for people aged 40-74 years 
Alcohol Misuse Services 
Pandemic and Seasonal Flu Services 
Adapted from PSNC website. 
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To accompany the introduction of the pharmacy contract, a document which outlined the strategy 
for pharmacists’ contribution to public health was published. ‘Choosing Health through Pharmacy’ 
(DoH, 2005) aimed to maximise how pharmacists and their staff contributed to health and health 
inequalities through extending their role, outlining how “pharmaceutical public health” and the 
“health promoting pharmacy” may look in 2015 by providing best practice guidelines. 
Choosing Health through Pharmacy followed on from the White Paper ‘Choosing Health: Making 
healthy choices easier’ (DoH, 2004) which positioned informed choice as its underpinning principle. 
Choosing Health posited that individuals want to make their own health decisions, however expected 
government to enable them to do so. However the policy acknowledges that making healthy choices 
is easier for some individuals in comparison to others and therefore proposed a strategy to reduce 
health inequalities through a co-ordinated effort from different organisations to deliver personalised 
services, tailored to individuals’ lives. Jepson, Hewison, Thompson, and Weller (2005) state that 
individuals should be provided with ‘adequate, high quality relevant, unbiased information’ in 
relation to all the consequences of their decision in order to enable an individual to make an 
informed choice.  It is part of the pharmacists’ role to provide patients with such information; 
Choosing Health through Pharmacy (2005) posits that the provision of information and advice is an 
important role for pharmacists in all settings. Specifically in relation to reducing health inequalities, 
the document states that pharmacists should signpost to or provide services targeted at specific 
groups. Such services include: smoking cessation services for pregnant women and unskilled workers; 
services to manage and prevent risk factors for cancer and coronary heart disease in people aged 
over fifty and in ‘manual social groups’ and providing space in pharmacies to enable other services to 
be accessed in disadvantaged communities.) However it has been argued that that informed choice 
and sharing decision making between patients and health professionals can increase health 
inequalities, benefitting patients who naturally seek out information, have higher levels of education 
and can advocate for themselves whilst marginalising patients who are socially disadvantaged 
(Coulter & Collins, 2011). A recent systematic review of interventions to promote shared decision 
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making to reduce health inequalities by Durand et al (2014) found a significant positive effect of 
shared decision making interventions on disadvantaged patients. The narrative synthesis suggested 
that shared decision making interventions increased knowledge, informed choice and participation in 
decision making although the authors state that caution should be exercised when interpreting the 
results due to small sample sizes and study heterogeneity. 
 The DoH (2005) envisaged the ‘health promoting pharmacy’ in 2015 to incorporate: information and 
advice; a range of health improvement services including smoking cessation, weight management, 
sexual health, substance misuse; immunisation; the identification of people at risk of disease and the 
provision of self-management advice; working with other organisations to improve other social 
determinants of health; linking with schools, workplaces and other community settings to provide 
health advice; acting as a health advocate in the community; supporting people with long term 
conditions; working in partnership with other health organisations; enhancing the extended 
pharmacy team through training and research, and using communications technology to provide 
health information and access electronic health records. The document situated most pharmacists as 
part of the ‘wider public health workforce’, defined as: 
“health care professionals or teachers who make a positive contribution to public health 
through their work but do not spend the majority of their time on public health” (p13) 
Despite frequently referring to the term ‘pharmaceutical public health’, the report did not give a 
definition of what is meant by this term and rather cited the list of activities that a health promoting 
pharmacy might provide described above which address both prevention and management of 
chronic conditions in addition to other activities. The services outlined in the pharmacy contract 
(DoH, 2005) of particular relevance to cardiovascular health include: providing smoking cessation 
advice and resources, identifying individuals at risk of developing diseases and offering lifestyle 
assessments, offering information and self-care support and contributing to the care of people with 
long term conditions through encouraging appropriate use of medications, promoting self-care and 
healthy lifestyles and carrying out Medicines Use Reviews (an advanced service which involves the 
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pharmacist reviewing the patient’s use of medication, ensuring the patient understands why they 
have been prescribed and know how to use their medication, identifying any problems with the 
patient’s medication use and providing feedback to the patient’s GP if necessary (PSNC, 2014). 
In addition to Choosing health through pharmacy, a more recent report on the NHS’s role in public 
health states that all healthcare professionals in the NHS should “make every contact count” by using 
every contact with individuals to maintain or improve their physical and mental health if possible, 
regardless of the health professional’s specialism or the individual’s reason for the contact with them 
(NHS Future Forum, 2012). The report found that pharmacy staff, along with other health 
professionals, were enthusiastic about their “broader health and well-being responsibilities”. 
Furthermore, the report cited a Healthy Living Pharmacy (see page 27 for definition) as an example 
of good practice. 
Concerns surrounding pharmacists’ training to deliver the newer public health roles outlined in the 
pharmacy contract have been raised, with systematic reviews investigating  pharmacists’ perceptions 
of their role in public health finding that pharmacists believed that they required further training to 
enable them to fulfil their public health role (Anderson et al., 2003; Eades et al.,2011). A survey of US 
pharmacy schools in 2005 found that few institutions gave pharmacy students the opportunity to 
gain knowledge and skills about lifestyle change that can improve health and wellbeing and prevent 
disease, with only four out of the fifty schools which responded to the survey offering a mandatory 
course on lifestyle change (Lenz, Monaghan & Hetterman, 2007). A comparable survey of UK 
pharmacy schools has not been conducted. 
It also should be noted that since the introduction of Choosing health through pharmacy (DoH, 2005) 
and the pharmacy contract (DoH, 2005), there have been substantial changes to the structure of the 
NHS which have implications for pharmacy practice, many of which occurred while the studies 
presented in this thesis were being conducted. The introduction of The Health and Social Care Act 
2012 brought about the biggest reforms since the NHS was formed. Amongst other reforms, the NHS 
in England was restructured, dissolving Primary Care Trusts (PCTs) and Strategic Health Authorities 
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and transferring the commissioning of health services from PCTs to Clinical Commissioning Groups 
(CCGs) run partly by GPs. A new body, Public Health England, was created, resulting in responsibility 
for commissioning public health services being transferred from the NHS to local authorities. This has 
implications for community pharmacies, which provide public health services. Under the new 
reforms, the Department of Health continues to determine the NHS reimbursement prices of 
medicines and appliances dispensed in community pharmacies. NHS England is responsible for the 
administration of the pharmacy contact whilst Local Area Teams, CCGs and local authorities can 
commission NHS pharmaceutical services including essential, advanced and enhanced services.  
Despite the introduction of the pharmacy contract (DoH, 2005) and Choosing Health through 
Pharmacy (2005) which outlined a role for pharmacy in public health and facilitating patient self-
management of chronic conditions, the process of ‘re-professionalisation’ has not been 
straightforward. Pharmacies can only be sustained if they are profitable businesses, and 80% of an 
average UK pharmacy’s income comes from dispensing NHS prescriptions (Conisbee, 2003). This can 
lead to conflict between the pharmacist’s desire to provide a health service and their need for the 
pharmacy to function as a successful business (Bush et al., 2009). Pharmacists have reported a 
reluctance to offer potentially unwelcome health advice as part of public health services for fear of 
offending patients (Anderson et al., 2003; Eades et al. 2003) who notably also have the dual role of 
customers to the pharmacy which is a business as well as a provider of healthcare. Role extension 
has also been perceived by pharmacists to cause an increased workload resulting in stress and 
decreased job satisfaction for English community pharmacists (Gidman, 2011). Furthermore, the 
extended role of community pharmacists has been met with some opposition. Some doctors have 
expressed concern about this extended role encroaching on their economic and professional 
domains (Bush et al., 2009). 
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1.5 Evidence for pharmacist-led public health services 
There have been several systematic reviews examining the efficacy of a range of community 
pharmacist-led public health services. The findings relating specifically to CVD and the respective risk 
factors are discussed below. 
A commonly cited large-scale RCT conducted by Tsuyuki (2002) evaluated a pharmacist-led lipid 
management programme for 675 patients at high risk of developing CVD. Patients who were 
randomly assigned to the intervention received a cardiac risk assessment, lifestyle advice and referral 
to other health professionals where appropriate, whereas patients assigned to the standard care 
group received an information pamphlet on CVD and usual pharmacy services. The primary outcome 
measure or primary endpoint was patients’ ‘cholesterol risk management’, which consisted of the 
patient’s blood cholesterol levels and whether they had been prescribed cholesterol-lowering 
medication/ had had their cholesterol lowering medication adjusted. Patients randomly assigned to 
the intervention group reached the primary endpoint more frequently than patients in the standard 
care group (57% vs. 31% respectively).  
An older systematic review conducted by Blenkinsopp et al. (2003) evaluated the effectiveness of 
community pharmacy based interventions to reduce risk factors and risk behaviours for coronary 
heart disease both in the UK and internationally, published between 1990-2001. The included studies 
were: five studies assessing smoking cessation interventions (two RCTs and three non-randomised 
experimental designs); two RCTs assessing lipid management interventions; one small descriptive 
study assessing a blood pressure management intervention and three studies using case finding 
interventions (which used pharmacy patient medication records to identify patients at risk of 
hyperlipidaemia). Blenkinsopp et al. (2003) concluded that there was good evidence demonstrating 
the efficacy of the role of community pharmacy in smoking cessation and cholesterol management, 
and that pharmacists can contribute to coronary heart disease prevention. However the authors 
questioned the generalisability of the studies given that they were conducted in the UK, Canada and 
the USA, raising questions about how transferable the results are between the different countries 
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and their respective care systems. Blenkinsopp et al. (2003) also noted that many of the studies were 
both conducted and evaluated by pharmacists, suggesting that this may have led to them drawing 
unduly positive conclusions about the future role of pharmacists in health promotion. 
Anderson et al. (2003)conducted reviews of both the peer reviewed and non-peer reviewed UK and 
international literature published between 1990 and 2002, assessing the contribution community 
pharmacy could make to the public’s health. The review of the peer-reviewed literature identified 35 
trials or other experimental studies in 40 papers, and 34 descriptive studies. The studies were found 
to be heterogeneous in design with varying outcome measures. The robustness of the study designs 
was also found to be variable. The services which were deemed to have good evidence of clinical and 
cost effectiveness along with being well received by patients at an international level, were smoking 
cessation services and lipid management to prevent the development of coronary heart disease, with 
wider provision of such services in the UK recommended by the authors. Anderson et al. (2003) 
concluded that whilst studies evaluating diabetes, anticoagulation therapy and weight reduction 
services looked promising, there was not a sufficient evidence base for the effectiveness of 
pharmacists providing these services. The authors found little evidence of pharmacy users’ views of 
services being tested and little evidence of user involvement in the development of services. The 
findings of the review of the non-peer reviewed literature supported the conclusions of the review of 
the peer-reviewed literature. 
Whilst the review described the tools used to assess the quality of the studies, it did not give a 
detailed overview of the quality of the included studies, just noting that the ‘robustness’ of the study 
designs varied. It is also noteworthy that the evaluation of efficacy of the pharmacists offering 
smoking cessation services was based on two randomised controlled trials, for which no information 
about study quality was provided. Anderson, Bleinkinsopp and Armstrong (2009) conducted an 
update of the evidence base for community pharmacist involvement in public health, including 186 
studies published over an eighteen year period (1990-2007). They suggested that there was a 
substantial evidence base supporting the contribution pharmacists can make to public health with 
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smoking cessation services and diabetes and lipid management included in the services deemed to 
have the strongest evidence for their efficacy. Hypertension services and cardiovascular disease 
prevention and management services were found to have some evidence supporting pharmacist 
involvement whilst Anderson et al. (2009) concluded that more research was required to determine 
the efficacy of pharmacist-led weight management services. 
A Cochrane systematic review was conducted by Nkansah et al. (2010) to evaluate the effect of 
outpatient pharmacy services other than, or in addition to, drug compounding and dispensing on 
patient outcomes and prescribing patterns. Ten of the 43 included studies were conducted in a 
community pharmacy setting. Nkansah et al. (2010) found that an improvement in most outcomes 
measured was found with pharmacist intervention; however this was not consistently statistically 
significant. The heterogeneity of study designs and interventions made it difficult for the authors to 
summarise the overall benefit of community pharmacist intervention however they concluded that 
the evidence supported the role of pharmacists in medicines management and counselling patients 
about other public health issues. Meta-analyses performed on hypertension and glycaemic control 
studies with comparable study characteristics showed a beneficial effect of pharmacist intervention 
on blood pressure and HbA1c levels respectively.  
Peterson, Fitzmaurice, Krupp, Jackson & Rasiah (2010) conducted a study which aimed to assess the 
suitability of Australian community pharmacies as a site specifically for CVD risk screening and 
evaluate the potential role of community pharmacists in identifying asymptomatic individuals at high 
risk of developing CVD. A projected 10 year risk assessment was calculated and explained to the 
participants in addition to providing psycho-educational material and verbal information about 
cardiovascular risk factors, diet and the role of exercise. No specific behavioural change was 
prescribed. Patients completed a questionnaire after three months to assess the outcomes of the 
intervention. Over a quarter of the 644 patients who participated in the study were identified as at 
increased risk of having a cardiovascular event and advised to consult a doctor whilst 73% of those 
screened were considered at increased risk because of their estimated 10 year cardiovascular risk or 
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abnormal test results. The patients were found to have a positive attitude towards pharmacists 
providing screening for risk of CVD. The majority of ‘high risk’ participants identified by the 
pharmacist reported discussing it with their doctor, and 50% of the 346 questionnaire respondents 
reported engaging in lifestyle modification or starting a new medication. Peterson et al. (2010) 
concluded that the pharmacist-led screening programme was feasible, and demonstrated the 
potential benefit of pharmacy screening as part of an intervention to alter cardiovascular risk. 
A more recent literature review conducted by Brown, Portlock, and Rutter (2012) reviewed the 
services provided by pharmacies that promote healthy living in order to identify services that should 
be provided in ‘Healthy Living Pharmacies’ (HLPs). Brown et al. (2012) define HLPs as a new concept 
designed to meet public health needs through pharmacy services commissioned through a tiered 
commissioning framework and tailored to meet local needs and tackle health inequalities. The 
review included 377 studies, and only discussed the studies the authors deemed to be of the highest 
quality (the number of these studies was not specified). Overall, Brown et al. (2012) concluded that 
there was ‘good’ evidence in support of community pharmacy services for smoking cessation, CVD 
prevention, hypertension and diabetes. Brown et al. (2012) concluded that the evidence for the 
efficacy of pharmacist-led weight management was weak.  
The review found good evidence for the effectiveness of hyperlipidaemia management, based upon 
a meta-analysis conducted by Machado et al. (2007) of 2246 patients in 13 studies which found that 
pharmacists’ interventions significantly reduced systolic blood pressure whilst control participant 
systolic blood pressure remained the same. Brown et al. (2012) therefore concluded that 
pharmacists could promote better cardiovascular health through cholesterol reduction. Brown et al. 
(2012) concluded that there was good evidence demonstrating that interventions delivered by 
pharmacists significantly reduced systolic (not diastolic) blood pressure but regular patient review 
was needed for this to be maintained. Based on the evidence, Brown et al. (2012) concluded that 
regular patient review and medicine adjustment and pharmacists collaborating with other healthcare 
professionals were the most effective interventions. Patient self-monitoring, patient education and 
 
 
33 
 
appointment reminders in isolation were not found to be as effective. Brown et al. (2012) concluded 
that there was ‘moderate’ evidence demonstrating that pharmacist interventions resulted in 
effective weight loss, and sustained weight loss over repeat pharmacy visits. Finally, whilst Brown et 
al. (2012) concluded that community pharmacy had the potential to screen patients for alcohol 
abuse and provide advice on healthier drinking they suggested that more research is required to 
explore the role of the pharmacist in giving alcohol advice concluding that there was weak evidence 
to demonstrate that pharmacists were interested in adopting this role. 
In contrast to the findings of Brown et al. (2012) regarding pharmacist-led weight management 
services, a systematic review to identify evidence for the efficacy and cost effectiveness of weight 
management interventions in the community pharmacy found that there was insufficient evidence 
for both the efficacy and cost-effectiveness of such interventions (Gordon, Watson, & Avenell, 2011). 
The review included studies with weight management as a primary focus conducted in a community 
pharmacy setting between 1999 and 2009, with weight loss as a primary outcome measure. Ten 
studies met the inclusion criteria, totalling 2,583 service users and 582 pharmacies. All of the 
interventions were comprised of multiple components, including a dietary element, yet none 
included a clear description of what the intervention incorporated, and all studies were judged to 
have reporting and methodological weaknesses by Gordon et al. (2011). The authors concluded that 
the interventions resulted in small but significant weight loss from baseline, however the 
effectiveness of the interventions was unclear. It is noteworthy that three studies used self-reported 
weight loss as an outcome measure, participant attrition was high and post-intervention follow up 
times were short. Gordon et al. (2011) also note that none of the studies assessed pharmacists’ 
attitudes towards overweight and obese participants, citing research (Flodgren et al., 2010; Puhl & 
Heuer, 2009) that has shown that health providers’ attitudes may be barriers to the efficacy of 
weight loss interventions.  
Santschi et al. (2011) carried out a systematic review of RCTs to evaluate the effect of pharmaceutical 
care on outpatient management of major modifiable CVD risk factors in this case smoking, 
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hyperlipidaemia, hypertension, diabetes and obesity. Thirty RCTs were included, comprising of 
11,765 patients. The review found that pharmacist interventions resulted in statistically significant 
reductions in blood pressure (diastolic and systolic), cholesterol (total and LDL) and risk of smoking, 
leading Santschi et al. (2011) to conclude that pharmacists are beneficial in the management of 
major CVD risk factors. However, as stated in relation to previous reviews, most studies included in 
this review were conducted in the US and Canada raising questions about the generalisabilty of the 
results given the different health care systems. Furthermore, the content of the interventions 
(including the frequency of delivery) ranged widely. This led the authors to conclude it was difficult to 
identify which aspects of the interventions were most effective in managing CVD risk factors, and 
more research is needed in this area. Patient satisfaction/evaluation was also not included as an 
outcome measure of the efficacy of the intervention therefore the acceptability of the interventions 
to patients is unknown. 
Evans et al. (2012) conducted a systematic review to assess the efficacy of community pharmacist 
interventions aimed at preventing or managing diabetes and/or cardiovascular disease and/or their 
major risk factors. Studies examining community pharmacist interventions for diabetes, CVD and 
their risk factors were included whilst studies focusing on patient screening were excluded. 
Literature published between 1978 and 2010 was searched; of the 40 studies included in the review, 
study designs varied, and whilst some randomised controlled trials (RCTs) were included, the 
majority of the studies were uncontrolled ‘before and after’ studies. Included studies had sample 
sizes ranging from eight to 1,493 and the authors concluded that the quality was poor in over half of 
the studies. The most common interventions were patient-education, patient follow-up and 
identifying medicine-related problems and subsequent referral to a doctor, which were found to be 
successful at producing a significant difference in the primary outcome measure (which varied across 
the studies) in most of the studies. The authors concluded that most studies demonstrated that 
community pharmacist intervention was beneficial for the reduction or management of diabetes or 
cardiovascular disease and their risk factors, however the quality of the studies overall was poor, 
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interventions were time consuming and none of the studies showed a change in major health 
outcomes. 
To summarise, there is evidence demonstrating the effectiveness of public health services delivered 
by pharmacists, both generally and specifically in relation to cardiovascular health. However caution 
should be exercised when interpreting these findings, given that concerns have been raised about 
the quality and heterogeneity of the studies. 
1.6 Pharmacists’ involvement in public health services 
Research suggests that pharmacists’ actual involvement in delivering public health services does not 
always reflect their desired involvement or that indicated in the pharmacy contract and the 
‘Choosing health through pharmacy’ best practice guidelines. Bush et al. (2009) examined the public 
health activities of 1023 (response rate: 51%) community pharmacists using self-administered 
questionnaires. They found that the public health activities of pharmacists varied in accordance with 
the ownership of their employer. Supermarket pharmacies were less likely to provide emergency 
hormonal contraception, needle exchange schemes and supervised administration of medicine (the 
most common of which are medicines used to support drug addiction withdrawal) than independent 
and multiple pharmacies whilst multiple and supermarket pharmacies more likely to provide 
screening services than independent and small chain pharmacies. Participating pharmacists believed 
that larger pharmacy chains and supermarkets with large turnovers would hold favourable positions 
when attempting to attract funding to develop new services. The implications of this being that 
independent community pharmacies would not be able to provide such a comprehensive range of 
public health services as supermarket and large chain pharmacies. Pharmacists working in corporate 
pharmacies also reported conflict with commercial interests as a significant barrier to providing the 
set public health agenda. This finding supports those of a study conducted by Maunder and Landes 
(2005) who examined the role of community pharmacists in oral healthcare. Most of the 
participating pharmacists reported that they would like to participate in oral health promotion, 
however employees of multiple ownership pharmacies stated that permission to engage in health 
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promotion would have to be sought from the company. The pharmacists identified this as a barrier to 
health promotion activities, indicating that senior management may not agree with their 
involvement in such activities. A recent Canadian study investigated pharmacists’ ideal and actual 
involvement in health promotion and prevention (Laliberte et al., 2012) Of the 574 pharmacists who 
returned the questionnaire (46% return rate), most believed that they should be ‘very involved’ in 
health promotion and prevention, particularly relating to smoking cessation (84.3%), screening for 
hypertension (81.8%), diabetes screening (76.0%) and dyslipidaemia (56.9%). However, when 
reporting their actual involvement in these activities, a smaller proportion of pharmacists reported 
being ‘very involved’ in providing such services. Only 4.5% of pharmacists reported being very 
involved in providing lifestyle services (including smoking cessation) whist fewer pharmacists were 
actively involved in providing hypertension screening (44.5%), diabetes (34.8%) and hyperlipidaemia 
(6.5%) screening respectively. As with previous studies, barriers to providing such services were 
identified as lack of: time; coordination with other health care professionals; staff or resources; 
remuneration and clinical tools. A study exploring Scottish community pharmacists attitudes towards 
and provision of advice on alcohol use found that only 5% of 497 respondents reported exploring 
how much patients drink once a week or more whilst 29% of respondents had never asked patients 
how much they drink (McCaig, Fitzgerald, & Stewart, 2011a). 
The gap between ideal and actual involvement in public health activities was also identified in the 
only study to date which has examined community pharmacists’ attitudes towards pharmacist-led 
public health provision specifically for cardiovascular health. O'Loughlin et al. (1999) examined 455 
Canadian pharmacists’ participation in health promotion and disease prevention as part of an 
initiative to raise awareness of CVD. The study found that pharmacists had high levels of interest in 
developing a prevention role; with 60% of participants rating integrating prevention into their daily 
practice as “very important” and 31% rating it as “important”. Despite this, few pharmacists reported 
routinely engaging in preventative practice, with less than one third reporting initiating a 
conversation with a patient about their health. The pharmacists demonstrated less interest in 
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developing projects relating to physical activity, diet and smoking. In line with this, only 17-18% of 
the participants reported frequently advising clients about behavioural changes to reduce the risk of 
CVD. Few pharmacists reported identifying “at risk” patients and providing them with educational 
information. O’Loughlin et al. (1999) suggested that this may be due to advice regarding behaviour 
change falling further outside of the pharmacist’s traditional role. In line with the findings of Laliberte 
et al. (2012), the most important perceived barriers to incorporating prevention into daily pharmacy 
practice were: lack of skills, staff shortage, not receiving remuneration in return for the provision of 
prevention services and a lack of consultation space. One third of the pharmacists surveyed reported 
that the barriers prevented them “a lot” or “somewhat” from engaging in prevention intervention 
practices.  
1.7 Health Professional behaviour and psychological theory 
The main purpose of this thesis was to understand pharmacists’ behaviour in relation to supporting 
patient self-management of CVD through lifestyle behaviours. A significant amount of work has 
examined health behaviour change in patients, however there has been less research examining how 
to change health professional behaviour in order to facilitate patient behaviour change. As outlined, 
there is some evidence to suggest that pharmacists can have a positive effect on the outcome of 
patients with CVD. However research suggests that pharmacists’ involvement in the provision of 
services to promote patient self-management of CVD and the provision of public health services in 
general does not match their desired involvement (Bush et al., 2009; Laliberte et al., 2012; Maunder 
& Landes, 2005; O'Loughlin et al., 1999) or that outlined in the UK pharmacy contract (DoH, 
2005).Therefore it appears that the behaviour of pharmacists needs to change in order for them to 
facilitate patient behaviour change. 
Psychological theories traditionally used to understand, explain and in some cases change, patient 
health behaviours have increasingly been applied to understand health professional behaviour. The 
publication of a paper by Marteau and Johnston (1991) was seminal in the field of health 
professional behaviour research. Marteau and Johnston (1991) argued that psychologists had not 
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accounted for the health professional as a source of variance in the health outcomes of patients, 
suggesting that this may be the result of adopting the implicit assumption that health professional 
behaviour is based on medical knowledge and therefore all health professionals hold the same set of 
empirically driven beliefs. Any deviation in health professional behaviour is therefore attributed to a 
lack of knowledge, forgetting or consciously choosing to disregard knowledge.  Marteau and 
Johnston (1991) challenged this assumption, citing evidence of variation in health professional 
behaviour to the same clinical situations and attributing this to health professionals having their own 
beliefs about health and illness like patients. Marteau and Johnston (1991) made three key 
arguments: health professional behaviour is influenced by other factors in addition to medical 
knowledge; psychological models used to investigate patient behaviour could be used to explain, 
predict and change health professional behaviour and in order to achieve effective patient care, 
health professional behaviour needs to be examined alongside the behaviour of patients.  
Subsequent research has supported the assertions made by Marteau and Johnston (1991). Godin, 
Belanger-Gravel, Eccles, and Grimshaw (2008) conducted a systematic review of factors influencing 
health professional behaviour based on social cognition theories. The 76 included studies examined a 
range of behaviours including hand washing, clinical exams, counselling and clinical guideline 
adherence across different health professional groups including pharmacists, doctors and nurses. The 
review found that social cognition models accounted for, on average, 31% of the variance in the 
prediction of health professional behaviour and 59% of the variance in intention. As suggested by 
Marteau and Johnston (1991), these findings are similar to those of patient health behaviours. 
Furthermore a series of studies which assessed five types of clinical behaviour (taking dental 
radiographs, performing dental restorations, placing fissure sealants, managing upper respiratory 
tract infections without prescribing antibiotics and managing low back pain without ordering x-rays) 
in two populations (doctors and dentists) using multiple theories found that psychological models 
used to predict patient behaviour were also predictive of health professional behaviour (Eccles et al., 
2012). The Theory of Planned Behaviour (Ajzen,1991), Social Cognitive Theory (Bandura, 1977), 
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Implementation Intentions (Gollwitzer, 1999) and Learning Theory (Bandura, 1977) predicted 25-
42.6% median variance in intention and 6.2-16% in behavioural simulation and 2.4-6.3% in 
objectively measured behaviour. The Knowledge-Attitudes-Behaviour model, which assumes that 
knowledge will change attitudes which will change behaviour (Eccles et al., 2012) was not a predictor 
of health professional intention or behaviour, and performed poorly across the studies. 
The Theory of Planned Behaviour (TPB) (Ajzen, 1991) was one of the psychological theories of 
behaviour considered in the current programme of work. The TPB is the most widely used social 
cognition model and has been used to understand a range of behaviours including: dietary 
behaviours, physical activity, safer sex, smoking cessation and abstinence from drugs of abuse 
(McEachan, Conner, Taylor, & Lawton, 2011) as well as health professional behaviour (Eccles et al., 
2012; Godin et al., 2008)The TPB has been used to examine pharmacists’ behaviour in a number of 
areas including: intention to report serious drug events (Gavaza et al., 2011); counsel children with 
asthma (Pradel, Obeidat, & Tsoukleris, 2007); use a drug monitoring database (Fleming et al., 2014); 
and dispense over-the counter medication (Walker, Watson, Grimshaw & Bond, 2004). 
An extension of the Theory of Reasoned Action (Fishbein and Ajzen 1975, Ajzen and Fishein, 1980), 
the TPB (and its predecessor) assume that people form attitudes through careful consideration of all 
the information available to them. The TPB proposes that individuals’ intentions to perform a 
behaviour along with their evaluation of the control they have over performing the target behaviour 
(perceived behavioural control) are the proximal determinants of them engaging in the behaviour. 
Behavioural intentions represent an individual’s conscious plan or decision to attempt to perform the 
behaviour (Conner & Norman, 2005) and are considered an important precursor to engaging in 
behaviour, reflecting the premise that people tend to engage in behaviours that they intend to 
perform. 
The TPB posits that intention is underpinned by three factors: attitude (towards the behaviour), 
perceived behavioural control (PBC) and subjective norm. Attitudes are formed by the individual’s 
beliefs about the consequences of engaging in the target behaviour based on their perception of the 
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outcome of performing the behaviour along with an evaluation of this outcome (e.g. “giving a patient 
smoking cessation advice may help them quit smoking, helping them quit smoking is good”). 
Subjective norm refers to an individual’s perception of important others’ beliefs regarding whether 
they should perform the behaviour in question. This is comprised of beliefs about whether significant 
others think that the individual should engage in the behaviour and the individual’s motivation to 
comply with the perceived expectation of significant others (e.g. “my boss wants me to give patients 
smoking cessation advice and my boss’s opinion is important to me”). Finally perceived behavioural 
control, defined as an individual’s beliefs about their ability to execute the behaviour, is the result of 
consideration of the power of both internal control factors (such as skills, abilities, emotions) and 
external control factors (such as barriers, opportunities and reliance on others) to facilitate or 
prevent execution of the behaviour (e.g. “I have the ability to give patients smoking cessation advice 
despite the pharmacy being busy”).  
The effectiveness of the TPB has been demonstrated in various studies. An early review of 87 studies 
conducted by Godin and Kok (1996) found that the TPB predicted an average of 41% of the variance 
in intention and 34% of the variance in behaviour whilst a widely cited systematic review and meta-
analysis of 185 studies by Armitage and Conner (2001) found that the TPB accounted for 27% of the 
variance in behaviour and 39% of the variance in intention. A recent systematic review of 237 
independent prospective studies of patient health behaviours conducted by McEachan et al. (2011) 
found that the TPB accounted for 19.3% of the variability of health behaviour and intention to be the 
strongest predictor of behaviour. Specifically in relation to health professional behaviour, Godin et al. 
(2008) found that studies using the TPB (and some studies utilising the precursor of the TPB, the 
Theory of Reasoned Action, (Ajzen & Fishbein, 1975; 1980))were significantly more predictive of 
health professional behaviours than studies using other theories and that the TPB was the best 
theoretical model at predicting health professional behaviour in their systematic review of factors 
influencing health professional behaviour based on social cognitive theories. 
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Whilst Godin et al. (2008) concluded that the TPB (Ajzen, 1991) was best at predicting health 
professional behaviour, the review concluded that another social cognitive model, Triandis’ Theory of 
Interpersonal Behaviour (TIB) (Triandis, 1979) was the best theory at capturing the variables 
underpinning health professionals’ intentions to engage in clinical behaviour. The TIB (Triandis, 1979) 
posits that behaviour is determined by three factors: intention (referring to an individual’s 
motivation to perform a behaviour), facilitating conditions (factors that can make it easy to carry out 
a behaviour verses barriers that can prevent realisation of the target behaviour) and habit (referring 
to how frequently a behaviour has been carried out in the past). According to the TIB, the 
determinants of intention are attitude, social factors and affect. Attitude is comprised of the 
individual’s beliefs about outcomes and their evaluation of outcomes. Social factors are comprised of 
norms (social rules about what should and should not be done), roles (beliefs about behaviours 
considered appropriate for an individual given their age, gender and social status) and self-concept 
(the level of congruence between an individual’s perception of themselves and the characteristics 
they associate with engaging in the target behaviour). Finally, affect refers to the emotional state the 
individual experiences when performing the behaviour. 
Based on the their findings, Godin et al. (2008) proposed a theoretical framework for health 
professional behaviour based upon the categories of variables most associated with health 
professionals’ intention and clinical behaviour (see Figure 1.1). This includes variables from the TPB 
(Ajzen, 1991) and the TIB (Triandis, 1979) described above. The two categories that most frequently 
predicated behaviour were intention and beliefs about capabilities whilst five categories of variables 
were found to significantly contribute to health professionals’ intention to adopt clinical behaviour: 
beliefs about consequences; moral norm; role and identity and characteristics of the health 
professional. 
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Figure 1.1: Godin et al. (2008) Framework of health professional behaviour 
 
 
 
 
 
 
 
 
 
 
 
 
Beliefs about capabilities (also referred to as self-efficacy) is a central component of Social Cognitive 
Theory (SCT) (Bandura, 1977), another commonly cited social cognitive model that has been used in 
health professional behaviour research.  A recent study examining the performance of different 
theoretical models across five clinical behaviours implemented by GPs and dentists, (Eccles et al., 
2012) concluded that SCT (along with the TPB) was successful at predicting health professionals’ 
intention to engage in clinical behaviours. SCT suggests that a key determinant of behaviour is self-
efficacy, which refers to an individual’s belief in their ability to perform a task and achieve a desired 
outcome. Proximal goals (the equivalent of intention in the TPB) and outcome expectations (physical, 
social and self-evaluative expectations of performing behaviour) and self-efficacy are direct 
predictors of behaviour when SCT is operationalised (Bandura, 1998). Unlike most theories of 
behaviour, SCT specifies how to modify self-efficacy (the main determinant of behaviour in this 
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model) through four techniques: mastery experiences, modelling, persuasion and ‘physiologically 
similar experiences’.  
Self-efficacy, a central component of STC (Bandura,) has been identified as playing an important role 
in pharmacists’ public health activity. Systematic reviews by Anderson et al. (2003) and Eades et al. 
(2011) found that pharmacists lacked confidence in their abilities to offer public health services and 
that pharmacists reported needing further support to behaviour based health promotion.  Further 
studies exploring pharmacists’ experiences of giving patients lifestyle advice also found they lacked 
confidence in their abilities to give such advice (Dhital, Whittlesea, Milligan, Khan, & Norman, 2013; 
Horsfield, Sheridan, & Anderson, 2011). Both Anderson et al. (2003) and Eades et al. (2011) 
concluded that training  was fundamental in changing pharmacists attitudes towards and 
engagement in public health services, with Eades et al. (2011) suggesting that pharmacists’ self-
efficacy should be targeted in future interventions to change pharmacists’ public health-related 
behaviour. Some studies have sought to change pharmacists’ public health related behaviour. 
However at present, no literature is available on the efficacy of interventions to change pharmacists’ 
behaviour with the view to change patients’ lifestyle behaviours, and the components of the 
interventions that work.  
1.8 Pharmacists’ attitudes towards their public health role 
As previously discussed, psychological theories such as the TPB (Ajzen, 1991) state that attitudes are 
a determinant of behaviour. This was demonstrated in a  study by (Laws et al., 2008) who found that 
Australian clinicians who reported high levels of engaging in conversations with patients about 
lifestyle behaviours had different attitudes and beliefs to clinicians who reported low levels of 
discussing lifestyle behaviours with patients. Another study by Cockburn and Pit (1997) examined the 
effect of General Practitioners (GPs) perceptions of patient expectations on the GPs’ medication 
prescribing behaviour, finding that GPs perceptions of patient expectations were the strongest 
determinant of medication prescribing behaviour. The study found that patients who expected to be 
prescribed medication were three times more likely to be prescribed medicine for a new condition 
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and patients were ten times more likely to be prescribed medication if the GP perceived that the 
patient expected to be prescribed medication. Finally a study by Little et al. (2004) found that whilst 
perceived medical need was the strongest predictor of GP behaviour, a considerable minority of 
patients were prescribed medication (19%), examined (15%), investigated (46%) or referred onto 
another service (22%) when the GPs believed there was a slight or no medical need to do so. After 
controlling for perceived medical need, GPs perceptions of patient pressure was an independent 
predictor of all GP behaviours measured (prescribing, examining, investigating and referring). It is 
therefore important to understand health professionals (including pharmacists) attitudes towards 
their role in facilitating patient self-management of CVD through giving lifestyle advice. 
Previous research has found variation in pharmacists’ attitudes towards their role in public health. In 
a study investigating Scottish pharmacists’ views and attitudes towards public health practice and 
competence, the majority of participating pharmacists agreed or strongly agreed that public health 
was an important component of their professional practice. Fifty-six per cent of participating 
pharmacists agreed or strongly agreed that they were public health practitioners (Pfleger, McHattie, 
Diack, McCaig, & Stewart, 2008). On the other hand, research has identified that pharmacists 
perceive their role in public health to be of less importance than other roles. A study examining 
community pharmacists’ attitudes towards their professional practice conducted in the Republic of 
Moldova found pharmacists rated public health activities of lower importance than other areas of 
practice such as dispensing(Cordina, Safta, Ciobanu, & Sautenkova, 2008). Furthermore, when 
participating community pharmacists were asked to rate their preference of hypothetical jobs, Scott, 
Bond, Inch, and Grant (2007) found that pharmacists would rather provide a minor illness service 
than provide health promotion advice, and were prepared to forgo £2798 in hypothetical 
remuneration as a result.  
Anderson, Blenkinsopp and Armstrong (2003) conducted a systematic review of peer reviewed and 
non-peer reviewed studies published between 1990 and 2001 investigating pharmacists’ attitudes 
towards and perceptions of their role in improving public health, identifying twelve studies for 
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inclusion in the review. Anderson et al. (2003) concluded that community pharmacists were largely 
enthusiastic about the role of pharmacy in public health. However in practice, the review found that 
pharmacists’ health promotion activities tended to be based around use and supply of medication. 
Pharmacists reported a reactive rather than proactive approach to health promotion which appeared 
to be driven by pharmacists’ concern of appearing “intrusive” to customers by delivering potentially 
unwelcome health advice. Pharmacists’ dispensing duties were identified as the key barrier to 
increased engagement with health promotion which Anderson et al. (2003) attributed to the way in 
which pharmacies are remunerated by the National Health Service (per prescription item dispensed), 
suggesting this causes dispensing to be prioritised above other activities. 
The findings of the Anderson et al. (2003) review were consistent with that of a later review 
conducted after the introduction of the pharmacy contract in England. Eades et al. (2011) concluded 
that the attitudes and beliefs of pharmacists could be categorised into four main topic areas: 
perceptions of role; competence and confidence; barriers; and training. The majority of pharmacists 
held positive attitudes towards providing public health services and viewed it as an important role. 
However, the review found that pharmacists considered their public health role as secondary to 
traditional medicine-related roles and were less confident in their abilities to provide public health 
services. In line with the findings of Anderson et al. (2003), Eades et al. (2011) found that pharmacists 
adopted a reactive rather than proactive approach to health promotion. The majority of studies 
found lack of patient demand for services and negative customer reactions were not a barrier to 
public health practice; however some pharmacists still perceived this to be a problem. Training was 
found to have a positive effect on pharmacists’ attitudes, and the review concluded that pharmacists 
are aware of the role they can play in health promotion and self-care. Eades et al. (2011) suggested 
that future interventions should target pharmacists’ low confidence in their abilities to provide public 
health services (self-efficacy). They assert that supporting pharmacists to become more proactive in 
their approach would increase patients’ exposure to public health services, which in turn would have 
a positive effect on the health and attitudes of the general public. Eades et al. (2011) called for future 
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research to investigate the efficacy of strategies to increase pharmacists’ confidence and change 
their public health practice behaviour. 
There have been other more recent studies examining pharmacists’ perceptions of their public 
health role since the publication of the Eades et al. (2011) systematic review, all of which are in 
keeping with the findings of the review. Horsfield et al. (2011) conducted a qualitative study with 22 
English pharmacists and 18 New Zealand pharmacists to explore pharmacists’ perceptions of 
providing screening and brief interventions for excessive alcohol consumption. They found that views 
on providing this service were mixed, with some pharmacists seeing a potential role for community 
pharmacists whilst others believed that providing brief alcohol interventions was not part of their 
role. Some pharmacists were apprehensive about providing the advice due to potentially offending 
patients. The pharmacists identified time, lack of experience and confidence, and privacy in the 
pharmacy as barriers to providing brief interventions whilst training, a public health campaign and 
screening tools were identified as facilitators. The authors concluded that there was potential for 
pharmacists to provide alcohol screening and brief interventions in a pharmacy setting, however 
suggest future research is required to examine implementation strategies and the efficacy of such 
interventions. Another study investigating pharmacist’s provision of advice on alcohol use found 
mixed views about the perceived appropriateness of pharmacist involvement in giving advice about 
alcohol use. McCaig, Fitzgerald, and Stewart (2011b) found that 13% of respondents strongly agreed 
that pharmacists had the right to ask patients about alcohol use whilst 26% of responding 
pharmacists strongly disagreed with this statement. 
1.9 The effect of patients on pharmacists behaviour  
As previously outlined, according to psychological theory, attitudes are determinants of behaviour. 
Given that there is evidence to suggest that health professionals’ perceptions of patients’ behaviour 
influence health professionals’ behaviour, it is also important to consider patients’ attitudes towards 
pharmacists as this is likely to affect patient behaviour which in turn may affect pharmacists’ 
behaviour.  
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In the past decade two systematic reviews of patients’ perceptions of the community pharmacist’s 
role in public health have been conducted. A systematic review of the peer and non-peer reviewed 
literature published before the introduction of the 2005 England and Wales pharmacy contract by 
Anderson et al. (2004b) found that pharmacy users did not view the pharmacy as a source of health 
advice and did not utilise it for this purpose; rather, pharmacists were viewed as ‘drugs experts’. In 
studies where participants did receive health advice from a community pharmacist, the majority of 
participants evaluated the pharmacist’s input positively. In their later systematic review Eades et al. 
(2011) noted the consistency in findings with the Anderson et al. (2004) review despite the significant 
changes to the pharmacy landscape within that time. Eades et al. (2011) found that most pharmacy 
users had not been offered public health services at the pharmacy, nor did they expect to be offered 
them. Despite this, the public held positive attitudes towards pharmacy-based public health 
provision, and consumers who had experienced public health services at the pharmacy were highly 
satisfied. However, pharmacy users’ perception of pharmacists’ ability to provide public health 
services was mixed, and as found by Anderson et al. (2004), lack of privacy in the pharmacy was cited 
as a concern. More recently, Perepelkin (2011) conducted a questionnaire telephone survey with 403 
participants in a Canadian province to assess their perception of pharmacists. In general respondents 
held positive attitudes towards community pharmacists, although this varied within the sample. 
Gender, age and socio-economic status were found to influence public perceptions of community 
pharmacists. The majority of respondents (65%) viewed themselves as customers, with only 14.9% of 
respondents describing themselves as patients when visiting the pharmacy.  
Despite CVD  being the leading cause of death worldwide (WHO, 2011), only a small number of 
studies have assessed pharmacy service utilisation specifically in relation to cardiovascular health 
from the perspective of the general public and patients diagnosed with/at risk of CVD. Peterson, 
Jackson and Hughes (2010) conducted 505 telephone interviews to assess the Australian public’s 
perception of community pharmacists’ role in CVD prevention and management. As with previous 
studies, the majority of participants were happy with the service provided at the pharmacy. 
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Participants perceived pharmacists to be most capable at providing medication information, with 
90% of participants happy to seek this advice from a pharmacist. Peterson et al. (2010) concluded 
that participants believed that community pharmacists were capable of providing screening services 
for hypertension and diabetes (with 52% of participants indicating this); however the results suggest 
that participants were more likely to use these services if provided by a doctor (97% of participants 
indicated this). Peterson et al. (2010) concluded that participants lacked awareness of the services 
available at the community pharmacy and knowledge of community pharmacists’ abilities. Another 
study conducted by van Geffen et al. (2011) in the Netherlands examined the attitudes of 578 new 
and chronic users of cardiovascular medication using a questionnaire design. The authors aimed to 
establish whether patients felt that they had received enough information about their cardiovascular 
medications in addition to ascertaining the extent to which these patients experienced counselling 
activity at the pharmacy. The authors concluded that a large proportion of patients were dissatisfied 
with the information they received on cardiovascular medication. Furthermore two thirds of 
respondents indicated that they had never experienced five of the eight listed counselling activities. 
Two thirds of respondents saw their GP as a primary source of information and their first point of 
contact should they experience any problems with their CV medication. New users of cardiovascular 
medications were less satisfied with their experience at the pharmacy in comparison to chronic 
medication users (those who had collected at least 40 prescriptions for CV medications in the last 
three years). The authors of the study support the assertions of Peterson et al. (2010) and suggest 
that patients are unfamiliar with what they describe as the crucial role that pharmacists can play in 
the management of chronic illness through education and counselling activities.  
Finally, in one of the few UK based studies, Clark et al. (2005) conducted a qualitative exploration of 
community pharmacists’ contribution to chronic heart failure management (CHF) in Scotland, 
interviewing 50 patients with CHF and 30 of their primary caregivers. Participants reported a range of 
unmet needs in relation to their medication. Unlike participants in the van Geffen et al. (2011) study, 
 
 
49 
 
many patients were reluctant to consult their GP with problems but felt comfortable to ask 
pharmacists who were perceived as knowledgeable about medication and CHF and easily accessible. 
1.10 Theory and behaviour change 
So far, it has been demonstrated that pharmacists’ involvement in public health services does not 
match their desired behaviour or that outlined in the UK pharmacy contract (DoH, 2005), and the use 
of theory to explain and predict pharmacists’ behaviour has been advocated. However there are 
problems associated with theories of behaviour; whilst theories of behaviour explain and predict 
behaviour, they do not specify how to change behaviour (Eccles, Grimshaw, Walker, Johnston & Pitts, 
2005).Taking the example of using the TPB (Azjen, 1991) to explain pharmacists’ lifestyle advice-
giving behaviour, pharmacists’ attitude towards giving lifestyle advice, subjective norms surrounding 
giving lifestyle advice and pharmacists’ perceived behavioural control over giving lifestyle advice will 
lead to pharmacists forming (or not forming) intentions to engage in lifestyle advice-giving 
behaviour. Therefore, according to the TPB, to change pharmacists’ lifestyle advice-giving behaviour, 
the aforementioned behavioural determinants should be targeted. However the TPB does not specify 
how to target the determinants in order to change behaviour. This was raised in recent criticism of 
the TPB (Ajzen, 1991) by Sniehotta, Presseau, and Araújo-Soares (2013) who argued that the TPB has 
lost its utility and does not aid the development of behaviour change interventions as the theory 
does not specify how to change behaviour. Azjen (2014) refuted Sniehotta et al.’s (2013) assertion 
that the TPB does not provide an adequate basis for behaviour change interventions, arguing that 
the TPB was developed as a theory to aid prediction and explanation of intention and behaviour 
rather than of behaviour change per se, however that the theory could be useful the development of 
behaviour change interventions.  
Given that theories of behaviour generally do not specify how to change behaviour, a different set of 
techniques are required for this. Michie and Johnston (2012) suggest that in order to understand the 
mechanisms that underpin behaviour change, clear and agreed standards are required to identify the 
‘active ingredients’ in behaviour change and to effectively design, report and evaluate behaviour 
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change interventions. They highlight that there is variation in the effectiveness of behaviour change 
interventions, and that a full understanding of the reasons for this variation is yet to be reached. 
Michie and Johnston (2012) suggest that in order to achieve this, specification and descriptions are 
required of: the target behaviours to be changed; the techniques used to change behaviour; the 
competencies required by individuals delivering the behaviour change techniques; the way the 
techniques are delivered, and the level of intervention. The behaviour change taxonomy (Abraham & 
Michie, 2008) was developed to aid behaviour change intervention design, reporting and evaluation 
by providing standardised definitions of BCTs. The behaviour change taxonomy was reached by 
expert consensus and now consists of 93 individual BCTs (Michie et al., 2013).  
There is on-going debate within the health psychology literature concerning whether interventions 
based on psychological theory are more effective than interventions that are not based on 
psychological theory. At present the evidence is unclear. There is some evidence that interventions 
based on theory are more effective than interventions not based on psychological theory. A 
systematic review and meta-analysis which assessed the use of the online interventions to promote 
health behaviour change (Webb, Joseph, Yardley, & Michie, 2010) found that more extensive use of 
theory was associated with increases in effect size (p=0.049) and interventions that used more 
behaviour change techniques (BCTs) (defined as “observable and replicable components of 
behaviour change interventions”(Michie & Johnston, 2012) were associated with higher effect sizes 
that interventions that used fewer behaviour change techniques.  
Prestwich et al. (2013) highlighted that whilst there is some evidence demonstrating that use of 
theory in behaviour change interventions is associated with larger intervention effects, other studies 
have found no association between use of theory and intervention effectiveness. Prestwich et al. 
(2013) conducted a systematic review and meta-analysis to assess whether the use of theory 
influenced the effectiveness of interventions targeting physical activity and healthy eating, finding 
that interventions based on theory were no more effective than those that did not report using a 
theory base to design the intervention. Furthermore a systematic review and meta-analysis of 
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interventions to limit gestational weight gain in pregnant women found that the two studies included 
in the review that evaluated interventions based on psychological theory had less impact on weight 
outcomes than interventions that did not report using theory to design the intervention (Gardner, 
Wardle, Poston, & Croker, 2011). However it is noteworthy that the authors state that due to poor 
reporting of the interventions and underuse of theory in gestational weight gain interventions, is it 
unclear if the ‘wrong’ theories were used, appropriate theories were not correctly applied, or the 
expected link between theory and intervention effectiveness was not present, problems that are 
applicable to the evaluation of behaviour change interventions in general (Michie, Jochelson, 
Markham & Bridle, 2009).  
Based on the evidence, the view taken in this thesis was that despite there being a lack of definitive 
evidence demonstrating that theory-based interventions are more effective than interventions not 
based on theory, the use of psychological theory in explaining, predicting and changing behaviour is 
beneficial. A clear description of the theoretical basis of an intervention facilitates an understanding 
of its ‘active ingredients’ and makes it easier for researchers to replicate interventions with 
confidence. The work presented in this thesis is of an exploratory nature and does not seek to 
develop an intervention to change pharmacists’ behaviour. Rather, the studies presented seek to 
explore pharmacists’ experiences of facilitating patient self-management of CVD through lifestyle 
advice and use psychological theory to understand pharmacists’ advice-giving behaviour. In order to 
change behaviour an understanding of the behaviour in question is required. Gaining an 
understanding of pharmacists’ lifestyle advice giving behaviour using theories of health behaviour is 
necessary in order to form an evidence base from which interventions using BCTs to change 
pharmacists behaviour can be developed. This thesis therefore also sought to review the efficacy of 
interventions that have been designed to change pharmacists’ lifestyle advice giving behaviours and 
identify if any BCTs were effective at doing so. Finally, it has been demonstrated that patient’s 
expectations and behaviour shape health professionals’ behaviour therefore an understanding of 
 
 
52 
 
patients’ perceptions and expectations of pharmacists’ role in facilitating patient CVD self-
management is required. 
1.11 Research aims and objectives 
The overarching aim of the work presented in this thesis was to understand and explain the 
behaviour of UK community pharmacists in relation to facilitating patient self-management of CVD 
through lifestyle behaviours. At present, not enough is known about pharmacists’ perceptions of and 
behaviour in relation to this role.  A mixed methods programme of work comprising of four studies 
was developed. The specific objectives of each of the studies were as follows: 
i. To explore community pharmacists’ experiences of giving lifestyle advice to patients with 
CVD (a qualitative study). 
ii. To identify the predictors of pharmacists’ lifestyle advice-giving behaviour in a cross-sectional 
sample of pharmacists (a quantitative study). 
iii. To systematically review evidence examining the efficacy of interventions designed to enable 
pharmacists to facilitate patient lifestyle behaviour change and identify what theories and 
behaviour change techniques, if any, had been used in effective interventions. 
iv. To explore the experiences of patients with hypertension and/or hyperlipidaemia related to 
having CVD and using community pharmacy services (a qualitative study)
 
2 Chapter Two: Methodology 
2.1 Introduction 
Combining qualitative and quantitative methods, typically referred to as ‘mixed methods’, is 
potentially difficult and contentious, with some qualitative and quantitative researchers expressing 
concern regarding whether the two methodologies can and should be combined. The debate stems 
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from the differences in theoretical perspectives and paradigms on which qualitative and quantitative 
research are based (Yardley & Bishop, 2008). This chapter will summarise the theoretical 
assumptions underpinning qualitative and quantitative research and make the case for a mixed 
methods approach underpinned by Pragmatism to examine the role pharmacists can play in 
facilitating patient self-management of cardiovascular disease. 
2.2 The differences between qualitative and quantitative methods 
Qualitative and quantitative research methods are often viewed as having opposing and competing 
paradigms (Todd, Nerlich, McKeown, & Clarke, 2004). At a very basic level, as described by Dures, 
Rumsey, Morris, and Gleeson (2011) researchers who work within a quantitative framework believe 
that reality is universal, objective and can be measured whilst qualitative researchers argue that 
reality is socially constructed by and between those who experience it. Hammersley (1991) outlined 
differences between qualitative and quantitative research as follows: the use of words in qualitative 
research and the use of numbers in quantitative research; the focus on meaning in qualitative 
research verses a focus on behaviour in quantitative research;  the adoption of a natural science 
model by quantitative researchers versus rejection of this model by qualitative researchers; the use 
of an inductive approach by qualitative researchers verses the use of a deductive approach by 
quantitative researchers  and the exploration of cultural patterns by qualitative researchers verses 
quantitative researchers seeking scientific laws. 
The differences between the approaches, for some researchers, are such that the debate about the 
use of qualitative verses quantitative methods has been referred to as “the paradigm wars” (Yardley 
& Bishop, 2008). Traditionally there has been an assumption that qualitative and quantitative 
approaches are incompatible paradigms to study the social world because of the differences in the 
assumptions the approaches make about the nature of reality (ontology) and how knowledge is 
studied and obtained (epistemology) (Dures et al., 2011). The ‘incompatibility thesis’ (Ericcsson & 
Simon, 1993) posited that qualitative and quantitative methods were incompatible with one another 
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and therefore could not and should not be mixed (Onwuegbuzie & Leech, 2005). The debate 
between the two epistemologies is neatly summarised by Todd et al. (2004): 
“…whereas qualitative researchers accuse quantitative ones of positivism, reductionism, 
determinism and objectivism, quantitative researchers accuse qualitative ones of fuzziness and 
subjectivity…” (p5) 
Qualitative research tends to be associated with ‘interpretative’ or ‘constructivist’ paradigms whilst 
quantitative research tends to be associated with ‘scientific’ or ‘positivist’ paradigms. The following 
sections will further define the assumptions associated with each approach. 
2.3 Positivist/ Scientific Paradigm 
The positivist approach traditionally has dominated psychology research, and arguably continues to 
do so (Ponterotto , 2005; Yardley & Bishop, 2008). Yardley and Bishop (2008) state that the 
epistemology that underpins the ‘scientific’ or ‘positivist’ paradigm dates back to Descartes, who 
suggested that the only direct available knowledge is of our own mind, and therefore all other 
knowledge must be gained through direct observation. From an ontological perspective, positivists 
believe that there is a single ‘true’ reality that is identifiable and quantifiable, referred to as naïve 
realism (Ponterotto, 2005). This epistemology highlights the importance of observations being as 
accurate as possible to gain the ‘correct’ understanding of the world. Consequently positivist 
methods can be seen as a way to achieve the most accurate observations through using controlled 
environments to account for sources of variability and the use of measures to avoid ‘inaccurate’ 
subjective observations (Yardley & Bishop, 2008). 
2.4 Constructivist/Interpretivist Paradigm 
In the 1960s, some psychologists became dissatisfied with using a quantitative approach to 
understand human behaviour, and adopted methods which they believed gave a more ‘naturalistic, 
contextual and holistic’ understanding of behaviour; methods which later became known as 
qualitative methods (Todd et al., 2004). In terms of ontology, constructivists believe that there are 
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multiple realities constructed by the individual’s experiences and perceptions, rather than there 
being a single true reality (Ponterotto, 2005). A constructivist paradigm therefore argues that the 
way we see the world (our reality) is guided by our individual subjective and socio-cultural 
experiences, suggesting that it is impossible to separate the values and assumptions which make up 
an individual’s identity and guide their activities. Constructivists therefore conclude that ‘objective 
knowledge’ cannot be achieved (Yardley and Bishop, 2008).  
Qualitative methods focus on the interpretative or hermeneutic understanding of the meaning of 
behaviour (Todd et al., 2004). A hermeneutic approach assumes that meaning is hidden and is 
accessed through deep reflection which can be achieved through studying the interaction between a 
participant and researcher (Ponterroto, 2005). Therefore the researcher and the participant create 
findings together through interaction and interpretation, referred to as ‘co-construction’ 
(Ponterroto, 2005). Qualitative researchers aim to assume the viewpoint of the participant being 
studied and recognise their role in the construction of knowledge and thus engage in reflexivity. By 
focusing on understanding rather than measuring the experiences of the participants they are 
studying, qualitative researchers aim to obtain a better understanding of human thoughts and 
behaviours (Todd et al., 2004). Constructivists argue that controlled experimental studies of 
behaviour remove elements such as individuality and social context which give the behaviour 
meaning. Furthermore, from this perspective standardised measures may prevent participants 
expressing contradictory perspectives and impose the researcher’s preconceptions onto the 
participant’s responses (Yardley & Bishop, 2008). 
2.5 Logics of inquiry 
Some researchers have taken a different approach and argued that the focus on methods per se is 
unhelpful. Hiles (2014) argued that the focus should be on the logic of inquiry rather than the type of 
data collected, and called for the terms ‘qualitative’ and ‘quantitative’ methods to be abandoned. 
Hiles (2014) proposed that all research makes paradigm assumptions and decisions about research 
design, data collection methods, data analysis and critical evaluation. Taking this approach, the 
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differences between qualitative and quantitative approaches are not just about the different types of 
data collected (and therefore concerns about opposing epistemologies) but about different 
strategies of research design and their underlying logic of inquiry.  
Hiles (2014) argues that there are three logics of inquiry: deduction, induction and abduction. 
Deduction is referred to as a theory driven approach and concerned with testing the prediction of 
data (findings) from theory. Quantitative research tends to be primarily deductive, with the 
researcher making theoretically driven predictions which are tested. Induction is referred to as a data 
driven approach and is concerned with generating theory from the data. Qualitative research tends 
to be data driven and based on ‘inductive inference’. The third logic, abduction, is described as a two 
way explanatory relationship between theory and data whereby the goal is not to test theory or to 
generate new theory but to make use of existing theories to make sense of the data. Hiles (2014) 
suggests that this type of design will often employ ‘mixed measures’, the term Hiles uses to describe 
research designs commonly referred to as ‘mixed methods’.  
2.6 Mixed Methods 
Yardley and Bishop (2008) argued that the differences between qualitative and quantitative 
approaches, summarised above, have been exaggerated and can be overcome. Mixed methods 
research has grown in popularity in the last ten or fifteen years and has become a research 
movement with a recognised name and identity (Denscombe, 2008). The growth has been such that 
mixed methods research has been described by Johnson, Onwuegbuzie and Turner (2007) as the 
third research paradigm whilst Bryman (2006) describes the practice of combining qualitative and 
quantitative methods as having become ‘unexceptional and unremarkable’ in recent years.  Johnson 
et al. (2007) position qualitative and quantitative methods at extreme ends of a continuum, with 
mixed methods falling in between, trying to respect the assumptions of both approaches whilst 
finding a workable solution to research problems. 
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Several, differing, definitions of ‘mixed methods’ have been suggested. In their handbook of Mixed 
Methods Research, Tashakkori and Teddlie (2003) defined mixed methods research as: 
“studies [which] use qualitative and quantitative data collection and analysis techniques in 
either parallel or sequential phases” (p11). 
A highly cited paper by R. B. Johnson et al. (2007) sought to identify a consensus definition of mixed 
methods research. Through reviewing nineteen definitions of mixed methods research, they 
suggested the following definition: 
“Mixed methods research is the type of research in which a researcher or team of researchers 
combines elements of qualitative and quantitative research approaches (e.g., use of qualitative 
and quantitative viewpoints, data collection, analysis, inference techniques) for the broad 
purposes of breadth and depth of understanding and corroboration.” (p.123) 
The use of mixed methods is based on the premise that there are multiple ways of making sense of 
the world and differing viewpoints on what knowledge is important and valuable (Greene, 2008). 
Mixed methods researchers subscribe to the viewpoint that an enhanced understanding of a 
phenomenon under study can be gained through using different methods and that no method 
(qualitative or quantitative) is ‘inherently superior’ in order to gain insights (Dures et al., 2008). 
However Yardley and Bishop (2008) stress the importance of researchers being aware of the 
different aims and theoretical assumptions of qualitative and quantitative research, suggesting that 
the assumptions and aims of the different approaches may be violated or not met if not 
acknowledged. This could result in the researcher applying irrelevant and inappropriate criteria for 
validity assessment of qualitative research (e.g. reliability, objectivity or use of a large random 
sample) and drawing unjustifiable conclusions (e.g. causal relationships) whilst equally lack of 
awareness of quantitative approaches could result in researchers not using a large, representative 
sample, reliable measures and appropriate statistical tests (Yardley & Bishop, 2008). 
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2.7 Pragmatism 
The absence of a framework that incorporates both qualitative and quantitative approaches equally 
can lead to problems integrating the findings from each method (Yardley & Bishop, 2008). 
Pragmatism has been posited as a framework to embrace and combine the differences between 
qualitative and quantitative approaches, and is widely accepted as the philosophical underpinning of 
mixed methods research. The premise of Pragmatism is combining different kinds of research 
without compromising the integrity of the method (Yardley & Bishop, 2009). Research underpinned 
by pragmatism seeks to achieve a richer account of human experience rather than seek truth 
independently from human experience. From a pragmatic perspective, there is no fundamental 
contradiction between the objectives and characteristics of qualitative and quantitative research 
despite differences between the methods of inquiry and the process of validation for each approach 
(Yardley & Bishop, 2009). Pragmatism rejects the incompatibility thesis, and pragmatist researchers 
view the research question as of primary importance rather than the method used or the paradigm 
underlying the method (Tashakkori and Teddlie, 2003).  
 
2.8 The case for mixed methods in pharmacy practice research 
Based on a literature review, Greene, Caracelli, and Graham (1989) developed a theoretical 
framework for conducting mixed methods research which identified five reasons for conducting 
mixed methods research: triangulation; complementarity; development; initiation and expansion. A 
more recent paper identified sixteen reasons for conducting mixed methods research (Bryman, 
2006). Despite an increase in the use of mixed methods by healthcare researchers (O'Cathain, 
Murphy, & Nicholl, 2007), it has been argued that mixed methods is not commonly used in pharmacy 
practice research (Hadi, Alldred, Closs, & Briggs, 2013). The work presented in this thesis was 
conducted from a pragmatist perspective and thus used a mixed methods approach. There are 
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several advantages to using a mixed methods approach to conduct the research presented in this 
thesis and these are outlined below. 
A multifaceted approach was required to meet the aim of the current research: to explore the role 
pharmacists can have in facilitating patient self-management of CVD. The premise of mixed methods, 
underpinned by pragmatism, is for the research question and the phenomenon under research to 
dictate the research method(s) rather than the researcher having an allegiance with a qualitative-
only or quantitative-only methodology and choosing the method in accordance with this. A mixed 
methods approach allows the researcher to choose and combine different methodologies to develop 
the best method to answer a research question in the most comprehensive way (Creswell & Plano 
Clark, 2011). In order to meet the overall aim of the current study, an understanding of both 
pharmacists’ experiences of facilitating patient self-management and patients’ experiences of 
receiving self-management support from pharmacists was required. Detailed qualitative research is 
required to understand the perceived factors that underpin pharmacists’ provision of self-
management support for patients with CVD. In line with this, detailed qualitative research is also 
required to understand the experiences of patients when managing CVD, how this relates to their 
interactions with pharmacists and what support patients with CVD expect and/or perceive that they 
need from pharmacists. This programme of work also sought to identify the predictors of 
pharmacists’ intentions to engage in two types of advice giving behaviour, for which a quantitative 
approach is most appropriate. Thus according to Hiles (2014), the current programme of work 
utilised an abductive approach.   
There are many advantages to using a mixed methods approach. Mixed methods research can give 
the answers to questions that could not be answered by quantitative or qualitative research alone. 
One of the primary advantages of using mixed methods is that it provides strengths that counteract 
the disadvantages of both qualitative and quantitative methodologies when used independently 
(Creswell& Plano Clark, 2011). It has been argued that quantitative research does not account for the 
social context in which the phenomenon which being researched occurs nor does it tend to 
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acknowledge the researcher’s personal bias, which qualitative research does. Conversely, qualitative 
research is often criticised for being subjective and not generalisable, whereas carefully conducted 
quantitative research can avoid these weaknesses. The environment pharmacists practice in has 
been associated with barriers to providing public health services (see chapter one). The use of 
qualitative methods in the present studies allowed an in-depth exploration of the phenomenon in 
the social context in which it occurred (from the perspective of both pharmacists and patients) which 
informed the development of a quantitative study conducted with a generalisable sample of 
community pharmacists. Therefore the use of mixed methods in the current project counteracts the 
disadvantages of studies using qualitative or quantitative methodologies in isolation.  
2.9 Summary 
A mixed methodology underpinned by Pragmatism was selected to conduct the work presented in 
this thesis in order to give the researcher the freedom to select the research method which best 
answered the research question for each study. This was chosen to facilitate the collection and 
analysis of rich data to give an insight into the experiences of patients and pharmacists in the social 
context in which they occurred. 
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3 Chapter Three: Pharmacists’ experiences of giving lifestyle 
advice to patients with CVD 
3.1 Introduction 
This chapter presents the findings of a qualitative study which explored pharmacists’ experiences of 
giving lifestyle advice to patients with CVD in order to facilitate patients’ self-management of their 
condition. A paper reporting the findings was published in Research in Social and Administrative 
Pharmacy: Morton, K, Pattison, H., Langley, C., & Powell, R. (2015). A qualitative study of English 
community pharmacists' experiences of providing lifestyle advice to patients with cardiovascular 
disease. Research in Social and Administrative Pharmacy, 11(1), e17-e29. doi: 
http://dx.doi.org/10.1016/j.sapharm.2014.04.006. A copy is provided in appendix 9.1. 
As outlined in chapter one, health behaviours associated with lifestyle such as diet, physical activity, 
tobacco use and alcohol consumption are responsible for approximately 80% of coronary heart 
disease and cerebrovascular disease, two of the major forms of cardiovascular disease (CVD) (WHO, 
2011). The risk of individuals with CVD developing further cardiovascular problems can be reduced 
through lifestyle behaviours such as: smoking cessation; regular physical activity; reducing alcohol 
and dietary salt consumption as well as taking medication to treat high blood pressure 
(hypertension) and high cholesterol (hyperlipidaemia) (WHO, 2011). Such behaviours are largely 
under the control of individuals and therefore can be regarded as part of patient self-management of 
CVD.  
Chapter one established that there is potential for UK pharmacists to play an influential role in 
facilitating patient self-management of CVD. UK community pharmacists are frequently described as 
the most accessible of health professionals given that they are geographically well-placed to provide 
local services and regularly interact with patients on a one-to-one basis, a service for which members 
of the public do not require an appointment to seek health advice (Holland, Brooksby, Lenaghan, et 
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al., 2007). Recent UK government policy suggests that health professionals, including pharmacists, 
should view every interaction with patients as an opportunity to promote healthy lifestyle choices 
(NHS Future Forum, 2012). Furthermore, UK pharmacists have a contractual obligation to promote 
engagement in healthy lifestyles and provide support to individuals with chronic conditions (DoH, 
2005). This includes supporting patients with hypertension and hyperlipidaemia, forms of CVD. These 
patients can be identified when they collect prescription items dispensed at the community 
pharmacy, creating an opportunity for pharmacists to facilitate patient self-management of CVD 
through advising patients to self-manage their condition (and prevent the development of further 
CVD) through engaging in health behaviours such as eating a healthy diet, engaging in regular 
physical activity, supporting smoking cessation and drinking alcohol in moderation. 
Research has demonstrated that pharmacists’ extended roles can have a positive effect on patient 
outcome however the quality of the evidence base has been questioned. A Cochrane systematic 
review conducted by Nkansah et al. (2010) concluded that there was evidence to support the role of 
pharmacists in medicine management and counselling patients (Nkansah et al., 2010). Furthermore, 
a  review  by (Brown et al., 2012) concluded that ‘good evidence’ exists for pharmacist-led smoking 
cessation, cardiovascular disease prevention, hypertension and diabetes services  whilst evidence to 
support the efficacy of pharmacist-led services to provide weight management was deemed as weak. 
However the review by Brown et al. (2012) was not systematic and only presented the evidence they 
deemed of best quality to support pharmacist-led public health services. Specifically in relation to 
cardiovascular health, two recent systematic reviews found that pharmacist interventions were 
beneficial for the reduction or management of cardiovascular disease and associated risk factors 
(Santschi et al., 2011; Evans et al., 2012). 
 As previously noted, pharmacists in the UK have a contractual obligation to provide public health 
services. However international and UK based research has identified varying levels of, and attitudes 
towards, pharmacist engagement in public health related activities (Cordina et al., 2008; Eades et al.; 
Laliberte et al., 2012; Pfleger et al., 2008; Scott et al., 2007). It is important to understand 
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pharmacists’ attitudes towards providing public health services as, according to psychological theory 
and previous research examining health professional behaviour, this will affect whether pharmacists 
perform the behaviours necessary to provide such services (Ajzen, 1991; Godin et al., 2008). 
Two systematic reviews which examined pharmacists’ attitudes towards providing public health 
services found that pharmacists were generally positive about their role in providing public health 
services, however this role was perceived as secondary to dispensing activities(Anderson et al., 2003; 
Eades et al., 2011). Pharmacists’ confidence in their ability to perform public health related roles was 
moderate to low. Many barriers to pharmacists achieving more involvement in public health services 
have been identified and include: workload; time pressure; lack of remuneration; fear of a negative 
patient reaction; lack of communication with other health professionals; and lack of training 
(Anderson et al., 2003; Eades et al., 2011; Laliberte et al., 2012; O'Loughlin et al., 1999). Additionally, 
pharmacy ownership has been found to influence pharmacists’ public health activity. Bush et al. 
(2009) found that pharmacists employed by pharmacy multiples reported conflict with commercial 
interest as a significant barrier to them achieving the set public health agenda. A recent Canadian 
study found marked differences between pharmacists’ ideal and actual involvement in health 
promotion and preventative services (Laliberte et al., 2012). The majority of the 577 participants 
indicated that ideally they should be “very involved” in health promotion services such as smoking 
cessation and CVD risk factor screening, however, in practice, only 5.7% of  pharmacists described 
their pharmacy as being “very involved” in lifestyle related services. 
In their systematic review of pharmacist-led interventions to prevent CVD, Santschi et al. (2011) state 
that in order to use the expertise of pharmacists in CVD care effectively, research is necessary to 
understand their role and contribution to patient care. To date, the only known publication assessing 
pharmacists’ attitudes specifically towards CVD prevention and promotion was conducted in Canada 
(O'Loughlin et al., 1999). The study found pharmacists had high levels of interest in developing a 
prevention role, with the majority of participants indicating it was important or very important to 
integrate prevention into their practice. Despite this only 17-18% (exact figure not given) of the 
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participants reported that they frequently advised clients about behavioural changes to reduce the 
risk of CVD. It would appear that no study has explored the community pharmacist’s experience of 
providing lifestyle advice for patients with CVD in a UK setting. 
Pharmacy settings differ across the world. In Australia, unlike the USA and the UK, pharmacies can 
only be owned by registered pharmacists, who can own up to three community pharmacies. Like in 
the UK, community pharmacists in Australia are commissioned to offer a range of services such as 
blood pressure measurement and cholesterol testing. They conduct medicines use reviews in 
patients’ own homes/residential homes as opposed to in the community pharmacy and receive 
greater reimbursement for doing so than UK pharmacists (Rawal, 2009). In the USA, approximately 
62% of pharmacists are employed as community pharmacists, the majority of whom work as 
employees of pharmacy chains (Bott, 2010). Unlike the UK, the healthcare system in the USA is for-
profit and insurance based. Pharmacists in the USA train for longer than UK pharmacists, completing 
a six year doctor of pharmacy degree as opposed to a four year masters of pharmacy degree in the 
UK, and pharmacists in the USA are required to complete between 500 and 1500 intern hours as part 
of their training.  
Unlike systems in place within other countries, in the UK community pharmacists are employed by 
community pharmacies (private businesses) which act as contractors to the publicly funded National 
Health Service (NHS), with 80% of pharmacy profits derived from the NHS prescription business 
(Conisbee, 2003). This sets the UK apart from other countries and therefore the impact of the setting 
pharmacists practice in on pharmacists’ advice-giving behaviour needs to be explored.  
To date, no study has sought to understand UK pharmacists’ experiences of supporting patients with 
CVD to manage the condition through lifestyle behaviours and examine the factors that may 
influence pharmacists’ implementation of lifestyle advice. Given the paucity of high quality 
qualitative research in this area and the need to understand pharmacists’ experiences in more depth, 
an inductive qualitative approach was deemed the most suitable method to collect this data. 
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Aim 
The study aimed to explore community pharmacists’ experiences of giving lifestyle advice for 
patients with CVD.  
3.2 Methods 
3.2.1 Study design 
This was a qualitative study. Ethical approval for the study was obtained from Aston University 
Research Ethics Committee (reference number 584). 
3.2.2 Study Setting 
Fifteen semi-structured interviews were conducted with community pharmacists face-to-face in a 
private room at their workplace or by telephone. Initially the researcher had planned to conduct all 
of the interviews with pharmacists face-to-face, however when the researcher was attempting to 
recruit participants for the study a number of pharmacists indicated that they would find it easier to 
be interviewed by telephone when the pharmacy was quiet or on their day off. Therefore the 
decision was made to offer pharmacists the option of participating in the study by telephone in order 
to allow more pharmacists the opportunity to participate in the study. 
3.2.3 Participants  
Fifteen community pharmacists participated in the study. These were six men and nine women, 
mean age 30.8 years (range: 23-55 years). Seven participants were interviewed in person and eight 
participants were interviewed by telephone. Pharmacy ownership was categorised according to the 
classification used by Bush et al. (2009) : supermarket; multiple (200 outlets or more); large chain 
(more than 20 outlets but fewer than 200); small chain (20 outlets or fewer but more than 5); 
independent (5 outlets or fewer). One participant was employed by a supermarket community 
pharmacy, seven by multiple community pharmacies, two by small chain pharmacies and four 
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participants by independent pharmacies. The mean time participants had practiced as qualified 
pharmacists was 7.2 years (range: 6 weeks to 34 years). 
A variety of methods were used to advertise the study to pharmacists: writing to community 
pharmacies and following up with a telephone call; presenting at a pharmacist professional 
development event and word-of-mouth and snowballing techniques. Pharmacists were purposively 
sampled from supermarket, multiple and independent community pharmacies to obtain as much 
breadth of perceptions and experiences as possible within the sample. One participant was 
interviewed but excluded from the analysis as she had stopped practising as a community pharmacist 
ten years ago. 
3.2.4 Data Collection 
The interviews were conducted at a time and place convenient to the participant (by phone or in 
person at their home or workplace and lasted on average 30 minutes (range: 20 to 50 minutes). The 
researcher explained what study participation would involve and gave the participant the 
opportunity to read through the Participant Information Sheet (PIS) (see Appendix 9.2), which they 
had received prior to the interview taking place. Participants were given the opportunity to ask the 
researcher any questions before being asked to sign a consent form indicating that they understood 
what participation involved and were happy to proceed with participation in the study (see Appendix 
9.3). Participants interviewed by telephone were read the consent form and gave their consent 
verbally. The researcher sat in a private room when conducting the telephone interviews in order to 
ensure the participant’s confidentiality. Participants were assured that the interview was not a test of 
their knowledge or professional practice, that the interview was strictly confidential and that they 
were free to withdraw at any point without providing a reason for doing so.  
A pre-prepared interview schedule was used to guide the interview. Open-ended questions allowed 
the participant to shape the direction the interview took, with the interviewer adopting a facilitative 
role, using the interview schedule to identify areas of interest and provide cues (see appendix 9.4). 
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The schedule covered the following topics: facilitators and barriers to giving lifestyle advice; 
experience of delivering lifestyle advice; relationships with patients and other health professionals; 
the role of the community pharmacist and the suitability of the community pharmacy environment 
for receiving advice.   
The interview began in an open-ended manner, asking participants to ‘tell me about your typical 
working day as a community pharmacist’, then slowly moving to more sensitive topic areas such as 
‘describe your working relationship with other professionals involved in cardiovascular healthcare’ 
once a rapport between the participant and interviewer had been established. The interviews were 
audio recorded and transcribed verbatim. After the first three interviews the interview schedule was 
reviewed to ensure that it was suitable and allowed the participants to easily give an account of their 
experiences. No problems with the interview schedule were identified by the participants or the 
researcher therefore the interview schedule was deemed an effective facilitator and no changes 
were made. The interviews were conducted until no new themes emerged. 
3.2.5 Analysis 
The interview transcripts were analysed thematically, focussing primarily on the participants’ 
experience (Braun & Clarke, 2006). The analysis was interpretative, recognising the interaction 
between the researcher and the data. A Framework approach was used to structure the analysis 
(Ritchie & Spencer, 1994). Framework Analysis is a five stage process of: familiarisation, forming a 
thematic framework, indexing, charting and mapping and interpretation. Familiarisation with the 
data was achieved through a process of reading and re-reading a small number of interview 
transcripts, noting the participants’ use of language, repetition of words or thought patterns 
emerging from the data and any contradictions within the participants’ accounts. This enabled the 
identification of emergent themes. The researcher defined emergent themes as: a collection of 
references indicating a pattern in participants’ experience of giving patients advice or how they 
perceived patients’ behaviour, the participants’ use of language to describe their experience of giving 
lifestyle advice and any conflicting ideas identified within or between the participants’ accounts. A 
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thematic framework was constructed using the emergent themes identified as described above, the 
interview schedule and prevalent themes in the literature identified through the literature review 
reported in chapter one.  Commonalities between emergent themes from the data and themes 
identified through the a-priori literature review were identified, with all themes given an equal 
weighting within the thematic framework. Each emergent theme and its associated sub-themes were 
assigned a number thus creating a numerical index to apply the thematic framework to the data. The 
researcher repeated the initial process of familiarisation and annotation with the remaining 
interview transcripts, adding any additional emergent themes to the thematic framework and 
applying the new items on the framework to previously analysed transcripts.  This enabled the 
construction of charts which summarised extracts from participants’ interviews and where they were 
situated within the data grouped by emergent and a-priori themes identified from the extant 
literature. The charts were analysed for patterns, similarities and differences between the 
participants’ accounts and provided a framework to aid reporting the study findings. The researcher 
(KK) continually verified the findings with her supervisory team (HP, CL and RP) to ensure the validity 
of interpretations. An example of the analysis is provided in appendix 9.5. 
3.3 Results 
The thematic analysis produced three main themes with associated sub-themes (see Table 3.1). In 
the reported analyses, participant pseudonyms were created to provide information about: 
pharmacy ownership [Supermarket (‘Super’) or multiple (‘Multi’) or independent (‘Indep’) which 
incorporated both independent and small chain pharmacy ownership; community pharmacist 
participant number (e.g. CP 1) and number of years the participant had been a practicing pharmacist 
(e.g. 8 yrs). In the quotations below, where respondents emphasised particular words, these words 
are italicised. 
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Table 3.1: Emergent themes and sub-themes 
Theme Sub-theme 
Pharmacists’ perceptions of patients Categorising patients 
Beliefs about patients with CVD 
Barriers to providing lifestyle advice Time and workload 
Patient perceptions of pharmacists 
Confidence in providing lifestyle advice 
Professional identity Health professional-patient relationship 
Lifestyle advice in Medicines Use Reviews 
Future direction of the profession 
Lack of remuneration in professional role 
Pharmacy as a business and associated role 
conflict 
 
 
3.3.1 Pharmacists’ perceptions of patients  
3.3.1.1 Categorising patients  
The way many of the pharmacists described their interactions with patients suggests that they 
primarily categorised patients in accordance with their medical condition and/or prescribed 
medication. IndepCP3(2yrs) described differentiating between patients according to their 
prescription type (acute or chronic): 
“…either they walk in with the prescription straight from the doctor’s so which is usually an 
acute prescription like amoxicillin or something like that or erm just repeat prescription…” 
IndepCP3(2yrs). 
This process appeared to be used to guide the advice the pharmacist provided,  
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“…if someone is on a statin, you always offer like…the ways to err reduce your cholesterol such 
as eating oily fish and stuff like that and eating your five a day, promoting exercise…” MultiCP4 
(0.1yr). 
The pharmacists had models of different ‘types’ of patients which they used to categorise the 
patients they encountered. One supermarket pharmacist described how staff identified patients 
whom they perceived would respond well to receiving lifestyle advice: 
“...so they know which ones who you can talk to and which ones ...won’t talk to you, which 
ones will follow through, which ones can provide advice for...” SuperCP1(8yrs).  
Within the context of a busy, pressured workplace environment and a legal responsibility to ensure 
that patients are dispensed the correct medication, it makes sense that pharmacists would develop 
cognitive ‘shortcuts’, also known as stereotypes, to interpret patients’ behaviour and be able to 
respond accordingly (Haslam, Turner, Oakes, Reynolds, & Doosje, 2002). The stereotypes created by 
pharmacists are important, as they are likely to influence the interactions the pharmacist has with 
patients and may influence the care patients receive. It follows that patients categorised as “ones” 
who “won’t talk” may be less likely to be given lifestyle advice than patients the pharmacist 
perceived to be more open to receiving lifestyle advice.  
3.3.1.2 Beliefs about patients with CVD 
Some pharmacists believed that patients with CVD lacked knowledge about their condition and 
appropriate self-management, 
“…when I do medicines use reviews with patients or we discuss blood pressure with patients 
they have no idea what it is.” IndepCP5(1yr).   
Yet many pharmacists simultaneously believed that the majority or all of patients, with CVD or 
otherwise, were aware of the direct association between health behaviours and poor health, citing 
this as a reason for not providing patients with uninvited lifestyle advice, 
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“...in all honesty there’s nobody on this planet that doesn’t know that they need to lose weight 
or doesn’t know that they need to cut their drinking a bit and so on, they know that, I don’t 
believe there’s anybody that doesn’t know that maybe they could be healthier” IndepCP6(26yr). 
Furthermore, many of the CPs interviewed appeared to conceptualise lifestyle advice as ‘common 
sense’, 
 “...it’s not a high level of information is it really...it’s not high level information, and that’s not 
because I’m saying pharmacists can’t deliver anything complicated it’s not a high level of 
information, most of it is common sense and it’s repetitive.” IndepCP1(23yrs). 
Whilst patients may be aware that they need to change their behaviour, information and knowledge 
alone are not sufficient to change behaviour. This did not appear to be recognised by many of the 
pharmacists, and many of the pharmacists did not discuss doing anything to help patients change 
their behaviour other than giving information. 
3.3.2 Barriers to providing lifestyle advice 
3.3.2.1 Time and workload 
The most frequently cited barriers were time and workload, which were evident throughout the 
accounts of all the participants. Many pharmacists described balancing multiple roles in a time-
limited environment which placed them under pressure, 
“…a large part of community pharmacy, ehh probably I’d say 80% of it is just checking 
prescriptions… so you don’t really get too involved with err specific individuals erm unless...for 
example if there is an [medication] interaction to pick up on … but otherwise you don’t really 
have time to go and review everybody…” MultiCP6(1yr). 
MultiCP6(1yr) appeared to believe that pharmacists have the capacity to provide individualised 
advice on cardiovascular health but did not have time to do so. Interestingly, through the use of the 
word “just” he appears to downplay the safety checking of prescriptions, which traditionally is a 
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“core” role of community pharmacist. Another pharmacist described the different roles she has to 
balance within time constraints in order to run the pharmacy. This appeared to cause her frustration, 
“…obviously the time as well, often these services are all very good but there’s only the one 
pharmacist so trying to balance you know getting the day to day stuff done as well as providing 
all of these services.” MultiCP1(1yr). 
 The pharmacists employed by multiple and supermarket pharmacies in particular described pressure 
to meet targets and provide a quick service, 
 “…companies are asking for more and more even though we haven’t really got the time to do 
it [laughs]…we are under a fair amount of pressure because you’re under pressure to deliver 
services.” MultiCP6(1yr). 
 This appeared to leave some pharmacists resigned to not being able to offer patients advice, 
“…people are waiting so obviously you can’t really talk to people …unless it’s a quiet period 
which is rarely that we’re quiet...” MultiCP4(6 weeks). 
The word ‘obviously’ gives a sense he is resigned to the notion that he cannot speak to patients if 
there are other patients waiting. Conversely, other pharmacists, notably more often those employed 
by independent pharmacies, appeared more confident to base the provision of advice on clinical 
need rather than the time available: 
“…the patients that we find need our time, they get our time and whether that means other 
people have to wait, they have to wait…” IndepCP3(2yr). 
It appeared that the respondent did not fear the repercussions of keeping patients waiting which 
contrasts with the experiences of many of the pharmacists employed by multiple community 
pharmacies. Interestingly, the pharmacy manager of a multiple community pharmacy had a different 
perspective, 
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“…we have targets…it’s the world we operate in, I know that people can feel pressurised about 
non delivery but actually…we can’t operate in a world where nobody has an aim or a goal or a 
target, we can’t just have a free for all when it just doesn’t work like that.” MultiCP7(34yr). 
Through this statement, the pharmacy manager appears to minimise other pharmacists’ experiences 
of targets placing them under pressure and justify the use of targets to influence pharmacists’ 
behaviour, appearing to imply that targets are necessary to maintain order. 
3.3.2.2 Patient perceptions of pharmacists 
Many of the pharmacists felt that the role of the community pharmacist was not clearly defined 
which meant patients did not have a good understanding of the pharmacists’ professional capacities. 
The pharmacists reported that the lack of a defined role made it difficult for them to provide lifestyle 
advice, as patients did not consider this part of the pharmacists’ role, 
“…I still think the pharmacist’s role isn’t as defined as it should be… people still…maybe 
because of the area I work in we have a lot of elderly people erm and obviously they still think 
the doctor’s word is… they will always go to the doctor first, erm I don’t think they realise what 
the pharmacist in the pharmacy can do…” MultiCP1(1yr). 
“I think a lot of patients just think the pharmacist gives out my tablets…” IndepCP5(1yr). 
The retail environment in which the pharmacists practice appeared to contribute to this perception, 
“…a lot of patients don’t see pharmacists as a healthcare professional, they see them as 
glorified shop owners…” MultiCP4(0.1yr). 
It was also perceived that patients expected a quick service from pharmacists; it may be that the 
retail environment was responsible for this, leading to expectations of the kind of service associated 
with sales staff rather than health professionals. This expectation of brief transactions appeared to 
make providing lifestyle advice difficult, 
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“… I think that is the main issue with pharmacy is that pharmacy is all about erm in and out, in 
and out, in and out, they, they don’t really see…very few patients see community pharmacists 
as a resource to be used like, like a GP…” MultiCP6(1yr). 
It is important to note that the perception that patients are not receptive to advice from pharmacists 
is an assumption made by the pharmacists. It may be that through assuming that patients do not 
understand the pharmacist’s role or are not interested in receiving advice from pharmacists prevents 
pharmacists from offering advice to patients who may be interested.  
3.3.2.3 Confidence in providing lifestyle advice 
The pharmacists’ confidence to provide lifestyle advice appeared to develop over time, however 
even experienced pharmacists could be reluctant to offer lifestyle advice uninvited: 
“…much as we’re supposed to do it… I will not just speak to someone who is clearly overweight 
and start a conversation about weight...” IndepCP6(26yr). 
Many pharmacists found it particularly difficult to initiate conversations about body weight: 
 “…obviously it’s a touchy subject, you know, if you’ve got a genuinely er larger person in front 
of you…you don’t want to insult them, you don’t want to...to make them feel uncomfortable so 
it’s a catch 22 a little bit…” IndepCP5(1yr). 
These pharmacists appeared to construct obesity as a taboo, making them reluctant to raise the 
topic with patients. However this reluctance was not limited to opportunistic advice which according 
to UK government policy (NHS Future Forum, 2012)  should be offered to patients regardless of their 
reason for visiting the pharmacy. One pharmacist was so concerned about eliciting a negative patient 
response that she avoided informing a patient that they were overweight even after weighing them. 
The reluctance to initiate conversations about lifestyle behaviours with patients appears to stem 
from pharmacists expecting a negative reaction from patients in response to their advice: 
 
 
75 
 
“…people can get aggressive but not many people do but you just don’t wanna offend 
someone, that the biggest thing… you still want to make them happy but give them advice.” 
MultiCP4(0.1yr). 
The perception that patients may react negatively to lifestyle advice may make pharmacists reluctant 
to have conversations with patients about their lifestyle and the impact health behaviours can have 
on the management of CVD. Some of the pharmacists felt that they did not receive appropriate skills 
training to prepare them to offer patients lifestyle advice: 
“…there is a lack of training as to how we will approach patients which I say is one of the 
challenges and how we would approach patients on you know, giving smoking [cessation 
advice] erm sort of the social skills side as well, having a general conversation with people and 
how we would convince them [to change their behaviour] …”. MultiCP1(1yr). 
Another pharmacist noted: 
“…a lot of university now is focused around healthcare, public health… but the way to put it 
across to people, there’s not much, you’ve got to develop your own way…” MultiCP4(0.1yr). 
This statement is particularly noteworthy, given that the pharmacist who does not feel he received 
appropriate training to convey public health messages (which often incorporate lifestyle advice) is a 
recent graduate and therefore has received his training after the introduction of the revised 
pharmacy contract which outlined the role of pharmacists in providing public health services. A 
perceived lack of training may also contribute to pharmacists’ reluctance to offer lifestyle advice if 
pharmacists do not feel they have the skills to offer such advice to patients. 
3.3.3 Professional Identity 
3.3.3.1 Health professional-patient relationship 
The pharmacists expressed positive opinions about the role community pharmacy has, or could have, 
in promoting health behaviours to varying extents. In line with the ‘health professional’ identity and 
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role of the community pharmacist, many of the pharmacists actively endorsed a patient-centred, 
collaborative approach to pharmaceutical practice: 
“…some patients will have a giggle, we have a bit this, we have a bit of that, but, you know 
what I mean, it’s...I say to them, I’m not there to stop you from having [certain types of food] 
that’s your choice...but we’re doing it to ensure that you know what I mean, maybe if you 
would reduce some saturated fats...let’s see what happens to your cholesterol...” 
SuperCP1(8yrs). 
The use of ‘we’ suggests that it is a joint venture to help the patient reduce their cholesterol levels 
whilst he ensures that the patient retains ownership of the behaviour, reinforcing that it is the 
patient’s choice to change their behaviour. The fact that he shares some humour with some patients 
suggests that he is creating an interaction where patients feel at ease. However the perceived 
importance of forming relationships with patients appeared to differ according to the status of 
pharmacists’ employers. When asked what the most important part of his working day was, one 
independent pharmacist said: 
“I think the biggest one is engaging with patients, I think that’s the biggest thing that 
pharmacists have to do” IndepCP5(1yr). 
Pharmacists employed by independent and notably the supermarket-owned pharmacies seemed to 
place more emphasis on the importance of building a relationship with patients than multiple-
ownership pharmacists. One pharmacist commented on the difference that they perceived between 
interactions with patients at her workplace and at other community pharmacies: 
“…the main difference [between the Independent workplaces and other pharmacies] is having 
a little talk with them about their medication … offer extra advice to them so they feel like 
somebody actually cares …” IndepCP7(2yr). 
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3.3.3.2 Lifestyle advice in Medicines Use Reviews  
The pharmacists conceptualised providing lifestyle advice as an activity that was performed as part of 
additional services offered in some English community pharmacies such as the Medicines Use Review 
(MUR) and New Medicines Service (NMS) which should incorporate advice on patients’ diet, exercise 
and smoking status, rather than a behaviour linked to routine dispensing practice. Most of the 
pharmacists appeared to be comfortable giving lifestyle advice in this setting as the advice was in 
conjunction with advice about medicines: 
“I try and tie it in with the medication first, erm whether I counsel them on new tablet that 
they’ve got or invite them in for a MUR, we’ll talk through the medication first and then if there 
are sort of lifestyle advice and things to go with it then we’ll feed that in…” IndepCP2(2yrs). 
However there appeared to be a clear distinction between providing lifestyle advice as part of 
MURs/NMS, which pharmacists reported as a common occurrence, and “core” aspects of community 
pharmacy practice such as checking and dispensing medication which did not appear to frequently 
incorporate lifestyle advice. Providing lifestyle advice appeared not to be a priority for some 
pharmacists: 
“…pharmacists have a number of other stuff to do…sometimes, I feel, [lifestyle advice] it 
becomes an afterthought….because…you feel…you’ve gotta get all the other stuff [to do]….” 
SuperCP1(8yrs). 
It appeared that giving lifestyle advice was seen as secondary to “core” aspects of pharmacy practice 
such as dispensing. However many pharmacists expressed a desire to do more for patients with CVD: 
 “…from my branch we don’t do a huge amounts of other things related to 
cardiovascular…probably not as much as sometimes I’d like to…” IndepCP2(2yrs). 
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This statement was echoed by many of the pharmacists who suggested a number of community 
pharmacy based initiatives aimed at CVD prevention but cited barriers discussed in the previous 
theme as preventing them from being able to put this into practice. 
3.3.3.3 Future direction of the profession 
The pharmacists had differing, sometimes conflicting, opinions on the future of community 
pharmacy. Some pharmacists described their wish to move away from traditional roles and build 
upon the ‘health professional’ identity that involves giving lifestyle advice: 
 “…ultimately my aim is to provide a high level of service and get away from the dispensing 
process and be more involved in, in you know … diagnosing blood pressure, promoting these 
sorts of things, erm doing medicines reviews, helping patients get the best out of their 
medicines that they are on but also to prevent them from having to take more because they’re 
not taking them correctly so it’s all about that for me, it’s pushing pharmacy towards a clinical 
role rather than the old dispensing.” IndepCP5(1yr). 
This pharmacist was very keen for pharmacists to have more direct involvement in patient care and 
to move away from the traditional dispensing process. However his use of the word ‘pushing’, which 
denotes a lack of agreement or readiness, suggests that he believes that not all pharmacists share his 
vision, and some pharmacists may be resistant to their role changing. Despite describing how much 
she enjoys providing additional pharmacy services, which incorporate lifestyle advice, one 
pharmacist suggested that this is not a view point shared by all pharmacists: 
 “…some people hate the additional services that they are doing now, they think that they 
should still be dispensing, dispensing, dispensing, I personally love the extra services…” 
IndepCP6(26yr). 
 Another pharmacist questioned whether lifestyle advice should be part of the community 
pharmacists’ role at all, 
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“…as the population gets more elderly and we get more obese and our intake of junk food gets 
worse we are looking at a nightmare scenario in the future and it would be good if somebody 
could stop it, but whether that is the role of the pharmacist or not I don’t know. It comes back 
again to time and our payment structure and I don’t think that’s going to be solved easily.” 
IndepCP1(23yrs). 
This pharmacist is unsure whether it should be the pharmacist’s responsibility to offer patients 
lifestyle advice. She cites barriers such as time constraints and the way pharmacists are remunerated 
as factors which she perceived to prevent pharmacists offering lifestyle advice.  This is an important 
insight, with remuneration identified by many pharmacists as an important factor in the provision of 
lifestyle advice. 
3.3.3.4 Lack of remuneration in professional role 
Some pharmacists highlighted the importance of the dispensing process as dispensing NHS 
prescription items provides the main source of the community pharmacy’s income, 
“…obviously the dispensing process is important because that’s where we get our, our core 
funding from erm at the moment…” IndepCP5(1yr). 
A number of the pharmacists suggested that current remuneration practices were not conducive to 
delivering lifestyle advice and health promotion: 
“….if you are stopping a heart attack then they’re not going to be taking any medicines and 
that’s ultimately putting yourself out of business so it’s not in your interests to keep people 
healthy as a pharmacist at the moment… what other profession does something to stop their 
future payments?” IndepCP1(23yrs). 
Some pharmacists indicated that current remuneration practices resulted in there being less 
incentive to provide lifestyle advice than other activities in the pharmacy which are remunerated, 
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“…you’re providing the [lifestyle] advice …erm and you’re getting no monetary reward for it… 
so most pharmacists will think oh I can’t be bothered to be giving that advice, when there’s no 
value to it for me”. MultiCP6(1yr) 
The pharmacist describes an inherent conflict between their role as a health professional with a 
responsibility to promote health through giving patients lifestyle advice, and their business employee 
role which focusses on  financial return, which giving lifestyle advice does not currently provide. This 
may result in pharmacists not being motivated to provide lifestyle advice, as suggested by 
MultiCP6(1yr). 
3.3.3.5 Pharmacy as a business and associated role conflict 
Most pharmacists explicitly made reference to the community pharmacy being a business 
environment in addition to a provider of healthcare, and discussing remuneration for the services 
they provided appeared to cause some of the pharmacists discomfort. This highlights an important 
issue of potential conflict in the community pharmacist’s role, which combines the roles of a 
healthcare professional advising patients on their health and working as an employee for a 
company/independent contractor. A pharmacy manager for a multiple chain community pharmacy 
described the experience he would like people to have when they visit community pharmacies 
owned by his employer, 
“…we are trying to always differentiate on customer care…the need and the expectation is that 
that person will sort of somehow when they next need some advice think “ooh, that nice person 
in that shop, I’ll go and see them again””. MultiCP7(34yr). 
Targeting the patient-pharmacist interaction as an opportunity to increase custom raises the 
question as to whether developing a patient-clinician relationship and enhancing profits are 
interlinked. In keeping with this, another pharmacist described how building a relationship with 
patients and business success are related,  
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“…making sure that you go that extra mile for people and then that gives them the confidence 
and trust in you to come and speak about their health problems, they take you more seriously if 
you do health promotion with them and that is what builds your business, it kind of goes into 
both.” IndepCP6(26yrs).   
The apparent overlap of business and health professional roles may cause further role conflict, as 
pharmacists may be less inclined to discuss health issues that they think may upset the patient. One 
pharmacist described her hesitance to offer potentially unwelcome health advice for fear it may 
affect custom to the pharmacy: 
“I mean it’s a business environment…erm so if you lose loads of customers your boss is on your 
back… if you insult somebody by telling them they look fat then you’re going to lose that 
customer [laughs]” IndepCP2(2yrs). 
Her belief that this would reflect on her employment status could lead to her not offering lifestyle 
advice, which conflicts with her health professional role. Another component of the pharmacists’ role 
as a business employee identified by the pharmacists was having business targets to meet.  Again, 
this potentially presents role conflict for community pharmacists, and some pharmacists expressed 
concern at company targets to perform a specified number of MUR consultations conflicting with the 
clinical need of patients: 
“…because I know colleagues....who are quite...they push it quite hard...but the problem is that 
I think the patient doesn’t get anything out of it because it’s just...I feel the patient’s 
being...cajoled into a room because you want to do something...” SuperCP1(8yrs). 
The company targets appear to be structuring the pharmacists’ behaviour and therefore potentially 
influencing clinical decisions, presenting a challenge to the pharmacists’ autonomy as a health 
professional. 
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3.4 Discussion  
This study aimed to explore community pharmacists’ experiences of providing lifestyle advice for 
patients with CVD within a UK setting. A thematic analysis using a Framework approach was 
conducted from which three themes emerged: ‘pharmacists’ perceptions of patients’, ‘barriers to 
providing lifestyle advice’ and ‘professional identity’. 
A novel finding from the study concerns the pharmacists’ perceptions of patients which appeared to 
influence the pharmacists’ provision of lifestyle advice. In addition to categorising patients by 
medical condition or the type of medication patients were prescribed, the pharmacists appeared to 
categorise patients in terms of ‘types’ of patients who were open to receiving lifestyle advice and 
those who were not. Importantly, these stereotypes may influence whether some patients are given 
lifestyle advice by pharmacists. The pharmacists also appeared to believe that patients with CVD 
lacked awareness and knowledge of CVD and CVD self-management , however simultaneously 
perceived lifestyle advice as “common sense” and that these patients were aware of the role health 
behaviours play in CVD development and management.  Additionally, some pharmacists believed 
that some patients with CVD were not motivated to change their behaviour. These beliefs may lead 
pharmacists to believe that giving lifestyle advice will not benefit patients with CVD, and 
consequently such advice may not be a high priority activity in a busy pharmacy. Street Jr, Gordon, 
and Haidet (2007) found physician communication behaviours to correlate with the physicians’ 
perceptions of patients, with physicians being more patient-centred, less contentious and showing 
more positive emotions towards patients who they perceived to be better communicators, more 
actively involved in the consultation, more likely to adhere to treatment and more satisfied with 
treatment. Notably it may be that patients who are not ‘actively involved’ in consultations, or 
perceived to be of a ‘type’ not open to receiving advice may in fact need more assistance than 
patients who are able to actively engage in encounters with health professionals.  
Furthermore, pharmacists in the present study believed that giving patients lifestyle advice may 
provoke a negative response, with some participants alluding to the potential of patients to become 
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aggressive. This supports the findings of previous systematic reviews which found that pharmacists 
feared ‘interfering’ with or offending patients (Anderson et al., 2003; Eades et al., 2011). A recent 
qualitative study exploring pharmacists’ attitudes towards providing advice about alcohol 
consumption also found that having concerns about offending or alienating customers was a major 
barrier to offering the service (Horsfield et al., 2011). Research conducted with Australian clinicians 
(nurses, Aboriginal health workers and allied health professionals including social workers, speech 
therapists and psychologists) found the clinicians’ perceptions of how acceptable clients felt it was 
for them to offer lifestyle advice affected providing such advice, with ‘low implementers’ expressing 
concerns of appearing judgmental, receiving negative reactions from clients and damaging the 
clinician-client relationship (Laws et al., 2008). Many pharmacists in the present study also believed 
that many patients did not fully understand the pharmacists’ role and did not expect or want to 
receive lifestyle advice from a community pharmacist. Believing that patients do not understand 
pharmacists’ professional capabilities and do not want or expect to receive lifestyle advice in a 
community pharmacy may paradoxically lead to pharmacists not giving lifestyle advice to patients 
who are open to receiving it.  
Professional identity emerged as a prominent theme in relation to the provision of lifestyle advice, 
appearing to underpin many of the perceived barriers to providing lifestyle advice. At the core of this 
appeared to be the retail environment in which community pharmacists practise, resulting in a dual 
role of health professional and business employee. In keeping with previous research (Anderson et 
al., 2003; Eades et al., 2011), most of the pharmacists were positive about playing a role in public 
health (in this case providing lifestyle advice) but reported difficulties achieving this due to barriers 
such as time, high workload and pressure to meet targets. It should be noted that there was not 
unanimous support for lifestyle advice provision being a part of the pharmacists’ role, and there was 
variation within the participants’ beliefs about the extent to which pharmacists should adopt 
additional roles more in line with a ‘clinician’ identity.  
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Remuneration appeared key to pharmacists’ provision of lifestyle advice for patients with CVD, with 
the pharmacists suggesting that current remuneration practices hindered their provision of lifestyle 
advice. Some pharmacists suggested that providing lifestyle advice was not in their best interests 
because they received no financial return for doing so. This may result in pharmacists not being 
motivated to provide lifestyle advice, and many pharmacists reported prioritising other activities 
(primarily dispensing) over providing lifestyle advice, again supporting the findings of previous 
studies (Anderson et al., 2003; Eades et al., 2011; O'Loughlin et al., 1999).  
However, the way barriers to providing lifestyle advice were perceived by pharmacists employed by 
different pharmacy ownerships varied. Despite reporting high workloads and time pressure, 
pharmacists employed by independent pharmacies appeared to be more comfortable spending time 
offering patients lifestyle advice, even if other patients were waiting to be seen. In contrast, these 
barriers seemed more salient to pharmacists employed by multiple pharmacies, with the 
supermarket pharmacist and many multiple pharmacists reporting pressure to provide a quick 
service and not keep other patients waiting. This in turn appeared to be underpinned by pressure to 
meet company targets, causing potential conflict between the pharmacist’s health professional and 
business employee roles. This has implications for pharmacists providing lifestyle advice, and in the 
current study appeared to manifest in two ways: pharmacists conducting consultations to meet 
company targets rather than in response to clinical need and pharmacists not offering potentially 
unwelcome health behaviour advice to patients, fearing that this may have repercussions on their 
employment status if the patient reacts badly. This supports previous research which found that 
pharmacists working in multiple pharmacies experienced conflict with commercial interests as a 
significant barrier to providing the set public health agenda (Bush et al., 2009). 
The retail environment of the community pharmacy was perceived to affect patients’ perceptions of 
the pharmacists’ role, with participants inferring that patients did not recognise the community 
pharmacist as a health professional. Consequently lifestyle advice provision was reportedly affected, 
due to patients not fully recognising the pharmacists’ professional opinion. This appeared to relate to 
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the retail environment of the community pharmacy. It may be that the ‘shop’ appearance of the 
community pharmacy results in patients having different expectations and perceptions of community 
pharmacists than they have of other health professionals. This may result in patients perhaps 
expecting the ‘customer service’ that they expect in a retail environment, resulting in less tolerance 
to wait to be seen by a community pharmacist than other health professionals operating in a more 
traditional clinical environment.  
In their respective systematic reviews, Anderson et al. (2003) and Eades et al. (2011) suggested that 
pharmacists have a reactive approach to public health provision and are most comfortable giving 
advice around medicines, which also appeared to be the case in the present study. The pharmacists 
seemed happy to provide lifestyle advice if the patient asked for it or if it related to medicine. The 
pharmacists appeared to conceptualise lifestyle advice as part of MURs, pharmacy services which 
provide some patients with a yearly consultation with a pharmacist to assess the patient’s use of 
medicine, incorporating some questions about their lifestyle. However, importantly, other than in 
these consultations there appeared to be a dichotomy between dispensing and lifestyle advice, and 
the pharmacists did not report routinely integrating lifestyle advice with their regular dispensing 
practices. This appeared to relate to a lack of time, fear of a negative patient response and a lack of 
confidence in giving lifestyle advice. According to Bandura (1977), self-efficacy (defined as confidence 
in one’s ability to carry out a behaviour), is a key predictor of whether the behaviour is performed. 
Some pharmacists reported a lack of confidence in their abilities to initiate conversations about 
health behaviours with patients, with some pharmacists reporting that they had not received 
appropriate training to enable them to provide lifestyle advice. Interestingly, this was not restricted 
to pharmacists who had qualified before the introduction of the pharmacy contract; newly qualified 
pharmacists also reported a lack of self-efficacy to give patients lifestyle advice. This supports the 
findings of previous reviews which concluded that pharmacists had low to moderate levels of self-
efficacy and required more training to increase their confidence in providing public health 
services.(Anderson et al., 2003; Eades et al., 2011). 
 
 
86 
 
The present study found that pharmacists reported their provision of lifestyle advice to be reactive 
rather than the provision of opportunistic lifestyle advice outlined in the “best practice” guidelines 
Choosing health through pharmacy (DoH, 2005) and the NHS Forum Report (2012). This supports the 
findings of previous systematic reviews by Anderson et al. (2003) and Eades et al, (2011).  It is well 
documented that research findings and clinical guidelines do not always readily translate into the 
routine clinical practice of health professionals (Lenfant, 2003). Marteau and Johnston (1991) 
highlighted the importance of viewing health professional behaviour as a source of variance in 
patient outcome, arguing  that health professional behaviour can be explained, predicted and 
changed using psychological models previously used to explain and predict the health behaviours of 
patients.  
The Godin et al. (2008) theoretical framework (see page 38) which extends the theory of planned 
behaviour (Ajzen,1991) can be applied to the findings of the present study. Beliefs about 
consequences appeared to be important in the pharmacists’ provision of lifestyle advice, with the 
pharmacists reporting perceived potential negative consequences of offering lifestyle advice such as 
offending patients and/or patients responding aggressively and the implications this may have on 
their employment status and future custom to the pharmacy. The pharmacists’ beliefs about their 
capabilities to provide lifestyle advice also appeared to be important, with many of the pharmacists 
indicating that they found providing lifestyle advice difficult and felt that they lacked appropriate 
training to do so.  Role and identity emerged as a key theme in the pharmacists’ accounts, and 
appeared to underlie many of the frequently cited barriers to providing lifestyle advice. Some 
pharmacists questioned whether pharmacists should offer lifestyle advice at all, some pharmacists 
saw lifestyle advice as important but secondary to their other roles whilst other pharmacists viewed 
giving patients lifestyle advice as of paramount importance. The way pharmacists are remunerated 
for their different roles was also cited as an important factor, with some pharmacists suggesting that 
the current pharmacy contract does lend itself to providing lifestyle advice and therefore 
pharmacists are not motivated to provide the advice. Many of the pharmacists also cited pressure 
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from their employer to meet targets and a high workload as preventing them from giving patients 
lifestyle advice. The pharmacists’ perceptions of patients’ willingness to receive advice emerged as a 
factor appearing to influence the pharmacists’ provision of lifestyle advice also appears to fit under 
‘social influences’ in the Godin et al (2008) model. Moral norm however did not appear to play a role.  
3.4.1 Strengths and Limitations 
There is a paucity of high quality in-depth qualitative research in this field of research. This was an in-
depth qualitative study conducted with community pharmacists in a UK setting and it is the first 
study to explore English community pharmacists’ experiences of providing lifestyle advice for 
patients with CVD. The richness of the data collected and the internal validity of the analysis is such 
that the findings are likely to be transferable if not statistically generalisable. 
There are however limitations to this research. First, in order to increase study participation, the 
method of interviewing participants differed, with seven pharmacists interviewed face-to-face and 
eight by telephone. This could have affected the quality of the data collected from the telephone 
interviews as the interviewer was not able pick up on the participants’ body language and any non-
verbal cues which may have affected the quality of the rapport established between the interviewer 
and participant. However, alternatively, the increased sense of anonymity may have enhanced the 
quality of the data collected. Pharmacists working in a variety of community pharmacy settings were 
sampled, resulting in contrasting as well as complementary accounts. Despite this, in the present 
study fewer participants from supermarket-owned pharmacies agreed to participate compared to 
participants from independent and multiple owned pharmacies. This may have affected the results 
and limited the comparisons that could be made between the experiences of supermarket-employed 
pharmacists compared to participants employed by independent and multiple pharmacies.  
3.5 Conclusion 
Many pharmacists saw the potential benefits of facilitating patient self-management of CVD through 
providing lifestyle advice. However, in practice they perceived multiple barriers to doing so and 
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giving patients with CVD lifestyle advice did not appear to be routine practice. Issues relating to 
professional identity appeared key barriers to the implementation of lifestyle advice, particularly 
concerning the way pharmacists are currently remunerated which seemed to result in lifestyle advice 
being a lower priority than other pharmacy activities. The extent to which pharmacists perceived 
barriers to providing lifestyle advice to patients with CVD differed, with pharmacists employed by 
multiple owned pharmacies in particular reporting pressure to provide a quick service and meet 
targets as preventing them from providing lifestyle advice. The retail environment of the community 
pharmacy was associated with potential role conflict and pharmacists perceived that this resulted in 
patients and other health professionals not appreciating the competencies of the community 
pharmacist.  
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4 Chapter Four: A comparison of the predictors of pharmacists’ 
intentions to give medication adherence advice and weight loss 
advice to patients with CVD 
4.1 Introduction 
The qualitative study reported in chapter three found that generally the participants were more 
comfortable giving patients with CVD advice relating to medicines and medication adherence than 
advising patients about lifestyle behaviours. Some pharmacists perceived giving patients weight loss 
advice to be particularly challenging. Based on these findings, the study presented in this chapter was 
conducted to identify and compare the predictors of pharmacists’ intentions to give medication 
adherence advice (an activity more in line with the traditional role of the pharmacist) and 
pharmacists’ intentions to give weight loss advice to overweight patients with CVD (a role which 
pharmacists adopted more recently through the introduction of the pharmacy contract (DoH, 2005). 
Both adhering to prescribed medication and engaging in lifestyle behaviours such as eating a healthy 
diet and regular exercise to lose weight if overweight are critical to patient self-management of CVD. 
However both pharmacists’ attitudes towards and engagement in public health activities vary (Eades 
et al., 2011), despite a contractual obligation for UK pharmacists to provide chronic disease self-
management support and promote behaviour change to result in patients leading healthy lifestyles 
(DoH, 2005).The identification of the predictors of pharmacists’ intentions to give weight loss advice 
(a behaviour pharmacists reported finding difficult) may facilitate the development of future 
interventions to change pharmacists’ advice-giving behaviour. Furthermore, the comparison of the 
predictors of advice-giving behaviour pharmacists report feeling comfortable performing (medication 
adherence advice) and that they report finding difficult (weight loss advice) will allow the 
identification of any predictors unique to the behaviour they find more difficult. Again, this could 
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inform the development of future behaviour change interventions to increase pharmacists’ 
engagement in the behaviour. 
As outlined in chapter one, health professional behaviour can be explained and predicted by 
psychological models traditionally used to understand patient health behaviours (Eccles et al., 2012; 
Godin et al., 2008; Marteau & Johnston, 1991). Based on the findings of their systematic review, 
Godin et al. (2008) developed a framework of health professional behaviour which includes variables 
from the Theory of Planned Behaviour (TPB) (Ajzen, 1991) and the Theory of Interpersonal Behaviour 
(TIP) (Triandis, 1979). The framework posits that beliefs about consequences, social influences, moral 
norms, role and identity and characteristics of the health professional are determinants of intention 
to engage in behaviour. Beliefs about capabilities and habit/past behaviour are determinants of 
intention and direct predictors of health professional behaviour. As with the TPB (Azjen, 1991), 
intention is a predictor of behaviour. A deductive analysis was performed, applying components of 
the Godin et al. (2008) model and other social cognitive theories to the findings of the qualitative 
study (chapter three) in a deductive analysis to inform the development of a questionnaire to assess 
the predictors of pharmacists’ intentions to give two different types of self-management advice. 
Both the Godin et al. (2008) theoretical framework of health professional behaviour (see page 38 for 
a full explanation) and the TPB (Ajzen, 1991) posit that beliefs about consequences (termed ‘attitude’ 
in the TPB) are a determinant of intention to engage in behaviour. This was evident in some of the 
pharmacists’ accounts of their experiences of giving lifestyle advice, with some pharmacists 
perceiving that by giving lifestyle advice they may offend patients and or patients may respond 
aggressively which could have implications for their status as an employee and future custom to the 
pharmacy. The Godin et al. (2008) framework and the TPB (Ajzen, 1991) also account for the role of 
an individual’s perceptions of others’ perceptions of them engaging in the target behaviour, termed 
‘social influences’ and ‘subjective norm’ respectively. Both Godin et al. (2008) and Azjen (1991) posit 
that an individual’s perception of an important other’s perception of them engaging in the behaviour 
is a determinant of the behaviour. The role of these constructs was evident in the qualitative 
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research. Some of the pharmacists perceived pressure from their employer to meet targets and 
provide a quick service, believing that this prevented them from giving lifestyle advice. This supports 
previous research which found pharmacy ownership influences pharmacists’ public health activity 
(Bush et al., 2009; Maunder & Landes, 2005). Furthermore, some of the pharmacists believed that 
patients with CVD did not want or expect to receive lifestyle advice from pharmacists. A related 
construct that was identified in the qualitative study was pharmacists’ perceptions of patients’ 
willingness to receive advice and change their behaviour which emerged as a factor appearing to 
influence the pharmacists’ provision of lifestyle advice. This is in keeping with the ‘social influences’ 
construct in the Godin et al (2008) framework, which suggests that social influences are a 
determinant of health professionals’ intention to engage in behaviour. 
The Godin et al. (2008) framework and Social Cognitive Theory (Bandura, 1977) both suggest that an 
individual’s perception of their ability to perform behaviour is a behavioural determinant. Godin et 
al.’s (2008) framework of professional behaviour proposes that the construct ‘beliefs about 
capabilities’ is a predictor of intention and a direct predictor of behaviour. Similarly, Bandura’s Social 
Cognitive Theory (1977) proposed that the construct ‘self-efficacy’, defined as an individual’s 
perception of their ability to execute a task successfully, is a key determinant of behaviour. The 
pharmacists’ beliefs about their capabilities to provide lifestyle advice appeared to be important, 
with many of the pharmacists indicating that they found giving lifestyle advice difficult and felt that 
they lacked appropriate training to equip them with the skills to do so. Previous research has also 
posited that self-efficacy is a key factor in pharmacists’ provision of public health services (Anderson 
et al., 2003; Eades et al., 2011).  
Role congruence emerged as an important factor in pharmacists’ experiences of giving lifestyle 
advice to patients with CVD, appearing to underpin many of the perceived barriers to giving patients 
lifestyle advice. Some pharmacists felt it was a key part of their role whilst other pharmacists 
questioned whether they should give patients lifestyle advice at all. Previous research has identified 
the role that role congruence plays in health professionals’ provision of lifestyle advice. Based on 
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qualitative research which investigated health professionals’ provision of lifestyle advice in primary 
care settings in Australia, Laws et al. (2009) developed a model of how clinicians’ beliefs and 
attitudes shape their implementation of lifestyle advice. Laws et al. (2009) concluded that 
implementation of advice is the result of health professionals’ beliefs about whether they should and 
can give lifestyle advice. Godin et al. (2008) also accounted for the role of role congruence in their 
framework of health professional behaviour, positing that a variable named ‘role and identity’ was a 
determinant of intention. 
Presseau, Francis, Campbell, and Sniehotta (2011) suggest that by focussing on a single goal directed 
behaviour, the TPB and other social cognitive models fail to capture whether other goal directed 
behaviours performed at the same time help or hinder the pursuit of the goal directed behaviour in 
question. This is important in the context of health professional behaviour and clinical consultations 
which require multiple clinical behaviours to be performed, some of which may be conflicting. 
Limited resources (such as lack of time or remuneration) may cause goal conflict: if a pharmacist has 
to offer lifestyle advice and check and dispense a prescription medication in a time pressured 
environment this may cause goal conflict and result in only one of the behaviours occurring. 
Alternatively, performing other clinical behaviours may increase the chance that a goal directed 
behaviour is performed. If a pharmacist has to offer medication adherence advice and check and 
dispense a prescription medication, the act of dispensing the prescription medication may facilitate 
the provision of medication adherence advice. A study exploring UK health professionals’ (GPs and 
nurses) provision of physical activity advice found that goal facilitation and goal conflict improved the 
prediction of physical activity advice provision, accounting for an additional 5.8% and 8.4% of the 
variance in behaviour over and above intention and perceived behavioural control (Presseau et al., 
2011). In the qualitative study the way that pharmacists are remunerated for their different roles 
was cited as a barrier to giving lifestyle advice, and some pharmacists suggested that they prioritised 
certain activities in the pharmacy (primarily dispensing) over other activities such as giving lifestyle 
advice because dispensing sustains the pharmacy as a business. A dichotomy between dispensing 
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and giving lifestyle advice was observed (goal conflict), despite government policy suggesting that 
dispensing activities should facilitate the provision of lifestyle advice (goal facilitation) (DoH, 2005). 
Again, the Godin et al. (2008) framework can be applied to these findings. Godin et al. (2008) 
proposed that characteristics of the health profession influence health professional behaviour. 
Arguably the way pharmacists are remunerated and the problems providing sensitive lifestyle advice 
whilst operating in a retail environment are arguably unique to the pharmacy profession. 
Finally, it has been suggested that the best predictor of future behaviour is past behaviour. Godin et 
al (2008) cited the importance of measuring past behaviour when studying health professional 
behaviour stating that much of health professional behaviour could be characterised as habitual. This 
was demonstrated by Walker, Grimshaw and Armstrong (2001) who conducted a study which 
investigated the utility of the TPB in predicting GPs intentions to prescribe antibiotics to adults with 
uncomplicated sore throats. The TPB explained 48% of the variance in GPs intention to prescribe 
antibiotics, with attitude and perceived behavioural control the most important independent 
variables. When past behaviour was added to the model the proportion of variance explained 
significantly increased to 63%.  
This chapter presents a study which builds upon the findings of the qualitative study (chapter three)  
using a cross-sectional questionnaire design to identify and compare the predictors of pharmacists’ 
intentions to provide medication adherence and weight loss advice. The present study aimed to 
identify and compare the predictors of both pharmacists’ intentions to advise overweight patients 
with CVD about losing weight and adhering to their prescribed medication respectively. The study 
sought to answer the following research questions. 
 (a) What are the predictors of pharmacists’ intention to advise overweight patients with CVD about 
losing weight and pharmacists’ intention to advise patients with CVD how to adhere to their 
prescribed medication? 
(b) What are the commonalities and differences between the predictors of pharmacists’ intention to 
advise overweight patients with CVD about losing weight and pharmacists’ intention to advise 
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patients with CVD how to adhere to their prescribed medication? 
 
4.2  Methods 
4.2.1 Study design 
The study used a cross-sectional questionnaire design to identify the predictors of pharmacists’ 
intentions to give medication adherence advice to patients with CVD and intention to give weight 
loss advice to overweight patients with CVD (dependent variables). The independent variables 
included: TPB variables (Azjen, 1991); self-efficacy (Bandura, 1977); constructs from the Godin et al. 
(2008) theoretical framework of health professional behaviour: past behaviour and role congruence; 
goal conflict and facilitation and demographic variables. Questionnaires were administered to English 
community pharmacists by post with the option to complete the questionnaires online if participants 
preferred. Ethical approval was obtained from Aston University Life and Health Sciences Research 
Ethics Committee (reference number 562).  
4.2.2 Participants 
An a priori power calculation was performed in accordance with guidelines from Tabachnick and 
Fidell (2013) to determine the necessary sample size: N ≥50+8m (m=number of Independent 
Variables) needed to test the multiple correlation and N≥104+m for individual predictors. These 
guidelines state ‘these rules of thumb assume a medium-size relationship between the IVs and the 
DV, alpha = .05, beta = .20’ (p.123). Accordingly, a minimum sample size of 194 participants was 
required to run the planned regression analyses which included eighteen independent variables (see 
page 100 to 104 for details).  
Potential participants were identified from the online NHS service directory which lists the postal 
address of every community pharmacy in England, grouped by Local Area Team 
(http://www.nhs.uk/servicedirectories/Pages/AreaTeamListing.aspx). Due to previous experiences of 
recruiting pharmacists to participate in research being problematic, a low response rate was 
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anticipated. Initially it was planned for enough questionnaire packs to be compiled for a response 
rate of 20% (1010 questionnaires) with the plan to send out a second wave of questionnaire packs if 
the required sample size was not obtained. One thousand two hundred packs were made up due to 
receiving extra copies when the questionnaire packs were printed. In order to obtain as 
representative a sample as possible, each community pharmacy listed in each of the 25 Local Area 
Teams in England was allocated a number, and 48 pharmacies from each area were randomly 
selected using a random number generator (48 x 25 = 1200). The questionnaire packs each contained 
one questionnaire and were addressed to ‘the community pharmacist’.  
In order to maximise recruitment, the questionnaire was also available online and a link to the 
webpage was included in the questionnaire pack sent to the randomly selected pharmacies should 
more than one pharmacist wish to participate in the study or prefer to complete the questionnaire 
online. In addition to this, in order to raise the profile of the study to ensure participant recruitment, 
social media (the Twitter account of the author, KK and her supervisor, CL) was used to tweet the link 
to the online questionnaire. Furthermore, Chemist and Druggist, a pharmacy trade magazine, 
included an article about the study along with a link to the questionnaire. 
4.2.3 Questionnaire development 
The items in the questionnaire were developed based on the findings of the qualitative research, and 
where available, guidance and examples in the literature of how theoretical constructs should be 
measured. The items in the questionnaire measuring TPB variables were developed in accordance 
with established methods of how to develop a TPB questionnaire (Francis et al., 2004). The self-
efficacy items were developed in accordance with guidance from (Bandura, 2006) based on barriers 
identified in the qualitative study (chapter three) whilst the goal conflict and goal facilitation items 
were adapted from items developed by Presseau et al. (2011). The remaining items measuring role 
congruence, perceptions of patients, perceptions of training and past behaviour were drawn from 
the Godin et al. (2008) framework of health professional behaviour and developed based on the 
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qualitative findings and were subject to ongoing refinement. The final questionnaire is presented in 
Appendix 9.6. 
Think-aloud interviews were conducted with a convenience sample of six community pharmacists. 
The think aloud method requires participants to verbalise thoughts that would normally be silent 
(Ericcsson & Simon, 1993); participants do not have to provide an explanation of their thought 
processes, rather they just report what they are thinking when completing a task (in this case filling 
out a questionnaire). In the present study, this was used to assess participants’ understanding of an 
initial draft of the questionnaire, allowing identification of any aspects of the questionnaire that 
participants found confusing or difficult to complete.  Based on the feedback from participants, items 
were removed to shorten the length of the questionnaire due to concerns raised about the time 
taken to complete it. The wording of the goal conflict and goal facilitation items was changed as 
participants felt that these items were confusing. An item measuring perceived behavioural control 
(PBC) was removed as the word ‘control’ appeared to elicit a defensive response from some 
participants which appeared to evoke feelings around professional autonomy. The formatting of the 
questionnaire was also amended to avoid duplication of the same question stems which assessed 
each behaviour, as in the think-aloud interviews the participants reported that they found this to be 
very repetitive and felt it made the questionnaire longer than necessary. 
4.2.4 Measures 
4.2.4.1 Background information 
Participants were asked to indicate: their gender (male/female/prefer not to say); how long they had 
worked as a community pharmacist; working hours (full time/part time); if they were working as a 
locum; employee status (pharmacy owner or employee/locum) and the ownership of the pharmacy 
they worked in according to the  Bush et al. (2009) classification (independent/small chain/large 
chain/multiple/supermarket).  
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4.2.4.2 Theoretical predictors 
The questionnaire items shared a common wording across the two behaviours (giving medication 
adherence advice and giving weight loss advice). All scale items were tested for acceptable internal 
consistency, which was set at Cronbach’s α ≥ 0.70, and summed where appropriate (Tabachnick & 
Fidell, 2013). Where internal consistency was not reached items were dropped from the variable 
measures until the maximum possible Cronbach’s alpha was reached or kept as separate items rather 
than summed. 
4.2.4.3 Attitude 
Four attitude items were included for each behaviour. Participants were asked to indicate the extent 
to which advising patients with hypertension/hyperlipidaemia how to adhere to their prescribed 
medication and lose weight was: good/bad; pleasant/unpleasant; useful/worthless and 
satisfying/unsatisfying. Internal consistency between the items was high (Cronbach’s α = 0.84 for 
adherence advice and 0.83 for weight loss advice) therefore the items were summed and the mean 
average taken. Responses were scored on a scale of one to five, with one indicating a strong positive 
attitude and five indicating a strong negative attitude towards the behaviour. 
4.2.4.4 Subjective norm 
Three subjective norm items were measured for each behaviour: ‘my current employer thinks’, 
‘patients collecting a prescription for hypertension/hyperlipidaemia think’ and ‘other pharmacists 
think’ respectively (1=strongly agree, 5=strongly disagree). Only participants who were pharmacy 
employees were asked to complete the first subjective norm item, as ‘my current employer thinks’ 
does not apply to pharmacy owners. Reliability between ‘patients think’ and ‘other pharmacists 
think’ was relatively low (Spearman Brown coefficient= 0.66 for medication adherence advice and 
0.52 for weight loss advice) therefore the items were analysed separately. 
4.2.4.5 Perceived behavioural control 
Initially three items for each behaviour were used to measure perceived behavioural control: ‘I am 
confident that I could advise a patient with hypertension/hyperlipidaemia how to [adhere to their 
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prescribed medication/lose weight]’; ‘For me, advising a patient with hypertension/hyperlipidaemia 
how to [adhere to their prescribed medication/lose weight] is easy’ and ‘Whether or not I advise a 
patient with hypertension/hyperlipidaemia how to adhere to their prescribed medication is entirely 
up to me’ or ‘Whether or not I advise an overweight patient with hypertension/hyperlipidaemia how 
to lose weight is entirely up to me’. Internal consistency between the three items was low 
(Cronbach’s α = 0.41 for medication adherence advice and 0.48 for weight loss advice). When the 
‘entirely up to me’ item was removed, the internal consistency increased (Cronbach’s α= 0.72 for 
medication adherence advice and 0.62 for weight loss advice).  The remaining two items for each 
behaviour were also found to have high internal consistency with the items derived to measure self-
efficacy. Therefore these items were summed with the items measuring self-efficacy (described 
below) and summed whilst the remaining item ‘entirely up to me’ was used to measure PBC for both 
behaviours. 
4.2.4.6 Self-efficacy 
In accordance with guidelines for constructing self-efficacy scales Bandura (2006), self-efficacy was 
measured using five items for each behaviour which assessed how confident pharmacists were in 
their ability to perform the behaviour despite potential barriers which were identified in the 
qualitative study (see chapter one). These were: ‘I am confident I can advise a patient with 
hypertension/hyperlipidaemia how to [adhere to their prescribed medication/lose weight if 
overweight] if they do not ask for the advice; appear uninterested; there are other patients in the 
pharmacy waiting to be seen; I know the patient well; the conversation is part of a Medicines Use 
Review. As described above, two items additionally used to measure PBC were added. There was 
high internal consistency between the items (Cronbach’s α =0.81 for medication adherence advice 
and 0.85 for weight loss advice). The items were measured on five point response scale, with one 
indicating strong agreement and five indicating strong disagreement. The scores were summed and 
averaged. 
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4.2.4.7 Goal conflict and goal facilitation 
Drawing from the items used by Presseau et al. (2011), a single item for each behaviour assessed 
goal facilitation: ‘my involvement in the dispensing activity in the pharmacy facilitates me in advising 
patients with hypertension/hyperlipidaemia how to adhere to their medication as prescribed’ and 
‘lose weight if overweight’ respectively. Goal conflict was operationalised as ‘my involvement in the 
dispensing activity in the pharmacy prevents me from advising patients with hypertension/ 
hyperlipidaemia how to adhere to their medication as prescribed’ and ‘lose weight if overweight’ 
respectively. The response scale was a five point scale with one indicating strong agreement and five 
indicating strong disagreement. 
4.2.4.8 Past behaviour 
Participants were asked to indicate the proportion of patients with hypertension and/or 
hyperlipidaemia that they advise about adhering to prescribed medication, think are overweight and, 
if overweight, give weight loss advice to on a five point scale (1= 0-20% to 5 = 81-100%). 
4.2.4.9 Perception of patients 
Three items assessed participants’ perceptions of patients on a five point scale for each of the 
behaviours. For medication adherence, the items: ‘I can tell which patients are going to react badly 
to me giving them advice’, ‘I can predict which patients with hypertension/hyperlipidaemia will 
benefit from my advice’, and I can easily distinguish patients who are motivated to adhere to their 
prescribed medication from patients who are not motivated to adhere to their prescribed 
medication’ had high internal consistency (Cronbach’s α =0.73) therefore the items were summed 
and the mean average taken. For weight loss, the items: ‘I can tell which patients are going to react 
badly to me giving them advice’, ‘I can predict which patients with hypertension/hyperlipidaemia will 
benefit from my advice’, and ‘I can easily distinguish patients who are motivated to lose weight from 
patients who are not motivated to lose weight’ also had high internal consistency (Cronbach’s α 
=0.73) therefore the items were summed and averaged. 
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4.2.4.10 Role congruence 
A single item for each behaviour assessed role congruence: ‘I feel that advising patients with 
hypertension/hyperlipidaemia how to adhere to their medication as prescribed is an important part 
of my role as a pharmacist’ and ‘I feel that advising overweight patients with 
hypertension/hyperlipidaemia is an important part of my role as a pharmacist. Responses were 
scored on a five point scale, with the anchors ‘strongly agree’ and ‘strongly disagree’; high scores 
indicated strong agreement with the statement. 
4.2.4.11 Training 
A single item for each behaviour assessed participants’ perceptions of the training they had received: 
‘I feel that I have been given the appropriate training to advise patients with 
hypertension/hyperlipidaemia how to adhere to their medication as prescribed’ and ‘lose weight (if 
overweight)’ respectively. 
4.2.4.12 Intention 
Intention was operationalised as a single item for each of the behaviours: ‘I intend to advise all 
patients collecting a prescription for hypertension/hyperlipidaemia about adhering to their 
prescribed medication and ‘I intend to give weight loss advice to all overweight patients with 
hypertension/hyperlipidaemia’. Reponses were scored on a five point Likert scale, with ‘strongly 
agree’  anchored at one indicating a strong intention to engage in the behaviour and ‘strongly 
disagree’ anchored at five indicating a strong intention not to engage in the behaviour. 
4.2.5 Procedure 
The addresses of the 1,200 randomly selected pharmacies were obtained and a questionnaire pack 
was posted to each pharmacy. This consisted of: an invitation letter (appendix 9.7), participant 
information sheet (appendix 9.8), a copy of the questionnaire (appendix 9.6) and a postage paid 
envelope. The brief invitation letter introduced the study. The participation information sheet gave 
more detailed information, and outlined the rationale for the research, informed potential 
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participants of their rights and reiterated that the questionnaire was anonymous and that 
participants would not be identifiable from the returned questionnaires. Participants were requested 
to return the paper version of the questionnaire in the postage paid envelope if they wished to take 
part in the study. 
The online questionnaire was designed using SNAP 11; survey software which can be used to design 
questionnaires that can distributed in multiple formats (including paper and online). Participants who 
opted for the online version of the questionnaire were provided with the information from the 
participant information sheet online (appendix 7) and required to indicate that they consented to 
take part in the study. The online questionnaire contained the same questions as the paper version 
(see appendix 5). 
4.2.6 Analysis  
Data were analysed using Statistical Package for Social Sciences IBM version 21. The data were 
screened for data entry errors and the frequency of missing values in the data set was calculated, 
with less than 10% of the total values missing and less than 10% of data missing for each item 
measured. George and Mallery (2012) state that it is acceptable to replace up to 15% of data by the 
mean of values for that variable and cause little damage to the resulting outcomes. George and 
Mallery (2012) also recommend that a case or variable missing more than 15% data is removed from 
the analysis. It was therefore decided to enter the series mean for the missing data whereby missing 
values were replaced by the mean value of all other values for that variable (George & Mallery, 
2012). 
Descriptive statistics were used to describe the sample in terms of gender, years worked and the 
ownership of the pharmacy participants were employed by. The distributions of the variables were 
checked for normality. Intention to give weight loss advice was normally distributed. Despite an 
acceptable skew value (0.84), on visual inspection the scores for intention to give medication 
adherence advice were not normally distributed and this variable was therefore transformed using a 
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square root transformation. Differences in gender, locum pharmacists (versus pharmacists who were 
not locums), pharmacy owners/employees and hours (full time/part time) by intention to give 
patients medication adherence advice and weight loss advice were analysed using t-tests. Two one-
way ANOVAs were performed to analyse differences between pharmacy ownership (independent, 
multiple and supermarket) by intention to give medication adherence advice and weight loss advice. 
Pearson’s bivariate correlations were performed to explore the relationships between the remaining 
continuous variables and intention to give medication adherence and weight loss advice respectively. 
Two paired samples t-tests were conducted to analyse the difference between pharmacists’ 
intention to provide medication adherence advice and intention to provide weight loss advice, and 
the difference between self-reported past advice-giving behaviour for advising patients on 
medication adherence and weight loss. 
4.2.6.1 Regression Analysis 
The eighteen independent variables were entered into two multiple hierarchical regressions models 
to determine the predictors of intention to provide medication adherence advice and intention to 
provide weight loss advice. In accordance with the Tabackhnic and Fidell (2013) guidance the 
following assumptions were checked: sample size; multicollinearity; singularity; outliers; normality; 
linearity; homoscedasticity and independence of residuals. The items derived from commonly used 
theories of social cognition identified as predictors of health professional intention and behaviour in 
previous literature (Eccles et al., 2012; Godin et al., 2008) were entered in the first step: attitude; 
subjective norm items (patients think and pharmacists think); perceived behavioural control and self-
efficacy. In the second step, additional variables that have been identified as predictors of health 
professional behaviour in previous studies (Godin et al., 2008 Laws et al., 2008, 2009; Presseau et al., 
2011) and were evident in the qualitative research were entered: perception of patients; goal 
facilitation and goal conflict; role congruence; past behaviour and training. Finally variables that 
cannot be altered through a behaviour change intervention were entered in the final step: 
independent ownership, multiple ownership, years worked, gender, locum status, working hours (full 
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time/part time). The questionnaire measured pharmacy ownership according to the Bush et al. 
(2009) definition. In order to perform regression analyses, the five categories were collapsed into 
three variables: independent + small chain = ‘independent’, large chain + multiple = ‘multiple’ and 
‘supermarket’. 
4.3 Results 
4.3.1 Response rate 
Two hundred and twenty-one of the 1200 postal questionnaires sent to 1200 individual community 
pharmacies were returned by the cut-off date resulting in an 18.4% response rate. An additional 
eighteen questionnaires were completed online giving 233 completed questionnaires in total (one 
blank questionnaire was returned). It was not possible to calculate a response rate for the online 
questionnaire. Two of the participants had more than 15% data missing and were therefore removed 
from the analysis (George and Mallery, 2012) leaving a sample of 231 participants. 
4.3.2 Characteristics of the sample 
The sample consisted of 116 men (50.2%) and 112 women (48.5%) with three participants (1.3%) 
preferring not to say. Most of the participants (190, 82.3%) were pharmacy employees, forty one 
participants (17.7%) were pharmacy owners (i.e. practising pharmacists who owned their own 
pharmacy). Most participants worked full-time (n=201, 87.0%) with the remainder (30, 13.0%) 
working part time. A small number of participants indicated that they were employed as locum 
pharmacists (22, 9.5%).  The majority of participants were employed by independent (96, 41.0%) and 
multiple-owned (102, 44%) pharmacies, with a minority of participants (27, 11.7%) employed by 
supermarket pharmacies. The mean number of years working as a community pharmacist was 13.79 
years (SD= 0.32) with a range from six months to 45 years.  
4.3.3 Comparison of variables between behaviours 
Paired-samples t-tests were conducted to compare the difference between each of the variables 
measured in relation to both types of advice (medication adherence and weight loss) (see table 4.1). 
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Given the risk of familywise errors associated with conducting this analysis, a more conservative 
probability value (p<0.01) was applied. There was a significant difference between all of the variables 
with the exception of perceived behavioural control.  There was a significant difference between all 
of the variables with the exception of perceived behavioural control.  Pharmacists were significantly 
more likely to intend to give patients with CVD medication adherence advice than give overweight 
patients with CVD weight loss advice, and were significantly more likely to report having given 
medication adherence advice in the past compared to weight loss advice.  Pharmacists were more 
likely to have positive attitudes towards giving medication adherence advice than weight loss advice, 
had higher self-efficacy to give medication adherence advice than weight loss advice, and giving 
medication adherence advice was perceived as significantly more role congruent than giving weight 
loss advice.  Pharmacists were more likely to believe that they had appropriate training to give 
medication adherence advice than weight loss advice. There was a significant difference between all 
of the subjective norm items: pharmacists were more likely to perceive that other pharmacists, 
patients and their employer respectively wanted them to give medication adherence advice than 
weight loss advice. Pharmacists were also more likely to believe that dispensing medicines facilitated 
them giving medication adherence advice than it did them giving weight loss advice. Conversely, 
pharmacists were more likely to believe that dispensing medicines conflicted with giving weight loss 
advice than giving medication adherence advice.  Finally, pharmacists were more likely to perceive 
that they could tell which patients would benefit from being giving medication adherence advice 
compared to weight loss advice. 
 
 
Table 4.1 presents a summary of the mean scores and standard deviations of the variables for the 
two behaviours. 
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Table 4.1: Table of means, standard deviations and the difference between means of variables 
relating to pharmacists’ medication adherence and weight loss advice 
 Medication adherence 
advice 
Weight loss advice Difference 
between means 
Mean (standard deviation) Mean (standard 
deviation) 
t  P 
Variable 
(Possible scores:1-5; 1 = 
high, 5= low) 
  
Intention 2.04 (0.90)* [2.0 ] 2.81(0.98) -43.02 <0.001 
Attitude  1.52 (0.57) 2.09 (0.81) -13.01 <0.001 
Perceived Behavioural 
Control (“up to me”) 
2.51 (1.10) 2.52 (1.03) 0.34 0.74 
Subjective Norm: 
employer thinks 
2.04 (1.05) 2.55 (0.99)  
Subjective Norm: patient 
thinks 
2.28 (0.93) 2.97 (0.97) -11.79 <0.001 
Subjective Norm: 
pharmacists think 
2.17 (0.93) 2.51(0.90) -6.44 <0.001 
Self-efficacy 1.90 (0.58) 2.75 (0.72) -18.96 <0.001 
Dispensing facilitates 
(goal facilitation) 
2.45 (1.03) 2.76 (1.02) -6.60 <0.001 
Dispensing prevents (goal 
conflict) 
3.21 (1.24) 3.07 (1.25) 3.69 <0.001 
Role congruence 1.50 (0.62) 1.89 (0.89) -6.60 <0.001 
Training  1.72 (0.86) 2.48 (1.18) 10.16 <0.001 
Perception of patients  2.48 (0.75) 2.54 (0.76) 
 
-3.81 <0.001 
Past behaviour 2.94 (1.20) 1.72 (0.97) 15.58 <0.001 
*Variable not normally distributed therefore median is presented in brackets. 
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4.3.4 The relationships between IVs and intention outcome variables for both behaviours 
The results of the bivariate analyses between the independent variables and intention to provide 
medication adherence advice and intention to provide weight loss advice respectively are presented 
in Table 4.2 below.  
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Table 4.2: Relationships between independent variables and intention outcome variables 
Variable Intention (medication 
adherence advice) 
Intention (weight loss advice) 
 R P R P 
Patients think (subjective norm) 0.502 <0.001 0.359 <0.001 
Pharmacists think (subjective 
norm) 
0.464 <0.001 0.483 <0.001 
Employer thinks (subjective 
norm) 
0.115 0.014 0.165 0.029 
Attitude 0.373 <0.001 0.448 <0.001 
Perception of patients 0.198 0.002 0.160 0.015 
Perceived behavioural control 
“Up to me” 
-0.166 0.12 -0.090 0.173 
Self-efficacy 0.392 <0.001 0.369 <0.001 
Goal facilitation 0.318 <0.001 0.334 <0.001 
Goal conflict -0.309 <0.001 -0.166 0.012 
Role congruence 0.479 <0.001 0.503 <0.001 
Past behaviour -0.463 <0.001 -0.389 <0.001 
Training 0.326 <0.001 0.284 <0.001 
Years worked 0.090 0.172 0.155 0.018 
 
 F (one-way 
ANOVA) 
P F (one-way 
ANOVA) 
P 
Pharmacy ownership 1.23 0.294 0.006 0.994 
     
 t  P t  P 
Gender 1.76 0.079 -0.215 0.830 
Employee status (pharmacy 
owner/employee) 
0.368 0.713 2.47 0.829 
Locum -0.067 0.946 -0.962 0.337 
Hours (part time/ full time) -0.121 0.904 -0.718 0.474 
Values shaded in the table above are statistically significant at p<0.05. 
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Self-efficacy, goal facilitation, role congruence and training were positively associated with intention 
to give medication advice: pharmacists who had lower scores on these measures (which indicated 
higher self-efficacy, agreement that dispensing facilitated giving patients with CVD medication 
adherence advice, that pharmacists perceived giving medication adherence advice as congruent with 
their role as a pharmacist and believed that they had received appropriate training to give 
medication adherence advice respectively) had higher intentions to give medication adherence 
advice (indicated by lower intention scores). This was also the case for weight loss advice: 
pharmacists who had lower scores on these measures (indicating higher self-efficacy, agreement that 
dispensing facilitated giving patients with CVD weight loss advice, that pharmacists perceived giving 
weight loss advice as congruent with their role as a pharmacist and believed that they had received 
appropriate training to give weight loss advice respectively) had higher intentions to give weight loss 
advice (indicated by lower intention scores).  
There was a positive relationship between past behaviour and intention to give medication 
adherence advice and intention to give weight loss advice: pharmacists who reported giving more 
weight loss advice in the past(indicated by higher scores) had higher intentions to give weight loss 
advice in the future (indicated by lower intention scores) whilst pharmacists who reported giving 
more medication adherence advice in the past (indicated by higher scores) had higher intentions to 
give medication adherence advice (indicated by lower intention scores). There was a negative 
association between intention to engage in either behaviour and goal conflict: pharmacists who 
perceived dispensing to cause high goal conflict with giving medication adherence advice (indicated 
by high conflict scores) had lower intentions to give medication adherence advice whilst pharmacists 
who perceived dispensing to cause less goal conflict with giving weight loss advice (indicated by low 
scores) had higher intentions to give weight loss advice. There was no relationship between years 
worked and intention to give medication adherence advice, however there was a positive association 
between years worked and intention to give weight loss advice: pharmacists who had worked as a 
pharmacist for longer had higher intentions to give weight loss advice. Finally, there was no 
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relationship between pharmacy ownership, gender, employee status, locum status, hours worked 
and intention to engage in either of the behaviours. 
4.3.5 Predicting intention to give medication adherence advice and intention to give 
weight loss advice 
Multiple regression analysis was conducted to identify the predictors of pharmacists’ intention to 
give weight loss advice to overweight patients with CVD and intention to give medication adherence 
advice to patients with CVD. In order for inclusion in the multiple regression, pharmacy ownership 
was entered as two dummy variables: independent ownership and multiple ownership verses 
supermarket ownership. All assumptions for multiple regression according to Tabachnick and Fidell 
(2013) were met. As previously described, the sample size was large enough for the results to be 
generalisable according to the sample size calculation recommended by Tabachnick and Fidell (2013) 
(see page 85). Multicollinearity was assessed by checking the correlations between the independent 
variables; none of the independent variables were highly correlated. The data were assessed for 
outliers (defined by Tabachnick and Fidell (2013) as those with standardised residual values above 
about 3.3 or less than -3.3: no outliers were removed. Finally, normality, linearity, homoscedasticity 
and independence of residuals was assessed: the residuals were normally distributed about the 
predicted dependent variable scores, the residuals had a linear relationship with the predicted 
dependent variable scores and the variance of the residuals about predicted dependent variable 
scores was the same for all predicted scores. The results of the analysis are presented in Tables 4.3 
and 4.4.  
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Table 4.3: Hierarchical multiple regression of variables predicting intention to provide medication 
adherence advice 
 Model 1 Model 2 Model 3 
 β P β p β P 
Subjective norm (patients 
think) 
0.296 <0.001 0.243 <0.001 0.258 <0.001 
Subjective norm 
(pharmacists think)* 
0.201 0.001 0.177 0.004 0.197 0.002 
Attitude 0.140 0.019 0.072 0.219 0.062 0.298 
Split PBC (“up to me”) -0.084 0.124 -0.060 0.259 -0.045 0.415 
Self-efficacy 0.196 0.001 0.109 0.094 0.112 0.093 
 
Perception of patients  0.119 0.030 0.116 0.041 
Goal facilitation -0.021 0.723 -0.027 0.656 
Goal Conflict -0.160 0.006 -0.164 0.005 
Role congruence 0.256 <0.001 0.252 <0.001 
Training -0.044 0.484 -0.059 0.356 
Past behaviour 0.109 0.030 0.116 0.029 
 
Pharmacy ownership – 
multiple (dummy 1) 
 0.011 0.896 
Pharmacy ownership – 
independent (dummy 2) 
-0.42 0.633 
Gender -0.122 0.026 
Locum -0.009 0.870 
Years worked -0.046 0.429 
Hours (full time/part 
time) 
-0.004 0.936 
Employee status 
(pharmacy 
owner/pharmacy 
employee) 
-0.046 0.429 
∆R
2
 0.383 0.086 0.016 
∆F 27.14 (p<0.001) 5.73 (p<0.001) 0.90 (p=0.51) 
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*NB. The third subjective norm ‘employers think’ was only relevant to the participants who were pharmacy 
employees rather than pharmacy owners therefore it was not included in the analysis. 
 
Step one explained 36.9% of the variance (adjusted R2) in intention to provide medication adherence 
advice, F(5, 219) = 27.14, p<0.001. All of the variables entered in this step were statistically significant 
apart from perceived behavioural control.  Pharmacists with more positive attitudes, higher self-
efficacy and believed that other pharmacists and patients wanted them to give medication 
adherence advice (indicated by lower scores on the respective measures) had higher intentions to 
give medication adherence advice (indicated by lower intention scores).The two subjective norm 
items were the strongest predictors of intention to give medication adherence advice, with the beta 
weightings suggesting that pharmacists’ perceptions of what patients thought were a stronger 
predictor of intention than their perception of what other pharmacists thought. 
At the second step the model explained 44.1% of the variance (adjusted R2) in intention to provide 
medication advice, F(11, 224)=17.06, p<0.001. Six variables were significant predictors of intention to 
give medication adherence advice: pharmacists had higher intentions to give medication adherence 
advice (indicated by lower intention scores) if they believed other pharmacists and patients wanted 
them to give medication adherence (the subjective norm items), perceived that they could tell which 
patients would adhere to medication, did not experience goal conflict, believed that giving 
medication adherence advice was congruent with their role as  a pharmacist  and  had given 
medication adherence advice to patients in the past. This step explained an additional 8.9% of 
variance in intention to provide medication adherence advice (R2 change =0.101, F change (6, 213) 
=5,73, p<0.001. At this step, attitude and self-efficacy, two of the variables that were significant in 
step one, were no longer significant. Role congruence, entered in the second step became the 
strongest predictor of intention, and this variable may be responsible for self-efficacy and attitude no 
longer being significant predictors of intention.  
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The model in the final step explained an additional 1.6% of the variance in intention (adjusted R2 
change= 0.016, F change (7, 206) =0.90) and at this step one additional variable, gender, was a 
significant predictor of intention, with female pharmacists scoring higher on intention to give 
medication adherence advice than males. However the overall addition of this step was not 
significant, therefore the final model explained 43.9% of the variance intention to give patients with 
CVD medication adherence advice (adjusted R2 =0.439) and the model was statistically significant 
(F(18, 224)= 10.74, p<0.001). Role congruence was the strongest predictor of intention: this suggests 
that pharmacists seeing behaviour (in this case giving medication adherence advice) as being part of 
their role was associated with higher intentions to engage in the behaviour. Subjective norms were 
also strong predictors: believing that patients and other pharmacists think that pharmacists should 
give medication adherence advice was associated with stronger intentions to engage in the 
behaviour. Goal conflict was a significant predictor of intention and there was a negative correlation 
between intention and goal conflict meaning that pharmacists who did not perceive dispensing 
activities to conflict with giving medication adherence advice had higher intentions to give 
medication adherence advice. Previous experience of giving patients with CVD medication adherence 
advice and pharmacists perceiving that they could predict how patients would behave were also 
associated with higher intentions to give medication adherence advice. 
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Table 4.4: Hierarchical multiple regression of variables predicting intention to provide weight loss 
advice to overweight patients with CVD 
 Model 1 Model 2 Model 3 
 β P β P Β P 
Subjective norm (patients 
think) 
0.182 0.02 0.165 0.005 0.170 0.005 
Subjective norm 
(pharmacists think) 
0.257 <0.001 0.201 0.001 0.195 0.002 
Attitude 0.289 <0.001 0.204 0.003 0.204 0.004 
Split PBC (“up to me”) -0.062 0.124 -0.063 0.256 -0.050 0.383 
Self-efficacy 0.132 .045 0.080 0.257 0.076 0.305 
 
Perception of patients  0.90 0.114 0.089 0.138 
Goal facilitation -0.009 0.886 -0.016 0.814 
Goal Conflict -0.089 0.114 -0.089 0.138 
Role congruence 0.230 0.001 0.220 0.002 
Training -0.015 0.817 -0.006 0.926 
Past behaviour 0.004 0.944 0.003 0.964 
 
Pharmacy ownership – 
multiple (dummy 1) 
 0.044 0.602 
Pharmacy ownership – 
independent (dummy 2) 
0.040 0.668 
Gender 0.018 0.763 
Locum 0.065 0.273 
Years worked 0.076 0.218 
Hours (full time/part 
time) 
-0.007 0.908 
Employee status 
(pharmacy 
owner/pharmacy 
employee) 
0.032 0.651 
∆R
2
 0.363 0.049 0.011 
∆F 24.95 (p<0.001) 2.99 (p=0.08) 0.56 (p=0.80) 
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For intention to provide weight loss advice, the model in step one explained 34.8% of the variance 
(adjusted R2), F(5,224)=15.46, p<0.001. Four of the five variables entered at this step were significant 
predictors of intention: Pharmacists with more positive attitudes, higher self-efficacy and who 
believed that other pharmacists and patients wanted them to give weight loss advice had higher 
intentions to give weight loss advice. Perceived behavioural control was not a significant predictor of 
intention.  
At the second step, the model explained 38.2% of the variance (adjusted R2) in intention to provide 
weight loss advice and was statistically significant F(11,224)= 13.59, p<0.001. One additional variable, 
role congruence was a significant predictor of intention: pharmacists who strongly believed that 
giving weight loss advice was congruent with their role as a pharmacist had higher intentions to give 
weight loss advice. Therefore pharmacists with more positive attitudes towards giving weight loss 
advice, believed that other pharmacists and patients wanted them to give weight loss advice and 
believed that giving weight loss advice was role congruent had higher intentions to give overweight 
patients with CVD weight loss advice. As with the medication adherence advice regression model, 
self-efficacy was no longer a significant predictor of intention when role congruence was added to 
the model.  
The model in the final step explained less of the variance in intention to provide weight loss advice 
than the model at step two (adjusted R2= 0.373) and R square change was not significant (R2 change 
=0.011, F change (7, 206) =0.55, p=0.80). None of the variables entered in this step was a significant 
predictor of intention.  
4.3.6 Further exploration of the role of role congruence 
As demonstrated above, pharmacists’ having a positive attitude was a significant predictor of 
intention to give weight loss advice but not medication adherence advice. Despite there being no 
collinearity between the variables, it was thought that there may be some overlap between the 
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attitude and role congruence variables. In order to assess this, sensitivity analysis was performed by 
removing role congruence from the regression models.  
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Table 4.5: Sensitivity analysis: hierarchical multiple regression of variables predicting intention to 
provide medication adherence advice to patients with CVD 
 Model 1 Model 2 Model 3 
 Β P Β p Β P 
Subjective norm (patients 
think) 
0.296 <0.001 0.243 <0.001 0.257 <0.001 
Subjective norm 
(pharmacists think) 
0.201 <0.001 0.216 0.001 0.235 <0.001 
Attitude 0.140 0.019 0.133 0.025 0.126 0.034 
Split PBC (“up to me”) -0.084 0.124 -0.076 0.167 -0.055 0.338 
Self-efficacy 0.196 0.001 0.150 0.025 0.157 0.022 
 
Perception of patients  0.130 0.022 0.124 0.034 
Goal facilitation -0.018 0.772 -0.026 0.684 
Goal Conflict -0.173 0.004 -0.180 0.003 
Training 0.010 0.870 -0.011 0.866 
Past behaviour 0.097 0.073 0.102 0.064 
 
Pharmacy ownership – 
multiple (dummy 1) 
 0.023 0.779 
Pharmacy ownership – 
independent (dummy 2) 
-0.018 0.0841 
Gender -0.131 0.021 
Locum -0.019 0.737 
Years worked -0.013 0.823 
Hours (full time/part 
time) 
-0.027 0.635 
Employee status 
(pharmacy 
owner/pharmacy 
employee) 
-0.013 0.858 
∆R
2
 0.383 0.043 0.019 
∆F 27.14 (p<0.001) 3.18 (p=0.009) 1.002 (p=0.431) 
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Step one explained 36.9% of the variance (adjusted R2) in intention to provide medication adherence 
advice (F(5, 219) = 27.14, p<0.001. All of the variables entered in this step were statistically 
significant apart from perceived control, with attitude towards giving medication adherence advice 
the strongest predictor of pharmacists’ intentions to give medication adherence advice. Pharmacists 
with more positive attitudes, higher self-efficacy and who believed that other pharmacists and 
patients thought that they should give medication adherence advice had higher intentions to give 
medication adherence advice. 
At the second step the model explained 39.8% of the variance in intention (adjusted R2) to provide 
medication advice F(10, 214)=15.84, p<0.001. Six variables were significant predictors of intention to 
give medication adherence advice: pharmacists had higher intentions to give medication adherence 
advice if they had more positive attitudes towards giving medication adherence advice, had higher 
self-efficacy, perceived that they could tell which patients would adhere to medication, did not 
experience goal conflict and  had given medication adherence advice to patients in the past (all 
indicated by lower scores) had higher intentions to give medication adherence advice. The model 
explained an additional 4.3% of variance in intention to provide medication adherence advice, F 
change (5, 214) =3.18, p<0.009.  
The model in the final step explained an additional 1.9% of the variance in intention, F change (7, 
207) =0.431) and at this step one additional variable, gender, was a significant predictor of intention 
however the overall addition of this step was not significant. Therefore the final model explained 
39.9% of the variance (adjusted R2) in intention to give patients with CVD medication adherence 
advice and the model was statistically significant (F(17, 207)= 9.73, p<0.001).  
The above analysis demonstrated that having a positive attitude towards giving medication 
adherence advice was a predictor of pharmacists’ intentions to give medication adherence advice 
when role congruence was not entered into the regression model, suggesting that there is some 
overlap between the two constructs. However the model that included role congruence predicted 
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more of the variance in pharmacists’ intention to give medication adherence advice than the model 
that did not (44.1% verses 39.9%) which suggests that role congruence was a valuable addition. 
4.4 Discussion 
This study aimed to identify and compare the predictors of pharmacists’ intentions to provide two 
different types of advice: medication adherence advice and weight loss advice. The study identified 
determinants of pharmacists’ intention to give both types of advice which predicted 44.1% of the 
variance in pharmacists’ intention to give patients with CVD medication adherence advice and 38.2% 
of the variance in pharmacists’ intention to give overweight patients with CVD weight loss advice. 
Superficially, both behaviours are the same (i.e. giving advice) however, whilst sharing some 
common determinants, the determinants of pharmacists’ intentions to give medication adherence 
advice and weight loss advice to overweight patients differed. Pharmacists intended to give 
medication adherence advice if:  
 they thought patients believed that they should give medication adherence advice 
 they thought other pharmacists believed that they should give medication adherence advice 
 they did not believe dispensing activities in the pharmacy prevented them from giving 
medication adherence advice 
 they believed giving medication adherence advice was an important part of their role as a 
pharmacist 
 they had given medication adherence advice in the past 
 they perceived that they could predict which patients would benefit from their advice and 
adhere to their medication.  
Pharmacists intended to give overweight patients with CVD weight loss advice if:  
 they believed patients thought that they should give weight loss advice 
 they believed other pharmacists thought they should give weight loss advice 
 they thought giving weight loss advice would have a positive outcome 
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 they thought giving weight loss was an important part of their role as a pharmacist.  
The study found that community pharmacists were significantly more likely to intend to give patients 
with CVD medication advice than they were to intend to give weight loss advice to overweight 
patients with CVD. Pharmacists reported having given significantly more medication adherence 
advice to patients with CVD than weight loss advice to overweight patients with CVD in the past. 
The TPB (Ajzen, 1991) posits that its four theoretical constructs alone successfully account for all 
effects on behaviour, with attitudes, subjective norm and perceived behavioural control determining 
an individual’s intention to engage in behaviour. Whilst the present study found some of the TPB 
constructs to be significant predictors of pharmacists’ intention to give medication adherence and to 
give weight loss advice, constructs outside the TPB accounted for additional variance in both 
behaviours. The model in the present study accounts for more of the variance in intention than other 
studies which have used the TPB to predict pharmacists’ intentions to engage in clinical behaviours. 
This supports the findings of various studies which identified constructs in addition to those included 
in the TPB as successful in accounting for additional variance in health professional intention and 
behaviour (Eccles et al., 2012; Godin et al.,. 2013; Presseau et al., 2011, 2013).  
Pharmacists’ attitude was a significant predictor of intention to give weight loss advice but not 
medication adherence advice. The pharmacists also had significantly more positive attitudes towards 
giving medication adherence advice than they had towards giving weight loss advice to overweight 
patients with CVD. When additional exploratory analysis was performed, attitude emerged as a 
strong significant predictor of pharmacists’ intention to give medication adherence advice when the 
role congruence item was removed from the regression model. This suggests that pharmacists’ 
attitudes towards giving medication adherence advice are related to their beliefs about whether 
giving medication adherence advice is an important part of the pharmacist’s role, and despite there 
not being multicollinearity between the items, these constructs have some shared variance. It may 
be that because advising about medications is considered a core component of the pharmacists’ 
identity and role, having a positive or negative attitude towards this type of advice is not as 
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important as in relation to a different kind of advice, weight loss advice, which is not directly linked 
to medicines and therefore may not be associated with the traditional role of the pharmacist. This 
may also explain the difference between the models in relation to subjective norm; pharmacists 
perceptions of what patients thought was a stronger prediction of intention to give medication 
adherence advice whereas what the participants’ perceptions of what pharmacists thought was a 
stronger predictor of their intentions to give weight loss advice.  
Subjective norms were found to be a strong predictor of pharmacists’ intentions to engage in both 
behaviours. Previous research has also found subjective norms to be important in predicting 
intention to engage in clinical behaviour; Gavaza et al. (2011) found subjective norms to be the 
strongest predictor of pharmacists’ intention to engage in clinical behaviours. They found that the 
TPB variables explained 34% of the variance in pharmacists’ intention to report serious adverse drug 
events, with subjective norms the strongest TPB predictor after controlling for attitude and perceived 
behavioural control (PBC).  Furthermore Pradel, Obeidat and Tsoukleris (2007) found subjective norm 
to be the most important predictor of pharmacists’ intention to counsel children with asthma whilst 
a recent study found that subjective norms were the most important predictor of pharmacists’ 
intentions to use a prescription drug monitoring database (Fleming et al., 2014). Gavaza et al. (2011) 
suggested that the importance of subjective norms in predicting pharmacists’ intentions to report 
serious drug events may be because the behaviour has implications for other people. Furthermore, 
Fleming et al. (2014) suggested that the reason subjective norms are the strongest predictors of 
pharmacists’ intentions to engage in behaviour may be that pharmacists feel pressure to benefit 
patients or to meet regulatory requirements more than other healthcare professionals. In the 
current study, whilst both significant predictors, what patients think was more important than what 
pharmacists think in relation to pharmacists intentions to provide medication advice. However, 
conversely, what other pharmacists thought was a stronger predictor of pharmacists’ intentions to 
provide weight loss advice than pharmacists’ perceptions of what patients thought. This finding 
demonstrates the value of analysing subjective norms separately rather than combining the 
 
 
121 
 
measures, given that in this case the perception of different groups of important others’ opinions 
differed according to the behaviour in question. 
The TPB posits that perceived behavioural control (PBC) is a predictor of intention to engage in 
behaviour as well as a direct predictor of behaviour (Ajzen, 1991). Furthermore, a systematic review 
of constructs from social cognitive theories which predicted health professional intention and 
behaviour found that PBC and intention were the two most important categories of variables in 
predicting health professional behaviour (Godin et al., 2008). However in this study PBC was not a 
significant predictor of intention to engage in either of the behaviours at any stage in the analysis. 
There are a number of possible explanations for this. 
Firstly the findings may reflect a problem with how PBC was operationalised. In accordance with 
established guidelines (Francis et al., 2004) for constructing TPB questionnaires, an item measuring 
PBC which used the phrase ‘The decision to advise a patient with CVD how to [lose weight/adhere to 
their prescribed medication] is beyond my control’ was included in an earlier version of the 
questionnaire. This was subsequently removed after conducting think aloud interviews; the word 
‘control’ appeared to evoke a defensive response from some of the participants. This appeared to be 
connected to their perceptions of their professional autonomy, and appeared to result in some 
participants perceiving that their professional autonomy was being questioned.  This is in keeping 
with the debates concerning whether pharmacy is in fact a profession with control over the social 
object of its practice (medicines) (Denzin & Metlin, 1966; Knapp & Knapp, 1968; Trausen & Bisell, 
2004). It follows, given this context, that a question which assesses the participants’ perceived level 
control over an area of their practice may be a sensitive area and may tap into wider concerns about 
their autonomy as a practitioner. This is a plausible explanation for the defensive response.  
It may be that by removing the word control from the item measuring PBC and instead using the 
wording “The decision to advise a patient with CVD how to [lose weight/adhere to their prescribed 
medication] is entirely up to me”, this statement did not in fact measure participants’ PBC as 
intended. Alternatively, the wording used in the item included in the final version of the 
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questionnaire may still have evoked a defensive response and affected the way participants 
answered the question, making it less likely for them to indicate that they had low PBC to give both 
types of advice. 
However, this is not the only study examining pharmacists’ behaviour which did not find PBC to be a 
significant predictor of intention. Gavaza et al. (2011) found that PBC was not a significant predictor 
of pharmacists’ intention to report adverse drug events whilst another study using the TPB found 
that PBC was not a significant predictor of pharmacists’ intentions to supply non-prescription 
antifungals to treat vulvovaginal candidiasis (Walker, Watson, Grimshaw & Bond, 2004). The present 
study measured pharmacists’ intentions to give medication adherence and weight loss advice rather 
than the behaviour itself. As previously mentioned, the TPB (Ajzen, 1991) posits that PBC is a direct 
predictor of behaviour in addition to being a predictor of intention. Despite intention being identified 
as a predictor of health professional behaviour (Eccles et al., 2006), it may be that PBC would emerge 
as a predictor of behaviour had behaviour been measured in addition to intention. 
Role congruence was operationalised in the present study as whether pharmacists believed that both 
types of advice were an important part of their role as a pharmacist. Previous research has identified 
role congruence as a factor influencing health professional behaviour. In a qualitative study of 
Scottish GPs, Fuller, Backett-Milburn, and Hopton (2003) found that younger GPs perceived giving 
preventative dietary advice to be an important part of their role, felt that GPs’ advice was a more 
credible source of dietary advice than other sources and perceived that patients welcomed their 
input even if they were not receptive to it at first. Conversely, Fuller et al. (2003) found that older 
GPs viewed their role as one of treating illness and disease and did not perceive giving dietary advice 
as part of their role, reporting seeing giving dietary advice as ineffective, perceiving that patients 
were not interested and that giving dietary advice could potentially damage their relationship with 
patients. Furthermore, in a qualitative study conducted with 48 Australian health professionals to 
establish a theoretical model to understand how clinicians’ perceptions affect the implementation of 
lifestyle advice in routine practice, Laws et al. (2009) identified role congruence as an important 
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factor which when combined with perceptions of scope to make a difference and client 
receptiveness to the advice, informed the first stage of the model: ‘commitment’. In the present 
study, role congruence was the strongest predictor of intention to give both types of advice, with 
pharmacists who perceived giving weight loss advice and medication adherence advice as an 
important part of their role as a pharmacist more likely to intend to give the advice. Pharmacists’ 
perceptions of their role in public health has been investigated in two systematic reviews, with both 
reviews finding that whilst pharmacists were positive about providing public health services and saw 
this as an important role, they viewed their role in public health as secondary to medicines related 
roles (Anderson et al., 2003; Eades et al., 2011). In the present study, pharmacists perceived giving 
medication advice as significantly more role congruent than giving weight loss advice to overweight 
patients. This is in keeping with the findings of Anderson et al. (2003) and Eades et al. (2011), with 
medicines related advice being viewed as more role congruent than weight loss advice. It also 
supports the findings of Elvey, Hassell and Hall (2013) who used a qualitative methodology to explore 
pharmacists perceptions of their professional identity, concluding that ‘the scientist’ emerged as the 
clearest identity for participants. The pharmacists perceived their scientific knowledge as being 
applied practically through their role in supplying medicines and also through their identity as 
advisors on medicines. Unsurprisingly, pharmacists’ professional identity appears to be grounded in a 
knowledge of and the supply of medicines. Giving weight loss advice is not directly linked to having 
knowledge of or in the supply of medicines, and therefore appears to be more role incongruent than 
giving medication adherence advice. 
Previous studies have identified self-efficacy as an important factor influencing pharmacists’ 
behaviour in relation to health-promotion roles (Anderson et al., 2003; Eades et al., 2011). In their 
systematic review Eades et al. (2011) concluded that pharmacists had moderate to low self-efficacy 
in their ability to perform public health related roles. The pharmacists mean score for self-efficacy for 
giving medication adherence advice was high, indicating that pharmacists were confident in their 
abilities to give this kind of advice whereas pharmacists’ mean score for self-efficacy for giving weight 
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loss advice was mid-range. There was a significant difference in pharmacists’ self-efficacy between 
the behaviours, with pharmacists having significantly higher self-efficacy to give medication 
adherence advice than to give weight loss advice. This supports the findings of previous systematic 
reviews which concluded that pharmacists were more confident in their roles related to medicines 
than public health roles (Anderson et al., 2003; Eades et al., 2011). However whilst the present study 
found that self-efficacy was a significant predictor of pharmacists’ intentions to give both medication 
adherence and weight loss advice in the first regression models, self-efficacy was no longer a 
significant predictor of intention to engage in either behaviour after the addition of role congruence 
to the model. 
There are a number of possible explanations why self-efficacy was not a significant predictor of 
pharmacists’ intentions to give medication adherence or weight loss advice in the current study. 
Firstly, it may be that other factors are more important determinants of pharmacists’ advice giving 
behaviour than self-efficacy. In addition to subjective norm, the present study found role congruence 
to be an important determinant of pharmacists’ intentions to give patients both medication 
adherence and weight loss advice. As described above, self-efficacy was no longer significant after 
the addition of role congruence to the regression model.  In the exploratory analysis which removed 
role congruence from the regression models to assess whether there was shared variance between 
role congruence and attitude in relation to medication adherence advice, self-efficacy became a 
significant predictor of intention when role congruence was removed from the models (which 
predicted less of the variance in pharmacists’ intention to give medication adherence advice). It may 
be that whether pharmacists believe that giving medication adherence advice and/or weight loss 
advice is part of their role is more important than their self-efficacy; pharmacists may have high self-
efficacy to engage in the behaviour but if they do not believe it is part of their role then they may not 
be motivated to or not intend to give the advice. 
Another possible explanation for this finding may concern the way self-efficacy is operationalised. Of 
the eleven studies discussed in relation to competence/confidence in the Eades et al. (2011) 
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systematic review which concluded that pharmacists lacked self-efficacy to perform tasks associated 
with their newer public health role, one of the studies described measuring the construct as ‘self-
efficacy’ and none of the studies reported developing the measures in accordance with guidelines to 
measure self-efficacy defined by Bandura (2006). Contrastingly the present study assessed self-
efficacy in accordance with these guidelines and found self-efficacy not to be predictive of 
pharmacists’ intentions to engage in either of the behaviours. Without assessing self-efficacy as it is 
intended to be measured, reliable conclusions about the effect of self-efficacy on pharmacists’ 
behaviour cannot be reached.  
Alternatively, it could be that self-efficacy is not critical in the formation of pharmacists’ intention to 
engage in either of the behaviours under investigation however this may differ in relation to actual 
enactment of the behaviours. The Godin et al. (2008) framework of health professional behaviour 
(see page 22) proposed that ‘beliefs about capabilities’ is a direct predictor of health professional 
behaviour as well as being predictive of intention formation. The present study measured intention 
to engage in the behaviours rather than directly measuring pharmacists’ behaviour. It could be that 
self-efficacy is predictive of pharmacists’ behaviour and therefore not evident in the current findings 
as behaviour was not measured.  In the present study, although pharmacists are contractually 
obliged to give lifestyle advice, their provision of lifestyle advice was not actively monitored. In 
previous studies, the behaviour may have been compulsory and performance checked, therefore in 
this situation, regardless of whether pharmacists believed that the activity was role congruent, they 
would have to engage in the behaviour as their performance was being assessed. In this situation, 
self-efficacy may then become more important. 
The present study found goal conflict, operationalised as ‘dispensing prevents’ to be a predictor of 
intention to provide medication adherence advice but not weight loss advice. Pharmacists who did 
not perceive dispensing activities in the pharmacy as a barrier to giving medication adherence advice 
were more likely to report intending to give medication adherence advice. Goal conflict was not a 
significant predictor of weight loss advice however pharmacists perceived dispensing to result in 
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significantly more goal conflict with giving weight loss advice than giving medication adherence 
advice. An explanation for this may be that despite pharmacists perceiving that dispensing causes 
significantly more goal conflict with weight loss advice than medication adherence advice, if 
pharmacists do not view giving weight loss advice as part of the routine dispensing process it will not 
cause goal conflict. In the qualitative study (chapter three), pharmacists did not integrate lifestyle 
advice and dispensing prescriptions, rather seeing Medicines Use Reviews as the setting in which to 
give lifestyle advice. This could explain why goal conflict with dispensing was not a predictor of 
pharmacists’ intentions to giving weight loss advice as weight loss advice was not seen as relevant to 
the dispensing process. Furthermore, dispensing was not seen as facilitator to giving medication 
adherence advice. Therefore it appears that pharmacists who intend to give medication adherence 
advice do not see dispensing as a barrier to giving the advice rather than viewing dispensing as aiding 
them to give medication adherence advice. This is noteworthy as best practice guidelines for 
pharmacists (DoH, 2005) and more recent government reports (NHS Future Forum, 2012) envisage 
pharmacists using the act of dispensing medicines as a platform to offer lifestyle advice.  
Pharmacy ownership was not predictive of pharmacists’ intentions to engage in either of the 
behaviours. This conflicts with previous research which found pharmacy ownership to influence 
pharmacists’ behaviour (Bush et al., 2009; Maunder & Landes, 2005). There are possible explanations 
for this.  Firstly, more participants from independent and multiple pharmacies responded to the 
questionnaire than participants from supermarket pharmacies meaning that an effect of ownership 
on intention to give both types of advice may have not been identified. Furthermore for inclusion in 
the multiple regression, pharmacy ownership was collapsed from five categories as measured by 
Bush et al. (2009) into three categories (independent, multiple and supermarket ownership) which 
also may have led to an effect of ownership not being detected. Alternatively, it could be that 
psychological variables assessed in the current study (which were not assessed in the study by Bush 
et al., 2009) moderate the impact of working conditions in different pharmacy ownerships or that the 
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pharmacists working in pharmacies under different pharmacy ownership differ in the psychological 
variables assessed in the current study.   
Finally, past behaviour was also found to be a significant predictor of pharmacists’ intentions to give 
both medication adherence advice and weight loss advice. Past behaviour being a predictor of 
intention is in line with previous research which found that past behaviour was predictive of GPs 
prescribing antibiotics (Walker et al, 2004) and also lends support to the Godin et al. (2008) model of 
health professional behaviour (described in more detail in chapter one).  
4.4.1 Strengths and Limitations 
This is the first study to assess the predictors of pharmacists’ intentions to give weight loss advice, 
and secondly, to compare the predictors of pharmacists’ intentions to give two different kinds of 
advice: medication adherence and weight loss advice to patients with CVD. The study was based on a 
qualitative study and is informed by psychological theory. The use of psychological theory increases 
the likelihood that the study can be effectively replicated. Furthermore, it allows the identification of 
determinants of pharmacists’ intentions to engage in behaviour which can potentially be used to 
develop interventions to promote behaviour change and increase engagement in the target 
behaviours. Due to the same participants completing questions on both behaviours, a direct 
comparison between the determinants of intentions to engage in the two different behaviours was 
possible. A substantial portion of variance in pharmacists’ intentions to give medication adherence 
and weight loss advice was accounted for. 
Despite this, there are some limitations to the study. The major limitation was that no direct, 
objective measure of the participants’ behaviour was obtainable. Whilst a substantial portion of 
variance in intention accounted for, this is likely to be less in objectively measured behaviour. A 
systematic review conducted by Eccles et al. (2006) concluded that intentions account for a similar 
proportion of variance in behaviour found in the non-health professional literature, with R2 ranging 
from 0.15 to 0.4 (Eccles et al., 2006; Eccles et al. 2012). The present study measured pharmacists’ 
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past behaviour, however the validity of clinicians’ self-reported behaviour has been questioned 
(Godin et al., 2008; Hrisos et al., 2009). Godin et al. (2008) found that when an objective measure of 
behaviour was used rather than a self-report measure, efficacy of prediction decreased, whilst a 
systematic review conducted by (Hrisos et al., 2009) found that the evidence for the validity of self-
report measures as a proxy for health professional behaviour is inconclusive. 
Although the sample size in the current study meant that all of the statistical analyses were 
sufficiently powered in accordance with the Tabachnick and Fidell (2013) guidelines, the response 
rate of 18.4% is still relatively low. Small sample sizes are not uncommon in theory based studies of 
health professional behaviour. As Presseau et al. (2011) have noted, seven of the fourteen 
prospective studies testing the TPB in relation to health professional behaviour included in the Godin 
et al. (2008) systematic review had sample sizes of 50 participants or fewer. Furthermore, many of 
the included studies which used postal questionnaires reported response rates of less than 25%. This 
was also found by Eccles et al. (2012) who conducted five studies with different health professionals 
examining different health behaviours, reporting response rates ranging from 21-48%. Eccles et al. 
(2012) failed to achieve the necessary sample size in two of their five studies. They state the need for 
higher response rates to give greater confidence in the representativeness of the findings, but 
contextualise the difficult of this in practice by citing slowly declining response rates to postal 
questionnaires by health professionals; 61% in the ten years up to 1995 and 57% in the decade after 
(Cane, O'Connor, & Michie, 2012). 
The recruitment strategy was designed to recruit a representative sample of pharmacists from across 
England however this cannot be guaranteed. It is noteworthy that there were considerably fewer 
responses from pharmacists employed by supermarket pharmacies which may have affected the 
results and mean that an effect of pharmacy ownership on intention was not detected. It is unclear 
whether this is a result of the recruitment strategy or whether pharmacists employed by 
supermarket chains are less likely to take part in research studies. Based on their experiences 
conducting research in this field, it has been suggested by the author that some pharmacy companies 
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appear not to actively promote pharmacist involvement in research.. It could be that this influenced 
participants employed by supermarkets more than other participants. 
Finally, emotion was not included as a predictor of pharmacists’ intention to engage in both advice 
giving behaviours. Given that participants in the qualitative study (chapter three) indicated that they 
were uncomfortable initiating conversations about weight loss in-case this caused offence to 
patients, this may be a determinant of pharmacists’ intention to give weight loss advice. 
4.5 Conclusion 
This study applied psychological theory to aid the identification of the predictors of pharmacists’ 
intentions to give patients with CVD two different types of advice to aid patient self-management of 
the condition. The models predicted  46.8% of the variance in pharmacists’ intentions to give 
medication adherence advice and 40.8% of the variance in pharmacists’ intentions to give weight loss 
advice.  Pharmacists were significantly more likely to intend to give medication adherence advice 
than they were to give weight loss advice to overweight patients with CVD, whilst pharmacists 
reported giving significantly more medication adherence advice than weight loss advice (to 
overweight patients) in the past. Despite being superficially similar, the variables predicting intention 
to engage medication adherence advice and weight loss advice shared some common predictors but 
were not the same. The results suggest that role congruence and subjective norms (primarily 
perceptions of what patients think in relation to medication adherence advice and what other 
pharmacists think in relation to weight loss advice) could be potential targets for changing 
pharmacists’ advice giving behaviour. 
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5 Chapter Five: Interventions to prepare pharmacists, pharmacy 
staff and pharmacy students to facilitate patient lifestyle 
behaviour change: A systematic review 
5.1 Introduction 
There have been considerable changes to the role of pharmacists in the past forty years, as 
highlighted in chapter one, with pharmacists adopting new roles which involve facilitating patient 
self-management of chronic conditions through behavioural approaches. The qualitative exploration 
of community pharmacists’ experiences of giving patients with CVD lifestyle advice presented in 
chapter three found that some pharmacists felt that they had not received appropriate training in 
providing lifestyle advice to facilitate patient self-management. As discussed, this finding supports 
those of a number of previous studies (Anderson et al, 2003; Eades et al., 2011). To date, the 
effectiveness of training for pharmacists relating to the public health roles outlined in the pharmacy 
contract (DoH, 2005) has not been determined.  Consequently a systematic review of the efficacy of 
interventions to prepare pharmacists to facilitate patient lifestyle behaviour change was undertaken. 
Facilitating both prevention and self-management of chronic conditions through promoting changes 
in patient lifestyle behaviour differ considerably from pharmacists’ traditional role which involves the 
preparation and distribution of medicines. It follows that facilitating a behavioural approach to 
patient self-management requires a different skill set from that traditionally required by pharmacists. 
Previous research has suggested that pharmacists do not always feel well equipped to successfully 
fulfil the more recently adopted public health roles (Anderson et al., 2003; Eades et al., 2011). As 
discussed in chapter one, both reviews concluded that pharmacists required further training to 
enable them to successfully fulfil public health roles, with Eades et al. (2011) suggesting that future 
interventions should seek to improve pharmacists’ self-efficacy to provide public health services. A 
survey of US pharmacy schools in 2005 found that few institutions gave pharmacy students the 
 
 
131 
 
opportunity to gain knowledge and skills about lifestyle change that can improve health and 
wellbeing and prevent disease, with only four out of the fifty schools which responded to the survey 
offering a mandatory course on lifestyle change (Lenz, Monaghan & Hetterman, 2007). A comparable 
survey of UK pharmacy schools has not been conducted. 
It is important to consider the training pharmacists receive and the effect this has on their behaviour, 
as health professional behaviour can determine patient outcome. Marteau and Johnston (1991) 
stressed the importance of viewing health professional behaviour as a source of variance in patient 
outcome, arguing that health professionals differ in their approaches to similar situations and that 
this difference is not fully attributable to medical knowledge; rather other cognitive processes such 
as beliefs, attitudes and intentions, in addition to knowledge, influence health professional 
behaviour. The effect of health professional behaviour on patient outcome was demonstrated in a 
systematic review of the research examining communication between patients and health 
professionals about medicines and the consequences for concordance (Stevenson, Cox, Britten, & 
Dundar, 2004). The review found that health professionals’ behaviour can limit or facilitate patient 
involvement in discussions about their treatment. Increased patient involvement in the interaction 
was associated with greater understanding of medical treatment, medication adherence and more 
satisfaction with the encounter. Given that health professional behaviour can have an effect on 
patient outcome, and that the ultimate aim of interventions to change provider behaviour is to have 
an impact on patient outcome, the present review included studies where patient outcome was the 
primary outcome measure of interventions to change pharmacists’, pharmacy students’ or pharmacy 
staff behaviour as well studies where participants’ behaviour was the primary outcome. 
As discussed in chapter one, there is some evidence demonstrating that interventions based on 
psychological theory are more effective than interventions that do not report using theory to 
develop the intervention although this is not conclusive (Gardner et al., 2011; Michie et al., 2009; 
Prestwich et al., 2013; Webb et al., 2010). The use of theory in designing interventions has additional 
benefits such as aiding identification of the components of the intervention that work (or not) and 
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making it easier for the intervention to be replicated. Therefore, this systematic review coded studies 
that met the specified inclusion criteria for use of theory using a theory coding scheme designed by 
Michie and Prestwich (2010). 
As outlined in chapter one, there is a difference between theories of health behaviour and theories 
of health behaviour change; the theories that can be applied to explain health professional behaviour 
do not always state how to change behaviour, and a separate set of techniques is required to do this. 
The behaviour change taxonomy (Michie et al, 2013) lists 93 individual behaviour change techniques 
(BCTs) that can be used to change behaviour. This review coded for BCTs In order to identify the 
techniques that were used in any interventions which successfully enabled pharmacists and or 
pharmacy students and staff to facilitate patient lifestyle behaviour change. 
In summary, pharmacists in the UK are contractually obliged to offer patients lifestyle advice to both 
prevent the development of chronic conditions and to facilitate patient self-management of chronic 
conditions. Despite the study presented in chapter four not finding self-efficacy or receipt of 
appropriate training to be a predictor of pharmacists’ intentions to give weight loss or medication 
adherence advice, a body of previous research has concluded that pharmacists lack the 
confidence/self-efficacy to provide lifestyle advice and require enhanced training to equip them with 
the necessary skills to facilitate patient behaviour change through lifestyle behaviours.  The present 
review aims to address the following research questions: 
Review Questions 
1. What interventions are effective at enabling pharmacists to facilitate patient lifestyle 
behaviour change?  
2. What theories, if any, were used in interventions that successfully enabled pharmacists to 
facilitate patient lifestyle behaviour change? 
3. What behaviour change techniques were used in interventions that successfully enabled 
pharmacists to facilitate patient lifestyle behaviour change? 
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5.2  Methods 
5.2.1 Developing the search strategy 
The Cochrane Database of Systematic Reviews library and the Centre for Reviews and Dissemination 
(CRD) database were initially searched to identify any ongoing or previously published systematic 
reviews of interventions developed to enable pharmacists to facilitate lifestyle behaviour change; no 
such reviews were identified. KK conducted preliminary scoping searches for relevant studies within 
medical and social science databases using the terms ‘pharma*’ AND ‘consultation skills’ OR 
‘pharmacy education’; AND ‘lifestyle advice’; OR diet OR smoking cessation OR alcohol OR exercise. 
The scoping searches identified that the literature evaluating interventions for pharmacists appeared 
to be small; therefore the search was expanded to include pharmacists, pharmacy students and 
pharmacy support staff. In accordance with guidance from the CRD (2009) and the Cochrane 
Handbook for Systematic Reviews of Interventions (Higgins & Green, 2011), a study protocol was 
developed prior to conducting the review using the PICOS format (Population, Intervention, 
Comparators, Outcome, Study design) which informed the development of  inclusion and exclusion 
criteria and search terms. 
It was decided that the current review would include qualitative, quantitative and mixed methods 
study designs. The value of qualitative evidence when assessing interventions has only been 
recognised relatively recently, however it has become more common for the evaluation of health 
interventions to include qualitative components and for the evaluation of complex interventions to 
use a ‘mixed methods’ approach (CRD, 2009; Pope , 2006). Qualitative evidence in particular can 
contribute to reviews of intervention effectiveness in relation to understanding “what, how and 
why” (Sheldon, 2005). Evidence from qualitative research can also aid the interpretation of 
systematic review results by enhancing the understanding of the way an intervention is experienced 
by those receiving it, and what components are viewed favourably/unfavourably and the reasons for 
this (Higgins & Green, 2011).  
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5.2.2 Inclusion and Exclusion Criteria 
The inclusion and exclusion criteria for the review are outlined in table 5.1 below. 
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Table 5.1: PICOS Criteria 
Category Inclusion Criteria Exclusion Criteria 
Participants  Pharmacists 
 Pharmacy Students 
 Pharmacy staff (technicians, 
dispensers, counter staff) 
 Participants who are not 
pharmacists/pharmacy students/ 
pharmacy staff. 
 Studies that include mixed groups 
of pharmacists/pharmacy 
students/pharmacy staff and 
other health professionals 
receiving the intervention. 
Intervention  Programme to provide pharmacists 
with the consultation skills to 
facilitate lifestyle behaviour 
changes with patients. 
 Can include training in relation to 
specific patient group or specific to 
a particular lifestyle behaviour. 
 The intervention may involve 
incentives or rewards for engaging 
in the target behaviour. 
 A component of the intervention 
may also target workplace factors 
(e.g. provide space to deliver 
lifestyle advice). 
 
 Interventions that do not include 
lifestyle advice consultation skills 
training. 
 Interventions that have not 
evaluated change in participants’ 
behaviour. 
Comparators Studies with and without a comparison 
group will be included. 
 
Outcome  Primary outcomes:  
 Change in participants’ consultation 
skills to facilitate lifestyle behaviour 
change with patients (self-
report/objective measures)  
 Change in patient outcome 
 
 Studies that did not measure the 
primary outcomes: change in 
participants’ consultation skills 
and/or change in patient 
outcome. 
Study Design  Any study design 
 Any country 
 Papers written in English language. 
 
 No study design will be excluded 
 Papers not written in English 
language. 
 
5.2.3 Population 
Studies sampling pharmacists, pharmacy students and pharmacy staff (e.g. dispensers, technicians 
and counter assistants) were included in the review. Studies were excluded if they did not sample the 
aforementioned participants or if the study sampled other participants in addition to 
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pharmacists/pharmacy students/pharmacy staff. There were no limits on study participants in terms 
of age, gender or study setting (i.e. hospital, community or academic institution). Studies conducted 
within the UK and international settings were included. 
5.2.4 Interventions 
To be included interventions evaluated had to provide participants with training to equip them with 
the consultation skills to facilitate patient lifestyle behaviour change; studies were excluded if they 
did not include this training. The training could be as part of formal pharmacy education, with 
training provided in the form of lectures, seminars and/or practical sessions incorporating role play 
with peers or simulated patients. The intervention could relate to specific patient groups or specific 
lifestyle behaviours. The intervention could also incorporate structural or workplace factors such as 
creating more time or a space to offer lifestyle advice. The intervention could also provide an 
incentive to, or reward for, offering lifestyle advice.  
Within the pharmacy practice literature, the term “communication skills” commonly refers to the 
process in which a message is transferred between individuals (typically between the pharmacist and 
the patient) whilst the term “counselling”, sometimes used synonymously with “advice”,  typically 
refers to information relating to a medicine, a medical condition or a patient’s health behaviour. This 
may include informing patients how often to take a medicine, the symptoms commonly associated 
with a medical condition or how to manage a long-term condition through lifestyle behaviours.  
For inclusion in the review, the intervention had to be evaluated; studies needed to assess whether 
the intervention resulted in a change in participants’ behaviour or patient outcomes.  Studies that did 
not evaluate the intervention (i.e. just described the intervention) were excluded. 
5.2.5 Comparators 
Preliminary searches identified that study designs incorporating a comparison group appeared to be 
uncommon in this research area, therefore studies with and without a comparison group were 
included in the review.  
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5.2.6 Outcomes 
The primary outcome measures were change in participants’ behaviour (consultation skills to provide 
lifestyle advice) and change in patient outcome (changes in patients’ health status or health 
behaviours).   
5.2.7 Study Design 
Based on the scoping reviews which identified a small research area with a variety of research 
designs, studies of any design which informed the research question were considered. Qualitative, 
quantitative and mixed methods studies were included in the review. Studies of all quality were 
included in the review, and a quality assessment was carried out. 
5.2.8 Language 
There were no resources to translate non English-language papers, therefore if the search identified 
non-English papers then the papers would be documented with language listed as the reason for 
excluding the study from the review.  
5.2.9 Year of publication 
The review included papers published from 1996, due to this being the start of the ‘Pharmacy In A 
New Age’ initiative by the Royal Pharmaceutical Society of Great Britain (RPSGB) which aimed to 
determine how pharmaceutical services could be developed to meet the needs of the public in the 
twentieth century. This initiative included managing chronic conditions and promoting and 
facilitating people to lead healthy lifestyles (Stone & Curtis, 2002). Despite the review including 
international studies, 1996 was deemed a good starting point to include UK based studies and it 
followed to use the same timeframe for international studies as well. 
5.2.10 Search methods for identification of studies 
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The following electronic databases were systematically searched on the 10th and 11th of December 
2013 for English language articles published between 1996 and 2014: Medline; Cochrane Database of 
Systematic Reviews and Web of Science. 
5.2.11 Grey Literature 
The Cochrane Handbook of Systematic reviews cites the importance of searching the grey literature 
due to effect of publication bias (Higgins & Green, 2011). Over representation of significant ‘positive’ 
and under representation of non-significant ‘negative’ results may affect the results of the systematic 
reviews therefore it is important to identify studies reported in conference proceedings and other 
grey literature (Higgins & Green, 2011). PhD theses were identified as a source of relevant grey 
literature, using the EthoS database. 
5.2.12 Other search strategies 
In addition to searching electronic databases, key journals in the research area were hand searched. 
These were: American Journal of Pharmaceutical Education; Patient Education and Counselling; 
Journal of Pharmacy Education; Journal of Pharmacy Practice; Research in Social and Administrative 
Pharmacy; Pharmaceutical Journal; International Journal of Pharmacy Practice; Pharmaceutical 
Health Services Research; Pharmacy Education. The reference lists of papers that met the inclusion 
criteria were also searched for relevant articles. 
5.2.13 Search terms 
Scoping reviews and consultation with an academic supervisory group and an information specialist 
were used to generate preliminary search terms and evaluate whether these search terms resulted 
in comprehensive searches which generated relevant articles. This iterative process allowed the 
search terms to be developed and refined. The final search terms were: 
1.  (Train* OR skills OR “role-play” AND (pharmaci* OR (pharmacy NEAR/2 staff) ) OR (pharmacy 
NEAR/2 student*) OR (pharmacy AND undergraduate*) OR (pharmacy NEAR/3 education) OR 
(pharmacy NEAR/3 school) ) OR (pharmacy NEAR/3 assistant)  
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2. ( (life-style NEAR/3 advi*) OR (life-style AND modification) OR (life-style NEAR/3 coaching) OR 
(life-style NEAR/3 change) OR life-style NEAR/3 intervention) OR “public health” OR “health 
promo*” ) 
3. ( (lifestyle NEAR/3 advi*) OR (lifestyle AND modification) OR (lifestyle NEAR/3 coaching) OR 
(lifestyle NEAR 3 change) OR lifestyle NEAR/3 intervention) OR “public health” OR “health 
promo*”) 
4. Obesity OR overweight OR “weight management” OR nutrition OR diet OR “weight loss” OR 
eating OR diet OR diet* 
5. Exercise OR “physical activity” OR walk* OR jog* OR run* 
6. Smoking OR “smoking cessation” OR Nicotine Replacement Therapy” OR “quit* smoking” 
7. Alcohol OR drink* OR “problem drinking” 
8. 1 AND 2 OR 3  
9. 1 AND 2 OR 3 AND 4  
10. 1 AND 2 OR 3 AND 5  
11. 1 AND 2 OR 3 AND 6  
12. 1 AND 2 OR 3 AND 7  
5.3 Data collection and analysis 
5.3.1 Study selection  
KK screened the titles and abstracts of all papers retrieved through each of the search strategies for 
potentially eligible studies and excluded irrelevant studies based upon the inclusion and exclusion 
criteria outlined in the a-priori review protocol. In order to avoid missing potentially eligible articles, 
KK was overly inclusive at this stage of assessment. Any articles that raised questions concerning 
eligibility for inclusion in the review were initially included and highlighted to be discussed within 
supervision to reach a consensus decision about the eligibility of the study. The full texts of 
potentially eligible studies were then obtained and assessed against the inclusion/exclusion criteria 
by KK. A list of excluded articles and the reason for their exclusion is provided in appendix 8. At this 
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stage the Cochrane Handbook for Systematic Reviews (Higgins & Green, 2011) suggests that a second 
reviewer independently assesses studies against the review inclusion/exclusion criteria. Due to time 
and resource constraints, it was not possible for a second author to double screen the texts for 
eligibility. To limit omitting potential eligible articles, if there was any uncertainty over the eligibility 
of papers for inclusion in the review KK discussed the paper with at least one of the supervisory team 
(HP, CL and RP) through which a decision was reached. 
5.3.2 Data extraction 
A data extraction form was used to collect the required information from the selected studies (see 
Appendix 9). All of the data were extracted by KK. The data extracted were: study authors; date 
published; study setting; study design; study population; description of the intervention (content and 
delivery, use of BCTs and theory); outcome measures (description and how they have been assessed) 
and authors’ conclusion. 
The authors of any relevant studies that did not include the details required for the present review 
were contacted directly by email by KK. 
5.3.3 Coding for Behaviour Change Techniques (BCTs) 
The interventions were coded for BCTs using the definitions listed in the Behaviour Change 
Taxonomy (v1) which has 93 hierarchically structured behaviour change techniques (Michie et al., 
2013). The coder (KK) had received training on using the behaviour change taxonomy at a workshop 
run by the researchers who developed it. KK familiarised herself with the behaviour change 
taxonomy and highlighted BCTs to change provider behaviour within the studies that matched the 
descriptions of BCTs listed in the behaviour change taxonomy. Given that the focus of the current 
review is on changing provider behaviour to facilitate behaviour change in patients, interventions to 
change patient behaviour alone were not coded in the current review. 
5.3.4 Coding for theory 
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The studies were coded for theory using the Michie and Prestwich (2010) ‘Theory Coding Scheme’. 
The scheme is comprised of 19 items and assesses whether theory was mentioned, how theory was 
used to develop the intervention, how the theory was used to explain the effect of the intervention 
on outcome measures and the implications for future development of theory (Michie et al., 2014). 
The coder (KK) familiarised themselves with the Theory Coding Scheme and applied the scheme to 
the studies which provided the information required to use the coding scheme. 
5.3.5 Quality Assessment 
In order to assess methodological quality, studies were assessed using the Mixed Methods Appraisal 
Tool (MMAT) (Pluye et al., 2011, Appendix 10). The MMAT is a critical appraisal tool designed for use 
in complex systematic reviews of quantitative, qualitative and mixed methods studies, and is 
currently the only validated tool for appraising mixed methods studies (Pluye & Hong, 2014). The 
MMAT further divides the three methodological domains (quantitative, qualitative and mixed 
methods studies) into three sub-domains: randomised-controlled, non-randomised and descriptive, 
resulting in the following five categories: qualitative; quantitative randomised controlled (trials); 
quantitative non-randomised; quantitative descriptive and mixed methods. Each of the five 
categories has associated methodological quality criteria to assess studies against, resulting in a 
quality score between 0 *s (no criteria met), * (25%), ** (50%), *** (75%) and **** (100%; 4 criteria 
met). The MMAT suggests that the overall quality of mixed methods studies cannot exceed the 
quality of its weakest component, therefore mixed methods studies are scored in accordance with 
the quality score of the study’s weakest component. In addition to the MMAT, risk of bias in the 
studies that used a randomised controlled trial design was assessed using the Cochrane risk of bias 
tool (Higgins & Green, 2011. 
5.3.6 Data Synthesis 
This review included all study designs producing heterogeneous results therefore the data are 
presented in summary tables and a narrative synthesis was carried out. A narrative synthesis is an 
approach to evidence synthesis which uses words and text to interpret and summarise the findings of 
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multiple studies (Pope, Mays & Popay, 2006). Popay et al. (2006) suggest that narrative synthesis is 
appropriate for use in systematic reviews which use diverse sources of evidence. The opportunity to 
conduct a meta-analysis on the quantitative findings was explored. The results of the qualitative 
findings were synthesised thematically; the first and second order constructs were extracted from 
the studies (see table 5.3) and thematic analysis was conducted.  
5.4 Results 
5.4.1 Literature Search 
The search of electronic bibliographic databases on 10 – 11 December 2013 identified 93 records 
whilst 30 additional records were identified through hand searching and citation searching (see 
Figure 5.1). An information specialist, Dr Georgina Hardy (GH), was consulted given the very small 
number of records initially identified from the search terms. GH repeated the searches and 
confirmed the result. 
After the removal of duplicates (n = 13), the titles of 110 records were screened. Seventy-eight 
records were excluded based on title and abstract resulting in 32 full text papers to be reviewed.  
5.4.2 Excluded studies 
One paper was only available as an abstract. When the study author was contacted, they informed 
KK that they had submitted the abstract to an academic conference and presented a poster, and had 
not fully written up the study. This study was therefore excluded as it did not contain sufficient 
information required for the current review.  Six of the studies were excluded because they did not 
target a relevant lifestyle behaviour. Twelve of the studies were excluded because they did not 
assess the effect of the intervention on behaviour, two of the studies designed an intervention 
targeting participants who were not pharmacists, pharmacy staff or pharmacy students and one of 
the studies evaluated training pharmacists and other health professionals (separate results could not 
be obtained).Ten studies met the criteria for inclusion in the review. 
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Figure 5.1: Summary of Records Identified 
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110 records 
screened 
78 records 
excluded 
32 full-text 
articles assessed 
for eligibility 
22 full-text articles excluded. 
Reason for exclusion: 
•  
• Intervention does not 
target relevant lifestyle 
behaviour: n =6 
 
Effect of intervention on 
behaviour not assessed: 
n =12 
 
• Information not 
available: n=1 
•  
• Intervention not aimed 
at pharmacists: n=2 
•  
• Training included other 
health  professionals: 
n=1 
10 studies 
eligible for 
inclusion in 
review 
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5.4.4 Description of studies 
The characteristics of the studies included in the review are detailed in Table 5.2. The studies were 
published in between 1997 and 2013 and conducted in three countries. The majority of the studies 
were carried out in the USA (n=7) and three studies were conducted in the UK .The majority of 
studies evaluated interventions delivered to community pharmacists (n=5), two studies evaluated 
interventions delivered to both community pharmacists and pharmacy support staff and two studies 
evaluated interventions delivered to pharmacy students. Most of the interventions targeted 
participants’ smoking cessation consultation skills (n= 8), one study targeted the provision of general 
lifestyle advice and one study targeted lifestyle behaviours associated with diabetes self-
management. Three of the studies (Corelli et al., 2005; Hudmon et al., 2003; Hudmon et al., 2004) 
evaluated a tobacco cessation consultation skills intervention called ‘Rx for Change’ (prescription for 
change) developed by Hudmon et al. (2003), whilst  two further studies (Martin, Bruskiewitz & 
Chewning, 2003; Martin & Chewning, 2011) evaluated an intervention using adapted materials from 
the ‘Rx for Change’  intervention. The papers by Martin et al. (2003) and Martin and Chewning (2011) 
presented evaluations of different components of the same intervention and therefore both studies 
will be considered together.  
The majority of studies adopted a quantitative methodology (n= 6), one study used qualitative 
methodology and two studies used a mixed methods approach. A variety of research designs were 
utilised; most studies used a before-after design (n= 5), three studies were randomised controlled 
trials and one study was an evaluation-only study. 
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Table 5.2: Summary of included studies 
Source, Setting & 
Participant 
Occupation 
Study design & 
No. of 
participants  
Health 
behaviour 
addressed 
Intervention 
Explicitly 
based on 
theory 
BCTs Intervention Content & 
delivery 
Outcome 
measures 
Main Findings Study 
Quality 
Score 
Anderson et al. 
(1997) 
UK; community 
pharmacists 
Qualitative 
before-after 
study; 40 ppts 
General 
health 
promotion.   
NR Behavioural 
practice (role-
play) 
 
 Role-play with 
peers 
 
 Duration: 7 days  
 
 Provider: NR 
 
Meaning of 
health, role of 
pharmacy in 
health 
promotion, 
change in 
knowledge, 
change in 
practice (semi-
structured 
telephone 
interviews) 
See qualitative results ** 
Corelli et al. 
(2005) 
USA; pharmacy 
students 
Before-after-
study; 493 ppts 
Smoking NR Instruction on 
how to perform 
behaviour. 
 
Behavioural 
practice (role-
play) 
 
Feedback on 
behaviour 
(performance in 
role-play) 
 
Adding objects 
to the 
environment 
(tobacco 
cessation 
counselling guide 
to help 
 
 Rx for change 
programme see 
(Hudmon et al. 
2003). 
 
 Duration: NR 
 Provider :NR  
 
 
Perceived 
counselling 
ability 
 
Self-efficacy for 
counselling 
 Perceived 
counselling ability 
increased 
significantly post 
intervention 
(p<0.001). 
 Post-training 
assessments of pre-
training abilities 
were significantly 
lower than pre-
training assessments 
of the same ability 
(p<0.001). 
 
** 
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Source, Setting & 
Participant 
Occupation 
Study design & 
No. of 
participants  
Health 
behaviour 
addressed 
Intervention 
Explicitly 
based on 
theory 
BCTs Intervention Content & 
delivery 
Outcome 
measures 
Main Findings Study 
Quality 
Score 
pharmacists 
apply ‘5As’). 
Hudmon et al. 
(2003) USA; 
pharmacy 
students 
Evaluation-only 
study; 544 ppts 
Smoking NR Instruction on 
how to perform 
behaviour. 
 
Behavioural 
practice (role-
play) 
 
Feedback on 
behaviour 
(performance in 
role-play) 
 
Adding objects 
to the 
environment 
(tobacco 
cessation 
 
 7 core modules, 5 
optional: Videoed 
interviews with 
smokers*; 
Epidemiology of 
tobacco use 
(20mins); Forms of 
tobacco (20 mins); 
Pharmacology of 
nicotine & 
principles of 
addiction*(40 
mins); Drug 
interactions with 
smoking* (5 mins); 
assisting patients 
with quitting*(90 
Self-reported 
pre and post-
training 
smoking 
cessation 
counselling 
abilities (likert 
scale, both 
rated post 
training) 
 Pre and post 
training abilities to 
help patients quit 
increased 
significantly (p= 
0.001). 
 
 
0 *s 
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Source, Setting & 
Participant 
Occupation 
Study design & 
No. of 
participants  
Health 
behaviour 
addressed 
Intervention 
Explicitly 
based on 
theory 
BCTs Intervention Content & 
delivery 
Outcome 
measures 
Main Findings Study 
Quality 
Score 
counselling guide 
to help 
pharmacists 
apply ‘5As’). 
mins); 
pathophysiology of 
tobacco related 
disease; genes and 
tobacco; history of 
tobacco control 
efforts; hands on 
experience with 
smoking cessation 
aids* (60 mins); 
role-play with case 
scenarios* 
(minimum 120 
mins). 
 
*Core module. 
 
 Duration: Varied 
between the four 
institutions 
intervention 
delivered at; 7-9 
hours delivered 
over 2-5 days.  
 
 Provider NR 
Hudmon et al. 
(2004)  
 
USA; pharmacy 
students 
Before-after-
study; 142 
Smoking NR Instruction on 
how to perform 
behaviour. 
Behavioural 
practice (role-
play) 
Feedback on 
behaviour 
 Rx for change 
programme see 
(Hudmon et al. 
2003). 
 8 hour duration 
 
 Provider NR 
Self-reported 
overall 
counselling 
ability (likert 
scale). 
 
Self-reported 
ability to 
 Overall counselling 
ability significantly 
increased pre and 
post training 
(p<0.001) 
 Confidence for 
counselling 
significantly 
** 
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Source, Setting & 
Participant 
Occupation 
Study design & 
No. of 
participants  
Health 
behaviour 
addressed 
Intervention 
Explicitly 
based on 
theory 
BCTs Intervention Content & 
delivery 
Outcome 
measures 
Main Findings Study 
Quality 
Score 
(performance in 
role-play) 
Adding objects 
to the 
environment 
(tobacco 
cessation 
counselling guide 
to help 
pharmacists 
apply ‘5As’). 
implement 5As 
(likert scale). 
 
Confidence for 
counselling 
(likert scale). 
improved post-
training (p<0.001).  
 
 
 
Maguire et al. 
(2001) 
England & 
Northern Ireland; 
community 
pharmacists 
RCT; 124 (not 
randomised) 
Smoking NR Material Reward 
(pharmacists paid 
for every smoker 
followed up after 
12 months). 
 Content: 
epidemiology of 
smoking, use of 
NRT, cycle of 
change and PAS 
model Maguire 
(1995, 1996, 1997). 
Also included 
detailed 
description of 
study methodology 
(training part of 
larger study where 
pharmacists 
delivered both 
intervention and 
standard care to 
patients they 
recruited who were 
randomised to 
either condition). 
 
 Duration:3 hours 
Experiences 
during study 
(interview and 
focus groups). 
 
Patient 
smoking status 
(self-reported 
abstinence and 
urinary cotinine 
test). 
 
 14.3% of patients 
had abstained for 12 
months compared 
with 2.7% of 
standard pharmacist 
care controls 
(p<0.001). At 3 
months 11% of 
standard care group 
reported not 
smoking compared 
with 27.5% of 
intervention group. 
 Cotinine levels 
(indication of 
nicotine 
consumption) were 
higher in 
intervention group 
than control group. 
* 
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Source, Setting & 
Participant 
Occupation 
Study design & 
No. of 
participants  
Health 
behaviour 
addressed 
Intervention 
Explicitly 
based on 
theory 
BCTs Intervention Content & 
delivery 
Outcome 
measures 
Main Findings Study 
Quality 
Score 
 
 Study author and 
another researcher 
provided training. 
Martin et al. 
(2003)  
USA; community 
pharmacists 
Before-after-
study; 25 
Smoking Based on 
self-efficacy 
theory. 
Goal setting (set 
clear learning 
goals and 
objectives). 
Problem solving 
(participants had 
to verbalise 
strategies to 
overcome 
problems 
presented in case 
studies). 
Demonstration 
of behaviour (by 
‘proficient peer’). 
Behavioural 
practice (with 
standardised 
patients). 
Feedback on 
behaviour (by 
peers and faculty 
staff).  
Material 
incentive 
(remunerated for 
each patient they 
offered smoking 
cessation service 
to). 
 Content: Adapted 
Rx for change 
materials (Hudmon 
et al., 2003). 
Didactic and 
education based 
home study 
component 
delivered by CD-
ROM. 
Training workshop 
incorporating case 
studies, modelling of 
skills, standardised 
patients and 
performance feedback. 
 
 Duration: 8 hour 
workshop + home 
study (duration not 
specified). 
 Provider NR 
 
Self-efficacy for 
counselling (12 
item likert 
scale). 
 
Evaluation of 
training 
programme (5 
item likert 
scale). 
 
Perceived 
overall ability 
to help patient 
stop smoking 
(likert scale). 
 
Knowledge (14 
MCQs). 
 
Indictors of 
service 
provision 
(phone 
interviews & 
invoices for 
smoking 
cessation 
therapies 
dispensed). 
 Self-efficacy scores 
sig. higher (p<0.001) 
after the live 
training intervention 
than before home 
study intervention. 
No significant 
difference found in 
self-efficacy after 
home study alone 
(p=0.163). 
 Self-rated 5As 
counselling skills 
significantly higher 
after live training 
(p<0.001) than 
before home study 
intervention and 
before live training 
intervention. No 
significant 
difference for 5A 
measures pre and 
post home study 
intervention 
(p=0.201). 
 
 Self-rated overall 
counselling ability 
significantly higher 
** 
 
 
150 
 
Source, Setting & 
Participant 
Occupation 
Study design & 
No. of 
participants  
Health 
behaviour 
addressed 
Intervention 
Explicitly 
based on 
theory 
BCTs Intervention Content & 
delivery 
Outcome 
measures 
Main Findings Study 
Quality 
Score 
than before 
programme 
(p<0.001). 
 
 18 of 24 participants 
completing 
programme offered 
tobacco cessation 
service post training. 
13 participants 
assisted patients 
with tobacco 
cessation 1 year 
after training. 
Martin & 
Chewning (2011)  
USA; community 
pharmacists 
Before-after-
study; 25 
Smoking Based on 
self-efficacy 
theory 
Goal setting (set 
clear learning 
goals and 
objectives). 
Problem solving 
(participants had 
to verbalise 
strategies to 
overcome 
problems 
presented in case 
studies). 
Demonstration 
of behaviour (by 
‘proficient peer’). 
Behavioural 
practice (with 
standardised 
patients). 
Feedback on 
Same as Martin et al. 
(2003) 
Role-play 
performance 
(videotaped 
and assessed 
by 2 
independent 
observers). 
 
Service 
provision (self –
report through 
phone 
interviews and 
invoices for 
services) 
 Counselling 
performance 
improved 
significantly post 
training in both 
standardised patient 
scenarios (p<0.02 
for Action Scenario 
& p<0.04 for 
Preparation 
Scenario). 
 
 75% of pharmacists 
implemented a 
tobacco cessation 
service post training. 
13 (> 15%) assisted 
patients with 
tobacco cessation 
up to one year after 
** 
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Source, Setting & 
Participant 
Occupation 
Study design & 
No. of 
participants  
Health 
behaviour 
addressed 
Intervention 
Explicitly 
based on 
theory 
BCTs Intervention Content & 
delivery 
Outcome 
measures 
Main Findings Study 
Quality 
Score 
behaviour (by 
peers and faculty 
staff).  
Material 
incentive 
(remunerated for 
each patient they 
offered smoking 
cessation service 
to). 
1 year.* 
 
 No relationship 
between previous 
tobacco cessation 
counselling 
experience and post 
–training service 
delivery. 
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Source, Setting & 
Participant 
Occupation 
Study design & 
No. of 
participants  
Health 
behaviour 
addressed 
Intervention 
Explicitly 
based on 
theory 
BCTs Intervention Content & 
delivery 
Outcome 
measures 
Main Findings Study 
Quality 
Score 
Padwardhan & 
Chewning (2012)  
USA; Community 
pharmacists  & 
pharmacy 
assistants       
RCT; 
Intervention:15 
Control: 15 
Smoking Based on 
constructs 
from Social 
Cognitive 
Theory 
(Bandura, 
1977). 
Instruction on 
how to perform 
behaviour. 
Demonstration 
on how to 
perform 
behaviour 
(model videos). 
Social support 
(unspecified) 
(support visit 
from researcher 
to identify and 
resolve any 
problems 
implementing 
behaviour). 
Adding objects 
to the 
environment 
(quit line cards 
given to 
pharmacists to 
use in 
consultation). 
Content 
 Control and 
intervention group 
given informational 
presentation about 
‘quit line’ and 
enrolled in free 
service which 
allowed 
pharmacists to 
refer tobacco users 
to quit line. 
 
 Intervention group: 
additional on-site 
training (in groups 
of 2-3) on how to 
conduct ‘AAR’ brief 
smoking cessation 
discussions. 
Incorporated 
didactic 
presentation on 
steps in AAR and 
technician and 
pharmacist specific 
model videos 
demonstrating how 
to initiate and 
conduct AAR. 
 
Duration 
 Presentation 
(duration not 
Number of 
patrons asked 
about tobacco 
use (self-
report) 
 
Number of 
tobacco users 
advised to quit 
(self-report) 
 
 
Number of 
tobacco users 
enrolled in 
quitline via 
active referral 
(objective 
measure) 
 
Number of 
tobacco users 
given quit line 
card (self-
report) 
 Significantly more 
patients asked 
about tobacco use 
at experimental 
pharmacies than 
control pharmacies 
(p<0.001). 
  
 Number of tobacco 
users who were not 
ready to quit in the 
next 30 days advised 
to quit was higher in 
experimental group 
pharmacies 
compared to control 
(p<0.001). 
 
 Significantly more 
tobacco users 
actively enrolled in 
quit line in 
experimental group 
compared to control 
(p<0.001). 
 
 More quit line cards 
given out by 
experimental group 
than control group 
(p<0.05). 
** 
 
 
153 
 
Source, Setting & 
Participant 
Occupation 
Study design & 
No. of 
participants  
Health 
behaviour 
addressed 
Intervention 
Explicitly 
based on 
theory 
BCTs Intervention Content & 
delivery 
Outcome 
measures 
Main Findings Study 
Quality 
Score 
stated). 
 30 minute training 
for intervention 
group 
 Follow up visit for 
intervention group 
(duration not 
stated). 
 
Provider 
 Delivered by 
primary author. 
Plake (2003)  
USA; Community 
pharmacists 
Before-after-
study; 30 
Diabetes 
self-
management 
lifestyle 
behaviours 
NR Behavioural 
practice (monitor 
patients in own 
pharmacy). 
Content 
 
 
 Educational 
sessions covering: 
pathophysiology 
and psychosocial 
Patient care 
provided (self-
report) 
 
Documentation 
of services and 
reported billing 
 Significant 
difference between 
hours spent on 
diabetes care 
activities per week 
(1.9 hours ‘pre 
intervention’ vs 5.7 
0 *s 
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Source, Setting & 
Participant 
Occupation 
Study design & 
No. of 
participants  
Health 
behaviour 
addressed 
Intervention 
Explicitly 
based on 
theory 
BCTs Intervention Content & 
delivery 
Outcome 
measures 
Main Findings Study 
Quality 
Score 
aspects of 
diabetes; 
‘therapeutic 
principles’; patient 
monitoring, 
complications of 
diabetes; nutrition, 
exercise; footcare, 
pregnancy and 
diabetes. 
 Required to 
monitor patients in 
their pharmacy 
using SOAP notes, 
complete reading 
assignments, 
complete ‘living 
the life’ of 
someone with 
diabetes exercise, 
hands on blood 
glucose monitor 
training and 
explain to peer 
group how to use 
insulin and blood 
glucose meter. 
 
Duration 
 Day session once a 
month for 4 
months. 
 
Provider 
(self-report) hours post 
intervention). 
 
 67% of pharmacists 
gave some kind of 
diabetes care after 
completing 
certificate. Most 
frequently reported 
were: training 
patients to use 
blood glucose 
monitors (66.1%), 
managing patient 
glucose levels 
(41.9%) providing 
nutritional 
education (35.5%) 
and helping patients 
set disease 
management goals 
(35.7%) 
 
 Impact of 
programme on 
services to patients: 
pre-test compared 
with posttest (NB 
not actually pre-post 
test). Stat. sig. 
differences between 
groups for blood 
glucose mangment 
(x2=6.21, p=0.013), 
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Source, Setting & 
Participant 
Occupation 
Study design & 
No. of 
participants  
Health 
behaviour 
addressed 
Intervention 
Explicitly 
based on 
theory 
BCTs Intervention Content & 
delivery 
Outcome 
measures 
Main Findings Study 
Quality 
Score 
 NR nutrition education 
(x2=6.21, p=0.014) 
and patient goal 
setting (x2=10.48, 
p=0.001). 
Pharmacists who 
completed prog also 
spent more time on 
diabetes care 
activities (t=2.70, 
p=0.009).  
Sinclair et al. 
(1998)  
Scotland; 
Community 
pharmacists  & 
pharmacy 
assistants          
RCT; 
Intervention:32 
Control:30 
Smoking NR (based 
around 
stages of 
change 
model 
(Prochaska 
& 
Diclemente, 
1983)to 
change 
patient 
behaviour 
but no 
theory 
explicitly 
stated to 
change 
provider 
behaviour). 
Not enough 
information 
provided. 
 Training used case 
studies of 
pharmacy 
customers and 
focussed on 
communication 
skills for 
negotiating change 
and providing 
continued support 
and 
encouragement.  
 Duration: 2 hour 
training session,12 
month follow up 
 Provider NR 
Patient self-
reported 
smoking 
cessation at 
one month & 
self-reported 
continuous 
abstinence 
from 0-4 
months and 0-9 
(questionnaire). 
 
Patient 
perceptions of 
support offered 
in pharmacy 
(semi-
structured 
interview) 
 
Intervention 
personnel’s 
perception of 
 No significant 
difference in 
smoking cessation 
outcomes between 
patients in 
intervention and 
control pharmacist 
condition at each 
time point (p=0.12, 
p=0.094 and 
p=0.089). 
 Intervention 
customers 
significantly more 
likely to have 
discussed stopping 
smoking with 
pharmacy personnel 
(p<0.01) and rated 
discussion with 
pharmacy personnel 
more highly 
(p=0.048) 
* 
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Source, Setting & 
Participant 
Occupation 
Study design & 
No. of 
participants  
Health 
behaviour 
addressed 
Intervention 
Explicitly 
based on 
theory 
BCTs Intervention Content & 
delivery 
Outcome 
measures 
Main Findings Study 
Quality 
Score 
training (semi-
structured 
interview) 
  Intervention 
customers also 
significantly more 
likely to have been 
asked about their 
health at the time of 
their initial purchase 
(p=0.0025) and 
advised on the 
strength of NRT 
(P=0.0037). Also 
signficantly more 
likely to report that 
“helpful support 
from pharmacy 
staff” had 
contributed to their 
smoking cessation. 
 
 Half of the 
customers who 
responded to 4 
month follow up 
had made previous 
quit attempt. When 
asked to compare 
current support to 
previous attempts, 
intervention group 
significantly more 
likely to rate support 
as “better” whereas 
controls more likely 
to rate as the 
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Source, Setting & 
Participant 
Occupation 
Study design & 
No. of 
participants  
Health 
behaviour 
addressed 
Intervention 
Explicitly 
based on 
theory 
BCTs Intervention Content & 
delivery 
Outcome 
measures 
Main Findings Study 
Quality 
Score 
“same” (p =0.001). 
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5.4.5 Intervention Structure, Delivery and Content 
There was considerable heterogeneity in the structure, delivery and content of the interventions 
included in the present review therefore the structure, delivery and content of the interventions is 
described  below grouped by the health behaviour the interventions trained participants to facilitate 
behaviour change. 
5.4.5.1 Tobacco Cessation Advice Interventions 
The most common intervention targeted the smoking cessation advice-giving behaviour of 
pharmacists, pharmacy support staff and pharmacy students. Three of the interventions evaluated  
the ‘Rx for Change’ model (Hudmon et al., 2003) offered as mandatory training for pharmacy 
students in the USA and ranged between seven and nine hours in duration, delivered over two to five 
days depending on the institution participants attended (Corelli et al., 2005; Hudmon et al., 2003; 
Hudmon et al., 2004). The lecture component of the intervention was reported to last a minimum of 
three hours fifteen minutes whilst the hands-on workshop component of the intervention was 
reported to last a minimum of two hours. No information was provided about the individuals 
delivering the intervention in any of the studies. 
The Rx for change programme (Hudmon et al., 2003) was described as consisting of a lecture 
component with core and optional models which include information about tobacco use, addiction 
and how to assist patients to stop smoking (a full list of lecture components is provided in table 5.2). 
The lectures were supplemented with a workshop that gave participants the opportunity to rehearse 
behaviour with standardised patients and hands-on experience with tobacco cessation aids. Hudmon 
et al. (2003) assert that the intervention teaches pharmacy students to change patients’ behaviour 
based upon the 5 “A”s, a programme based on the Transtheoretical Model (Prochaska & DiClemente, 
1983) and posits that health professionals should complete the following five tasks: Ask about 
tobacco use; Advise tobacco users to quit; Assess readiness to quit (assess patient’s stage of change); 
Assist patients with quitting and Arrange follow up counselling. Students were provided with a 
counselling guide sheet to facilitate the discussion based upon the 5 “A”s and a tobacco use log to 
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use with patients to help patients understand their tobacco use behaviour prior to a quit attempt. 
When coded for use of behaviour change techniques, the studies assessing the Hudmon et al. (2003) 
Rx for change intervention (Corelli et al., 2005; Hudmon et al., 2003; Hudmon et al., 2004) were 
found to have used four BCTs. These were ‘instruction on how to perform behaviour’ (in this case 
how to advise patients to stop smoking); ‘behavioural practice’ in the form of role-playing advising 
patients to stop smoking; ‘feedback on behaviour’ by providing participants with feedback on their 
performance in the role-play consultations and ‘adding objects to the environment’ by providing 
participants with a smoking cessation counselling guide to help them apply the 5As in the 
consultation. 
An intervention evaluated by Martin et al. (2003) and Martin and Chewning (2011) adapted the Rx 
for change intervention developed by Hudmon et al. (2003). The intervention consisted of a home 
study component delivered by CD-ROM for which the duration was not specified and an eight hour 
workshop. Neither of the studies provided information about the individuals delivering the 
intervention. The intervention was described as offering a didactic and education based home study 
component for practising community pharmacists followed by a training workshop that incorporated 
case studies, modelling of skills, behavioural rehearsal with standardised patients and feedback on 
the participant’s performance in these tasks. The intervention was assessed to have used six BCTs: 
‘goal setting’ through setting clear learning goals and objectives for participants; ‘problem solving’ 
whereby participants were asked to verbalise strategies to overcome problems presented to them in 
case studies; ‘demonstration of behaviour’ by a peer deemed ‘proficient’ in giving smoking cessation 
advice; ‘behavioural practice’ with standardised patients; ‘feedback on behaviour’ by peers and 
university staff on performance in the role-play with standardised patients and ‘material incentive’, 
with participants given financial remuneration for each patient they offered a smoking cessation 
service to. 
Another intervention based on the Hudmon et al. (2003) model was evaluated by Patwardhan and 
Chewning (2012). The intervention was short in duration (30 minutes) and the paper stated that it 
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was delivered by the primary author, however no other information about the individual delivering 
the intervention was given. The intervention was reported to consist of guidance on how to perform 
the ‘Ask Advise Refer’ (AAR) smoking cessation intervention with patients in the form of a lecture and 
a video demonstrating how to perform the behaviour. Participants were also given a presentation 
about a ‘quit line’ for patients to use and enrolled in a free service which allowed pharmacists to 
refer tobacco users to quit line. The duration of this presentation was not specified. As with the 
previous study, the AAR approach is also derived from the “5As” model used in the Rx for Change 
intervention (Hudmon, 2003), however it is less time intensive (30 minutes as opposed to the Rx for 
change intervention (Hudmon et al, 2003)) which was between seven and nine hours in duration) 
and recommended for use in settings where the 5As may not be appropriate such as busy settings 
(Patwardhan & Chewning, 2012). In accordance with the AAR approach, Patwardhan and Chewning 
(2012) stated that pharmacists were directed to ask tobacco users whether they smoke, advise 
tobacco users to quit and refer tobacco users to an intensive smoking cessation programme. The 
intervention was deemed to incorporate four BCTs: ‘instruction on how to perform the behaviour’; 
‘demonstration on how to perform the behaviour’ through a video which provided a demonstration; 
‘social support (unspecified)’ provided by a researcher on a support visit to identify and resolve any 
problems participants had in implementing the behaviour and ‘adding objects to the environment’ 
whereby participants were given quit line cards to use in smoking cessation consultations with 
patients. 
Maguire, McElnay, and Drummond (2001) evaluated a three hour intervention to train pharmacists 
to offer smoking cessation advice delivered as part of a study examining the effect of pharmacist-led 
smoking cessation. The intervention was delivered in the form of a workshop, by the study author 
and another researcher followed by a visit by the researcher. No other information about the 
individuals delivering the intervention or the duration of components of the workshop or the follow 
up visit was provided. The authors reported that the workshop consisted of information about: the 
study methodology, the epidemiology of smoking, the use of Nicotine Replacement Therapy and the 
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“cycle of change” and “Pharmacists Action on Smoking” model developed by the author, followed up 
by a visit by the researcher. The intervention was deemed to have used one BCT, ‘material incentive’, 
with participants financially remunerated for every patient who smoked that they followed up after 
twelve months. 
Finally Sinclair et al. (1998) evaluated a two hour training programme delivered to participants in the 
intervention group of their study and followed up participants after twelve months. Again, the 
duration of individual components of the intervention or the follow up visit was not detailed. No 
information was given about the individual(s) delivering the intervention. Sinclair et al. (1998) 
described the intervention as consisting of case studies of patients, small group discussion and role 
play, focussing on communicating with patients and negotiating behaviour change. Participants were 
also asked to record the number of patients that declined to receive tobacco cessation advice. There 
was not enough information provided in the paper to assess for BCTs used in the intervention. 
5.4.5.2 General health promotion 
One study evaluated an intervention to give pharmacists skills to offer general lifestyle advice. 
Anderson and Alexander (1997) described the duration of their intervention as delivered over seven 
days and two evenings however the amount of time this amounted to was not stated. The 
intervention was delivered in the form of lectures, role-play and group discussion sessions however 
the duration of each component was not specified. No information was given about the intervention 
providers. The authors described the intervention as covering the following topics: coronary heart 
disease; asthma; diabetes; exercise, nutrition; dental health; AIDS/HIV; drug use; mental health and 
travel health and involving role-play and discussion group sessions (the duration of which was not 
specified). The intervention was found to have used one BCT: ‘behavioural practice’ whereby 
participants engaged in role-play sessions with peers. 
5.4.5.3 Diabetes self-management 
One paper reported an intervention to enable participants to facilitate lifestyle behaviour change as 
part of diabetes self-management skills interventions. The intervention evaluated by Plake, Chesnut, 
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and Biebighauser (2003) was delivered over the course of one day a month for four months (the 
duration of each ‘day’ was not specified. No information was provided about the intervention 
providers. Plake et al. (2003) described the intervention as consisting of information about diabetes 
management including: pathophysiology patient monitoring; complications; nutrition; exercise and 
foot care. Participants also had to complete a ‘living the life’ of someone with diabetes exercise and 
apply the information taught on the course to monitoring of patients in their workplace. The 
intervention was found to include one BCT: ‘behavioural practice’; participants were required to 
monitor patients in their workplace. 
5.4.6 Findings from Quantitative and Mixed Methods Studies 
5.4.6.1 Primary outcome measures 
5.4.6.1.1 Counselling Ability 
The most common way to assess behaviour was self-reported or observed counselling ability 
assessed by eight of the studies. All of these interventions resulted in an increase in counselling 
ability. Four of the studies found a significant increase in participants’ self-reported counselling 
abilities (rated on a five point rating scale; 1= poor, 5=excellent) in relation to smoking cessation post 
intervention (p<0.001) (Corelli et al., 2005; Hudmon et al., 2003; Hudmon et al., 2004; Martin et al., 
2003). However it should be noted that Hudmon et al. (2003) asked participants to report both pre 
and post intervention counselling ability at the same time (post intervention) eight weeks after 
receiving the intervention so this finding is likely to be subject to bias. Furthermore, two studies 
found an increase in participants’ observed counselling abilities. Martin and Chewning (2011) found 
counselling performance with pseudo patients in two different scenarios (assessed by two 
independent observers using an evaluation tool based on the performance of the “5As”: ask, advise, 
assess, assist and arrange) improved significantly post intervention in both scenarios (p<0.02 and 
p<0.04). 
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5.4.6.1.2 Service Delivery Indicators 
The two studies which included service delivery (defined as the number of times pharmacists offered 
the intervention) as a measure of intervention efficacy found increased service delivery in the form 
of patient counselling post-intervention. The only study with a comparison group, Patwardhan and 
Chewning (2012), found that the number of patients asked about tobacco use and the number of 
tobacco users advised to quit (both measured by self-report) was significantly higher at experimental 
pharmacies compared to controls (p<0.001). Furthermore, the number of tobacco users enrolled in a 
tobacco cessation ‘quitline’ programme (an objective measure) was significantly higher in the 
experimental pharmacies (81 patients) compared to control pharmacies (8 patients) (p<0.001) as was 
the self-reported number of tobacco users given ‘quit line’ information cards (240 patients at 
experimental pharmacies and 85 patients at control pharmacies)(p<0.05). The effect size was not 
reported. Plake (2003) found a statistically significant difference between pre and post intervention 
groups of pharmacists reporting that they engaged in blood glucose management (p=0.013), 
nutrition education (p=0.014) and patient goal setting (p=0.001), with pharmacists in the post 
intervention condition reporting spending more time overall on diabetes care activities than those 
yet to receive the intervention (mean hours in pre-intervention condition = 1.9 (SD:2.23) and mean 
hours in post-intervention condition = 5.7 (SD:9.31), p=0.009). No information about effect sizes was 
provided. However it should be noted that participants in the study described as in the “pre 
intervention condition” were not the same participants compared in the condition the study 
described as the “post intervention condition”. The poor methodological quality of this study is 
discussed in the quality section below. 
5.4.6.1.3 Patient Outcome 
The effect of the interventions on patient outcome was inconclusive, with the two studies which 
assessed the efficacy of training pharmacists and pharmacy staff to offer smoking cessation advice by 
patient outcome measures reporting conflicting findings (Maguire et al. 2001; Sinclair et al., 1998). 
Sinclair et al. (1998) found no significant difference in patient reported smoking cessation outcomes 
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between patients in intervention and control pharmacist condition at three time points across 12 
months (p=0.012, p=0.094 and p= 0.089). However patients given advice by pharmacists receiving 
the intervention were significantly more likely to have discussed smoking cessation with pharmacy 
personnel (p<0.01) and rated the discussion more highly than customers in the control group 
(p=0.048). Conversely, Maguire et al. (2001) found that 14.3% of patients in the intervention 
condition reported that they had abstained from smoking compared with 2.7% of patients in the 
standard pharmacist care condition (p<0.001).  However, cotinine levels, used as a biological 
indicator of nicotine consumption, were found to be higher in patients in the intervention group 
compared to the control group. It is noteworthy that pharmacists were not randomised to condition 
in this study, with the same pharmacists delivering intervention and standard care treatment to 
patients. 
5.4.7 Additional Outcome Measures 
5.4.7.1 Confidence/Self-efficacy in consultation skills 
All three of the studies which assessed participants’ self-efficacy found the interventions increased 
participants’ self-efficacy in their consultation skills. The studies (Corelli et al. 2005; Hudmon et al. 
2004; Martin et al., 2003) which used or were based upon the Rx for Change smoking cessation 
intervention developed by Hudmon et al. (2003) used a 12 item confidence for counselling scale. 
Both Corelli et al. (2005) and Hudmon et al. (2004) found a significant increase in self-efficacy post 
intervention (p<0.001). Martin et al. (2003) assessed self-efficacy at three time points (pre home 
study intervention, post home study intervention, pre live training intervention and post live training) 
finding that self-efficacy scores were significantly higher after the ‘live training’ intervention 
incorporating role play than before the home study component of the intervention (p<0.001). No 
significant difference in self-efficacy was observed between the pre and post home study component 
of the intervention (p=0.163), and no statistical difference in self-efficacy was observed between 
providers and non-providers of smoking cessation advice. 
5.4.8 Quality of Included Quantitative and Mixed Methods Studies 
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The overall quality of the reported studies, assessed using the Mixed Methods Appraisal Tool 
(MMAT) (ref), was generally poor, with only one study scoring *** (75%) and the remaining studies 
scoring ** (50%) or less (quality scores are displayed in table 5.2). Three studies (Corelli et al., 2005; 
Hudmon et al., 2003; Plake, 2003) did not explicitly state a research question or objective, therefore 
quality assessment was conducted based upon whether the collected data answered the research 
questions of the present review. Three studies did not meet any of the criteria for quality 
assessment, scoring 0 *s (Hudmon et al., 2003; Lenz, 2007; Plake, 2003). Hudmon et al. (2003) did 
not provide any information about participant recruitment therefore it was unclear if the study 
sampling strategy was relevant to address the research question (which was not stated) or if the 
sample was representative of the population under study. Furthermore, the measures used were 
inappropriate, with participants asked to rate both their pre and post intervention counselling 
abilities after the intervention had been delivered, meaning that some participants provided this 
information eight weeks after receiving the intervention. Despite this, the paper states that the 
intervention had already been rolled out to other pharmacy schools in the USA. Furthermore, Plake 
(2003) compared different participants in “pre” and “post” intervention conditions as a means to 
assess the efficacy of the intervention however this is not an appropriate test of intervention efficacy 
as the scores of different participants will vary subject to the characteristics of individuals therefore 
any difference in score cannot be reliably attributed to the intervention. 
Overall, reporting of the interventions tended to be poor, meaning that quality assessment was 
difficult and that future replication of the studies is likely to be problematic. The duration of each 
intervention components was not specified in six of the studies (Anderson & Alexander, 1998; 
Maguire et al. 2001; Martin et al., 2003; Martin & Chewning, 2011; Patwardhan & Chewning, 2012; 
Sinclair et al. 1998). Two studies did not report the gender of participants (Anderson & Alexander, 
1997; Maguire et al., 2001), whilst one study (Sinclair et al., 1998) reported the gender of 
participants as a whole, but did not report the gender composition of participants allocated to the 
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intervention and control group respectively. Only three of the ten studies (Corelli et al., 2005; 
Hudmon et al., 2003; Hudmon et al., 2004) reported the ethnicity of participants.  
Reporting of participant recruitment was also poor; none of the studies using quantitative 
descriptive/mixed methods designs that detailed the information necessary for quality appraisal 
provided enough information to determine if the sampling strategy produced a representative 
sample of the target population. Furthermore, five of the studies did not state the proportion of the 
sample providing complete outcome data (Corelli et al., 2005; Hudmon et al., 2005; Maguire et al., 
2001; Martin & Chewning 2011; Patwardhan & Chewning, 2012). Only one of the studies (Sinclair et 
al., 1998) provided a complete explanation of reasons for participant withdrawal or exclusion. There 
was also inadequate reporting of the intervention delivery.  As previously highlighted, only two of the 
studies (Maguire, 2001; Patwardhan & Chewning, 2012) provided any information about the 
characteristics of the individual(s) delivering the intervention.  Two of these studies (Patwardhan & 
Chewning, 2012; Maguire, 2001) involved the study author both delivering and evaluating the 
intervention. This is problematic as it compromises the objectivity of the evaluation by potentially 
introducing bias.  
The risk of selection bias is high in the quantitative descriptive studies given the lack of 
randomisation and lack of control groups, therefore it cannot reliably be determined if the observed 
changes were a result of the intervention. None of the studies reported conducting power analysis to 
determine the minimum number of participants they required. This means the validity of the findings 
are questionable.  Furthermore, some of the quantitative studies had small sample sizes (Martin et 
al., 2003; Chewning et al., 2011) which raises questions about the generalisability of the findings. 
Three studies used a randomised controlled trial design. None of the studies reported if complete 
outcome data (which the MMAT defines as >80%) were collected. Dropout or withdrawal rates were 
not reported in one study (Maguire et al., 2001), were low (<20%) in one study (Patwardhan & 
Chewning, 2012) and high in the remaining study (Sinclair et al., 1998). Two studies (Patwardhan & 
Chewning, 2012; Sinclair et al., 1998) provided a clear description of the randomisation process they 
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utilised. Patwardhan and Chewning  (2012) provided no description of allocation concealment whilst 
both Maguire et al. (2001) and Sinclair et al. (1998) provided a description of allocation concealment; 
however allocation concealment only applied to customers, with pharmacy staff in both studies 
aware of their condition arm, increasingly the likelihood of performance bias occurring. Furthermore, 
pharmacists in the Maguire et al. (2001) study all received the same training intervention and were 
then required to offer standard pharmaceutical care as normal, or an enhanced smoking cessation 
consultation based on their training, depending on the condition patients were assigned to (which 
they were aware of). Again, this design introduces the risk of performance bias. Lastly, two of the 
studies (Maguire et al., 2001; Padwardhan & Chewning, 2012) were part of larger studies which 
required the participants to recruit patients for other, related studies. This may have changed the 
participants’ behaviour as they may have been more motivated to recruit patients if a researcher was 
monitoring their recruitment activities and/or they were paid for the patients they recruited; 
however this was not considered as a source of bias in any of the studies. 
All of the studies collected baseline data and followed up at a later time point, however one of the 
studies (Plake, 2003) collected baseline data from one group of participants and follow up data from 
different participants as a means of assessing intervention efficacy. Furthermore, Hudmon et al. 
(2003) asked participants to rate their consultation skills prior to the intervention at the same time as 
rating their perceived consultation skills after they had received the intervention, which for some 
participants occurred two months after receiving the event.  
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5.4.9 Qualitative Findings 
Qualitative findings were reported in three of the included studies (Alexander & Anderson, 1997; Maguire et al., 2001; Sinclair et al., 1998), the findings of 
which are summarised in table 5.3 and presented below. 
Table 5.3: Matrix of 1st & 2rd order constructs (extraction of study findings) 
 
 Anderson & Alexander (1997) Maguire et al. (2001) Sinclair et al. (1998) 
Theme 1 
 
 
 
 
 
 
 
 
Theme title: 
Meaning of health 
 
Indicative extracts: 
 
Change in meaning before and after: 
 
“Health is having nothing medically wrong with 
you” then “Health is an overall feeling of 
wellbeing in mind and body” 
Themes and supporting quotes 
not reported. 
 
Results reported: 
 Pharmacists believed 
model of smoking 
cessation used in 
intervention was 
practical and useful. 
 
Themes and supporting quotes 
not reported. 
 
Results reported:  
 Almost all 
pharmacists/pharmacy 
assistants positive about 
counselling. 
 
Theme 2 
 
 
 
 
 
 
 
 
Theme title: Role in pharmacy health 
promotion 
 
Indicative extracts: 
 
After training saw role as facilitators:  
“to help people think about their lifestyle” 
“My role is an instigator and facilitator, to 
encourage and promote health at the three 
levels” 
 
 Lack of time and 
insufficient 
remuneration main 
barriers whilst some 
participants felt 
project lost them 
custom. 
 
 Perceived barriers were: 
smoker’s perceived need 
for support; pharmacy and 
customer time constraints 
and counselling in a 
commercial setting. 
Theme 3 
 
 
Theme title: 
Contact with other health professionals and 
customers 
Participants felt they needed 
more training to improve 
communication skills to 
 Pharmacy staff not keen 
on record keeping and 
identified barriers to doing 
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 Anderson & Alexander (1997) Maguire et al. (2001) Sinclair et al. (1998) 
 
 
 
 
 
 
 
Indicative extracts: 
“I am trying but GPs see pharmacists as in-
fringing on their territory” 
 
“Contact has always been good. I use the 
knowledge gained [from training] at our 
monthly meetings”. 
“I joined in a study group with some other girls 
on the course”. 
 
“Definitely, I’m coming forward more and they 
[customers] are returning more”. 
 
 
facilitate patients becoming 
more receptive to health 
promotion advice. 
so (time, privacy, part-
time staff and customer 
aversion to it). 
 
 
Theme 4 Theme title: Leaflets and displays 
 
Indicative extracts: 
 
“I’m more aware of the leaflets and who they 
are targeted at” 
 
“I have less out on display, but have others 
available to hand out” 
 
  
Theme 5 Theme title: Changes in practice 
 
Indicative extracts: 
 
“I’m more confident that I can do it [health 
promotion] as a result of the training” 
“I’m more proactive rather than waiting for 
people to ask” 
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 Anderson & Alexander (1997) Maguire et al. (2001) Sinclair et al. (1998) 
“I now ask about smoking when medicines are 
requested for a cough” 
Theme 6 Theme title: 
Constraints 
 
Indicative extracts: 
“People are not wanting to have to listen but I 
have been trying” 
“Need to see the task as related to 
profitability” 
“We overcome the time constraints with 
having double [pharmacist] cover at the busy 
times” 
 
  
Theme 7 Theme title: Further training  
 
Indicative extracts: 
 
“Need ongoing training indicating changes and 
what should be done, perhaps biannual 
meetings of a couple of evenings” 
“We need training with other health 
professionals to maximise effect”. 
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5.4.9.1 Barriers to implementing training 
All of the studies identified barriers to implementing the lifestyle advice consultation skills the 
interventions aimed to promote. All of the studies identified perceived lack of time and insufficient 
remuneration whilst two of the studies identified counselling in a commercial setting as a barrier to 
implementing the skills (Maguire et al., 2001; Sinclair et al., 1998). Furthermore, two of the studies 
identified participants’ beliefs about patients’ perception of their need for counselling as a barrier to 
implementing the skills the intervention aimed to provide. 
5.4.9.2 Perception of Counselling Role 
Two of the studies reported that participants were positive about their role in patient counselling. 
Sinclair et al. (1998) found that the majority of participating pharmacists and pharmacy staff were 
positive about offering counselling, whilst Anderson and Alexander (1997) reported that pharmacists 
perceived that they had a role in health promotion as that of a facilitator after receiving the 
intervention. 
5.4.9.3 Perception of intervention 
All of the studies reported that participants viewed the intervention they received positively, 
perceiving the intervention as helpful. Two studies reported that participants were not keen on the 
record keeping and paperwork aspects of the intervention, and felt that less paperwork would 
improve future interventions (Maguire et al., 2001; Sinclair et al., 1998) 
5.4.9.4 Practice Change 
Anderson and Alexander (1997) reported a change in pharmacists’ knowledge of disease areas 
requiring health promotion, with fewer pharmacists unable to name any target health promotion 
areas post intervention. The authors also found that pharmacists reported feeling more confident 
and being more proactive in their practice post intervention, particularly in relation to smoking 
cessation. Anderson and Alexander (1997) also found that some pharmacists reported increased 
 
 
172 
 
contact with health professionals (such as GPs) and patients post intervention, however discussing 
dietary intake with patients was reported to be more difficult than other forms of advice. 
5.4.9.5 Need for further training 
In two of the studies participants identified a need for further training (Anderson & Alexander, 1997; 
Maguire et al., 2001). Maguire et al. (2001) reported that pharmacists and pharmacy staff felt that 
they needed training to improve their communication skills to enable patients to become more 
receptive to health promotion advice whilst Anderson and Alexander (1997) found that pharmacists 
wanted ongoing training to consolidate the skills they had already learnt in addition to training with 
other health professionals. 
5.4.10 Quality of reported qualitative studies 
The quality of the reporting and analysis in studies that had used qualitative methods was poor. 
According to the MMAT criteria, two of the studies only scored one star (Maguire et al.,2001; Sinclair 
et al., 1998) whilst Alexander and Anderson (1997) scored two stars out of a possible four. The study 
conducted by Anderson and Alexander (1997) did not consider how the findings related to the 
context in which the data were collected whilst Maguire et al. (2001) and Sinclair et al.(1998) did not 
provide any data to justify their interpretations or list any themes. None of the studies using 
qualitative methods gave appropriate consideration to how the findings related to the researchers’ 
influence and description of how the data was analysed was poor (Anderson & Alexander, 1997; 
Maguire et al., 2001; Sinclair et al., 1998). Only one of the studies using a mixed methods approach 
integrated the qualitative and quantitative findings (Sinclair et al., 1998). In accordance with the 
MMAT criteria, there was no consideration of the limitations associated with integrating qualitative 
and quantitative data in any of the mixed methods studies.  
5.4.11 Use of theory  
The review coded use of theory in the development of interventions to change the behaviour of 
pharmacists, pharmacy students and pharmacy support staff using the theory coding scheme 
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developed by Michie and Prestwich (2010). Only one of the studies contained enough information to 
identify a theoretical framework. Seven of the ten studies (70%) did not explicitly describe use of 
theory in the development of the interventions to change provider behaviour. Three of the papers 
which assessed two interventions (Martin et al., 2003; Martin & Chewning, 2011; Padwardhan & 
Chewning, 2009) stated that the invention was based on Social Cognitive Theory (SCT), however this 
was the only information Patwardhan and Chewning (2009) provided. The intervention evaluated in 
two papers by Martin et al. (2003) and Martin and Chewning (2011) was the only study to provide 
sufficient detail to identify a theoretical framework according to the Prestwich (2010) theory coding 
scheme. The intervention was based on SCT and targeted self-efficacy as a predictor of pharmacists’ 
tobacco cessation advice giving behaviour. One of the intervention techniques (modelling) was 
explicitly linked to a theory-relevant construct, self-efficacy, which was measured pre and post 
intervention. However each of the intervention techniques were not explicitly linked to at least one 
theory-relevant construct and not all of the measures of theory relevant constructs had been 
validated or had evidence of reliability. 
All of the interventions which targeted participants’ smoking cessation advice-giving behaviour cited 
the use of theory, primarily the Transtheoretical Stages of Change Model (Prochaska & DiClemente, 
1983), in changing patients’ behaviour, with most of the interventions basing the intervention 
material on this model. However, as previously stated, the focus of the current review is on changing 
provider behaviour to facilitate behaviour change in patients, therefore interventions based on the 
transtheroretical model to change patient behaviour alone were not coded. 
5.4.12 Use of Behaviour Change Techniques 
Eight of the studies provided enough detail to identify BCTs. Of the studies that provided enough 
information to identify BCTs, all of the interventions used at least one BCT. The mean number of BCT 
used in the interventions was 3.3 (range 1-5). Figure 5.2 below illustrates the frequency of BCTs used 
in the interventions. 
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Figure 5.2: Frequency of BCTs used in the interventions 
 
The most frequently used BCTs were ‘behavioural practice’ (Corelli et al., 2005; Hudmon et al., 2004; 
Hudmon et al., 2005; Martin et al., 2003; Martin and Chewning, 2011; Plake, 2003), ‘instruction how 
to perform behaviour’ (Corelli et al, 2005; Hudmon et al., 2004; Hudmon et al., 2005; Patwardhan & 
Chewning, 2012), ‘feedback on behaviour’ (Corelli et al., 2005; Hudmon et al., 2004; Hudmon et al., 
2005; Martin et al., 2003; Martin and Chewning, 2011; Plake, 2003) and adding objects to the 
environment (Corelli et al., 2005; Hudmon et al., 2004; Hudmon et al., 2005; Patwardhan & 
Chewning, 2012). Other  less frequently used BCTs were ‘goal setting’, ‘problem solving’, providing a 
‘demonstration of the target behaviour’, providing a ‘material incentive’ (remunerating pharmacists 
for providing services) and ‘social support’ in the form of a follow up visit from a researcher post-
intervention to assist pharmacists with any problems they had providing smoking cessation advice 
(Patwardhan & Chewning, 2012). 
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5.5 Discussion 
This systematic review of the literature identified ten studies published between 1996 and 2014 
which evaluated the effect of interventions to prepare pharmacy students, pharmacists and 
pharmacy staff to facilitate lifestyle patient behaviour change. Despite extensive searches, as with 
other similar reviews of interventions aimed at nurses and doctors (Chisholm, Hart, Mann, Harkness 
and Peters 2012; Fillingham, Peters, Chisholm and Hart 2013) the number of studies relevant to this 
review was low.  
A range of interventions to enable pharmacists to facilitate patient lifestyle change had been 
developed and evaluated; most studies used quantitative methods however qualitative and mixed 
methods were also utilised. There was considerable variation in the intervention content, delivery 
and duration. A variety of different methods were used to deliver the interventions, comprising of 
one or a combination of: didactic oral presentations; discussion of case studies; setting behavioural 
self-monitoring tasks; video presentations; and role-play with peers, standardised patients and 
patients. The primary outcome measures of the review were participants’ behaviour and patient 
outcome (as an indirect measure of participants’ behaviour). All eight of the interventions that 
measured pharmacist/pharmacy staff/pharmacy student behaviour found increased counselling 
ability (objectively or subjectively measured) or increased service delivery to patients post 
intervention. The effect on patient outcome was inconclusive; one study found increased smoking 
cessation in patients whilst the other found no difference in patient smoking status between patients 
receiving smoking cessation services from pharmacists receiving the behaviour change intervention 
and pharmacists in the control group. In addition to behavioural outcome measures, three of the 
studies measured pharmacists’ confidence/self-efficacy in their counselling ability, all of which found 
a significant increase in confidence/self-efficacy as a result of the intervention. However, these 
findings should be interpreted with caution, as the evidence was not strong enough to be sure that 
the change was due to the intervention. 
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The findings from the qualitative evidence identified lack of time and insufficient remuneration as 
barriers to implementing the skills targeted in the interventions. These are commonly reported 
barriers to pharmacists engaging in public health activities (Anderson et al., 2003; Eades et al., 2011). 
Most of the studies reported that participants’ perceived a need for further training whilst two of the 
studies identified counselling in a commercial setting (with problems associated with lack of time and 
sufficient remuneration), and patients’ perceptions of their (lack of) need for counselling as barriers. 
Again this is congruent with previous findings within the literature (Anderson et al., 2003; Eades et 
al., 2011). Most of the studies reported that participants perceived the intervention they received 
positively. 
The poor reporting of intervention content and lack of a reported theoretical basis for the 
development of the majority of the interventions makes it very challenging to draw conclusions 
about the effective components, or ‘active ingredients’ (Michie et al., 2013) of the interventions. As 
previously noted, all of the interventions bar one (Sinclair et al., 1998) resulted in increased 
counselling ability, service provision or improved patient outcome. Unfortunately there was not 
sufficient information reported in the Sinclair et al. (1998) paper to identify BCTs, therefore a 
comparison between the content of this intervention and the interventions that were effective is not 
possible.  All of the interventions providing sufficient information about the intervention to identify 
BCTs (n=8) incorporated at least one behaviour change technique listed in the behaviour change 
taxonomy (Michie et al., 2013) however the number and combination of BCTs utilised in each study 
varied (mean number of BCTs used = 3.3, range: 1-5). The most commonly used BCTs were 
‘behavioural rehearsal’ (n=5), ‘feedback on behaviour’ (n=4), ‘adding objects to the environment’ and 
‘instruction how to perform behaviour’ (n=4). 
Two of the studies used BCTs associated with reward (remunerating participants for providing 
services) according to the behaviour change taxonomy (Michie et al., 2013), but did not report them 
as a way of changing behaviour. This is important, particularly given that the results from the 
qualitative studies identified lack of remuneration for providing lifestyle behaviour change services as 
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a barrier to engaging in the behaviour, therefore rewarding participants for performing a target 
behaviour may change their behaviour and may make them more motivated to perform the 
behaviour. If ‘reward’ is not described as a BCT and therefore a component of the intervention, it 
may affect replication in future studies or how the intervention is implemented in practice that does 
not reward pharmacists for delivering the intervention. This is an important factor that was not 
considered in any of the studies. 
The majority of the studies did not describe the use of theory to change the pharmacists, pharmacy 
students or pharmacy staffs’ behaviour in the development of the intervention. Many of the studies 
described using the ‘5 As’ approach which is based on the Transtheoretical Model (Prochaska & 
Diclemente, 1983) however they did not apply a theoretical approach to changing the provider 
behaviour. The types of intervention included in this review are changing provider behaviour in order 
to change patients’ health behaviours. This needs to be reflected in the development of the 
intervention through the application of psychological theory and BCTs to change provider behaviour 
and a separate level of psychological theory and BCTs to inform the intervention delivered by the 
provider behaviour. 
The quality of the studies included in the current review was generally poor, with the study designs 
introducing a high risk of bias. Reporting of the studies and description of the intervention content 
also tended to be poor. This may mean that there were other BCTs used in the interventions but they 
could not be identified due to insufficient information. The aforementioned factors meant that 
reliable conclusions about the effectiveness of the interventions could not be drawn. These findings 
fit with recent, related systematic reviews of health professional behaviour. Fillingham, Peters, 
Chisholm and Hart (2013) assessed the efficacy of educational interventions in undergraduate nurse 
training regarding obesity whilst Chisholm, Hart, Mann, Harkness and Peters (2012) assessed the 
efficacy of interventions to prepare medical students to facilitate lifestyle changes with obese 
patients. As with the current review, both Fillingham et al. (2012) and Chisholm et al. (2013) found 
only a small number of studies that met the inclusion criteria (n=8 and n= 12 respectively). Both 
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reviews also found that due to a failure to adopt procedures to control for bias, the studies were 
highly susceptible to bias and therefore the efficacy of the interventions could not be determined. 
Furthermore, both studies also found that the reporting of the interventions was poor, that many of 
the study conclusions did not support the results presented and that the majority of the 
interventions were deemed atheoretical by the authors.  
A lack of intervention transparency due to poor reporting is not uncommon, with a large evidence 
base showing that reporting of interventions in health research is inadequate (Hoffman et al., 2014). 
Consequently the factors that underpin behaviour change, termed the “active ingredients” of 
interventions cannot be reliably identified (Michie & Johnston, 2012). A recent analysis of all non-
pharmacological interventions in RCTs reported in six leading medical journals in 2009 found that 
only 39% were deemed adequately described, increasing to 59% when study authors were contacted 
for further information (Hoffman, Erueti & Glasziou, 2013). Hoffman et al. (2014) recently published 
the ‘TIDieR’ guidelines, an extension of the commonly cited CONSORT guidelines which state that 
interventions should report enough detail for each group to allow replication, to improve the 
reporting and consequently the replicability of interventions.  The guidelines state that studies 
should report: a precise intervention title; the rationale, theory and goals underpinning the 
intervention; a detailed description of all materials used; description of all details, processes or 
activities the intervention provider(s) carried out; the expertise, background and any specific training 
given to provider(s); how the intervention was delivered; the location where the intervention was 
delivered; when and how much of the intervention was delivered; if the intervention was tailored 
then what, why, when and how; if the intervention was modified (what, why, when and how); how 
intervention fidelity was assessed and the extent to which the intervention was delivered as planned 
(if assessed). Following such guidelines would allow the effectiveness of future interventions 
designed to enable pharmacists to facilitate patient lifestyle behaviour change to be assessed. 
Many of the problems associated with the studies originate from the use of study designs that do not 
incorporate a control group. Whilst the majority of the studies established baseline and post 
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intervention measures for participants, the absence of a control group means that the results of the 
study cannot reliably determine the effectiveness of the interventions.  Some of the studies utilised a 
randomised control design, however poor reporting of complete outcome data, randomisation 
procedures and lack of blinding of participants and assessors to group allocation introduced a risk of 
bias. Future research is required to conduct rigorous studies of high methodological quality to 
reliably assess the effectiveness of interventions to enable pharmacists and pharmacy staff to 
facilitate patient lifestyle behaviour change and identify the components of effective interventions. 
5.5.1 Strengths and limitations of the review  
This review, to present knowledge, is the first study to assess the effectiveness of interventions to 
enable pharmacists to facilitate patient lifestyle change. The review synthesised the evidence from a 
wide range of studies with differing designs and methodologies, and provides recommendations for 
the design of future studies to reliably assess the efficacy of interventions to enable pharmacists, 
pharmacy staff and pharmacy students to facilitate patient lifestyle behaviour change. There are 
however limitations to this review. The main limitation is due to resource constraints. Only one 
researcher conducted the searches, extracted data and evaluated the eligibility of articles for 
inclusion in the review in consultation with a supervisory group. This may have resulted in potentially 
eligible studies being missed. Again, due to resource limitations, only studies in English language 
were included which also may have resulted in potentially relevant papers being missed. The 
heterogeneity in the included studies also meant that a meta-analysis could not be performed.  
5.6 Conclusion 
In conclusion, this systematic review identified a relatively small number of studies that assessed the 
effectiveness of interventions to enable pharmacists, pharmacy students and pharmacy staff to 
facilitate patient lifestyle behaviour change. There was considerable variation in the intervention 
delivery, content and duration whilst the majority of the interventions were not based on theory. 
The interventions increased service delivery, counselling ability and participants’ self-efficacy in their 
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counselling skills. The effect of the interventions on patient outcome was mixed. Participants 
perceived that the interventions were helpful however they identified barriers including lack of time 
and remuneration to implementing the skills promoted in the interventions.  A need for further 
training was identified. Due to poor methodological quality and high risk of bias, the findings of the 
studies cannot be relied upon and consequently effectiveness of the interventions could not be 
reliably determined. Rigorous, well designed studies need to be conducted in the future to 
determine the effectiveness of interventions to enable pharmacists, pharmacy students and 
pharmacy staff to facilitate patient lifestyle behaviour change.
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6 Chapter Six: The experiences of patients with hypertension 
and/or hyperlipidaemia who use community pharmacy services 
6.1 Introduction 
Hypertension and hyperlipidaemia are major risk factors for the development of coronary heart 
disease and cerebrovascular disease, two of the major forms of cardiovascular disease (CVD) (WHO, 
2012) . Unlike other risk factors for CVD, hypertension and hyperlipidaemia are asymptomatic 
conditions. Patients may therefore manage the condition(s) differently to patients diagnosed with 
symptomatic conditions that are also risk factors for CVD such as diabetes. According to the Common 
Sense Self-Regulation Model, Leventhal (2003), individuals form illness representations about the 
identity, cause, consequences, timeline and whether the illness can be controlled. These 
representations guide their coping behaviours in response to health threats. These behavioural 
responses (such as self-management behaviours and help-seeking) are continually evaluated and 
amended, if deemed necessary, in an iterative process. The model also proposes that individuals 
simultaneously form emotional representations (such as fear) which also guide coping behaviours. 
Therefore, according to the CS-SRM, the absence of symptoms experienced by patients with 
hypertension and hyperlipidaemia may affect how they perceive and manage the condition (Meyer, 
Leventhal & Guttman, 1985). This subsequently may affect how these patients utilise community 
pharmacy services. This assertion is based on a recent systematic review which found that patients 
with hypertension attributed symptoms to the condition despite it being asymptomatic (Marshall et 
al., 2012), and research which found patients who believed that their hyperlipidaemia was stable and 
asymptomatic had better cholesterol control and were more adherent to medication (Brewer et al., 
2002).                                                                                                                                                          
The literature suggests that whilst the general public largely appreciate pharmacist-led public health 
services when they are provided, patients do not expect such services from their pharmacist, and lack 
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awareness of the pharmacists’ role (Anderson et al., 2003; Eades et al., 2011). However very few 
studies have focussed specifically on the perceptions of patients prescribed cardiovascular 
medication who use community pharmacies. Of the studies that have, none has specifically explored 
the experience of patients with hypertension and/or hyperlipidaemia (asymptomatic conditions) and 
compared it with the experiences of patients with hypertension and/or hyperlipidaemia and 
symptomatic conditions. This is necessary, as, due to an absence of symptoms, these patients may 
perceive self-management of the conditions through taking antihypertensive medication(s) and/or 
statins and engaging in lifestyle behaviours of less importance than patients with chronic conditions 
that have associated symptoms that may occur/worsen if self-management behaviours are not 
performed. Subsequently, such patients may require different or enhanced support from pharmacists 
to enable them to successfully self-manage the condition(s) from patients with symptomatic chronic 
conditions. 
Aim  
The primary aim of this study was to understand patients diagnosed with hypertension and/or 
hyperlipidaemias’ experience of using community pharmacy services. The study also aimed to 
understand the patients’ experiences of having hypertension and/or hyperlipidaemia in order to 
contextualise their experiences of using pharmacy services. 
6.2 Methods 
6.2.1 Study Design and Setting 
This was a qualitative study which used an inductive approach to data analysis. Semi-structured 
interviews were conducted with participants in their own home (n=1) or a private room (n=7) at 
Aston University depending on their preference. Ethical approval for the study was obtained from the 
Research Ethics Committee Northern Ireland (reference number: 13/NI/0048). 
6.2.2 Participants 
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For inclusion in the study, participants had to be diagnosed with and prescribed medication for the 
treatment of hypertension and/or hyperlipidaemia, to be able to understand written information 
and/or verbal explanations given in English and be able to give informed consent to participate in an 
interview.  
Participants were recruited from Aston University via the staff magazine and its associated website. A 
summary of the study was published in the staff magazine along with the researcher’s contact 
details, stating that potential participants should contact the researcher for further information if 
they were interested in taking part in the study. Originally it was intended that patients would be 
recruited through an external organisation that facilitates self-management groups for patients with 
chronic illnesses in Birmingham (hence the need for NHS ethical approval to conduct the study). 
However when data collection commenced the organisation was no longer able to fulfil its role in 
recruiting participants. Therefore the population to recruit potential participants was smaller than 
intended, with all participants recruited through Aston University which had originally been intended 
as a means of recruiting participants to pilot the interview schedule.  
Eight people participated in the study (see table 6.1). These were seven men and one woman with a 
mean age of 63.3 years (range: 43-67 years). Originally the researcher aimed to recruit up to ten 
participants with hypertension and/or hyperlipidaemia and up to ten participants with diabetes in 
addition to hypertension and/or hyperlipidaemia in order to obtain a range of experiences and 
perspectives however this was not possible within the timeframe because of the considerable 
difficulties recruiting participants described above. The mean time participants had been diagnosed 
with hypertension and/or hyperlipidaemia was 11.3 years (range: 2-43 years). In addition to 
hypertension and or hyperlipidaemia, five participants were diagnosed with chronic conditions which 
require self-management. These were type 1 diabetes (=1), type 2 diabetes (n=1) depression (n=2), 
gout (n=1), asthma (n=1) benign prostatic hyperplasia (n=1); and psoriasis (n=1). One participant had 
received an organ transplant and consequently engaged in self-management behaviours to prevent 
rejection of the organ. 
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All of the participants indicated that they were regular visitors to a particular pharmacy. Three of the 
participants regularly visited a multiple pharmacy, four participants cited an independent ownership 
pharmacy as their regular pharmacy and one participant cited a supermarket owned pharmacy as his 
regular pharmacy. 
6.2.3 Procedure 
The interviews were conducted at a convenient time and place for the participant and on average 
lasted 30 minutes (range: 15-35 minutes). Prior to the interview, all the participants were sent an 
electronic copy of the participant information sheet (appendix 9.12). The researcher asked the 
participant if they would like to have another chance to read the participant information sheet and if 
they had any questions about what participation in the study involved. If the participant was happy 
to continue, they were asked to sign a consent form (appendix 9.13) indicating that they understood 
what study participation involved and that they were happy to proceed. The researcher reiterated 
that the interview was completely confidential and that participants were free to withdraw from the 
study at any point without providing an explanation for doing so. None of the participants decided to 
withdraw from the study. 
An interview schedule was used to guide the interviews (appendix 9.14). The use of open-ended 
questions allowed the participant to contribute to the direction of the interview,  placing the 
interviewer in a facilitative role using the interview schedule and follow up questions to probe areas 
of interest and provide the participant with cues to enable them to describe their experience. The 
interview schedule contained the following topics: how participants were diagnosed with the 
hypertension/hyperlipidaemia/diabetes; perceived cause of the conditions, how participants 
monitored and managed the condition(s); perceived role of the pharmacist in general and in 
facilitating their condition self-management; experiences of visiting the pharmacy; experience of 
receiving advice from a pharmacist and thoughts on the suitability of the pharmacy as a place to 
receive advice. In order to put the participant at ease, the interview began with the researcher asking 
a general question: “tell me about your high blood pressure” and/or “tell me about your high 
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cholesterol”. Once a rapport had been established, the researcher moved onto more sensitive 
questions such as ‘how does having high blood pressure/high cholesterol affect you?”. The interviews 
were audio recorded and transcribed verbatim. As previously discussed, due to difficulties recruiting 
participants a sample size smaller than the researcher had intended to obtain a breadth of 
experiences was achieved. However despite the sample being smaller than planned and lacking the 
range of participants intended, no new themes emerged from the accounts of the participants 
recruited in the time available. 
6.2.4 Analysis 
The transcripts were analysed thematically with the focus on the participant’s experience (Braun & 
Clarke, 2006). The analysis was primarily inductive and was interpretative, recognising the interaction 
between the researcher and the data. A Framework approach was used to structure the analysis 
(Ritchie & Spencer, 1994) using QSR NVivo 10 software. A detailed description of Framework analysis 
is provided in chapter three. In brief, the process involves: familiarisation with the data; forming a 
thematic framework from analysing a small number of transcripts; applying the thematic framework 
to the remaining transcripts through numerical indexing, charting and mapping the data in 
accordance with themes and sub-themes (using QSR NVivo 10) and interpretation of the findings. 
This was an iterative process performed by the researcher (KK) who discussed the findings with her 
supervisory team to ensure the validity of the interpretations. 
6.3 Results 
The patients were assigned codes which reflect: participant number; whether the participant had 
hypertension (HTN) and/or hyperlipidaemia (HLD) and if they have any other chronic conditions 
(C/M, indicating co-morbidities). Therefore P1-HLD-C/M denotes participant number one who had 
hyperlipidaemia and other co-morbidities. The codes are displayed along with a description of 
participant characteristics in table 6.1 below. 
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Table 6.1: Participant Characteristics  
Participant Gender Age Diagnosed medical 
condition(s) 
Time diagnosed 
with HTN/HLD 
Regular  
pharmacy 
ownership 
P1-HLD-C/M Female 54  Type 1 Diabetes  
 Hyperlipidaemia 
 Depression 
2 years Multiple. 
 
P2-HTN-C/M 
Male 67  High Blood pressure 
 Gout 
 Sciatica 
 Benign Prostatic 
Hyperplasia (enlarged 
prostate) 
4 years Independent 
 
P3-HTN- C/M 
Male 48  High blood pressure 
 Borderline high 
cholesterol 
 Asthma 
16 years Supermarket 
 
P4-HTN-C/M 
Male 57  High blood pressure 
 Depression 
 Psoriasis 
4 years Multiple 
 
 
P5-HTN 
Male 43  High blood pressure 
 Hay fever 
6.5 years Independent 
 
P6-HTN-C/M 
Male 63  High blood pressure 
 Recipient of organ 
transplant  
43 years Independent 
 
P7-HTN, HLD-
C/M 
Male 55  High blood pressure 
 High cholesterol 
 Type 2 diabetes 
5 years Independent 
 
P8-HTN 
Male 56  High Blood Pressure 10 years Multiple 
 
Three themes emerged from the results. The themes and associated sub-themes are presented in the 
following table. 
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Table 6.2: Table of Themes 
Theme Sub-theme 
Perceptions of hypertension and 
hyperlipidaemia 
Cause of hypertension and hyperlipidaemia 
Perceived severity 
Condition management 
Concerns about taking medication 
Perceptions of pharmacists Pharmacists as professionals 
Patients unsure of pharmacist’s role 
Suitability of pharmacists giving lifestyle advice 
Role of the pharmacy setting 
Experiences of using community pharmacy 
services 
Seeking advice from pharmacists 
Receiving advice from pharmacists 
Concerns about confidentiality  
Role of pharmacy location 
 
6.3.1 Perceptions of hypertension and hyperlipidaemia 
6.3.1.1 Cause of the condition(s) 
When asked what they thought caused their hypertension and/or hyperlipidaemia, the participants 
expressed a range of beliefs. The majority of participants cited lifestyle behaviours as the primary 
factor or a contributor to them developing the condition(s): 
 “Um I think it’s really um weight and imported European lager related… um the overall 
unfitness…you know I was up to twenty and a half stone…” P3-HTN-C/M 
Interviewer: “What do you think caused your high cholesterol?” 
Participant: “Poor diet, not looking after myself yeah and the diabetes as well…” P7-HTN, HLD-
C/M 
Some of the participants who had hypertension also cited stress as a causal factor in the 
development of the condition: 
 “I would say it was probably a combination of a long period, fifteen twenty years of high 
pressured work that’s my view and obviously the type of person I am… I tend to worry and be 
conscious of things, things like that so you know what I mean…” P8-HTN 
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In addition to a stressful working environment, this participant appeared to attribute his perceived 
personality type as a causal factor in developing hypertension. Another participant believed that 
significant life events, combined with inherent factors caused him to develop hypertension: 
 “Um I’ve been told by the doctor that it’s a factor of my, the fact that I’m male, my age…my uh 
background sort of Scottish whatever, uh and it was pretty well inevitable that some time I 
would have high blood pressure…the overall picture’s not been helped by the fact that I had um 
well the death of my father and my wife decided to initiate divorce proceedings at the same 
time…” P4-HTN-C/M 
This participant gave a sense that it was inevitable that he would develop hypertension and that 
there was little he could do about it. Having little sense of control may affect his perception of how 
much control he has over the management of the condition and consequently may affect his self-
management behaviours.  
On the other hand, a minority of the participants were unsure what had caused the condition: 
“We don’t know what caused the cholesterol to rise and it was quite rapid as well…it would be 
interesting to identify why all of a sudden it’s risen and whether that’s just an add on to what 
I’ve experienced sort of medically recently” P1-HLD-C/M 
“It was just before the birth of my first child um and I was working I was quite busy but two 
children now are quite stressful the whole time and you know I’m quite busy still…that’s one of 
the reasons I wanted to take part in this [research study] really I wanted to find out if there 
should be more [medical care or investigation]…” P5-HTN 
For both the participants, it appeared important to have an understanding of what caused them to 
develop hyperlipidaemia and hypertension respectively. Whilst P1-HLD-C/M later reported that she 
would continue to investigate the cause of her hyperlipidaemia with her medical team, P5-HTN 
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appeared to feel particularly aggrieved that he had not been given an explanation of why he 
developed hypertension.  
6.3.1.2 Perceived severity of hypertension and hyperlipidaemia 
There appeared to be differences in the way participants with hypertension and/or hyperlipidaemia 
and the participants who had diabetes in addition to hypertension and hyperlipidaemia perceived the 
conditions. Participants with diabetes appeared to view this as a more serious condition that 
hypertension and/or hyperlipidaemia: 
“I should be actually just as worried about the high blood pressure and cholesterol but I see the 
package all together…if I didn’t have that [diabetes] those [hypertension and hyperlipidaemia] 
would still be a concern, possibly because of you know historical views I might not be doing as 
much about it…so I think the diabetes, the focus on the diabetes…” P7-HTN, HLD-C/M 
“I think at the moment to actually detach it from the diabetes because the problems that I’ve 
had with the diabetes it probably had been put on the backburner a little bit…so I wouldn’t say 
it’s my number one priority…” P1 HLD-C/M 
These participants appeared to view hypertension and/or hyperlipidaemia as components of their 
diabetes, which appeared to take precedence, rather than viewing them as separate conditions of 
equal severity. This appeared to relate to the participants’ perceptions of the potential consequences 
of having unmanaged diabetes: 
“Um I’m terrified about um losing my sight! Um I’m very worried about losing the use of my uh 
legs, and I realise uh just how susceptible I could be to uh coronary heart disease so yeah so uh 
there’s plenty of cricket still to be watched so (laughs)…” P7-HTN,HLD-C/M   
“…particularly in the last two years I’ve been very aware of the associated problems [with 
diabetes] with my eyes and my feet and so I’ve probably concentrated on those…I think that’s 
quite fair to say that cholesterol management has been lower down the priority list…” 
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These participants perceived diabetes to have particularly serious consequences, with P7-HTN,HLD-
C/M  alluding to diabetes potentially being life threatening. Another participant with hypertension 
appeared more concerned about developing diabetes than having hypertension: 
“…develop Type 2 Diabetes and lose toes and things like that…be really bad and also vision 
through a glaucoma so I’m trying to sort of be realistic…and be healthier…” P3-HTN- C/M 
The risk of developing diabetes appears to be a driver of his motivation to change his behaviour 
rather than the hypertension. In comparison, the majority of participants with hypertension and/or 
hyperlipidaemia did not make reference to potential consequences of having the conditions. 
Interestingly, the exception was one participant who perceived hypertension as a serious medical 
condition but felt this perspective was not shared by the health professionals he encountered: 
 “…to me it was quite a serious diagnosis but to them [health professionals] it was just like oh 
yeah just stick you on some tablets and you’ll be alright…” P5-HTN 
It may be that some health professionals also share some of the participants’ belief that diabetes is a 
more serious condition with more severe consequences than hypertension. 
The absence of symptoms associated with hypertension and hyperlipidaemia may explain why the 
participants with diabetes in addition to these conditions perceived diabetes as a more serious 
condition than hypertension and hyperlipidaemia. One of the participants did not experience any 
symptoms and did not believe he had hypertension but decided to have his blood pressure measured 
when he saw an advertisement at his community pharmacy: 
“So I thought ok I might as well um have have it [blood pressure measured], I don’t think I’ve 
got high blood pressure…but…it’s, it’s sensible…” P2-HTN-C/M 
This led to P2-HTN-C/M being diagnosed with hypertension, to his surprise. On the other hand, 
despite hypertension being an asymptomatic condition, some participants described symptoms they 
perceived to be related to the condition: 
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“…crashing headaches uh a feeling of incapacity…regular headaches flushed cheeks really not 
feeling right…” P5-HTN 
“Just either get headaches or I can feel the back of my own skin tingling sort of thing you know, 
just generally you feel differently and having had it now for ten fifteen years you know when 
you’re chilled, and you know when things are starting to get a little bit out of hand…” P8-HTN 
Both participants gave a sense of being able to ‘feel’ changes in their blood pressure through 
perceived somatic experiences. This may lead to the patients perceiving that if they do not have 
symptoms which they associate with hypertension and/or hyperlipidaemia then they have the 
condition under control: 
 “Um as I say it’s controlled so most of the time I don’t have any problems with it but um you 
know I think that… I don’t have tend to have like headaches or things like that but you know um 
I think you would feel a bit stressed or that sort of thing if I did have high blood pressure…” P6-
HTN-C/M 
The participant appeared to believe that he could tell if his blood pressure was raised, assuming that 
it was not as he was not experiencing the symptoms he perceives to be indicative of hypertension. 
This could potentially result in him not engaging in necessary self-management behaviours such as 
lifestyle behaviours or taking antihypertensive medication. 
6.3.1.3 Condition management 
The majority of participants believed that their hypertension and/or hyperlipidaemia could be 
controlled through lifestyle behaviours and/or medication: 
“And I’ve noticed that if I can control my weight a little bit better and be sensible then the blood 
pressure itself seems to come down and…approach normal levels” P3-HTN-C/M 
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“I would have high blood pressure if it wasn’t controlled, my blood pressure is now normal…but 
if I stopped taking the beta blockers it [hypertension] would happen as it has happened in the 
past…” P6-HTN-C/M 
Many of the participants described changes they had made to their lifestyle after receiving a 
diagnosis of hypertension and/or hyperlipidaemia: 
“…the blood pressure did come down…although I’d been living fairly healthily but I changed my 
lunchtime patterns from sort of toasted cheese and omelette and bacon and egg to chicken 
salads and salmon…which probably helped my cholesterol…” P2-HTN-C/M 
“I’m probably consciously doing more…exercise and probably for the first time in a long while 
starting to record weight…” P7-HTN, HLD-C/M 
“I did cut out caffeine…and am much more serious about losing a bit of weight you know…I lost 
two and a half stone I’ve put back on about twelve pounds but I lost [weight]…” P5-HTN 
Despite many of the participants describing medication as a way to control their hypertension and/or 
hyperlipidaemia, some participants appeared to experience some doubts about the need to take 
medication: 
“I did a little experiment where I didn’t take the meds a few months ago…and I shoulda and the 
numbers were interesting 130 over 90 uh 95 oh right start taking the pills again and it comes 
back down to under 120…”  P3-HTN-C/M 
The absence of symptoms associated with hypertension may have caused P3-HTN-C/M to question 
whether he needed to take medication, and it was through seeing his blood pressure raise when not 
taking the medication that prompted him to begin taking the medication again. 
As with the participants’ perceptions of condition severity, there appeared to be some differences in 
the way that that some of the patients with symptomatic conditions in addition to hypertension 
and/or hyperlipidaemia behaved compared to patients who just had hypertension and/or 
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hyperlipidaemia. P5-HTN described making some changes to his behaviour but not at the expense of 
the things he enjoyed: 
“…I did cut out caffeine and I did and am much more serious about losing a bit of weight you 
know…I have an increased awareness of salt and uh various sort of stuff that’s good and stuff 
that’s not so good to eat um but even so I’m not evangelical and I’m not you know I won’t not 
have a cream cake if one’s on offer do you know what I mean?” P5-HTN 
On the other hand, P1-HLD-C/M, who had Type 1 diabetes in addition to high cholesterol, described 
carefully managing her food intake to control her diabetes: 
“…you’re probably a bit more aware of your body and what it’s sort of um doing than most 
because you know it isn’t something that you can think oh I haven’t bothered to think about 
what I’m eating today you know that’s not an option for us…” P1-HLD-C/M 
Unlike hypertension, Type 1 diabetes is a symptomatic condition and therefore the patient will 
experience symptoms if it is not effectively managed. It may be that P1-HLD-C/M engages in more 
active self-management than P5-HTN as she will experience symptoms associated with diabetes if 
she does not. Furthermore, Type 1 diabetes management, as described by the participant in her 
interview, requires regular monitoring of blood glucose levels and food intake, providing participants 
regular feedback on their self-management behaviours. This may make the need to self-manage 
through lifestyle behaviours more salient for patients with diabetes than for patients with 
hypertension/hyperlipidaemia. Contrastingly, few participants without diabetes reported regularly 
self-monitoring their condition. 
There also appeared to be variation in how confident participants felt about their ability to engage in 
appropriate lifestyle behaviours to self-manage their condition. Some participants appeared to be 
confident in their abilities, perceiving that they had their hypertension and/or hyperlipidaemia well 
controlled whilst others appeared to struggle:  
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“I think ooh I’m getting healthier one minute…over all general fitness and be able to you know 
play squash for a lot longer…and running longer without collapsing so it’s really continuing with 
that and keeping up the momentum and then Christmas is going to arrive and then everything 
I’ve said will be complete nonsense…” P3-HTN-C/M 
“I’m not on the right levels of fruit still eating probably uh, too much meat and I’ve not given up 
the drink (laughs)...and I always say my biggest battle for me is my weight…” P7-HTN, HLD-
C/M 
Both these participants had indicated that they needed to lose weight but found it difficult to engage 
in the necessary lifestyle behaviours to achieve this. This appeared to be an emotive issue for these 
participants: 
“I’m more interested in having a good game of squash and losing than a mediocre game of 
squash because you can’t move fast enough to get to the ball and you just pissed off the other 
guy cause what’s the point in turning up?” P3-HTN-C/M 
“I say well ok if you know sort of those [hypertension, hyperlipidaemia, diabetes] are all defects 
and um they’re all self-inflicted defects…” P7-HTN, HLD-C/M 
Both participants appeared to blame themselves for developing hypertension and hyperlipidaemia 
and for being overweight. Their accounts gave a sense of being negatively evaluated by others. 
Throughout his account, P3-HTN-C/M used self-depreciative humour and inferred that the researcher 
would laugh at his attempts to lose weight through engaging in exercise.  
6.3.1.4 Concerns about taking medication 
A number of the participants described concerns about the medications they were taking to manage 
hypertension and/or hyperlipidaemia. One of the participants described experiencing problems with 
side effects of a statin she was prescribed to lower her cholesterol: 
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“… from my previous knowledge of taking new medication sometimes you do sort of to begin 
with you do suffer from side effects and you know that’s the sort of cost that you have to pay to 
you know deal with that however after three months the level of muscle pain that I was 
experiencing was quite intense to the point that it was impacting on my everyday wellbeing so I 
returned to the doctor…” P1-HLD-C/M 
This participant described being willing to tolerate side effects of a medication when commencing 
treatment, however she appears to have weighed up the impact of the side effects against the 
benefits of the treatment and decided that the side effects of the medication outweigh the benefits.  
Other participants described not being keen to take medication: 
“I have a certain reluctance to take more medicines than I really need to um but you know I 
take the blood pressure pill, the water tablets, the antidepressants otherwise I’d be in a lot 
worse state.” P3-HTN- C/M 
This participant appeared to have balanced his reluctance to take medication against his perception 
of the effectiveness of the treatment and concluded that treatment is beneficial to him. Another 
participant shared P3-HTN- C/M’s reluctance to take more medication than necessary: 
 “… if I knew twenty years ago what I knew now um I’d a done things differently, um but I’m 
absolutely determined to you know not become insulin dependent not becoming, you know 
more drugs than I need…chemists think it’s Christmas when I come (laughs)” P7-HTN, HLD-C/M 
This participant appeared to regret his previous lifestyle choices, and it seemed to be very important 
to him not to have to take more medications than he needed. He appeared to be using this as a 
driver to change his lifestyle behaviours as he seemed to fear becoming reliant on another 
medication. Another participant cited being able to stop taking medication altogether as motivation 
to change his lifestyle behaviours: 
 
 
196 
 
“…but this healthier lifestyle not perfect but making better informed choices to um lessen the 
condition maybe um to eradicate the condition and therefore take that medicine out of the 
equation and therefore not suffer the side effects of the medication plus the condition as 
well…” P3-HTN-C/M 
Being able to stop taking the medication and consequently not experience any associated side effects 
appears to be desirable for this participant. Highlighting this as a potential outcome of engaging in 
healthy lifestyle behaviours may be a useful discussion, when appropriate, for pharmacists to have 
with patients taking medication for hypertension and/or hyperlipidaemia. 
6.3.2 Perceptions of pharmacists 
6.3.2.1 Pharmacists as professionals 
There was variation in the way participants conceptualised the pharmacist’s role. Some participants 
saw pharmacists as having specific expertise in medicines, appearing to view this as the key 
component of the pharmacist’s role. One participant described a time when he was given advice by a 
pharmacist who identified that the over-the-counter medication he had attempted to buy would 
interact with his prescribed medication: 
“…that also alerted me to the fact that as I’m taking these [tablets] and one or two other things 
[medications] that I would check with the pharmacist before buying any over the counter 
remedy…so I think that you know relying on a pharmacists who will look out for that and in that 
case took the initiative because it didn’t occur to me to think you know can I take this?” P2-
HTN-C/M 
The act of seeking medication advice from a pharmacist after this experience suggests that he 
perceives pharmacists as a credible source of knowledge or expertise in this area (which he does not 
possess). His use of the phrase ‘relying on’ suggests that he feels comfortable to place his trust in 
pharmacists, implying that he is confident in their knowledge about medicine. Another participant, 
when asked who he would seek advice from if he was having problems managing his condition, 
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remarked that he would seek advice from a pharmacist about problems related to the medication he 
was taking: 
“…if I was having problems with the medicine as in I was reacting…it would probably be the 
community pharmacist I mean I’ve noticed that they don’t always stick to the same brand and 
even if it’s the same medication different brands can cause issues to do with absorption or 
things like that…” P5-HTN 
This participant identified the pharmacist as the first person he would consult for advice if he 
experienced problems which he perceived as being caused by the medication, which again appears to 
indicate that he also sees the pharmacist as an expert in this area. In accordance with this, some 
participants described instances when they had specifically sought out a pharmacist’s advice in 
relation to their medication. Pt1-HLD-C/M consulted a pharmacist after an optician informed her that 
the medication she was taking for high cholesterol may have negative consequences for her: 
“And he [the pharmacist] said ooh let me have it [the medication] and he checked through and 
explained to me why that medication and actually the optician had been a bit alarmist because 
there weren’t actually many substantive cases to suggest that this medication caused the 
problem that the optician thought so…that was quite a reassuring um sort of instance where 
the pharmacist’s knowledge of the medication was actually invaluable because I came away 
from the optician’s feeling very alarmed that I was given something that would actually cause 
more problems…” P1-HLD-C/M 
This participant had actively sought out the pharmacist’s advice on medication as the first port of call, 
which may indicate that she values the pharmacist’s opinion highly. By sharing their expertise, and 
advising the participant of the reasons for taking the medication and explaining the problems 
associated with its use, the pharmacist gave Pt1-HLD-C/M reassurance which appeared to reduce her 
anxiety about taking the medication. However not all participants shared this experience. One 
participant reported that he did not receive the advice about medicines that he needed: 
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“… the one area I mentioned that was of concern was when my drugs were changed and 
nobody told me about potential side effects or certain things and I think if somebody, when the 
pharmacist knows it’s a change of drug that, to me, would have been really helpful…” P6-HTN-
C/M 
This patient was not informed that grapefruit juice could interact with the antihypertensive 
medication that he was prescribed. Through reporting concern at not receiving advice about 
medication changes from the pharmacist, Ppt-HTN(43yrs)Co-morbid appears to demonstrate that he 
perceives giving medication advice as part of the pharmacist’s role, as he is concerned that the 
pharmacist did not provide him with this information which he feels he should have received. 
Whilst some participants viewed pharmacists as professionals and/or possessing expert knowledge in 
medicines, other participants did not appear to conceptualise pharmacists in this way, and appeared 
to feel that the pharmacist’s role did not extend beyond dispensing prescriptions: 
“I’m not sure there’s a greater role than giving me the tablets…” P2-HTN-C/M 
“...well I suppose I would see them [pharmacists] as being somebody who provided a lower 
level of medical advice to the doctor…based around a pharmacy for me the pharmacist is just a 
place where you have to go to uh to get your uh prescriptions filled…” P8-HTN 
These participants did not appear to perceive pharmacists as professionals of equal standing to other 
health professionals, nor did they see pharmacists having a role in facilitating patient self-
management or promoting healthy lifestyles. The phrase ‘lower level of medical advice’ used by P8-
HTN suggests that he may not value the input from pharmacists as much as he would value input 
from doctors.  Another participant made the comparison between pharmacists and other health 
professionals: 
 “…you know obviously it’s the same I suppose you go the doctors or you go to see the nurse at 
the doctor and all the rest of it and um you expect professional people who know what they’re 
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talking about and whatever and obviously pharmacists are qualified professional people and all 
the rest of it…um but uh sometimes it’s a little bit about confidence whether you’ve got 
confidence in the people…” P6-HTN-C/M 
Unlike the previous participants, P6-HTN-C/M conceptualised pharmacists as ‘professionals’, 
however his comment about having confidence in people may suggest that he is not fully confident in 
pharmacists capabilities as health professionals.  
Like P6-HTN-C/M, many participants used General Practitioners (GPs) as a frame of reference when 
considering the role of pharmacists, comparing the pharmacist’s role to that of the GP. Most of the 
participants indicated that they preferred to consult their GP for issues relating to their hypertension 
and/or hyperlipidaemia: 
“…if it was something like getting your blood pressure checked or what cough medicine should I 
take…then I’d be quite happy going to the pharmacist…to any more level than that I think I’d 
want to go to a doctor…you can never take the doctor out of the equation…” P6-HTN-C/M 
Some patients perceived that GPs had control over their medical care and therefore pharmacists had 
little to offer them: 
“…if you’re having high blood pressure there’s usually some underlying reason for it um the 
pharmacist might be able to advise you but I’d be surprised if they didn’t say well if it’s 
temporary maybe we’ll check it in a week or so but if it’s still the same then you need to go to 
your GP about it…” P6-HTN-C/M  
“…the pharmacist…has a role in dispensing medicines and yeah they are specialists in the sort 
of pharmaceutical side of stuff…at the end of the day…anything that is you know prescribed it’s 
more the doctor has the final say…yeah you can get information from the pharmacist… and 
whilst…the community pharmacist might like to expand their role um there is a sort of logistical 
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problem that they’re not when it comes to prescribed drugs or medicines or whatever, they’re 
not the ones prescribing…” P4-HTN-C/M 
P4-HTN-C/M appears to see the doctor as having power and responsibilities that most pharmacists 
do not have in prescribing medications and therefore he appears to feel that the pharmacist is not in 
a position to add anything to his care. His comparison of the doctor’s role to the pharmacist’s role 
positions doctors as powerful in comparison to what he appears to view as the lesser role of the 
pharmacist, who may wish to adopt addition responsibilities but cannot as they do not possess the 
power doctors have.  In addition to this, other participants had concerns that pharmacists may offer 
different advice to doctors, who, as already outlined, they appeared to hold in high esteem: 
“ …and there is you know the danger with somebody who perhaps doesn’t hear what they want 
to hear…and then they hear conflict so actually the pharmacist said this but the GP said this …” 
P7-HTN, HLD-C/M 
This participant appeared concerned that pharmacists may offer differing advice to doctors that may 
lead patients not engaging in behaviours to benefit their health. This may be a reflection of 
perceiving that pharmacists have less knowledge or expertise than doctors therefore they may 
provide conflicting advice. 
Conversely, some participants appeared to conceptualise pharmacists as having expertise that was 
equal to that of other health professionals. One participant, Ppt1-HLD(2yrs)Co-morbid appeared to 
view pharmacists in the same esteem as other health professionals: 
“I would ask a pharmacist or ask a doctor or a medical profession because they are the experts” 
P1-HLD-C/M 
This sentiment was shared by another participant: 
“It [the pharmacist] is another version of the GP really I think that needs to be emphasised 
more…" P5-HTN 
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He added: 
 “…the community pharmacist isn’t someone who just um uh…someone who sells medications 
they are they know they have a massive qualification behind this and you know they have the 
experience and the expertise I know that so I would welcome…” P5-HTN 
P5-HTN appeared to view pharmacists as having qualifications, experience and expertise, qualities 
that tend to be associated with professional status. It is noteworthy this participant identified the 
pharmacists as his first port of call if he was experiencing problems which he perceived to be 
associated with his medication.  
6.3.2.2 Patients unsure of pharmacist’s role 
Some of the participants appeared to experience confusion surrounding the term ‘community 
pharmacist’ when the interviewer asked them what they thought the role of the community 
pharmacist was: 
 
“Do you see a community pharmacist as different from any other pharmacist or are all 
pharmacists are high street pharmacists different from community pharmacists…?” P2-HTN-
C/M 
 “I’m assuming by you saying community pharmacist you mean the guy who actually sits in the 
chemist and dispenses the prescription?” Pt8-HTN(10yrs)  
“Right ok that’s a good one (laughs) when you say, I mean the community pharmacist are we 
talking just the normal chemist?” Pt6-HTN(43yrs)Co-morbid 
The terminology appeared to cause these participants confusion; it seems that some of the patients 
were more familiar with the term ‘chemist’ than ‘community pharmacist’. This is noteworthy, as 
health promotion campaigns tend to direct patients to their ‘community pharmacist’ rather than 
accessing other services. This may not be effective if patients are confused about the terminology.  
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One participant also appeared to be unsure about the enhanced services pharmacists can offer: 
 “… yeah I’m not too sure I know I’m not too sure how it works …whether there are some 
pharmacists who are actually providing a blood pressure service or other things…you know 
whether its check for diabetes or various things like that so I’m not sure about how they about 
how that sort of works …I don’t know how that would work in terms of the National Health 
whether it’s something it would pay for or how that would work …” P6-HTN-C/M 
This participant added that he felt greater clarification of the pharmacists’ roles in addition to those 
associated with medication was necessary in order for patients to benefit from such services: 
 “…what I understand of a pharmacist and I think that most people recognise a pharmacist 
whether there is more in what a pharmacist could offer and whatever that would need to be 
more generally publicised I think so people need to understand what pharmacists can offer…” 
P6-HTN-C/M 
This was a sentiment shared by other participants interviewed.  P6-HTN-C/M gives a sense that he 
would be open to pharmacists having roles in addition to dispensing and providing advice on 
medication, however this would need to be publicised so patients are aware of this and accept it as 
part of the pharmacist’s role which he does not appear to perceive to happen at present.  
The confusion surrounding the pharmacist’s role experienced by some of the participants may relate 
to the changes to the pharmacist’s role in more recent years: 
“Um traditionally I would always have seen the chemist you know the pharmacist just 
dispensing your prescription…um but I I’ve seen that change probably perhaps in the last 
decade…when I go into a chemist these days is I see people going in and um the pharmacist 
coming out and giving advice…whereas before you only see your GP… I see that changing and 
I’ve found some very helpful people…” P7-HTN, HLD-C/M 
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“I think…quite often when you get medication you do really think that the doctor is the only one 
that knows what that medication is going to do and how it’s going to affect you what’s become 
increasingly apparent over the last couple of years is the pharmacist is a very untapped 
resource…” P1-HLD-C/M 
However, despite the substantial changes to the landscape of community pharmacy in recent years, 
most participants did not make any reference to this or describe changes in their care as described by 
the participants above. This may suggest that the changes to the pharmacist’s role have had little 
impact on the care of most of the participants interviewed. 
6.3.2.3 Suitability of pharmacists giving lifestyle advice 
The participants’ views on the suitability of the community pharmacy as a place to receive lifestyle 
advice varied. Some patients were positive about pharmacists giving lifestyle advice: 
“I think that…if you were looking at how community pharmacists might actually get involved 
with individual patient care then I think it [pharmacists offering lifestyle advice] is a good 
thing…I welcome that as a good thing that wouldn’t put me off talking to them…” P5-HTN 
“…maybe instead of people looking at it as purely medical look at it from a general wellbeing 
point of view in that if you have got any concerns about maybe a weight issue or smoking and I 
think they do address that already that you know the wider sort of resource there [in the 
pharmacy] I just think is limitless…” P1-HLD-C/M 
P1-HLD-C/M was very enthusiastic about pharmacists having a role in lifestyle advice provision and 
facilitating patient self-management which was evident throughout her interview. She appeared to 
believe that there needed to be a shift in the general public’s attitude towards the role of community 
pharmacy in order for pharmacists to play a more active role in patient care. It is interesting to note 
that P5-HTN stated that pharmacists giving him lifestyle advice would not prevent him consulting 
pharmacists. This may reflect a belief that not all patients are open to pharmacists giving them 
lifestyle advice. 
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Another participant believed it was acceptable for a pharmacist to give him weight loss advice as he 
accepted that he was overweight: 
“ Because I’ve acknowledged it’s a problem it [receiving weight loss advice from a 
pharmacist]… doesn’t concern  me um and I suppose it’s something I will learn to accept…the 
first time people were discussing weight I’d actually gone to see an ear nose and throat 
specialist and I felt like saying well what’s it got to do with you…because it was the attitude it 
was said um but I think there’s probably more of an acceptance of that now and of course 
because it’s related to my condition um but again I think it’s about that expanding role of the, 
you know and allowing and accepting the pharmacist’s got a part to play…” P7-HTN, HLD-C/M 
This participant appeared to have had a negative experience of being given weight loss advice in the 
past which he attributes to the way in which the advice was delivered and the person who delivered 
the advice. The way he described learning to accept weight loss advice suggests that this may be 
difficult advice to receive. It appears that the participant needed to be able to understand the link 
between the condition and being given weight loss advice in order for this to be acceptable to him. 
The participant did not appear to understand how his weight related to problems he consulted an ear 
nose and throat specialist for, therefore could not see the relevance of the advice and why this was 
offered to him which appeared to evoke a defensive response. Pt7-HTN, HLD(5yrs)Co-morbid 
appeared comfortable with the idea of being given weight loss advice by a pharmacist as he 
acknowledges that he is overweight and recognises that this has an impact on his hypertension, 
hyperlipidaemia and diabetes therefore appears to see giving weight loss advice as part of the 
pharmacist’s role.  
On the other hand, some participants did not share this perspective and did not view giving lifestyle 
advice as part of the pharmacist’s role at present: 
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“…maybe it’s me but when I think of a pharmacist…I think about providing drugs and whatever 
giving you a little bit advice on one or two things but I think that…diet can be a little bit specific 
to people’s you know lifestyle…” P6-HTN-C/M 
He went on to add: 
“…if it was recognised that the pharmacist could give you advice on diet could give you advice 
on exercise and various other things um and I don’t think I’d have a problem doing that 
contacting them speak to them about it it’s just sort of um at the moment it’s not something I 
would do…I don’t think it’s part of their role at the moment…” P6-HTN-C/M 
“… it wouldn’t be my first port of call [the pharmacy]…If felt I’d got a real problem I’m quite 
comfortable asking the pharmacist for information about the drug…or the medicines, or things 
like that – if they interact - but I wouldn’t naturally go to the pharmacist to say ooh do you 
think I’m a bit overweight now or do you think I’m, do you know what I mean?” P8-HTN 
Both these participants appeared to view the provision of lifestyle advice as incongruent with 
pharmacist’s current role. For P6-HTN-C/M this incongruence seemed to relate to his perception that 
giving lifestyle advice is not widely recognised as part of the pharmacist’s role. The opinions 
expressed by the participants above contrasts with their perceptions of the pharmacist’s role in 
giving medicines advice,  which both participants perceived as part of the pharmacist’s role. Both 
these participants did not appear to conceptualise pharmacists as health professionals, whereas the 
participants who perceived lifestyle advice to be part of the pharmacist’s role appeared to 
conceptualise pharmacists as health professionals.  
6.3.2.4 Role of the pharmacy setting 
The retail environment was identified by some participants as a barrier to pharmacists performing 
roles such as providing lifestyle advice: 
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“…in terms of educating people in terms of how to cope better with daily life um I think the 
pharmacist could have an important role there but the pharmacist is busy…counselling and 
managing the store…” P3-HTN-C/M 
The environment pharmacists practice in appeared to affect the participants’ perceptions of the 
pharmacist’s role: 
“…you have to distinguish that it was different from telling your life story to someone who is a 
shop assistant even though they obviously have the qualification and the knowledge and the 
status to go with it…” P5-HTN 
The retail environment resulted in the majority of patients viewing themselves as customers: 
“ I think as a customer, yeah…‘cause it’s a shop…well they do a bit of pharmacy but they would 
also sell me a hot water bottle if I wanted one or whatever, you know what I mean? Or 
sunglasses so you know…” P8-HTN 
This appeared to affect how the patients perceived the role of the pharmacist: 
“It’s like going into Tescos and somebody saying, when you get to the till somebody saying oh 
can we just go and have a discussion you know about why you’ve bought the stuff that you’ve 
bought?” P4-HTN-C/M 
“…I suppose I see myself as a customer…to me a pharmacy is basically a shop…where you’re 
going in for goods supplies drugs whatever…” P6-HTN-C/M 
This patient viewed pharmacists as shop employees rather than health professionals with a role to 
advise patients and ensure that medicines dispensed or bought will not harm patients. He appeared 
to view pharmacists’ input as an intrusion.  
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The retail environment also appeared to result in the participants having a different set of 
expectations that they may not have of other health professionals practising in obvious clinical 
environments: 
“…there’s a kind of language that comes with the barrier of oh well this is a shop and 
actually…you need that kind of consultation service where you can…access people in a setting 
of your choosing and more of your expectations….that there’s a perception that you would be 
going there to get a medical consultation and you don’t really do that across a shop type 
setting so you’d have to have another area for that…” P5-HTN 
 “… I would consider myself a customer if I was just going to pick it [prescription] up do I get a 
nice smile and so on but actually I know I would be talking to someone who would at least have 
the knowledge of what I was going to talk about…” P5-HTN 
This participant expects characteristics associated with good customer service when he goes to 
collect his prescription from the pharmacy, viewing himself as a customer rather than a patient, 
although he acknowledges that pharmacists have knowledge of the medication he is collecting.  
6.3.3 Experiences of using community pharmacy services 
6.3.3.1 Seeking advice from pharmacists 
In keeping with the conceptualisation of pharmacists being experts in medicine which was held by 
some of the participants, all of the participants who reported seeking advice from a pharmacist did so 
in relation to prescription medications, over-the-counter medication and minor ailments: 
“ The only time’s [asking a pharmacist for advice] been when um if I’ve had a really bad cold or 
I sometimes get sinus problems…and I’m very conscious that there are certain types of 
medicine for colds and cough medicines I can’t take …or they exacerbate the situation so the 
advice has been more of what can I take…”  P8-HTN 
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“…if there was something … you might have an earache or something wrong with the eyes …we 
have gone to the pharmacy then you know I’ve got an earache can you recommend some 
eardrops this sort of thing rather than ringing your doctor and saying I’ve got an earache it’s a 
bit pathetic in a sense…but at the same time…you could do without earache so I think it’s on 
that sort of issue…” P2-HTN-C/M 
These participants appeared comfortable seeking advice from pharmacists in relation to minor 
ailments that they perceived were not serious enough to require input from a doctor, or in relation to 
interactions between medicines.  This may be because they saw this as part of the pharmacist’s role 
and therefore saw them as an appropriate source of advice. However, whilst most of the participants 
indicated that they were happy to seek or receive advice from pharmacists in relation to medication 
and/or minor ailments, and had done so in the past, many of the participants did not perceive that 
they needed help from pharmacists to manage their CVD other than medication advice: 
“I have to say I’m not really looking for anything from them [pharmacist] do you know what I 
mean? Other than that advice service when I’ve got a problem and I need to know what 
[medication] I can take…” P8-HTN 
It appeared that several of the participants interviewed in the present study did not feel they 
required support from pharmacists as they were satisfied with the input they received from other 
health professionals:  
“…um I haven’t haven’t asked any questions about the medication or my condition…to a 
pharmacist because I didn’t feel that I needed…the extra information um the GP has had taken 
the time… and had given me follow up appointments and then transferred to the practice 
nurse…” P3-HTN-C/M 
This appeared particularly applicable to patients who had other chronic conditions in addition to 
CVD: 
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“…if I was going in to see my doctor anyway which I do fairly frequently um I might well say um 
I think my blood pressure’s gone up and this has happened or that’s happened…” P2-HTN-C/M 
Having other chronic conditions meant that this participant had consultations with his GP on a 
regular basis which may provide him with more opportunities to raise any concerns he has about his 
blood pressure and be given self-management support by the GP than patients who do not have 
other chronic conditions. This may result in him feeling that he does not require additional support 
from a pharmacist. Another participant who already had regular input from other health 
professionals appeared resistant to involving more people in his medical care: 
“I have to go and see the doctor once every two months for review uh and to get various 
prescriptions renewed including the antidepressants so uh he takes the blood pressure then at 
other times he may ask me to come in and see the practice nurse…the um discussions I have 
with the doctors … they are pretty much managing my health so um at the moment I don’t see 
a need to involve anybody else…” P4-HTN-C/M 
In addition to this, another participant felt they did not require support from a pharmacist because of 
the quality of the relationship that they had with their GP: 
“It’s not so much as qualified I think it’s just I suppose I’m fortunate in that I’ve got a fairly good 
relationship with my GP…in the sense that I live in a village where it’s a small practice the GP’s 
been there for a number of years, do you know what I mean?” P8-HTN 
However, this experience was not shared by all participants. One participant was unhappy with the 
input he received from his GP in relation to his hypertension: 
“since then [hypertension diagnosis] other than putting me on medication and following me 
along for a few weeks to change the dose… that was kind of it really… it was just like oh yeah 
just stick you on some tablets and you’ll be alright…” P5-HTN 
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This participant did not have any other chronic conditions in addition to high blood pressure. It may 
be that participants with other co-morbid conditions in addition to hypertension and/or 
hyperlipidaemia receive more support than those without the conditions due to interacting with 
health professionals on a more frequent basis providing more opportunities for health professionals 
to intervene. Participants without other chronic conditions who do not receive the same amount of 
input from other health professionals may benefit from input from a pharmacist. 
Finally, another participant suggested that pharmacists play a minimal role in his medical care as he 
was not seeking advice and does not always visit the pharmacy himself: 
“…I suppose I don’t have much to do with them [pharmacists] as instigated by me…I tend to get 
a repeat prescription and my wife actually picks them up because I’m not around so she picks 
up the prescription and that means I won’t necessarily see them [the pharmacist]…” P5-HTN 
As P5-HTN does not collect his prescription himself, there is not the opportunity for the pharmacist 
to advise him on self-management of his high blood pressure if needed. This may also be the case for 
other patients. 
6.3.3.2 Receiving advice from pharmacists 
The majority of participants gave the impression that, overall, the input they received from 
pharmacists was minimal. None of the participants reported being offered lifestyle advice by a 
pharmacist: 
Interviewer: “What role, if any, does your community pharmacist play in helping manage your 
blood pressure? 
Participant: In reality very little” P4 HTN-C/M 
 
Interviewer: “And could you tell me about a time, if any, that a pharmacist has discussed diet 
or exercise or alcohol intake or smoking with you? 
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Participant: “…it’s never really happened” P6-HTN-C/Morbid 
Some participants reported situations that potentially could have been used by pharmacists to 
facilitate patient self-management but were not utilised. One patient responded to a an advert 
promoting blood pressure testing services within a pharmacy, had his blood pressure tested and 
consequently was found to have high blood pressure: 
Interviewer: “And did the pharmacist give you any advice themselves? 
Patient: “Um I don’t think so uh it was it was it was um yeah very much…you might well have a 
problem so you need to do something about it…” P2-HTN-C/M 
The patient describes a situation where the pharmacist has been involved in the identification of high 
blood pressure and signposted the patient to seek help from other sources, however  it appears that 
the pharmacist did not supplement this with advice on how the patient could manage the condition.  
Another patient described the limited input he had received from pharmacists: 
“I mean have to say in all the years that I’ve had the tablets that I’m on I think probably only 
about once …when I went to go pick up a prescription …that they said ooh can the pharmacist 
have a quick word with you?... and there it was very much a quick sit down, five minutes, and 
he had some sort of checklist from memory, whizzed through it and that was it….Do you know 
what I mean? So it had a very minimal impact I would say on any management of my blood 
pressure…” P8-HTN 
 He later elaborated: 
“…they had a checklist…to go though and it was do you exercise, how much do you drink, you 
know, do you know what weight are you, I wasn’t weighed at all…it was just a checklist and 
you know, are you experiencing any problems? Well no…off you go then…” P8-HTN 
 
 
212 
 
This patient describes a rushed consultation that does not appear to have benefitted them given the 
way that it was recalled. It does not appear to have been a concordant consultation, with little 
opportunity for the patient to discuss any concerns he had. Similarly, another patient described a 
consultation that did not appear to benefit him: 
“… I was sort of uh taken off and uh had a review session by the pharmacist which was the first 
time ever…I just sort of have felt it was a bit of um an imposition really… you know we’ve got 
your prescription but you’re not getting it until we’ve given you a review and uh…you know the 
purpose of the review wasn’t really ever explained...I just thought you know why I am doing 
this?…it wasn’t what I wanted and you know I knew very well the side effects and the problems 
um of coming off some of these tablets…” P4-HTN-C/M 
On the other hand, a minority of the participants described pharmacists and pharmacy staff 
proactively inquiring if they required input or advice: 
“…just as a general matter of course the staff always ask us you know is everything ok with 
your medication today are there any questions for the pharmacist is there anything you don’t 
understand…” P1-HLD-C/M 
“…and it was different pharmacists basically but on both occasions the dose changed they 
commented…and said oh things must be going in the right direction…which is nice because you 
feel that somebody’s actually taking an interest…you know and sharing good news it helps with 
your motivation so I really appreciated that…” P7-HTN, HLD-C/M 
6.3.3.3 Concerns about confidentiality 
Some participants raised concerns about confidentiality and privacy in the pharmacy environment: 
“…you wouldn’t necessarily have the confidentiality or the atmosphere of trust and sharing… 
obviously they’re on one side of the counter and you’re on the other…” P5-HTN 
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“I would feel less happy about discussing my medical affairs with somebody over the counter in 
a sort of busy shop…there’s always signs up saying you know you can talk to your pharmacist 
about this and whatnot…I would probably not feel that sort of confident about it…you know if 
my neighbours came into the pharmacy at the same time I might be less happy about 
discussing um my medical uh issues…with a pharmacist…” P4-HTN-C/M 
“…there’s no confidential area…you’ve just got a screen with a chair…but you are in the public 
area…and everybody can hear what’s being said…so I don’t really think that particular’s got 
suitable environment especially if you had a problem and you wanted to talk about it…” P8-
HTN 
The participants gave a sense of the shop counter acting as a barrier, and the shop environment not 
being suitable to discuss sensitive issues such as lifestyle behaviours. P4-HTN-C/M in particular did 
not appear to feel comfortable with the idea of discussing his health with a pharmacist in a public 
setting. Throughout his account, P4-HTN-C/M described his battle with mental illness in addition to 
hypertension, indicating that he would not feel comfortable discussing the conditions, which he saw 
as a private matter, in a retail setting. 
6.4 Discussion 
This study aimed to explore the experience of using community pharmacy services from the 
perspective of patients with hypertension and/or hyperlipidaemia. A thematic analysis using a 
Framework approach was conducted from which three themes entitled: ‘perceptions of hypertension 
and hyperlipidaemia’, ‘perceptions of pharmacists’ and ‘experiences of using community pharmacy 
services’ emerged. 
The CS-SRM (Leventhal et al., 2003) can be applied to the participants’ perceptions of hypertension 
and hyperlipidaemia and associated self-management behaviours. The majority of participants 
believed that lifestyle behaviours had caused them to develop hypertension and/or hyperlipidaemia 
and described making or attempting lifestyle behaviour change to control the conditions. This 
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suggests that most of the participants were aware of the role of lifestyle behaviours in CVD and that 
they needed to engage in regular exercise, stop smoking, drink alcohol in moderation and eat a 
healthy diet in order to self-manage the conditions. Understanding the cause of the condition also 
appeared important in order to understand the need to engage in appropriate lifestyle behaviours to 
self-manage the condition. Despite understanding the cause of their condition(s) and the need to 
control their condition through lifestyle behaviours, some participants found this difficult. Weight 
loss was an emotive issue for some participants, who appeared to blame themselves and feel judged 
for developing a preventable condition. It may be beneficial for pharmacists to have an awareness of 
how lifestyle behaviours are emotive topics for some patients and therefore need to be broached in a 
sensitive manner. 
There appeared to be differences in the way participants with hypertension and/or hyperlipidaemia 
alone and participants with diabetes perceived the conditions. Diabetes was considered a more 
serious condition with more significant consequences; participants with diabetes reported concerns 
about having hypertension and/or hyperlipidaemia, but tended to perceive the conditions as related 
to their diabetes. The participants with diabetes described fearing the potential consequences of 
having diabetes (ranging from problems with foot care to death) whereas participants without 
diabetes did not appear to experience concerns about the potential consequences of hypertension/ 
hyperlipidaemia so saliently. Subsequently the participants with diabetes appeared to perceive 
engaging in self-management through lifestyle behaviours as of higher importance than some of the 
patients who only had hypertension and/or hyperlipidaemia, which appears to relate to their 
perceptions of the consequences of the respective conditions. Given that hypertension and 
hyperlipidaemia are asymptomatic, patients will not experience symptoms (which relate to the 
‘identity’ domain of the CS-SRM) if they do not engage in self-management behaviours, unlike 
patients with symptomatic conditions such as diabetes. This may explain why the participants with 
diabetes perceived engaging in self-management through lifestyle behaviours of greater importance 
than patients with hypertension and/or hyperlipidaemia alone, as they would not experience any 
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symptoms if they did not engage in self-management behaviours. In addition to this, through daily 
blood glucose testing, many patients with diabetes receive regular feedback on the effectiveness of 
their self-management behaviours compared to patients with hypertension/hyperlipidaemia. This 
may act as a regular reminder of the potential consequences of not engaging in self-management 
behaviours (including lifestyle behaviours) therefore making the consequences of having diabetes 
more salient. 
Furthermore, despite being an asymptomatic condition, some of the participants described 
symptoms that they perceived to be indicative of high blood pressure, a previously well-established 
finding (Meyer et al., 1985; Brewer et al., 2002; Marshall et al, 2012). Some of the participants 
appeared to associate effective self-management of hypertension with the absence of such 
symptoms. Consequently, some of the participants reported that they felt their hypertension was 
well managed because they did not experience any symptoms they perceived to be associated with 
the condition. This may result in patients believing that engaging in self-management behaviours 
(including lifestyle behaviours) is not important. 
Many of the participants stated that they took medication to control their 
hypertension/hyperlipidaemia, however some of the participants reported that they did not like 
taking medication and were keen not to take any more medication than was necessary. Many other 
patients described a desire to be on as little medication as possible. This could be a starting point for 
pharmacists to initiate conversations about self-management, and the role lifestyle behaviours can 
play in self-management of conditions such as hypertension and hyperlipidaemia. 
There was variation in the way participants perceived the pharmacist’s role. Many of the participants 
directly stated or implied that they viewed pharmacists as having specialist knowledge in medicines, 
as reported in previous studies (Anderson et al., 2004; Eades et al., 2011; Latif et al., 2011; Peterson 
et al., 2010; Twigg et al., 2013). Some participants appeared to view pharmacists as health 
professionals and were keen on pharmacists playing more of an active role in facilitating patient self-
management. Other participants did not appear to view pharmacists as health professionals and saw 
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no role beyond dispensing prescriptions, believing that giving lifestyle advice was not part of the 
pharmacist’s role. These findings are in line with Eades et al. (2011) and an earlier systematic review 
by Anderson et al. (2004b), which found that patients’/pharmacy users’ perceptions of pharmacist’s 
ability to provide public health services were mixed; with some participants believing that 
pharmacists were capable of doing so whilst others questioned pharmacists’ abilities. This also 
supports the findings of two recent qualitative studies, one conducted in Scotland and one in North 
West England, which found that patients did not view pharmacists as experts in health, and had 
concerns about pharmacists’ competencies in public health (Gidman & Cowley, 2013; Saramunee et 
al., 2014).  
There appeared to be some confusion surrounding the pharmacist’s role, with some participants 
unsure about the services community pharmacists offer and how they are paid for. This is a common 
finding within the literature. A survey conducted by Weidmann et al. (2012) found that members of 
the general public in Scotland were not aware that pharmacists could offer weight management 
services, whilst a qualitative exploration conducted by Gidman and Cowley (2013) also found that 
members of the Scottish  general public had a limited knowledge of the services pharmacists could 
offer and were unsure how to access them. Furthermore, another qualitative study conducted in 
Portugal found that despite reporting that they were satisfied with the service they received, patients 
were unable to conceptualise the pharmacists’ role (Guerreiro, Cantrill, & Martins, 2010) and 
Perepelkin (2011) found that participants in a Canadian survey had conflicting conceptualisations of 
the pharmacists’ role. Additionally, in a qualitative study of the views and experiences of patients 
with Type 2 diabetes, Twigg, Poland, Bhattacharya, Desborough, and Wright (2013) concluded that 
patients were not against pharmacist input, rather they did not have a clear understanding of how 
pharmacists could help them manage their condition.  
Some of the participants in the present study believed that if pharmacists were to have a role in 
facilitating self-management of hypertension and hyperlipidaemia, there needed to be greater 
publicising of this so that the general public were aware that such services can be provided by 
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pharmacists. This was reported by Rapport et al. (2010) who conducted focus groups with 
pharmacists, pharmacy staff, stakeholders and the general public, and concluded that patients 
wanted a clearer identification of the pharmacist’s role and recommended greater publicising of the 
pharmacist’s role. The terminology ‘community pharmacist’ also initially appeared to confuse some 
participants, who appeared to be more familiar with the term ‘chemist’. Despite the significant 
changes to the landscape of community pharmacy, moving from the traditional role to adopting roles 
further removed from dispensing medication that are more traditionally associated with a health 
professional identity, few patients noted this. This could be a reflection of patients not realising that 
pharmacists now have additional components to their role.  However, this could also be a reflection 
of the intended changes to the pharmacists’ role outlined in the pharmacy contract (DoH, 2005) not 
translating into changes in pharmacists behaviour in practice. In the present study, none of the 
patients reported pharmacists playing an active role in facilitating the self-management of their 
hypertension and/or hyperlipidaemia through advising about and facilitating engagement in lifestyle 
behaviours. Concerns about the workload of pharmacists increasing as a result of the expansion of 
services in accordance with the pharmacy contract along with increases in dispensing loads have 
been raised (Johnson et al. 2014). Between 2000 and 2010, the number of prescription items 
dispensed annually by community pharmacies increased by 67.9% to 926.7 million (NHS Information 
Centre, 2011). This is compounded by the fact that workload growth has not been matched by 
relative increases in numbers of registered pharmacists (Hassell, Seston, Schafheutle, Wagner, & 
Eden, 2011).  A review of the literature by Hassell et al. (2011) concluded that there is some evidence 
supporting a link between heavy workloads and pharmacist wellbeing; the evidence suggests that 
pharmacists are experiencing stress in relation to high workloads although there was no conclusive 
evidence that this impacting on patient safety. It is likely that the dispensing workload is impeding 
pharmacists’ abilities to play an active role in facilitating patient self- management through the 
provision of lifestyle advice, and supports patients’ perceptions of the pharmacists’ role primarily 
relating to dispensing medicines. 
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The retail environment of the community pharmacy appeared to underpin the views of participants 
who believed that lifestyle advice was not part of the pharmacists’ role. Working in a setting that also 
sells cosmetics and other goods not associated with healthcare appeared to make the environment 
incongruent with lifestyle advice for some participants who appeared to view pharmacists as shop 
employees rather than health professionals. This supports the work of Hibbert, Bissell, and Ward 
(2002) who found consumerism to be a significant threat to professional work in the community 
pharmacy.  Hibbert et al. (2002) conducted observation of pharmacist-patient interactions in the 
pharmacy along with one-to-one interviews and focus groups with participants exploring the role of 
the pharmacist in advice-giving in relation to over the counter medication. Like the present study, 
Hibbert et al. (2002) found that participants’ focus was on obtaining a product rather than a 
professional service.  The authors concluded that their findings illustrated antagonism between the 
consumer and the ‘professionalising pharmacist’, demonstrating examples of the pharmacists not 
being able to demonstrate their expertise in facilitating patient self-management (in this case in 
relation to minor ailments). 
The current study findings are also in line with the findings of a recent qualitative study which 
concluded that the commercial environment of the pharmacy undermined patients’ confidence in 
pharmacists, with patients raising concerns about the integrity of health professionals working in a 
business environment (Twigg et al., 2013). Notably, Rapport et al. (2010) concluded that the most 
significant environmental constraint of the community pharmacy is the retail environment which the 
authors assert causes a distraction from the pharmacist’s work and may ‘demean’ the pharmacist 
from the patients’ perspective. Relatedly, whilst there was some variation, the majority of 
participants perceived themselves primarily as customers rather than patients. This appeared to 
result in participants having different expectations of pharmacists, including good customer service, 
which may not be expected of other health professionals to the same extent. Again, this supports the 
findings of previous studies; Perepelkin (2011) found that the majority of 403 participants that 
completed a telephone questionnaire study described themselves as customers with only 14.9% of 
 
 
219 
 
respondents describing themselves as patients when visiting the pharmacy. Furthermore Renberg, 
Tornqvist, Sporrong, Lindblad, and Tully (2011) found that there was a distinct group of patients in 
their sample who saw the exchange between themselves and pharmacists as a business like in other 
shops. 
In addition to the environment affecting patients’ perception of the pharmacists’ role, participants 
also raised concerns about a retail setting not being suitable for providing lifestyle advice due to 
concerns about privacy and patient confidentiality. Perceived lack of privacy and concerns about 
patient confidentiality have been reported in a number of previous studies (Anderson, Blenkinsopp, 
& Armstrong, 2004a; Eades et al., 2011; Rapport et al., 2010; Saramunee et al., 2014). 
Several of the participants used GPs as a frame of reference when describing their perception of the 
pharmacist’s role. As found in previous studies (Anderson et al., 2004a; Eades et al., 2011; Wendy 
Gidman & Cowley, 2013), participants appeared comfortable consulting pharmacists for advice on 
acute symptoms, minor ailments and medication interactions that they perceived were not serious 
enough to merit consulting their GP, in accordance with the conceptualisation of pharmacists as 
medicines specialists. However most participants reported that their GP was their preferred source 
of self-management support and advice. Again, this supports the findings of previous studies.  
Gidman and Cowley (2013) found that participants with long-term conditions chose their GP as a 
source of information and healthcare, perceiving pharmacy services as inferior to those offered by 
GPs whilst Weidmann et al. (2012) found that most patients interviewed would not feel comfortable 
discussing weight loss with a pharmacist, stating that they would prefer to see a GP or nurse who 
they perceived to have more expertise. A survey of the Australian general public conducted by 
Peterson et al. (2010) found that whilst participants believed that pharmacists could offer screening 
services for hypertension and hyperlipidaemia, participants indicated that they were more likely to 
use the services if provided by a doctor. Twigg, Poland, et al. (2013) concluded that patients view the 
GP as the ‘controller’ of their treatment as part of a ‘strict health hierarchy’, so approaching a 
pharmacist for advice potentially violates the natural order. This explanation appears to fit with the 
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results of the current and previous studies, with many participants appearing to perceive that the 
doctor is the expert controlling medical management of the condition. Therefore, the pharmacist, 
who many participants perceived to have less expertise than a doctor, was seen as having no role to 
play in helping them manage their hypertension and/or hyperlipidaemia. 
Perhaps unsurprisingly, given the participants’ perceptions of the pharmacist’s role, in keeping with 
previous studies (Anderson et al., 2004a; Eades et al., 2011), most participants interviewed in the 
present study reported that they were not seeking support to self-manage their hypertension and/or 
hyperlipidaemia from a pharmacist. As previously discussed, the patients appeared to view their GP 
as the primary source of health advice and self-management support, and most of the patients 
reported that they did not require any more support. Having a chronic condition in addition to 
hypertension and/or hyperlipidaemia, as experienced by the majority of participants in the current 
study, appeared to result in increased opportunities to consult health professionals in primary and 
secondary care, potentially creating more opportunities to receive self-management support from 
health professionals than the participants who had no co-morbid chronic conditions. 
6.4.1 Strengths and Limitations 
This study provides an in-depth exploration of the experiences of patients with hypertension and 
or/hyperlipidaemia when using community pharmacy services. Conducting qualitative research with 
individual patients resulted in a rich description of the patient’s experience; a methodology used less 
frequently than other approaches in pharmacy practice research. The interviewer was not a 
pharmacist; the patients may therefore have felt more at ease to express any concerns they had with 
pharmacy services than if they were interviewed by a pharmacist. However there are also limitations 
associated with this study. Due to time constraints, less time was allocated for recruiting participants 
for this study in comparison to other studies presented in this thesis given that the primary focus was 
on pharmacist behaviour. The population from which the participants were recruited was smaller 
than intended which may have limited the breadth of experiences in the sample and influenced the 
results. Only one female participated in the study and there was a larger proportion of patients with 
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co-morbidities than patients with just hypertension and/or hyperlipidaemia. Furthermore none of 
the participants were of low socioeconomic status. There was also considerable heterogeneity within 
the sample; one of the participants had received an organ transplant whilst two of the participants 
had diabetes. This is likely to have had an impact on the data collected and the conclusions that were 
drawn. The goal of qualitative research is to obtain rich and meaningful data; the heterogeneity in 
the sample is likely to mean that there was greater variation in the experiences of participants than 
there might have been in that of a sample that was more homogenous (e.g. a group of participants 
that was diagnosed with hyperlipidaemia/hypertension only). Had the sample been more 
homogenous, with greater shared experience, the data collected might have been richer and allowed 
a more in depth exploration of the experiences of this specific group when using community 
pharmacy services and therefore allowed more meaningful conclusions about the support needs of 
this group to be drawn. Despite these limitations, this study provides a valuable insight into how 
patients with hypertension and/or hyperlipidaemia perceive and use community pharmacy services.  
6.5 Conclusion 
In conclusion, there was variation in the way participants viewed pharmacists and their role in 
helping patients with CVD self-manage the condition: some felt that pharmacists were health 
professionals who had the potential to enhance their care whilst others felt that pharmacists’ role did 
not extend beyond the provision of medicines. The retail environment appeared to influence 
participants’ perceptions of the pharmacists’ role. Despite being ‘patients’ collecting a prescription 
for a chronic condition,  participants in this study viewed themselves as customers and they 
preferred to receive self-management advice from their doctor.  
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7 Chapter Seven: General Discussion 
7.1 Introduction 
The overarching aim of the work presented in this thesis was to understand and explain the 
behaviour of UK community pharmacists in relation to facilitating patient self-management of CVD 
through lifestyle behaviours. A programme of work was developed to address this aim which 
comprised of four studies with the following objectives: 
i. To explore community pharmacists’ experiences of giving lifestyle advice to patients with 
CVD (a qualitative interview study). 
ii. To identify the predictors of pharmacists’ lifestyle advice-giving behaviour in a cross-sectional 
sample of pharmacists (a quantitative survey study). 
iii. To systematically review evidence examining the efficacy of interventions designed to enable 
pharmacists to facilitate patient lifestyle behaviour change and identify which theories and 
behaviour change techniques, if any, had been used in effective interventions. 
iv. To explore the experiences of patients with hypertension and/or hyperlipidaemia related to 
having CVD and using community pharmacy services (a qualitative interview study). 
More specific research questions were developed in order to answer the objectives above. These 
were as follows: 
i. What are community pharmacists’ experiences of giving lifestyle advice to patients with CVD.  
ii. a) What are the predictors of pharmacists’ intention to advise overweight patients with CVD 
about losing weight? 
(b) What are the predictors of pharmacists’ intention to advise patients with CVD how to 
adhere to their prescribed medication? 
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iii. a) What interventions are effective at enabling pharmacists to facilitate patient lifestyle 
behaviour change?  
b) What theories, if any, were used in interventions that successfully enabled pharmacists 
to facilitate patient lifestyle behaviour change? 
c) What behaviour change techniques were used in interventions that successfully enabled 
pharmacists to facilitate patient lifestyle behaviour change? 
iv. a)  What is the experience of using community pharmacy services in patients diagnosed with 
hypertension and/or hyperlipidaemia? 
b) What is the patients’ experience of having hypertension and/or hyperlipidaemia in order 
to contextualise their experiences of using community pharmacy services? 
A mixed methods approach was deemed the most suitable to answer the above research questions 
(see chapter two for a full discussion of the rationale). This chapter will summarise the findings from 
each of the studies and discuss how they integrate with each other and the existing literature. 
Recommendations for pharmacy policy and practice and future research will be made along with a 
consideration of the strengths and limitations of this programme of work. 
7.2 Summary of findings 
The qualitative exploration of pharmacists’ experiences of giving patients with CVD lifestyle advice 
(chapter three) found that while most of the pharmacists expressed positive attitudes towards 
facilitating patient self-management through giving lifestyle advice in theory, in practice they 
identified many barriers to doing so and did not appear to view the behaviour as routine 
pharmaceutical practice. Issues relating to professional identity, primarily role congruence and the 
perceived lack of appropriate remuneration for giving lifestyle advice, appeared to underpin 
commonly reported barriers to implementation which seemed to result in lifestyle advice being of 
lower priority than other pharmacy activities. The retail environment in which pharmacists practice 
was associated with role conflict between pharmacists’ health professional and business employee 
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identities, and was perceived by participants to undermine the professional role of pharmacists to 
both patients and other health professionals. For pharmacists employed by multiple-owned 
pharmacies, perceived barriers to providing lifestyle advice to patients with CVD were more salient 
than for pharmacists employed by independent pharmacies. The former reported that pressure to 
provide a quick service and meet targets prevented them providing lifestyle advice. Some 
pharmacists felt that they did not have the appropriate training to approach sensitive topics such as 
lifestyle behaviours with patients, and some pharmacists appeared to lack the confidence to do so. 
Participants appeared more comfortable providing advice in relation to medicines, and if they did 
give patients lifestyle advice it appeared to be based around or in conjunction with advice about 
medicines in an MUR setting. 
The cross-sectional survey, administered to community pharmacists in England (chapter four) found 
that pharmacists had significantly higher intentions to give medication adherence advice than weight 
loss advice to patients. There was also a significant difference in self-reported past behaviour, with 
participants reporting significantly higher provision of medication adherence advice than weight loss 
advice to patients with CVD who were overweight. The predictors of pharmacists’ intentions to give 
medication adherence advice were: role congruence; what patients think about pharmacists giving 
medication adherence advice (subjective norm); what other pharmacists think about giving 
medication adherence advice (subjective norm); goal conflict (dispensing prevents giving patients 
medication adherence advice); past behaviour (medication adherence advice giving) and 
pharmacists’ perceptions of patients. The model accounted for 44.1% of the variance in pharmacists’ 
intentions to give patients with CVD medication adherence advice. 
The predictors of pharmacists’ intentions to give weight loss advice to overweight patients with CVD 
were: role congruence; what patients think about pharmacists giving weight loss advice (subjective 
norm); what other pharmacists think about giving weight loss advice (subjective norm), attitude 
towards giving overweight patients with CVD weight loss advice and past behaviour. The model 
accounted for 38.2% of the variance in pharmacists’ intentions to give overweight patients with CVD 
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weight loss advice and was significant (p<0.001). The strongest predictor of pharmacists’ intentions 
to engage in both behaviours was role congruence whilst subjective norms (perceptions of what 
patients think and pharmacists think of advice giving) were also strong predictors. Despite the 
superficial commonalities between the behaviours (i.e. giving advice to facilitate successful 
management of CVD) the determinants of pharmacists’ intentions to engage in the behaviours 
differed.  This suggests that although they share some common predictors, different constructs 
would need to be targeted to change pharmacists’ engagement in two behaviours that appear to be 
the same. 
The systematic review (chapter five) identified a very small number of relevant studies (n=10) and 
the reporting and methodological quality of the included studies was generally very poor. The 
majority of the interventions targeted participants’ tobacco cessation advice giving, with one 
intervention targeting general lifestyle behaviour advice and one intervention targeting lifestyle 
advice in relation to diabetes self-management. The interventions were found to result in increased 
counselling ability (self-report or measured by an assessor) with the interventions which measured 
service delivery finding evidence of increased counselling post intervention. Of the two studies which 
measured patient outcome, one study found increased patient self-reported smoking cessation after 
intervention from pharmacists, the other finding increased self-reported smoking cessation in 
patients who had received the intervention however cotinine levels (a biological measure of nicotine 
consumption) were higher in intervention patients than controls. The interventions which measured 
self-efficacy found participants reported having increased self-efficacy to facilitate patient behaviour 
change post-intervention. However this finding should be interpreted with caution given that none of 
the studies measured self-efficacy as suggested by Bandura (1998). The behaviour change techniques 
used in the effective interventions were: instruction to perform behaviour; behavioural practice; 
demonstration of the behaviour; adding objects to the environment (e.g. counselling guides to help 
pharmacy students conduct tobacco cessation consultations with patients); social support and 
material reward. Social Cognitive Theory (Bandura, 2001) was cited as the theoretical basis of one 
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intervention. Despite these findings, due to the poor quality and reporting of the included studies, 
definitive conclusions about the effectiveness of the interventions cannot be drawn and the results 
should be interpreted with caution. 
The final study presented in this programme of work (N.B this does not reflect the order in which the 
studies were conducted) sought to explore the experiences of patients with CVD using community 
pharmacy services (chapter six). This qualitative study found that whilst participants felt that there 
was the potential for pharmacists to help them self-manage their condition, there was variation in 
the way they perceived pharmacists. Some patients saw pharmacists as ‘just’ suppliers of medicines 
whilst others viewed pharmacists as health professionals who had the ability to facilitate self-
management of their CVD. Most patients viewed themselves primarily as customers, did not expect 
to receive self-management support from a pharmacist and indicated that they preferred to consult 
their GP for CVD self-management advice and support. Some patients appeared to perceive 
hypertension and hyperlipidaemia as less severe than other chronic conditions such as diabetes. 
Patients without co-morbid chronic conditions appeared to receive less input from other health 
professionals and may benefit from pharmacist input more than patients with other co-morbidities 
who already receive self-management support, however it should be noted that such patients in this 
study indicated that they were not seeking this kind of support.  
7.3 Pharmacists’ perception of their role in supporting patients with CVD 
Eades et al. (2011) conducted a  systematic review of pharmacists’ and patients’ beliefs about 
pharmacists providing public health services (which covered diverse topics including smoking 
cessation, sexual health services, drug misuse, osteoporosis screening, type 2 diabetes, weight 
management, alcohol consumption and asthma management). They found that most pharmacists 
were positive about providing public health services and saw this as an important part of their role 
supporting the findings of an earlier review by Anderson et al. (2003). Both these reviews found that 
despite this, pharmacists viewed their public health roles as of less importance than those related to 
medicines, and that pharmacists were more comfortable providing advice in relation to medicines 
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than other types of advice (Anderson et al., 2003; Eades et al., 2011). The work presented in this 
thesis examined pharmacists’ perceptions of a specific component of their public health role: 
facilitating patient self-management of CVD through lifestyle behaviours. The qualitative study of 
pharmacists’ experiences of giving patients with CVD lifestyle (chapter three) supported the findings 
of the previous studies (Anderson et al., 2003; Eades et al., 2011), with most of the pharmacists 
appearing to view the provision of lifestyle advice as important, however secondary to and separate 
from medicines-related roles.   
The quantitative study (chapter four) took this research a stage further and compared the predictors 
of pharmacists’ intentions to give two different kinds of advice: one related to medicines (advice 
about medication adherence) and advice associated with pharmacists’ newer public health role 
(weight loss advice for overweight patients with CVD). This added to the previous literature, 
supporting the finding that pharmacists viewed their public health roles as of less importance than 
those related to medicines: pharmacists had significantly more positive attitudes towards giving 
patients with CVD medication adherence advice than giving overweight patients with CVD weight loss 
advice, and were significantly more likely to intend to give patients with CVD medication adherence 
advice than they were to intend to give overweight patients with CVD weight loss advice. They were 
also significantly more likely to report having given patients medication adherence advice than giving 
overweight patients with CVD weight loss advice in the past. This study is the first to perform a 
within-participants comparison of intentions to engage in two different behaviours associated with 
pharmaceutical practice. The qualitative exploration of pharmacists’ experiences of giving lifestyle 
advice (chapter three) identified considerable variation in the participants’ attitudes towards 
pharmacists having a role in public health. Some participants believed that community pharmacists 
should move away from involvement in the dispensing process towards a more ‘clinical’ role with 
more involvement in facilitating patient self-management of CVD and other chronic conditions 
through lifestyle advice, whilst other participants believed that pharmacists should remain primarily 
involved in traditional roles rather than adopting additional clinical roles. This divergence was not 
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reflected in the findings of either of the systematic reviews by Anderson et al. (2003) and Eades et al. 
(2011). 
The importance of pharmacists’ perceptions of whether particular activities should be part of their 
role (role congruence) identified in the qualitative study was demonstrated in relation to 
pharmacists’ intention to engage in medication adherence advice and weight loss advice giving 
behaviour in the quantitative study (chapter four), with role congruence emerging as the strongest 
predictor of pharmacists’ intentions to give both types of advice. To date, this finding has not been 
reported within the pharmacy practice literature although it has been implicated in the lifestyle 
advice giving behaviour of other health professionals (Laws et al., 2008; 2009). 
7.4 Patients’ perceptions of pharmacists’ role in facilitating CVD self-
management 
The exploration of the experiences of patients with CVD when using community pharmacy services 
found that the patients’ perceptions of the pharmacists’ role in facilitating CVD self-management 
through lifestyle behaviour change advice were mixed. Some patients appeared to view the 
pharmacist as a health professional who had the potential to provide self-management advice and 
support them to manage their CVD whilst other patients saw the pharmacists’ role as one of 
dispensing and advising about medicines, and whilst some noted potential, they did not feel the 
pharmacists’ role currently extended beyond this. This study reported more variation in patients’ 
views that the conclusions of the Anderson et al. (2003) and Eades et al. (2011) systematic reviews 
which suggested that although patients did not expect to receive public health services from 
pharmacists, they were happy to receive this when it was offered. In the present study, all of the 
patients indicated that they saw their GP as the first port of call and preferred to receive self-
management advice from this source.  
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7.5 Self-efficacy 
Previous pharmacy practice research has identified pharmacists’ confidence in their ability to 
perform public health roles, also known as self-efficacy (Bandura, 1977), as a factor that could 
influence the implementation of pharmacist-led public health services. Anderson et al. (2003) 
concluded that pharmacists were more confident providing services in relation to medicines and 
needed support to extend their role in public health whilst Eades et al. (2011) concluded from the 
results of their systematic review that pharmacists’ self-efficacy was moderate to low in relation to 
performing public health related roles. The qualitative study which explored pharmacists’ 
experiences of giving patients with CVD lifestyle advice (chapter three) found that some participants 
appeared to lack self-efficacy to give patients lifestyle advice, especially in relation to weight loss 
which they perceived to be a particularly sensitive topic. However, the quantitative study which 
examined the predictors of pharmacists’ intentions to give medication adherence advice and weight 
loss advice to patients with CVD found that self-efficacy was not a significant predictor of 
pharmacists’ intentions to engage in either behaviour in the final models. 
In keeping with the findings of Eades et al. (2011), pharmacists’ self-efficacy to give advice relating to 
medicines (in this case medication adherence advice) was significantly higher than pharmacists’ self-
efficacy to perform public health related roles (in this case give weight loss advice to overweight 
patients with CVD).  Pharmacists’ self-efficacy to perform public health related roles was moderate to 
low (pharmacists’  mean self-efficacy to give weight loss advice was 2.76; a score of 1 indicated high 
self-efficacy and a score of 5 indicated low self-efficacy), again supporting the findings of Eades et al. 
(2011). However, hierarchical regression analysis demonstrated that whilst self-efficacy was a 
significant predictor of pharmacists’ intentions to give both medication adherence and weight loss 
advice in the first step of the analysis (when TPB and SCT constructs were entered), when other 
variables including role congruence, goal facilitation and perceptions of patients were entered, self-
efficacy was no longer a significant predictor of pharmacists’ intention to give either type of advice. 
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This finding conflicts with the conclusions of the systematic reviews by Anderson et al. (2003) and 
Eades et al. (2011). 
Role congruence was the strongest predictor of pharmacists’ intentions to engage in both 
behaviours. When sensitivity analysis was performed and role congruence was removed from the 
model, self-efficacy was a significant predictor of pharmacists’ intentions to give medication 
adherence advice however it was not the strongest predictor, and less variance in intention was 
explained by the model. Role congruence is an important determinant of pharmacists’ intentions to 
give both types of advice, and it may be misleading to just focus on self-efficacy in order to promote 
engagement in either behaviour: pharmacists may be self-efficacious to give either types of advice 
however if they do not perceive these activities to be role congruent then they may not engage in 
them. 
The current research did not assess pharmacists’ behaviour and despite intention being a strong 
predictor of behaviour (Azjen, 1991; Godin et al., 2008) it could be that other factors are 
independently predictive of behaviour. It may be that self-efficacy comes to the fore when 
pharmacists are in a situation where they are required to engage in the behaviour (e.g. their 
behaviour is monitored in a training session) whereas constructs such as role congruence and 
subjective norms are important in the formation of intention to engage in the behaviour. 
7.6 Training pharmacists to give lifestyle advice 
The qualitative study of pharmacists’ experiences of giving patients with CVD lifestyle advice found 
that some pharmacists felt that they had not received the appropriate training to prepare them to 
facilitate patient self-management of CVD through giving lifestyle advice. This supported the findings 
of previous studies (Anderson et al., 2003; Eades et al., 2011) which suggested that pharmacists 
lacked self-efficacy in their abilities to give patients lifestyle advice and recommended that training to 
target pharmacists’ low confidence/self-efficacy to perform public health related roles and expand 
their role this area was developed. The systematic review of interventions to prepare pharmacists, 
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pharmacy staff and pharmacy students to facilitate patient lifestyle behaviour change (chapter six) 
found the studies that measured the effect of the intervention on self-efficacy/confidence in 
counselling abilities, all found that the intervention increased participants’ self-efficacy/confidence in 
their counselling abilities. One of the interventions (the results of which were presented in two 
separate papers) was stated to be based on Social Cognitive Theory (Bandura, 1977), of which self-
efficacy is a central component. However, due to poor reporting of intervention content and delivery, 
and the poor methodological quality of the studies, reliable conclusions about the role of self-efficacy 
in interventions that resulted in increased counselling behaviour cannot be drawn.  
Whilst the quantitative study (chapter four) found that significantly more pharmacists felt that they 
had received appropriate training to give patients with CVD medication adherence advice compared 
with giving overweight patients with CVD weight loss advice, pharmacists’ perceived receipt of 
appropriate training was not a significant predictor of intention to give either type of advice. A 
possible explanation for this may relate to self-efficacy. Previous research (Anderson et al., 2003; 
Eades et al., 2011) suggests that pharmacists lack self-efficacy in their abilities to give lifestyle advice 
and that training should focus on increasing pharmacists’ self-efficacy. Of the relatively small number 
of interventions designed to prepare pharmacists to promote patient lifestyle change that have 
assessed self-efficacy, the intervention was found to increase pharmacists’ self-efficacy (though, as 
previously highlighted, these findings should be interpreted with caution). Yet the quantitative study 
(chapter four) found that self-efficacy was not a determinant of pharmacists’ intentions to give 
patients lifestyle advice (in this case, specifically weight loss to overweight patients with CVD). 
Therefore training may be successful at increasing pharmacists’ self-efficacy to give lifestyle advice, 
however if self-efficacy is not a determinant of the behaviour in question (in the quantitative study 
self-efficacy was not a determinant of pharmacists’ intentions to give either type of advice) then 
training will not be predictive of the outcome, which was the case for both types of advice.  
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7.7 The retail environment of community pharmacy 
The ease of access and out of hours availability is frequently highlighted as a strength of community 
pharmacy, providing a means of accessing a large portion of the population, including individuals in 
both good and poor health and those who do not routinely use other healthcare services (Anderson 
et al., 2003;DoH, 2008; Eades et al. 2011). This has been attributed in part to pharmacies operating in 
retail environments (Bush et al., 2009; DoH, 2005). However the research presented in this thesis 
found that the environment also appeared to present significant challenges in relation to pharmacists 
providing lifestyle advice to facilitate patient self-management, with the environment appearing to 
structure pharmacists’ behaviour. 
First, the qualitative study (chapter three) found that practicing in a retail environment and therefore 
being a business employee appeared to result in a fundamental conflict between the ‘health 
professional’ and business employee components of the pharmacist’s identity. Previous literature has 
identified that pharmacists can be reluctant to offer patients lifestyle advice for fear of a negative 
reaction (Anderson et al., Eades et al., 2011) however the qualitative research (chapter three) 
identified that role conflict may underpin this. The retail environment appeared to result in 
challenges that elicited role conflict for the pharmacists. Some of the pharmacists perceived that 
offering potentially unwelcome advice may affect their employment status, fearing that patients may 
stop coming to the pharmacy (and therefore not provide the pharmacy with remuneration for 
prescription items, which pharmacies currently rely on in order to be sustainable business). This 
appeared to result in some pharmacists not offering lifestyle advice to patients with CVD. 
Furthermore, as pharmacists are currently primarily remunerated for prescription items rather than 
the provision of lifestyle advice, some pharmacists indicated that, in combination with other factors, 
pharmacists are not motivated to give patients lifestyle advice as they receive no financial reward for 
doing so when they are already operating in a time-pressured environment that is reliant on 
dispensing prescriptions. One of the pharmacists suggested that the pharmacy contract, as it stands, 
does not support pharmacists facilitating patients to self-manage conditions through lifestyle 
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behaviours rather than use of medicines. This is due to pharmacists not being remunerated for 
lifestyle advice in the same way as they are for checking and dispensing medication, and if patients 
were to successfully self-manage their condition through lifestyle behaviours and not require 
medication pharmacists would actually lose revenue. Again, this presents a fundamental role conflict. 
The findings from the qualitative study (chapter six) and previous research (Anderson et al., 2003; 
Eades et al., 2011) suggested that pharmacists felt under pressure from their employer to provide a 
quick service (by checking and dispensing medicines quickly) so patients did not have to wait. Some 
pharmacists cited this as preventing them from giving patients lifestyle advice, and this appeared to 
be particularly salient for participants employed by multiple-ownership pharmacies. The quantitative 
study (chapter four) found that participants who did not perceive the dispensing process to cause 
goal conflict with giving medication adherence advice (i.e. they did not feel that the dispensing 
process interfered with or prevented them giving medication adherence advice) were more likely to 
intend to give medication adherence advice than participants who perceived dispensing to cause goal 
conflict. However goal conflict from the dispensing process was not predictive of pharmacists’ 
intention to give weight loss advice. Furthermore, pharmacy ownership was not a predictor of 
pharmacists’ intentions to give either weight loss or medication adherence advice.  
The findings of the qualitative study suggested that some of the participants felt that the retail 
environment they practiced in affected patients’ perceptions of their role, and that the shop 
appearance meant that patients perceived them as shopkeepers rather than health professionals 
with expertise and responsibility for patient safety. There was some evidence to support this in the 
accounts of some of the patients with CVD who participated in the qualitative study (chapter six). As 
previously discussed, some patients saw the pharmacists’ role as that of dispensing medicines and 
nothing more. This appeared to relate to the retail environment and the other activities that occur in 
the pharmacy environment such as selling cosmetics and other products not related to healthcare. In 
addition to affecting patients’ perceptions of the pharmacist’s role, the retail environment appeared 
to affect how patients with CVD perceived themselves and their role in the interaction between them 
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and the pharmacist. In keeping with previous literature, the patients who participated in the 
qualitative study all primarily saw themselves as customers, however some participants felt this 
status was interchangeable and moved from customer to patient if the pharmacist gave them health 
advice. As discussed in more detail in chapter six, this may result in users of pharmacy services having 
different expectations of pharmacists than they might have of other healthcare professionals working 
in more obvious clinical environments, and this was evident in the accounts of some participants who 
appeared to expect characteristics associated with good customer service in shops in their 
interaction with pharmacists. 
As reported in previous studies (Anderson et al., 2003; Eades et al., 2011), some of the patients who 
participated in the qualitative study (chapter six) expressed concerns about their privacy and 
confidentiality, in this case if they were to receive lifestyle advice from pharmacists in a retail 
environment.   
7.8 Pharmacists’ engagement in pharmacy practice research 
A major challenge encountered when conducting the current programme of research was recruiting 
pharmacists to participate in the research studies. This appears not to be uncommon, and other 
researchers working in pharmacy practice in the UK have stated that conducting research in 
community pharmacy poses difficulties due to pharmacy practice research being relatively new 
(Twigg, Bhattacharya, et al., 2013). It took approximately one year to recruit fifteen community 
pharmacists to participate in the qualitative study (chapter three) and the method of data collection 
had to be adapted to offer telephone interviews instead of face-to-face interviews to increase 
participation. Despite reaching the number of participants required for the study to be adequately 
powered, the response rate to the cross sectional questionnaire study with pharmacists (chapter 4) 
was relatively low at 18.4%. As discussed in chapter four, recruitment of health professionals to 
participate in research is notoriously difficult and low response rates are common (Cane, O’Connor & 
Michie, 2012; Eccles et al., 2012; Presseau et al., 2011).  
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Pharmacy practice research is a relatively new research area (DoH, 2008) and has been subject to 
change with the changing role of the pharmacist. In order for community pharmacy practice to 
develop, research to evaluate pharmacy services in order to develop new services is essential 
(Rosenbloom et al., 2000; Armour, Brilliant and Krass, 2007; Herbert et al., 2013). In 1997, the 
Pharmacy Practice Research Development Task Force recommended that all pharmacists should use 
research to inform their practice and improve health care, suggesting that a small portion of 
pharmacists (10%) should actively participate in research through collecting data and taking part in 
interventions (Gilbert, Mills, & Ward, 2006). Furthermore, the white paper Pharmacy in England: 
building on strengths – delivering the future (Department of Health, 2008) concluded that the 
evidence base for the efficacy and cost effectiveness of pharmacy services on clinical outcomes was 
at that time ‘at best, patchy’ and required further research to strengthen it. The White Paper goes on 
to highlight six principal research domains to evaluate pharmacy services: patient and public 
perceptions and satisfaction; impact on care and outcomes (including clinical and cost effectiveness, 
safety and people’s understanding of their medicines); quality of service provision; value for money; 
impact on workload and flow and pharmacy staff attitudes.  
However the limited research conducted in this area (outside the UK) has shown that pharmacist 
engagement in research is low. A cross sectional questionnaire study conducted in Australia by 
Peterson, Jackson, Fitzmaurice and Gee (2009) found that only one third of the 365 participants 
returning questionnaires (response rate: 35%) were currently participating in or had participated in 
research whilst a further one third of participants indicated that they were not interested in 
participating in research. The remaining one third had not previously participated in research but 
reported that they would consider doing so. Lack of time, lack of awareness of research opportunities 
and not being approached were cited as barriers to participating in research. A recent survey 
conducted by Hébert et al. (2013) investigating the willingness of 571 pharmacists in Montreal, 
Quebec to participate in a practice based network (defined as groups interested in designing, 
evaluating and disseminating solutions to problems in clinical practice) found that just over half 
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(58.9%) of participants indicated they were ‘interested’ or very’ interested. Yet 41.1% of participating 
pharmacists indicated that they had little or no interest in participating and participants were more 
likely to report interest in services supporting clinical practice rather than research.  
Some researchers have sought to examine why pharmacist participation in research is low. 
Rosenbloom et al. (2000) used a questionnaire to assess English community pharmacists perceptions 
of pharmacy practice research and barriers to engagement. They found that the majority of the 392 
participating pharmacists perceived research as important, with 92% of respondents indicating that 
they felt it was important for pharmacists to be kept informed of research findings yet just over half 
(53.9%) of the participants were willing to participate in pharmacy practice research. Remuneration 
was identified as an important factor in research participation, with 74.2% of participants agreeing 
with the statement ‘I would only participate in research if I was paid to do so’. Approximately two 
thirds (65.9%) of participants indicated that their daily activities prevented them from participating in 
research and 72.1% of participants agreed that they would get more involved in research if they had 
more time. Pharmacy ownership was identified as a factor influencing research participation, with 
30.9% of participants employed by independent ownership pharmacies agreeing with the statement 
‘I have the opportunity to do research’ compared to 16.4% of pharmacists employed by large 
ownership pharmacies. Rosenbloom et al. (2000) stated that it has been reported anecdotally that 
pharmacists employed by large ownership pharmacies are less likely to complete self-report 
questionnaires, however they reported that they did not find evidence of this in their study. When 
conducting the research presented in this thesis, all of the head office representatives of the large 
ownership pharmacies in England were contacted by the researcher. They either stated that they had 
a ‘no research policy’, that they were not willing to distribute information about the study to their 
employer or did not respond to the researcher. In the research presented here, participation was 
lowest amongst pharmacists from supermarket-owned pharmacies. 
Compounding the problem of recruiting pharmacists was the difficulty of there being no other means 
(as a researcher who was not a pharmacist) of contacting pharmacists to participate in the research: 
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pharmacists cannot participate in research if the organisation they are employed by does not 
facilitate engagement in research and there is no other accessible database of pharmacists’ contact 
details for pharmacy practice researchers. The Royal Pharmaceutical Society (RPS), when contacted, 
stated that they could only assist with pharmacist recruitment in studies that they had funded, and 
that the researcher would have to be a member of the RPS for this to occur. This is problematic, as 
not all researchers conducting pharmacy practice research are pharmacists. 
Concerns about the research culture (or lack of it) in the pharmacy profession have been raised. 
Writing in the Pharmaceutical Journal, Wilson (2005) questioned why community pharmacy 
contributed so little original research with Gilbert, Mills & Ward (2006) responding by questioning 
whether pharmacists have ‘sufficient interest and desire’ to ‘create’ the time to run research 
projects. It could be that this is also related to pharmacists’ role congruence, and pharmacists’ 
perception of the relevance of research to their role. A recent article by Allen (2014) in Clinical 
Pharmacist called for research to be seen as ‘everybody’s business’ and for  100% of the pharmacy 
population to be ‘research active’, defined as being ‘aware and involved with varying levels of 
engagement’ which range from using research evidence to inform practice, to collaborating in 
research as a partner to leading research. Whilst it is important for pharmacists to be involved in 
conducting research, it is also imperative that community pharmacists participate in research 
exploring the behaviour of pharmacists in order to improve pharmaceutical practice/ support for 
both patients and pharmacists themselves. 
In order to explore perceptions of and identify facilitators to pharmacists participating in research, 
Armour et al. (2007) conducted a qualitative study exploring the views of eleven pharmacists who 
had participated in pharmacy research. Three themes emerged: pharmacists’ perception of the 
purpose of research, pharmacists’ personal motivation for participation in research and pharmacists’ 
desired role in research. Four barriers to community pharmacists participating in research (both as 
participants and researchers)were identified: pharmacists mind-set (pharmacists who had conducted 
research perceived it as difficult to conduct and not part of standard pharmacy practice); lack of 
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communication (the pharmacists reported they were unaware of opportunities to participate in 
research and that research findings were not communicated back to them);  infrastructure (the 
pharmacists perceived research to be time consuming with insufficient remuneration for 
participation) and skills/ knowledge (the pharmacists felt that they lacked the skills or knowledge to 
conduct research which Armour et al. (2007) concluded was closely linked to a lack of confidence).  
Armour et al. (2007) suggested a number of strategies to overcome these barriers including: 
educating pharmacy students about the importance of evidence based practice and the role 
pharmacists can have in this; educating practising pharmacists about services that are currently 
available due to previous research and the need for research to develop new services; improving 
communication of research outcomes between pharmacists and academics; researchers minimising 
demands on time, money and staff by  being mindful of this when designing research protocols and 
considering how other pharmacy staff could support research and researchers providing 
organisational and administrative support to pharmacists participating in research.  
7.9 Implications for research 
As discussed above, the problems encountered when attempting to recruit pharmacists for the 
research presented in this thesis are an important finding in its own right and have considerable 
implications for pharmacy practice research and the advancement of evidence-based pharmacy 
practice.  Pharmacist engagement and participation in research is required in order for an evidence 
base of the efficacy of pharmacy-based interventions to accumulate (outlined as an aim by the DoH, 
2008) and to identify how to support pharmacists to change their behaviour in order to change the 
health behaviours of patients. It appears that a culture of engagement in research is currently not 
present in pharmacy practice in the UK. In order to advance pharmacy practice it appears that 
organisational level changes to support pharmacists’ engagement in research need to occur. A 
database of pharmacists who are interested in participating in research that is accessible to 
pharmacy practice researchers (both with and without a pharmacy background) may also help 
facilitate pharmacists to engage in research. 
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Building upon the research presented here, the next step would be to examine the effect of the 
psychological constructs identified as predictors of pharmacists’ intentions to engage in the different 
advice-giving behaviours on pharmacists’ actual engagement in the behaviours. The (differing) 
constructs identified as predictive of pharmacists’ intentions to give medication adherence advice 
and weight loss advice could also be targeted using appropriate behaviour change techniques in 
respective interventions designed to change pharmacists’ behaviour. As highlighted in the findings of 
the systematic review (chapter six), there is a paucity of interventions to change pharmacists’ lifestyle 
advice giving behaviour that are theory based, accurately described and rigorously evaluated using 
appropriate study designs to determine the effectiveness of the intervention on changing 
pharmacists’ behaviour. Therefore any interventions developed need to follow these principles. 
The importance of the role of role congruence in pharmacists’ advice giving behaviour identified in 
the present research (appearing to underpin commonly cited barriers to pharmacists giving lifestyle 
advice) is interesting and warrants further exploration in more detail.  The importance of this 
construct in relation to the provision of advice may extend beyond that of pharmacists, and therefore 
it may be useful to build upon previous work (eg. that by Laws et al., 2009) and examine the role of 
role congruence in the behaviour of other health professionals. 
7.10 Implications for pharmacy policy and practice 
The findings of the current programme of work have implications for community pharmacy practice 
specifically in relation to pharmacists supporting patients with CVD to self-manage their condition 
through lifestyle behaviours, and potentially more generally in relation to pharmacist-led public 
health services. 
The aim of this programme of work was not to develop an intervention to change the behaviour of 
pharmacists in relation to facilitating patient self-management of CVD, and this falls out with the 
scope of this project. Nevertheless, there are a number of important findings from this research that 
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could be used to inform the development of interventions to support pharmacists to enable patient 
self-management of CVD. 
The qualitative research demonstrated that there was variation in the pharmacists’ perceptions of 
whether pharmacists should offer lifestyle advice whilst role congruence was the strongest predictor 
of pharmacists’ intentions to give both medication adherence advice and weight loss advice. 
Therefore it may be beneficial for interventions aiming to increase pharmacists’ provision of lifestyle 
advice to facilitate patient self-management of CVD, and potentially other conditions, to target role 
congruence through demonstrating the congruence of the target behaviour with the pharmacists’ 
role. Subjective norms were also a significant predictor of pharmacists’ intention to give medication 
adherence and weight loss advice, with what patients think appearing to be more important in 
relation to medication adhere advice and what other pharmacists think appearing to be more 
important in relation to weight loss advice. This suggests that interventions designed to promote 
pharmacists’ giving patients medication adherence advice should promote the idea that patients 
think that pharmacists should provide this kind of advice, whilst interventions designed to promote 
pharmacists giving weight loss advice should promote the idea that other pharmacists think that they 
should offer this advice. 
The qualitative study (chapter 3), in keeping with previous studies (Anderson et al, 2003) found that 
pharmacists did not integrate the provision of lifestyle advice and dispensing medicines as suggested 
in Choosing health through pharmacy (2005) or the NHS Future forum report (2012); rather they 
viewed them as separate activities. The quantitative research (chapter 4) found that pharmacists who 
intended to give medication adherence advice did not perceive dispensing activities in the pharmacy 
to cause goal conflict with giving medication adherence advice. Interventions to promote integrating 
the provision of lifestyle advice and dispensing activities may be helpful. It should be noted that 
interventions should not target advice giving per se, as despite superficially appearing to be the same 
behaviour, the research presented here demonstrated that whilst sharing some common 
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determinants, the determinants of intention to give weight loss advice and medication adherence 
advice differed. 
The above recommendations are targeted at the individual level (i.e. individual pharmacists’ 
behaviours). However, this programme of research has demonstrated that the environment 
pharmacists practice in plays an important role, and appears to affect pharmacists and patients 
perceptions of the pharmacist’s role and structure both pharmacists’ and patients’ behaviour. 
Therefore it appears that changes at an organisational and policy level are required for pharmacists 
to fulfil the roles outlined in the pharmacy contract (DoH, 2005). The findings of this programme of 
research suggest that the pharmacy contract, at present, does not support the facilitation of patient 
self-management of CVD through giving lifestyle advice and the pharmacists’ description of practice 
does not match the vision for the 2015 health promoting pharmacy outlined in Choosing health 
through pharmacy (DoH, 2005).Changing the way pharmacists are remunerated for the provision of 
lifestyle advice may result in increased provision of lifestyle advice by pharmacists. This may also 
have the knock-on effect of improving pharmacists’ role congruence in relation to these activities 
through providing validation that this is an important part of the pharmacists’ role.  
7.11 Contributions to health psychology theory 
The findings of the present study support extended TPB models such as the Godin et al. (2008) theory 
of health professional behaviour along with Law’s theory of implementation (Laws et al., 2009). As 
discussed in chapter one, there has been controversy surrounding the TPB (Ajzen, 1991), with some 
authors questioning the utility of the model (Ogden, 2014; Sniehotta et al., 2013). The findings 
presented here suggest that whilst the TPB constructs alone are not sufficient to explain pharmacists’ 
intentions to engage in two types of advice-giving behaviour (which the TPB (Azjen, 1991) posits), the 
results fit with a model of health professional behaviour (Godin et al., 2008) which augments TPB 
constructs with other constructs. The present research found role congruence to be particularly 
important in the advice-giving behaviour of pharmacists, adding support to the role of this construct 
in health professional behaviour (Godin et al., 2008; Laws et al., 2008, 2009). 
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The findings of the quantitative study (chapter four) highlight the value of analysing subjective norms 
separately rather than as a single variable, demonstrating that the perceptions of important others 
can vary: the beta weighting for the subjective norm relating to patients was higher than that relating 
to pharmacists for medication adherence advice whereas it was the opposite for weight management 
advice.  
7.12 Strengths and Limitations 
One of the major strengths of this programme of work was the use of mixed methods, a 
methodology that has been underutilised in pharmacy practice research (Hadi et al., 2013). As 
previously stated, the role of pharmacists in the UK has been subject to substantial changes and 
pharmacy practice is a relatively new area of research (DoH, 2008) and there is a lack of high quality, 
rigorous qualitative research in this field.  The two qualitative studies presented in this thesis used 
semi structured interviews conducted with individual participants which generated rich data 
describing patients’ and pharmacists’ experiences. Detailed analysis of this data was subject to 
ongoing supervision from the author’s (KK) supervisory team which ensured the validity of the 
research findings. 
The quantitative study was developed based on the findings of the qualitative study, and was 
grounded in psychological theory. The study measured the predictors of participants’ intentions to 
engage in two kinds of behaviour, allowing within participant comparison of intentions to engage in 
both behaviours. The use of theory based constructs with associated guidance describing how the 
constructs should be operationalised means that the research can be replicated in the future and 
allows identification of constructs that can potentially inform the development of behaviour change 
interventions. The systematic review, to present knowledge, is the first to review the effectiveness of 
interventions to enable pharmacists, pharmacy staff and pharmacy students to facilitate patient 
lifestyle behaviour change. The review synthesised diverse findings from studies using qualitative, 
quantitative and mixed methodologies, coding for use of theory and behaviour change techniques in 
order to identify the components of successful interventions.  
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There are however limitations to the research. Despite sampling participants with a breadth of 
opinions and experiences, as previously discussed, there were difficulties recruiting pharmacists to 
participate in this programme of research and consequently only one participant in the qualitative 
study (chapter three) was employed by a supermarket-owned pharmacy. Whilst qualitative research 
is not concerned with the number of participants and generalisability, instead assessing validity 
through the richness of the data collected and how close it gets to describing the phenomenon being 
researched, a greater breadth of views and richer data may have been collected if more pharmacists 
employed by supermarket pharmacies participated in the research. Furthermore, due to changes to 
the structure of the NHS and contracts going to tenure at the time the research was conducted, the 
organisation that had agreed to facilitate the recruitment of patients with CVD was not able to fulfil 
this role. This meant that participants were recruited from a potentially less diverse sample 
(employees at a university) rather than patients about to begin chronic disease self-management 
group, and as with the qualitative study with pharmacists, a greater breath of views and richer data 
may have been collected if more patients from more diverse backgrounds were recruited.  
As previously highlighted in chapter four, emotion was not included as a determinant of pharmacists’ 
advice giving behaviour.  In the qualitative study, some pharmacists indicated that they were 
uncomfortable initiating conversations about weight loss in case patients found this offensive. It 
could be that emotion (in this case fear of patients’ potential responses) is influencing pharmacists’ 
advice- giving behaviour. It may also be the case that there is a wider range of negative emotions 
associated with giving lifestyle advice; in the qualitative research some pharmacists indicated that 
they did not think that it should be part of the pharmacists’ role to give lifestyle advice. There 
therefore may be anger associated with the provision of lifestyle advice which may impact on 
pharmacists’ advice giving behaviour. Despite not emerging as prominently as other factors such as 
role congruence in relation to the provision of advice in the qualitative research, it could be that 
emotion is an important determinant of pharmacists’ advice giving behaviour. The role of emotion in 
pharmacists’ advice giving behaviour therefore warrants further exploration in future work. 
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7.13 Conclusion 
This programme of work evaluated the role UK community pharmacists could play in facilitating 
patient self-management of CVD, with a particular focus on the provision of lifestyle advice. Previous 
research had identified that whilst pharmacists perceived providing public health services as an 
important activity, there were a number of barriers to providing such services and pharmacists’ 
actual provision of public health services did not match their ideal. A pragmatic approach which 
utilised mixed methods was used to explore the experiences of both patients with CVD and 
community pharmacists, assess the efficacy of interventions to train pharmacists to support patients 
to change lifestyle behaviours, and identify the predictors of pharmacists intentions to engage in two 
different types of advice giving behaviour to support patient self-management of CVD; one related to 
medicines and one related to lifestyle. The research found that psychological and environmental 
factors appeared to be key to pharmacists’ provision of lifestyle advice, and pharmacists’ perception 
of their role appeared to underpin many of the commonly cited barriers (such as time and workload) 
perceived to prevent pharmacists giving lifestyle advice. This emerged as more important than self-
efficacy and receipt of appropriate training, which have been identified as the key factors of 
pharmacists’ provision of lifestyle advice in the literature. The retail environment that pharmacists 
practice in appeared to structure pharmacists’ behaviour and affect patients and pharmacists 
perceptions of their respective roles in the pharmacist-patient/customer interaction. 
 
7.14 Final Reflections 
The ‘potential’ for UK community pharmacists to provide a range of public health services is 
frequently alluded to within the pharmacy practice literature and policy documents. However, 
despite there being a great deal of potential, the effect on patient outcome and cost effectiveness of 
pharmacist-led interventions in facilitating patient self-management of CVD (and other chronic 
conditions) has not been reliably demonstrated and, at present, the scientific evidence base is poor. 
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Furthermore, as this thesis has outlined, there are formidable barriers to for researchers to overcome 
to gain access to practising community pharmacists to in order to conduct high quality research in 
which has the potential to improve the scientific evidence base for pharmacist-led services.  
Despite there being great potential, in theory, for UK community pharmacists to facilitate patient 
self-management of CVD through lifestyle advice, at present, in practice, the retail environment and 
pharmacists’ contractual framework does not appear to be conducive to pharmacists offering this 
kind of support.  Pharmacists in the present study did not have strong intentions to offer patients 
lifestyle advice (in this case weight loss advice) and there appears to be variation in pharmacists’ 
perceptions of whether they should offer lifestyle advice to facilitate patient self-management of 
CVD. Importantly, patients’ perceptions of whether pharmacists could and should offer this kind of 
support was mixed, and all of the patients who participated in the current research project indicated 
that they would prefer to receive self-management advice from their GP rather than a community 
pharmacist. Changes to pharmacists’ and patients’ attitudes and behaviour in addition to changes to 
the pharmacy environment and remuneration practices would need to occur in order for pharmacist 
mediated patient self-management of CVD to occur as suggested in the best practice guidelines 
Choosing health through pharmacy (DoH, 2005).  
  
 
 
247 
 
8 References 
Abraham, C., & Michie, S. (2008). A taxonomy of behavior change techniques used in interventions. 
Health Psychology, 27(3), 379-387.  
Ajzen, I. (1991). The theory of planned behaviour. Org Beh Hum Decis process, 50, 179-211.  
Ajzen, I., & Fishbein, M. (1980). Understanding Attitudes and Predicting Social Behavior Englewood 
Cliffs, NJ: Prentice-Hall. 
Allen, B. (2014). Putting research at the centre of practice is everybody's business. Clinical 
Pharmacist, 6(3).  
Anderson, C., & Alexander, A. (1997). Wiltshire pharmacy health promotion training initative: a 
telephone survey. International Journal of Pharmacy Practice, 5(4), 185-191.  
Anderson, C., Blenkinsopp, A., & Armstrong, M. (2003). Pharmacists’ perceptions regarding their 
contribution to improving the public’s health: a systematic review of the United Kingdom and 
international literature 1990–2001. International Journal of Pharmacy Practice, 11, 111-120.  
Anderson, C., Blenkinsopp, A., & Armstrong, M. (2004a). Feedback from community pharmacy users 
on the contribution of community pharmacy to improving the public's health: a systematic 
review of the peer reviewed and non-peer reviewed titerature 1990-2002. Health 
Expectations, 7(3), 191-202.  
Anderson, C., Blenkinsopp, A., & Armstrong, M. (2004b). Feedback from community pharmacy users 
on the contribution of community pharmacy to improving the public’s health: a systematic 
review of the peer reviewed and non-peer reviewed literature 1990–2002. Health 
Expectations, 7(191-202).  
Anderson, C., & Rajyaguru, R. (2002). The role of community pharmacists and medicines counter 
assistants in health promotion: reflections from a folic acid campaign. International Journal of 
Pharmacy Practice, 10(1), 17-22. doi: 10.1111/j.2042-7174.2002.tb00583.x 
Armitage, C. J., & Conner, M. (2001). Efficacy of the Theory of Planned Behaviour: A meta-analytic 
review. British Journal of Social Psychology, 40(4), 471-499. doi: 10.1348/014466601164939 
Armour, C. L., Brillant, M., & Krass, I. (2007). Pharmacists’ views on involvement in pharmacy practice 
research: Strategies for facilitating participation. Phamacy Practice, 5(2).  
Azermai, M., Vander Stichele, R. R. H., Van Bortel, L. M., & Elseviers, M. M. (2014). Barriers to 
antipsychotic discontinuation in nursing homes: an exploratory study. [Article]. Aging & 
Mental Health, 18(3), 346-353. doi: 10.1080/13607863.2013.832732 
Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change. Psychological 
Review, 84(2), 191-215.  
Bandura, A. (1977). Self efficacy: towards a unifying theory of behavior change. Psychological Review, 
84, 191 - 215.  
Barlow, J., Wright, C., Sheasby, J., Turner, A., & Hainsworth, J. (2002). Self-management approaches 
for people with chronic conditions: a review. Patient Education and Counseling, 48(2), 177-
187. doi: 10.1016/s0738-3991(02)00032-0 
Blenkinsopp, A., Anderson, C., & Armstrong, M. (2003). Systematic review of the effectiveness of 
community pharmacy-based interventions to reduce risk behaviours and risk factors for 
coronary heart disease. Journal of Public Health Medicine, 25(2), 144-153. doi: DOI 
10.1093/pubmed/fdg030 
Boardman, H., Lewis, M., Croft, P., Trinder, P., & Rajaratnam, G. (2005). Use of community 
pharmacies: a population-based survey. Journal of Public Health, 27(3), 254-262. doi: 
10.1093/pubmed/fdi032 
Bott, Q. (2009). Pharmacy practice the American way!  Retrieved 9 February, 2015, from 
http://www.pjcareers.com/article/pharmacy-practice-the-american-way-/ 
 
 
248 
 
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in 
Psychology, 3(2), 77-101. doi: 10.1191/1478088706qp063oa 
Brewer, N. T., Chapman, G. B., Brownlee, S., & Leventhal, E. A. (2002). Cholesterol control, 
medication adherence and illness cognition. British Journal of Health Psychology, 7(4), 433-
447. doi: 10.1348/135910702320645408 
Brown, D., Portlock, J., & Rutter, P. (2012). Review of services provided by pharmacies that promote 
healthy living. International Journal of Clinical Pharmacy, 34(3), 399-409. doi: 
10.1007/s11096-012-9634-2 
Bryman, A. (2006). Integrating quantitative and qualitative research: how is it done? Qualitative 
Research, 6(1), 97-113. doi: 10.1177/1468794106058877 
Bush, J., Langley, C. A., & Wilson, K. A. (2009). The corporatization of community pharmacy: 
Implications for service provision, the public health function, and pharmacy's claims to 
professional status in the United Kingdom. Research in Social and Administrative Pharmacy, 
5(4), 305-318. doi: 10.1016/j.sapharm.2009.01.003 
Cane, J., O'Connor, D., & Michie, S. (2012). Validation of the theoretical domains framework for use 
in behaviour change and implementation research. Implement Sci, 7(1), 37.  
Choosing health through pharmacy - programme for pharmaceutical public health 2005-2015. (2005). 
Department of Health. 
Clark M, A., McMurray, V. J. J., Morrison, E. C., Murdoch, L. D., Capewell, S., & Reid, E. M. (2005). A 
qualitative study of the contribution of pharmacists to heart failure management in Scotland. 
Pharmacy World & Science, 27, 453-458.  
Cockburn, J., & Pit, S. (1997). Prescribing behaviour in clinical practice: patients' expectations and 
doctors' perceptions of patients' expectations—a questionnaire study (Vol. 315). 
Conisbee, M. (2003). Ghost Town Britain: A Lethal Prescription. London: New Economics Foundation. 
Cordina, M., Safta, V., Ciobanu, A., & Sautenkova, N. (2008). An assessment of community 
pharmacists' attitudes towards of professional practice in the Republic of Moldova. . 
Pharmacy Practice 6(1-8).  
Corelli, R. L., Kroon, L. A., Chung, E. P., Sakamoto, L. M., Gundersen, B., Fenlon, C. M., & Suchanek 
Hudmon, K. (2005). Statewide evaluation of a tobacco cessation curriculum for pharmacy 
students. Preventive Medicine, 40(6), 888-895. doi: 
http://dx.doi.org/10.1016/j.ypmed.2004.10.003 
Coulter, A., & Colllins, A. (2011). Making shared decision a reality: no decision about me without me. 
London: Kings Fund. 
Denscombe, M. (2008). Communities of Practice: A Research Paradigm for the Mixed Methods 
Approach. Journal of Mixed Methods Research, 2(3), 270-283. doi: 
10.1177/1558689808316807 
Denzin, N. K., & Metlin, C. J. (1966). Incomplete professionalization: The case of pharmacy. Soc 
Forces, 46, 375-381.  
Dhital, R., Whittlesea, C. M., Milligan, P., Khan, N. S., & Norman, I. J. (2013). The impact of training 
and delivering alcohol brief intervention on the knowledge and attitudes of community 
pharmacists: A before and after study. Drug and Alcohol Review, 32, 147-156.  
Durand, M. A., Carpenter, L., Dolan, H., Bravo, P., Mann, M., Bunn, F., & Elwyn, G. (2014). Do 
Interventions Designed to Support Shared Decision-Making Reduce Health Inequalities? A 
Systematic Review and Meta-Analysis. PLoS ONE, 9(4), e94670. doi: 
10.1371/journal.pone.0094670 
Dures, E., Rumsey, N., Morris, M., & Gleeson, K. (2011). Mixed Methods in Health Psychology: 
Theoretical and Practical Considerations of the Third Paradigm. Journal of Health Psychology, 
16(2), 332-341. doi: 10.1177/1359105310377537 
Eades, C. E., Ferguson, J. S., & O'Carroll, R. E. (2011). Public health in community pharmacy: A 
systematic review of pharmacist and consumer views. BMC Public Health, 11, 582. doi: Artn 
582 Doi 10.1186/1471-2458-11-582 
 
 
249 
 
Eccles, M., Grimshaw, J., MacLennan, G., Bonetti, D., Glidewell, L., Pitts, N., . . . Johnston, M. (2012). 
Explaining clinical behaviors using multiple theoretical models. Implementation Science, 7(1), 
99.  
Eccles, M., Grimshaw, J., Walker, A., Johnston, M., & Pitts, N. (2005). Changing the behavior of 
healthcare professionals: the use of theory in promoting the uptake of research findings. 
Journal of Clinical Epidemiology, 58(2), 107-112. doi: DOI 10.1016/j.jclinepi.2004.09.002 
Ericcsson, K. A., & Simon, H. A. (1993). Protocol analysis: Verbal reports as data. Cambridge, MA: MIT 
Press.  
Fleming, M. L., Barner, J. C., Brown, C. M., Shepherd, M. D., Strassels, S., & Novak, S. (2014). Using the 
theory of planned behavior to examine pharmacists' intention to utilize a prescription drug 
monitoring program database. Research in Social and Administrative Pharmacy, 10(2), 285-
296. doi: http://dx.doi.org/10.1016/j.sapharm.2013.05.009 
Flodgren, G., Deane, K., Dickinson, H. O., Kirk, S., Alberti, H., Beyer, F. R., . . . Eccles, M. P. (2010). 
Interventions to change the behaviour of health professionals and the organisation of care to 
promote weight reduction in overweight and obese people. Cochrane Database of 
Systematic Reviews(3). doi: Artn Cd000984 Doi 10.1002/14651858.Cd000984.Pub2 
Fuller, T. L., Backett-Milburn, K., & Hopton, J. L. (2003). Healthy eating: the views of general 
practitioners and patients in Scotland. The American Journal of Clinical Nutrition, 77(4), 
1043S-1047S.  
Gardner, B., Wardle, J., Poston, L., & Croker, H. (2011). Changing diet and physical activity to reduce 
gestational weight gain: a meta-analysis. Obesity Reviews, 12(7), e602-e620. doi: 
10.1111/j.1467-789X.2011.00884.x 
Gavaza, P., Brown, C. M., Lawson, K. A., Rascati, K. L., Wilson, J. P., & Steinhardt, M. (2011). 
Examination of pharmacists’ intention to report serious adverse drug events (ADEs) to the 
FDA using the theory of planned behavior. Research in Social and Administrative Pharmacy, 
7(4), 369-382. doi: http://dx.doi.org/10.1016/j.sapharm.2010.09.001 
Gidman, W. (2011). Increasing community pharmacy workloads in England: causes and 
consequences. International Journal of Clinical Pharmacy, 33(3), 512-520. doi: DOI 
10.1007/s11096-011-9498-x 
Gidman, W., & Cowley, J. (2013). A qualitative exploration of opinions on the community 
pharmacists' role amongst the general public in Scotland. International Journal of Pharmacy 
Practice, 21(5), 288-296. doi: 10.1111/ijpp.12008 
Gilbert, H., Mills, E., & Ward, E. (2006). How can community pharmacists become involved in practice 
research? The Pharmaceutical Journal, 276.  
Global Atlas on Cardiovascular Disease Prevention and Control. (2011). In S. Mendis, P. Puska & B. 
Norrving (Eds.). Geneva. 
Godin, G., Belanger-Gravel, A., Eccles, M., & Grimshaw, J. (2008). Healthcare professionals' intentions 
and behaviours: A systematic review of studies based on social cognitive theories. 
Implementation Science, 3(1), 36.  
Godin, G., & Kok, G. (1996). The theory of planned behaviour: a review of its applications to health-
related behaviours Behavior Change, 11(2), 87-98.  
Gollwitzer, P. (1999). Implementation intentions: Strong effects of simple plans. American 
Psychologist, 54(7), 493-503.  
Gordon, J., Watson, M., & Avenell, A. (2011). Lightening the load? A systematic review of community 
pharmacy-based weight management interventions. Obesity Reviews, 12(11), 897-911. doi: 
10.1111/j.1467-789X.2011.00913.x 
Greene, J. C. (2008). Is Mixed Methods Social Inquiry a Distinctive Methodology? Journal of Mixed 
Methods Research, 2(1), 7-22. doi: 10.1177/1558689807309969 
Greene, J. C., Caracelli, V. J., & Graham, W. F. (1989). Toward a Conceptual Framework for Mixed-
Method Evaluation Designs. Educational Evaluation and Policy Analysis, 11(3), 255-274. doi: 
10.3102/01623737011003255 
 
 
250 
 
Guerreiro, M., Cantrill, J., & Martins, P. (2010). Acceptability of community pharmaceutical care in 
Portugal: a qualitative study. Journal of Health Services Research Policy, 15(4), 215-222.  
Hadi, M. A., Alldred, D. P., Closs, S. J., & Briggs, M. (2013). Mixed-methods research in pharmacy 
practice: basics and beyond (part 1). International Journal of Pharmacy Practice, 21(5), 341-
345. doi: 10.1111/ijpp.12010 
Harding, G., & Taylor, K. (1997). Responding to change: the case of community pharmacy in Great 
Britain. Sociology of Health & Illness, 19(5), 547-560. doi: 10.1111/j.1467-
9566.1997.tb00419.x 
Haslam, S. A., Turner, J. C., Oakes, P. J., Reynolds, K. J., & Doosje, B. (2002). From personal pictures in 
the head to collective tools in the word: how shared stereotypes allow groups to represent 
and change social reality. . In C. McGarty, V. Y. Yzerbyt & R. Spears (Eds.), Stereotypes as 
explanations: The formation of meaningful beliefs about social groups (pp. 157-185). 
Cambridge: University Press. 
Hassell, K., Seston, E. M., Schafheutle, E. I., Wagner, A., & Eden, M. (2011). Workload in community 
pharmacies in the UK and its impact on patient safety and pharmacists’ well-being: a review 
of the evidence. Health & Social Care in the Community, 19(6), 561-575. doi: 10.1111/j.1365-
2524.2011.00997.x 
The health and social care act. (2012). 
Hébert, J., Laliberté, M.-C., Berbiche, D., Martin, E., & Lalonde, L. (2013). The willingness of 
community pharmacists to participate in a practice-based research network. Canadian 
Pharmacists Journal / Revue des Pharmaciens du Canada, 146(1), 47-54. doi: 
10.1177/1715163512473240 
Hibbert, D., Bissell, P., & Ward, P. R. (2002). Consumerism and professional work in the community 
pharmacy. Sociology of Health & Illness, 24(1), 46-65. doi: 10.1111/1467-9566.00003 
Hiles, D. (2014). Qualitative inquiry, mixed methods and the logic of scientific inquiry. QMiP(17), 49-
61.  
Holland, R., Brooksby, I., Ashton, K., Hay, L., Smith, R., Shepstone, L., . . . Harvey, I. (2007). 
Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed 
randomised controlled trial. BMJ, 334(7603), 1098. doi: 10.1136/bmj.39164.568183.AE 
Holland, R., Brooksby, I., Lenaghan, E., Ashton, K., Hay, L., Smith, R., . . . Harvey, I. (2007). 
Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed 
randomised controlled trial. BMJ, 334(7603), 1098. doi: 10.1136/bmj.39164.568183.AE 
Horne, R. (2003). Treatment perceptions and self regulation. In L. D. Cameron & H. Leventhal (Eds.), 
The self-regulation of health and illness behaviour (pp. 138–153.). London: Routledge. 
Horne, R., Chapman, S. C. E., Parham, R., Freemantle, N., Forbes, A., & Cooper, V. (2013). 
Understanding Patients’ Adherence-Related Beliefs about Medicines Prescribed for Long-
Term Conditions: A Meta-Analytic Review of the Necessity-Concerns Framework. PLoS ONE, 
8(12), e80633. doi: 10.1371/journal.pone.0080633 
Horne, R., Weinman, J., & Hankins, M. (1999). The beliefs about medicines questionnaire: The 
development and evaluation of a new method for assessing the cognitive representation of 
medication. Psychology & Health, 14(1), 1-24. doi: 10.1080/08870449908407311 
Horsfield, E., Sheridan, J., & Anderson, C. (2011). What do community pharmacists think about 
undertaking screening and brief interventions with problem drinkers? Results of a qualitative 
study in New Zealand and England. International Journal of Pharmacy Practice, 19(3), 192-
200. doi: 10.1111/j.2042-7174.2011.00112.x 
Hrisos, S., Eccles, M., Francis, J., Dickinson, H., Kaner, E., Beyer, F., & Johnston, M. (2009). Are there 
valid proxy measures of clinical behaviour? a systematic review. Implementation Science, 
4(1), 37.  
Hudmon, K. S., Corelli, R. L., Chung, E., Gundersen, B., Kroon, L. A., Sakamoto, L. M., . . . Prokhorov, A. 
V. (2003). Development and implementation of a tobacco cessation training program for 
students in the health professions. Journal of Cancer Education, 18(3), 142-149. doi: 
10.1207/s15430154jce1803_07 
 
 
251 
 
Hudmon, K. S., Kroon, L. A., Corelli, R. L., Saunders, K. C., Spitz, M. R., Bates, T. R., & Liang, D. (2004). 
Training future pharmacists at a minority educational institution: Evaluation of the Rx for 
Change tobacco cessation training program. Cancer Epidemiology Biomarkers & Prevention, 
13(3), 477-481.  
Jepson, R. G., Hewison, J., Thompson, A. G. H., & Weller, D. (2005). How should we measure informed 
choice? The case of cancer screening. Journal of Medical Ethics, 31(4), 192-196. doi: 
10.1136/jme.2003.005793 
Jiwa, M., Nichols, P., Magin, P., Pagey, G., Meng, X., Parsons, R., & Pillai, V. (2014). Management of 
behavioural change in patients presenting with a diagnosis of dementia: a video vignette 
study with Australian general practitioners. [; Research Support, Non-U.S. Gov't]. BMJ open, 
4(9), e006054. doi: 10.1136/bmjopen-2014-006054 
Johnson, R. B., Onwuegbuzie, A. J., & Turner, L. A. (2007). Toward a Definition of Mixed Methods 
Research. Journal of Mixed Methods Research, 1(2), 112-133. doi: 
10.1177/1558689806298224 
Johnson, S. J., O'Connor, E. M., Jacobs, S., Hassell, K., & Ashcroft, D. M. (2014). The relationships 
among work stress, strain and self-reported errors in UK community pharmacy. Research in 
Social and Administrative Pharmacy, 10(6), 885-895. doi: 
http://dx.doi.org/10.1016/j.sapharm.2013.12.003 
Knapp, D. A., & Knapp, D. E. (1968). An appraisal of the contemporary practice of pharmacy. Am J 
Pharm Educ(32), 747-758.  
Laliberte, M.-C., Perreault, S., Damestoy, N., & Lalonde, L. (2012). Ideal and actual involvement of 
community pharmacists in health promotion and prevention: a cross-sectional study in 
Quebec, Canada. Bmc Public Health, 12(1), 192.  
Latif, A., Boardman, H. F., & Pollock, K. (2013). Understanding the patient perspective of the English 
community pharmacy Medicines Use Review (MUR). Research in Social and Administrative 
Pharmacy, 9(6), 949-957. doi: http://dx.doi.org/10.1016/j.sapharm.2013.01.005 
Laws, R., Kemp, L., Harris, M., Davies, G., Williams, A. E., & Eames-Brown, R. (2009). An exploration of 
how clinician attitudes and beliefs influence the implementation of lifestyle risk factor 
management in primary healthcare: a grounded theory study. Implementation Science, 4(1), 
66.  
Laws, R., Kirby, S., Powell Davies, G., Williams, A. E., Jayasinghe, U., Amoroso, C., & Harris, M. (2008). 
"Should I and can I?": A mixed methods study of clinician beliefs and attitudes in the 
management of lifestyle risk factors in primary health care. BMC Health Services Research, 8, 
44.  
Lenfant, C. (2003). Clinical Research to Clinical Practice — Lost in Translation? New England Journal of 
Medicine, 349(9), 868-874. doi: doi:10.1056/NEJMsa035507 
Lenz, T. L. (2007). An elective course on lifestyle modifications in pharmacotherapy. American Journal 
of Pharmaceutical Education, 71(5).  
Lenz, T. L., Monaghan, M. S., & Hetterman, E. A. (2007). Therapeutic lifestyle strategies taught in U.S. 
Pharmacy Schools. Prev Chronic Dis, 4(4), A96.  
Leventhal, H. (2003). The common-sense model of self-regulation of health and illness. . In H. 
Leventhal, I. Brissette, A. E. Leventhal & D. Cameron, L. (Eds.), The self-regulation of health 
and illness behaviour (pp. 42-65). New York: Routledge. 
Little, P., Dorward, M., Warner, G., Stephens, K., Senior, J., & Moore, M. (2004). Importance of 
patient pressure and perceived pressure and perceived medical need for investigations, 
referral, and prescribing in primary care: nested observational study (Vol. 328). 
Living Well for Longer: National Support for Local Action to Reduce Premature Avoidable Mortality. 
(2014).  Retrieved from 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/307703/L
W4L.pdf. 
Lorig, K., & Holman, H. (2003). Self-management education: History, definition, outcomes, and 
mechanisms. Annals of Behavioral Medicine, 26(1), 1-7. doi: 10.1207/s15324796abm2601_01 
 
 
252 
 
Machado, M., Bajcar, J., Guzzo, G. C., & Einarson, T. R. (2007). Sensitivity of Patient Outcomes to 
Pharmacist Interventions. Part II: Systematic Review and Meta-Analysis in Hypertension 
Management. Annals of Pharmacotherapy, 41(11), 1770-1781. doi: 10.1345/aph.1K311 
Maguire, T. A., McElnay, J. C., & Drummond, A. (2001). A randomized controlled trial of a smoking 
cessation intervention based in community pharmacies. Addiction, 96(2), 325-331. doi: 
10.1046/j.1360-0443.2001.96232516.x 
Marshall, I. J., Wolfe, C. D. A., & McKevitt, C. (2012). Lay perspectives on hypertension and drug 
adherence: systematic review of qualitative research (Vol. 345). 
Marteau, T. M., & Johnston, M. (1991). Health professionals: a source of variance in health outcomes. 
Psychology & Health, 5(1), 47-58.  
Martin, B. A., Bruskiewitz, R. H., & Chewning, B. A. (2003). Effect of a tobacco cessation continuing 
professional education program on pharmacists' confidence, skills, and practice-change 
behaviors. J Am Pharm Assoc., 50(1), 9-16.  
Martin, B. A., & Chewning, B. A. (2011). Evaluating pharmacists’ ability to counsel on tobacco 
cessation using two standardized patient scenarios. Patient Education and Counseling, 83(3), 
319-324. doi: http://dx.doi.org/10.1016/j.pec.2010.12.010 
Maunder, P. E. V., & Landes, D. P. (2005). An evaluation of the role played by community pharmacies 
in oral healthcare situated in a primary care trust in the north of England. 
[10.1038/sj.bdj.4812614]. Br Dent J, 199(4), 219-223.  
McCaig, D., Fitzgerald, N., & Stewart, D. (2011a). Provision of advice on alcohol use in community 
pharmacy: a cross-sectional survey of pharmacists' practice, knowledge, views and 
confidence. International Journal of Pharmacy Practice, 19(3), 171-178. doi: 10.1111/j.2042-
7174.2011.00111.x 
McCaig, D., Fitzgerald, N., & Stewart, D. (2011b). Provision of advice on alcohol use in community 
pharmacy: a cross-sectional survey of pharmacists' practice, knowledge, views and 
confidence. The International journal of pharmacy practice, 19(3), 171-178. doi: 
10.1111/j.2042-7174.2011.00111.x 
McEachan, R. R. C., Conner, M., Taylor, N. J., & Lawton, R. J. (2011). Prospective prediction of health-
related behaviours with the Theory of Planned Behaviour: a meta-analysis. Health Psychology 
Review, 5(2), 97-144. doi: 10.1080/17437199.2010.521684 
Meyer, D., Leventhal, H., & Guttman, M. (1985). Common-sense models of illness: The example of 
hypertension. Health Psychology 4(2), 115-135.  
Michie, S., Jochelson, K., Markham, W. A., & Bridle, C. (2009). Low income groups and behaviour 
change interventions: A review of intervention content, effectiveness and theoretical 
frameworks. Journal of Epidemiology and Community Health. doi: 10.1136/jech.2008.078725 
Michie, S., & Johnston, M. (2012). Theories and techniques of behaviour change: Developing a 
cumulative science of behaviour change. Health Psychology Review, 6(1), 1-6. doi: 
10.1080/17437199.2012.654964 
Michie, S., Richardson, M., Johnston, M., Abraham, C., Francis, J., Hardeman, W., . . . Wood, C. 
(2013a). The Behavior Change Technique Taxonomy (v1) of 93 Hierarchically Clustered 
Techniques: Building an International Consensus for the Reporting of Behavior Change 
Interventions. Annals of Behavioral Medicine, 46(1), 81-95. doi: 10.1007/s12160-013-9486-6 
Michie, S., Richardson, M., Johnston, M., Abraham, C., Francis, J., Hardeman, W., . . . Wood, C. E. 
(2013b). The Behavior Change Technique Taxonomy (v1) of 93 Hierarchically Clustered 
Techniques: Building an International Consensus for the Reporting of Behavior Change 
Interventions. Annals of Behavioral Medicine, 46(1), 81-95.  
Naderi, S. H., Bestwick, J. P., & Wald, D. S. (2012). Adherence to Drugs That Prevent Cardiovascular 
Disease: Meta-analysis on 376,162 Patients. The American Journal of Medicine, 125(9), 882-
887.e881. doi: http://dx.doi.org/10.1016/j.amjmed.2011.12.013 
The NHS's role in the public's health: a report from the NHS future forum (D. o. Health, Trans.). 
(2012). 
 
 
253 
 
Nkansah, N., Mostovetsky, O., Yu, C., Chheng, T., Beney, J., Bond, C. M., & Bero, L. (2010). Effect of 
outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. 
Cochrane Database of Systematic Reviews, 7(7), CD000336.  
O'Cathain, A., Murphy, E., & Nicholl, J. (2007). Why, and how, mixed methods research is undertaken 
in health services research in England: a mixed methods study. BMC Health Services 
Research, 7(1), 85.  
O'Loughlin, J., Masson, P., Déry, V., & Fagnan, D. (1999). The Role of Community Pharmacists in 
Health Education and Disease Prevention: A Survey of Their Interests and Needs in Relation 
to Cardiovascular Disease. Preventive Medicine, 28(3), 324-331. doi: 
10.1006/pmed.1998.0436 
Ogden, J. (2014). Time to retire the theory of planned behaviour?: one of us will have to go! A 
commentary on Sniehotta, Presseau and Araújo-Soares. Health Psychology Review, 1-3. doi: 
10.1080/17437199.2014.898679 
Onwuegbuzie, A., & Leech, N. (2005). Taking the “Q” Out of Research: Teaching Research 
Methodology Courses Without the Divide Between Quantitative and Qualitative Paradigms. 
Quality and Quantity, 39(3), 267-295. doi: 10.1007/s11135-004-1670-0 
Patwardhan, P. D., & Chewning, B. A. (2012). Effectiveness of intervention to implement tobacco 
cessation counseling in community chain pharmacies. Journal of the American Pharmacists 
Association, 52(4), 507-514. doi: 10.1331/JAPhA.2012.10117 
Perepelkin, J. (2011). Public opinion of pharmacists and pharmacist prescribing. Canadian 
Pharmaceutical Journal, 144(2), 86-93.  
Peterson, G., Fitzmaurice, K., Kruup, H., Jackson, S., & Rasiah, R. (2010). Cardiovascular risk screening 
program in Australian community pharmacies. Pharmacy World & Science, 32(3), 373-380. 
doi: 10.1007/s11096-010-9379-8 
Peterson, G. M., Jackson, L. S., & Hughes, D. J. (2010). Public perceptions of the role of Australian 
pharmacists in cardiovascular disease. Journal of Clinical Pharmacy and Therapeutics, 35, 
671-677.  
Peterson, G. M., Jackson, S. L., Fitzmaurice, K. D., & Gee, P. R. (2009). Attitudes of Australian 
pharmacists towards practice-based research. [Article]. Journal of Clinical Pharmacy and 
Therapeutics, 34(4), 397-405. doi: 10.1111/j.1365-2710.2008.01020.x 
Pfleger, D., McHattie, L., Diack, H., McCaig, D., & Stewart, D. (2008). Views, attitudes and self-
assessed training needs of Scottish community pharmacists to public health practice and 
competence. Pharmacy World & Science, 30(6), 801-809. doi: 10.1007/s11096-008-9228-1 
Pharmacy in England: building on strengths – delivering the future (2008).  Retrieved from 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/228858/73
41.pdf. 
Plake, K. S., Chesnut, R. J., & Biebighauser, S. (2003). Impact of a Diabetes Certificate Program on 
Pharmacists' Diabetes Care Activities. American Journal of Pharmaceutical Education, 67(4), 
116. doi: 10.5688/aj6704116 
Pluye, P., & Hong, Q. N. (2014). Combining the Power of Stories and the Power of Numbers: Mixed 
Methods Research and Mixed Studies Reviews. Annual Review of Public Health, Vol 35, 35, 
29-45. doi: DOI 10.1146/annurev-publhealth-032013-182440 
Pluye, P., Robert, E., Cargo, M., Bartlett, G., O’Cathain, A., Griffiths, F., . . . Rousseau, M. C. (2011). 
Proposal: A mixed methods appraisal tool for systematic mixed studies reviews.  Retrieved 10 
June 2014 
Ponterotto, J. G. (2005). Qualitative research in counseling psychology: A primer on research 
paradigms and philosophy of science. Journal of Counseling Psychology, 52(2), 126-136. doi: 
http://dx.doi.org/10.1037/0022-0167.52.2.126 
Popay, J., Roberts, H., Sowden, A., Petticrew, M., Arai, L., Rodgers, M., . . . Duffy, S. (2006). Guidance 
on the Conduct of Narrative Synthesis in Systematic Reviews: A Product from the ESRC 
Methods Programme.  
 
 
254 
 
Pope, C., Mays, N., & Popay, J. (2006). Synthesizing qualitative and quantitative health evidence 
[electronic resource] : a guide to methods  
Pradel, G. F., Obeidat, A. N., & Tsoukleris, G. M. (2007). Factors affecting pharmacists' pediatric 
counseling. J Am Pharm Assoc., 47(737-746).  
Prescriptions Dispensed in the Community: England, Statistics for 2000 to 2010. (2011).  London. 
Presseau, J., Francis, J., Campbell, N., & Sniehotta, F. (2011). Goal conflict, goal facilitation, and health 
professionals' provision of physical activity advice in primary care: An exploratory prospective 
study. Implementation Science, 6(1), 73.  
Prestwich, A., Sniehotta, F. F., Whittington, C., Dombrowski, S. U., Rogers, L., & Michie, S. (2013). 
Does Theory Influence the Effectiveness of Health Behavior Interventions? Meta-Analysis. 
Health Psychology ( Advance online publication). doi: 10.1037/a0032853 
Prochaska, J., & DiClemente, C. (1983). Stages and processes of self-change in smoking: toward an 
integrative model of change. J Consult Clin Psychol, 51, 390 - 395.  
PSNC. (2014). MURs: the basics - What is the Medicines Use Review & Prescription Intervention 
Service?  Retrieved 1 September 2014, from http://psnc.org.uk/services-
commissioning/advanced-services/murs/murs-the-basics/ 
Puhl, R. M., & Heuer, C. A. (2009). The Stigma of Obesity: A Review and Update. Obesity, 17(5), 941-
964. doi: 10.1038/oby.2008.636 
Rapport, F., Doel, M. A., Hutchings, H. A., Wright, S., Wainwright, P., John, D. N., & Jerzembek, G. S. 
(2010). Eleven themes of patient-centred professionalism in community pharmacy: 
innovative approaches to consulting. International Journal of Pharmacy Practice, 18(5), 260-
268. doi: 10.1111/j.2042-7174.2010.00056.x 
Renberg, T., Tornqvist, K. W., Sporrong, S. K., Lindblad, A. K., & Tully, M. P. (2011). Pharmacy users' 
expectations of pharmacy encounters: a Q-methodological study. Health Expectations, 14(4), 
361-373. doi: DOI 10.1111/j.1369-7625.2010.00643.x 
Ritchie, J., & Spencer, L. (1994). Qualitative data analysis for applied policy research. 
Roberts, D. (1988). DISPENSING BY THE COMMUNITY PHARMACIST - AN UNSTOPPABLE DECLINE. 
Journal of the Royal College of General Practitioners, 38(317), 563-564.  
Rosenbloom, K., Taylor, K., & Harding, G. (2000). Community pharmacists' attitudes towards 
research. Int J Clin Pharm, 8, 103-110.  
Santschi, V., Chiolero, A., Burnand, B., Colosimo, A. L., & Paradis, G. (2011). Impact of pharmacist care 
in the management of cardiovascular disease risk factors: a systematic review and meta-
analysis of randomized trials. JAMA Internal Medicine, 171(16), 1441-1453.  
Saramunee, K., Krska, J., Mackridge, A., Richards, J., Suttajit, S., & Phillips-Howard, P. (2014). How to 
enhance public health service utilization in community pharmacy?: General public and health 
providers' perspectives. Research in Social and Administrative Pharmacy, 10(2), 272-284. doi: 
http://dx.doi.org/10.1016/j.sapharm.2012.05.006 
Scarborough, P., Bhatnagar, P., Wickramasinghe, K., Smolina, K., Mitchell, C., & Rayner, M. (2010). 
Coronary heart disease statistics. British Heart Foundation. 
Scott, A., Bond, C., Inch, J., & Grant, A. (2007). Preferences of community pharmacists for extended 
roles in primary care. Pharmacoeconomics 25, 783-792.  
Sheldon, T. A. (2005). Making evidence synthesis more useful for management and policy-making. 
Journal of Health Services Research & Policy, 10(suppl 1), 1-5. doi: 
10.1258/1355819054308521 
Sinclair, H. K., Bond, C. M., Lennox, A. S., Silcock, J., Winfield, A. J., & Donnan, P. T. (1998). Training 
pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: a 
randomised controlled trial in Scotland. Tobacco Control, 7(3), 253-261.  
Sniehotta, F. F., Presseau, J., & Araújo-Soares, V. (2013). Time to retire the theory of planned 
behaviour. Health Psychology Review, 8(1), 1-7. doi: 10.1080/17437199.2013.869710 
Stevenson, F. A., Cox, K., Britten, N., & Dundar, Y. (2004). A systematic review of the research on 
communication between patients and health care professionals about medicines: the 
consequences for concordance. Health Expectations, 7(3), 235-245. doi: 10.1111/j.1369-
7625.2004.00281.x 
 
 
255 
 
Stone, P., & Curtis, S. J. (2002). Pharmacy Practice (3 ed.). London: Pharmaceutical Press. 
Street Jr, R. L., Gordon, H., & Haidet, P. (2007). Physicians’ communication and perceptions of 
patients: Is it how they look, how they talk, or is it just the doctor? Social Science & Medicine, 
65(3), 586-598. doi: http://dx.doi.org/10.1016/j.socscimed.2007.03.036 
Tashakkori, A., & Teddlie, C. (2003). Handbook of Mixed Methods in Social & Behavioral Research. 
Thousand Oaks: Sage. 
Taylor, K. M. G., & Harding, G. (2003). Corporate pharmacy: implications for the pharmacy profession, 
researchers and teachers. Pharmacy Education, 3, 141-147.  
Todd, Z., Nerlich, B., McKeown, S., & Clarke, D. (2004). Mixing methods in psychology: the integration 
of qualitative and quantitative methods in theory and practice. Hove: Pyschology Press. 
Traulsen, J. M., & Bissel, P. (2004). (9) Theories of professions and the pharmacist. International 
Journal of Pharmacy Practice, 12(2), 107-114. doi: 10.1211/0022357023727 
Triandis, H. C. (1979). Values, attitudes, and interpersonal behavior. Nebraska Symposium on 
Motivation, 27, 195-259.  
Tsuyuki, T. R. e. a. (2002). A randomized trial of the effect of community pharmacist intervention on 
cholesterol risk managment. Archive International Medicine, 162, 1149-1155.  
Twigg, M. J., Bhattacharya, D., Poland, F., Desborough, J. A., & Wright, D. J. (2013). The views of 
pharmacists who participated in a community pharmacy randomised controlled trial. 
International Journal of Pharmacy Practice, 21(2), 128-130. doi: 10.1111/j.2042-
7174.2012.00228.x 
Twigg, M. J., Poland, F., Bhattacharya, D., Desborough, J. A., & Wright, D. J. (2013). The current and 
future roles of community pharmacists: Views and experiences of patients with type 2 
diabetes. Research in Social and Administrative Pharmacy, 9(6), 777-789. doi: 
http://dx.doi.org/10.1016/j.sapharm.2012.10.004 
van Geffen, E. C. G., Philbert, D., van Boheemen, C., van Dijk, L., Bos, M. B., & Bouvy, M. L. (2011). 
Patients’ satisfaction with information and experiences with counseling on cardiovascular 
medication received at the pharmacy. Patient Education and Counseling, 83(3), 303-309. doi: 
10.1016/j.pec.2011.04.004 
Walker, A., Watson, M., Grimshaw, J., & Bond, C. (2004). Appling the theory of planned behaviour to 
pharmacists' beliefs and intentions about the treatment of vaginal candidiasis with non-
prescription medicines. Family Practice, 21(6), 670-676.  
Walker, A. E., Grimshaw, J. M., & Armstrong, E. M. (2001). Salient beliefs and intentions to prescribe 
antibiotics for patients with a sore throat. British Journal of Health Psychology, 6(4), 347-360. 
doi: 10.1348/135910701169250 
Webb, T. L., Joseph, J., Yardley, L., & Michie, S. (2010). Using the Internet to Promote Health Behavior 
Change: A Systematic Review and Meta-analysis of the Impact of Theoretical Basis, Use of 
Behavior Change Techniques, and Mode of Delivery on Efficacy. Journal of Medical Internet 
Research, 12(1), e4. doi: 10.2196/jmir.1376 
Weidmann, A. E., Cunningham, S., Gray, G., Hansford, D., Bermano, G., & Stewart, D. (2012). Views of 
the Scottish general public on community pharmacy weight management services: 
international implications. International Journal of Clinical Pharmacy, 34(2), 389-397. doi: 
10.1007/s11096-012-9624-4 
Wilson, J. (2005). Research is not just for academics. The Pharmaceutical Journal, 274, .  
Yardley, L., & Bishop, F. (2008). Mixing qualitative and quantitative methods: a pragmatic approach. 
In C. Willig & R. Stainton (Eds.), The SAGE Handbook of Qualitative Research in Psychology. 
London: Sage Publicationsd Ltd. 
 
 
 
 
 
256 
 
9 Appendices 
9.1 RSAP Paper 
Title: A qualitative study of English community pharmacists’ experiences of providing lifestyle 
advice to patients with cardiovascular disease 
 
Authors 
Kirsty Morton, MSc. PhD Student.  
Life & Health Sciences, Aston University, Aston Triangle, Birmingham, B4 7ET, UK 
 
*Professor Helen Pattison, PhD. Professor of Health Psychology. 
Life & Health Sciences, Aston University, Aston Triangle, Birmingham, B4 7ET, UK 
 
Professor Chris Langley, PhD.  Professor of Pharmacy Law and Practice 
Life & Health Sciences, Aston University, Aston Triangle, Birmingham, B4 7ET, UK 
 
Dr Rachael Powell, PhD. Lecturer in Health Psychology 
School of Psychological Sciences & Manchester Centre for Health Psychology, University of 
Manchester, Coupland 1 Building, Oxford Road, Manchester, M13 9P 
 
*Corresponding Author. Email: h.m.pattison@aston.ac.uk, Telephone Number: +44 (0) 121 
204 4073 
 
 
Keywords: cardiovascular disease, community pharmacists; lifestyle advice; professional 
identity; self-management 
Abstract (245 words) 
 
Background: The progression of cardiovascular disease (CVD) is modifiable through 
lifestyle behaviours. Community pharmacists are ideally placed to facilitate self-management 
of cardiovascular health however research shows varied pharmacist engagement in 
providing lifestyle advice.  
 
Objective: This study explored community pharmacists’ experiences and perceptions of 
providing lifestyle advice to patients with CVD.  
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Methods: In-depth semi-structured interviews were conducted with fifteen pharmacists 
recruited through snowballing from community pharmacies across the Midlands, England. A 
thematic analysis was conducted using a Framework approach. 
 
Results: Pharmacists categorised patients according to their perceptions of the patients’ 
ability to benefit from advice. Many barriers to providing lifestyle advice were identified. 
Confidence to provide lifestyle advice varied, with pharmacists most comfortable providing 
lifestyle advice in conjunction with conversations about medicines. Some pharmacists felt 
lifestyle advice was an integral part of their role whilst others questioned whether 
pharmacists should give lifestyle advice at all, particularly when receiving no remuneration for 
doing so.                                                                                                                          
Conclusion: Many pharmacists viewed providing lifestyle advice as important but identified 
many barriers to doing so. Lifestyle advice provision was influenced by pharmacists’ 
perceptions of patients. Professional identity and associated role conflict appeared to 
underpin many of the barriers to pharmacists providing lifestyle advice. Pharmacists may 
benefit from enhanced training to: increase their confidence to provide lifestyle advice; 
integrate lifestyle advice with regular pharmaceutical practice and challenge their perceptions 
of some patients’ receptiveness to lifestyle advice and behaviour change. Changes to the 
way UK pharmacists are remunerated may increase the provision of lifestyle advice 
 
 
 
 
INTRODUCTION 
 
Health behaviours such as diet, physical activity, tobacco use and alcohol consumption are 
responsible for approximately 80% of coronary heart disease and cerebrovascular disease, 
two of the major forms of cardiovascular disease (CVD).("Global Atlas on Cardiovascular Disease Prevention and 
Control," 2011) The risk of individuals with CVD developing further cardiovascular problems can be 
reduced through health behaviours such as: smoking cessation; regular physical activity; 
reducing alcohol and dietary salt consumption and taking medication to treat high blood 
pressure (hypertension) and high cholesterol (hyperlipidaemia).("Global Atlas on Cardiovascular Disease 
Prevention and Control," 2011) Such behaviours are largely under the control of individuals and 
therefore can be regarded as part of self-management of CVD. Recent UK government 
policy suggests that health professionals, including pharmacists, should view every 
interaction with patients as an opportunity to promote healthy lifestyle choices.("The NHS's role in the 
public's health: a report from the NHS future forum," 2012) The introduction of a new contractual framework and 
the “best practice” guidelines “Choosing health through pharmacy” which outline how 
pharmacists can provide public health services gave UK pharmacists a more defined role in 
public health.(Choosing health through pharmacy - programme for pharmaceutical public health 2005-2015, 2005) This includes 
supporting patients with chronic conditions such as hypertension and hyperlipidaemia. These 
patients can be identified when they collect prescription items dispensed at the community 
pharmacy, creating an opportunity for pharmacists to facilitate patient self-management of 
CVD through offering lifestyle advice. 
 
However, previous research has identified varying attitudes and levels of pharmacist 
engagement in public health related activities.(Cordina et al., 2008; Eades et al.; Laliberte et al., 2012; Pfleger et al., 
2008; Scott et al., 2007) Two comprehensive systematic reviews (Anderson et al., 2003; Eades et al., 2011) found 
that pharmacists were generally positive about their role in public health, however in practice 
the role was viewed as secondary to dispensing activities. Pharmacists’ confidence in their 
ability to perform public health related roles was moderate to low. Many barriers to 
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pharmacists achieving more involvement in public health services have been identified and 
include workload, time pressure, lack of remuneration and lack of training.(Anderson et al., 2003; Eades 
et al., 2011; O'Loughlin et al., 1999) Additionally, pharmacy ownership has been found to influence 
pharmacists’ public health activity. Bush, Langley and Wilson (2009) found that pharmacists 
employed by pharmacy multiples reported conflict with commercial interest as a significant 
barrier to them achieving the set public health agenda.(Bush et al., 2009) 
 
To date, the only known publication assessing pharmacists’ attitudes specifically towards 
CVD prevention and promotion was conducted in Canada.(O'Loughlin et al., 1999) Despite most 
pharmacists indicating an interest in developing a role in CVD prevention, few reported 
frequently advising about behaviour change to reduce CVD risk. To our knowledge, no study 
has explored the community pharmacist’s experience of providing lifestyle advice for patients 
with CVD in a UK setting. Unlike systems in place within other countries, in the UK 
community pharmacists are employed by community pharmacies (private businesses) which 
act as contractors to the publicly funded National Health Service (NHS), with 80% of 
pharmacy profits derived from the NHS prescription business.(Conisbee, 2003) This sets the UK 
apart from other countries and therefore the impact on pharmacists’ advice-giving behaviour 
needs to be explored. A qualitative approach was used to gain a deeper understanding of 
pharmacists’ experiences, particularly given the number of potential barriers to engagement 
in public health activities identified in previous research. 
 
Aim 
 
The study aimed to explore English community pharmacists’ experiences of providing 
lifestyle advice for patients with CVD.  
 
 
METHODS 
 
Study Design and Setting 
Semi-structured interviews were conducted with community pharmacists at their workplace or 
by telephone. Ethical approval for the study was obtained from Aston University Research 
Ethics Committee. 
 
Participants  
Fifteen community pharmacists participated in the study. These were six men and nine 
women, mean age 30.8 years (range: 23-55 years). Pharmacy ownership was categorised 
according to the classification used by Bush et al. (2009)(Bush et al., 2009): supermarket; multiple 
(200 outlets or more); large chain (more than 20 outlets but fewer than 200); small chain (20 
outlets or fewer but more than 5); independent (5 outlets or fewer). One participant was 
employed by a supermarket community pharmacy, seven by multiple community pharmacies, 
two by small chain pharmacies and four participants by independent pharmacies. The mean 
time participants had practiced as qualified pharmacists was 7.2 years (range: 6 weeks to 34 
years). 
 
A variety of methods were used to advertise the study to pharmacists: writing to community 
pharmacies and following up with a telephone call; word-of-mouth and snowballing 
techniques. Where possible, the authors sampled pharmacists from supermarket, multiple 
and independent community pharmacies to obtain a breadth of perceptions and experiences. 
 
 
Data Collection 
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The interviews - seven in person at the participants’ workplace and eight by telephone - were 
conducted at a time convenient to the participant and lasted on average 30 minutes (range: 
20 to 50 minutes). Open-ended questions allowed the participant to shape the direction the 
interview took, with the interviewer adopting a facilitative role, using an interview schedule to 
identify areas of interest and provide cues (see appendix). The schedule covered the 
following topics: facilitators and barriers to giving lifestyle advice; experience of delivering 
lifestyle advice; relationships with patients and other health professionals; the role of the 
community pharmacist and the suitability of the community pharmacy environment for 
receiving advice.  The interview began in an open-ended manner, asking participants to ‘tell 
me about your typical working day as a community pharmacist’, then slowly moving to more 
sensitive topic areas such as ‘describe your working relationship with other professionals 
involved in cardiovascular healthcare’ once a rapport between the participant and interviewer 
had been established. The interviews were audio recorded and transcribed verbatim. The 
interviews were conducted until no new themes emerged. 
 
Analysis 
 
The interview transcripts were analysed thematically, focussing primarily on the participants’ 
experience (Braun & Clarke, 2006). The analysis was interpretative, recognising the interaction 
between the researcher and the data. A Framework approach was used to structure the 
analysis. (Ritchie & Spencer, 1994) Framework Analysis is a five stage process of: familiarisation, 
forming a thematic framework, indexing, charting and mapping and interpretation. 
Familiarisation with the data was achieved through a process of reading and re-reading a 
small number of interview transcripts, noting the participants’ use of language, repetition of 
words or thoughts patterns emerging from the data and any contradictions within the 
participants’ accounts. This enabled the identification of emergent themes, constituted by: a 
collection of references indicating a pattern in how participants experienced the act of giving 
patients advice or how they perceived patients’ behaviour, the participants’ use of language 
to describe their experience of giving lifestyle advice and any conflicting ideas identified 
within or between the participants’ accounts.  A thematic framework was constructed using 
the emergent themes identified as described above from the interview, and prevalent themes 
identified through an a-priori literature review. Commonalities between emergent themes 
from the data and themes identified through the a-priori literature review and interview 
schedule were identified, with all themes given an equal weighting within the thematic 
framework. Each emergent theme and its associated sub-themes were assigned a number 
thus creating a numerical index to apply the thematic framework to the data. The researcher 
(KM) repeated the initial process of familiarisation and annotation with the remaining 
interview transcripts, adding any additional emergent themes to the thematic framework and 
applying the new items on the framework to previously analysed transcripts.  This enabled 
the construction of charts which summarised the participants’ extracts and where they were 
situated within the data alongside the emergent themes. The first author continually verified 
the findings with the co-authors to ensure the validity of interpretations. 
 
RESULTS 
 
The thematic analysis produced three main themes with associated sub-themes (see Table 
1). In the reported analyses, participant pseudonyms were created to provide information 
about: pharmacy ownership [Supermarket (‘Super’) or multiple (‘Multi’) or independent 
(‘Indep’) which incorporated both independent and small chain pharmacy ownership; 
community pharmacist participant number (e.g. CP 1) and number of years the participant 
had been a practicing pharmacist (e.g. 8 yrs). In the quotations below, where respondents 
emphasised particular words these words are italicised. 
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Table 1: Emergent themes and sub-themes 
Theme Sub-theme 
  
Barriers to providing lifestyle advice Time and workload 
 Patient factors 
 Confidence 
  
Professional identity Health professional-patient relationship 
 Lifestyle advice in Medicines Use Reviews 
 Future direction of the profession 
 Remuneration 
 Pharmacy as a business and associated role 
conflict 
  
Pharmacists’ perceptions of patients Categorising patients 
 Beliefs about patients with CVD 
  
 
 
261 
 
 
 
 
Barriers to providing lifestyle advice 
 
Time and workload. The most frequently cited barriers were time and workload, which were 
evident throughout the accounts of all the participants. Many pharmacists described 
balancing multiple roles in a time-limited environment which placed them under pressure. 
The pharmacists employed by multiple and supermarket pharmacies in particular described 
pressure to meet targets and provide a quick service. This appeared to leave some 
pharmacists resigned to not being able to offer patients advice: 
 
“…people are waiting so obviously you can’t really talk to people …unless it’s a 
quiet period which is rarely that we’re quiet...” MultiCP4-(6 weeks). 
 
Conversely, other pharmacists, notably more often those employed by independent 
pharmacies, appeared more confident to base the provision of advice on clinical need rather 
than the time available: 
 
“…the patients that we find need our time, they get our time and whether that 
means other people have to wait, they have to wait…” IndepCP3(2yr). 
 
It appeared that the respondent did not fear the repercussions of keeping patients waiting 
which contrasts with the experiences of many of the pharmacists employed by multiple 
community pharmacies. 
 
 
Patient factors. Many of the pharmacists felt that the role of the community pharmacist was 
not clearly defined which meant patients did not have a good understanding of the 
pharmacists’ professional capacities. The pharmacists reported that the lack of a defined role 
made it difficult for them to provide lifestyle advice, as patients did not consider this part of 
the pharmacists’ role: 
 
“…I still think the pharmacist’s role isn’t as defined as it should be… people still… 
they will always go to the doctor first, erm I don’t think they realise what the 
pharmacist in the pharmacy can do…” MultiCP1(1yr). 
 
“I think a lot of patients just think the pharmacist gives out my tablets…” 
IndepCP5(1yr). 
 
The retail environment in which the pharmacists practice appeared to contribute to this 
perception: 
 
“…a lot of patients don’t see pharmacists as a healthcare professional; they see 
them as glorified shop owners…” MultiCP4(0.1yr). 
 
It was also perceived that patients expected a quick service from pharmacists; it may be that 
the retail environment was responsible for this, leading to expectations of the kind of service 
associated with sales staff rather than health professionals. This expectation of brief 
transactions appeared to make providing lifestyle advice difficult: 
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“… I think that is the main issue with pharmacy is that pharmacy is all about erm in and 
out, in and out, in and out, they, they don’t really see…very few patients see community 
pharmacists as a resource to be used like, like a GP…” MultiCP6(1yr). 
 
 
Confidence. The pharmacists’ confidence to provide lifestyle advice appeared to 
develop over time, however even experienced pharmacists could be reluctant to offer 
lifestyle advice uninvited: 
“…much as we’re supposed to do it… I will not just speak to someone who is 
clearly overweight and start a conversation about weight...” IndepCP6(26yr). 
Many pharmacists found it particularly difficult to initiate conversations about body 
weight: 
 “…obviously it’s a touchy subject, you know, if you’ve got a genuinely er larger 
person in front of you…you don’t want to insult them, you don’t want to...to make 
them feel uncomfortable so it’s a catch 22 a little bit…” IndepCP5(1yr). 
These pharmacists appeared to construct obesity as a taboo, making them reluctant to raise 
the topic with patients. However this reluctance was not limited to opportunistic advice which 
according to UK government policy
("The NHS's role in the public's health: a report from the NHS future forum," 
2012) should be offered to patients regardless of their reason for visiting the pharmacy. One 
pharmacist was so concerned about eliciting a negative patient response that she avoided 
informing a patient that they were overweight even after weighing them. The reluctance to 
initiate conversations about lifestyle behaviours with patients appears to stem from 
pharmacists expecting a negative reaction from patients in response to their advice: 
 
“…people can get aggressive but not many people do but you just don’t wanna 
offend someone, that the biggest thing… you still want to make them happy but 
give them advice.” MultiCP4(0.1yr). 
 
The perception that patients may react negatively to lifestyle advice may make pharmacists 
reluctant to have conversations with patients about their lifestyle and the impact health 
behaviours can have on the management of CVD. 
 
Some of the pharmacists felt that they did not receive appropriate skills training to prepare 
them to offer patients lifestyle advice: 
 
“…there is a lack of training as to how we will approach patients which I say is 
one of the challenges and how we would approach patients on you know, giving 
smoking [cessation advice] erm sort of the social skills side as well, having a 
general conversation with people and how we would convince them [to change 
their behaviour] …”. MultiCP1(1yr). 
Another pharmacist noted: 
“…a lot of university now is focused around healthcare, public health… but the 
way to put it across to people, there’s not much, you’ve got to develop your own 
way…” MultiCP4(0.1yr). 
 
This statement is particularly noteworthy, given that the pharmacist who does not feel he 
received appropriate training to convey public health messages (which often incorporate 
lifestyle advice) is a recent graduate and therefore has received his training after the 
introduction of the revised pharmacy contract which outlined the role of pharmacists in 
providing public health services. A perceived lack of training may also contribute to 
 
 
263 
 
pharmacists’ reluctance to offer lifestyle advice if pharmacists do not feel they have the skills 
to offer such advice to patients. 
 
Professional Identity 
Health professional-patient relationship. The pharmacists expressed positive opinions 
about the role community pharmacy has, or could have, in promoting health behaviours to 
varying extents. In line with the ‘health professional’ identity and role of the community 
pharmacist, many of the pharmacists actively endorsed a patient-centred, collaborative 
approach to pharmaceutical practice. However the perceived importance of forming 
relationships with patients appeared to differ according the status of pharmacists’ employers: 
 
“…the main difference [between the Independent workplaces and other 
pharmacies] is having a little talk with them about their medication … offer extra 
advice to them so they feel like somebody actually cares …” (IndepCP7-2yr). 
 
Pharmacists employed by independent and notably the supermarket-owned pharmacies 
seemed to place more emphasis on the importance of building a relationship with patients 
than multiple-ownership pharmacists.  
 
Lifestyle advice in Medicines Use Reviews . The pharmacists conceptualised providing 
lifestyle advice as an activity primarily performed as part of additional services offered in 
some English community pharmacies such as the Medicines Use Review (MUR) and New 
Medicines Service (NMS) which should incorporate advice on diet, exercise and smoking 
status. There appeared to be a clear distinction between providing lifestyle advice as part of 
MURs/NMS, which pharmacists reported as a common occurrence, and “core” aspects of 
community pharmacy practice such as checking and dispensing medication which did not 
appear to frequently incorporate lifestyle advice. Providing lifestyle advice appeared not to be 
a priority for some pharmacists: 
 
“…pharmacists have a number of other stuff to do…sometimes, I feel, [lifestyle 
advice] it becomes an afterthought….because…you feel…you’ve gotta get all the 
other stuff [to do]….” SuperCP1(8yrs). 
 
Future direction of the profession. The pharmacists had differing, sometimes 
conflicting, opinions on the future of community pharmacy. Some pharmacists 
described their wish to move away from traditional roles and build upon the ‘health 
professional’ identity that involves giving lifestyle advice: 
 “… it’s pushing pharmacy towards a clinical role rather than the old dispensing.” 
IndepCP5(1yr). 
This respondent was very keen for pharmacists to have more involvement in patient care and 
to move away from the traditional dispensing process. However his use of the word ‘pushing’, 
which denotes a lack of consent or readiness, suggests that he believes that not all 
pharmacists share his vision, and some pharmacists may be resistant to their role changing. 
Another pharmacist questioned whether lifestyle advice should be part of the community 
pharmacists’ role at all: 
“…we are looking at a nightmare scenario in the future and it would be good if 
somebody could stop it [ageing population and obesity], but whether that is the 
role of the pharmacist or not I don’t know. It comes back again to time and our 
payment structure…” IndepCP1(23yrs). 
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This pharmacist appears to distance themself from the responsibility of offering patients 
lifestyle advice through citing barriers such as time constraints and the way pharmacists are 
remunerated.  This is an important insight, with remuneration cited by many pharmacists as 
an important factor in the provision of lifestyle advice. 
Remuneration. Some pharmacists referenced the importance of the dispensing process due 
to it providing the main source of the community pharmacy’s income. A number of the 
pharmacists suggested that current remuneration practices were not conducive to delivering 
lifestyle advice and health promotion: 
 
“….if you are stopping a heart attack then they’re not going to be taking any 
medicines and that’s ultimately putting yourself out of business so it’s not in your 
interests to keep people healthy as a pharmacist at the moment… what other 
profession does something to stop their future payments?” IndepCP1(23yrs). 
 
Some pharmacists indicated that current remuneration practices resulted in there being 
less incentive to provide lifestyle advice than other activities in the pharmacy which are 
remunerated, 
 
“…you’re providing the [lifestyle] advice …erm and you’re getting no monetary 
reward for it… so most pharmacists will think oh I can’t be bothered to be giving 
that advice, when there’s no value to it for me”. MultiCP6(1yr) 
 
The pharmacist describes an inherent conflict between their role as a health 
professional with a responsibility to promote health through giving patients lifestyle 
advice, and their business employee role which focusses on  financial return, which 
giving lifestyle advice does not currently provide. 
 
Pharmacy as a business and associated role conflict. Most pharmacists explicitly made 
reference to the community pharmacy being a business environment in addition to a provider 
of healthcare. A pharmacy manager described the experience he would like people to have 
when they visit the community pharmacy: 
 
“…we are trying to always differentiate on customer care…the need and the 
expectation is that that person will sort of somehow when they next need some 
advice think “ooh, that nice person in that shop, I’ll go and see them again””. 
MultiCP7(34yr). 
 
Targeting the patient-pharmacist interaction as an opportunity to increase custom raises the 
question as to whether developing a patient-clinician relationship and enhancing profits are 
interlinked. One pharmacist described her hesitance to offer potentially unwelcome health 
advice for fear it may affect custom to the pharmacy: 
 
“I mean it’s a business environment…erm so if you lose loads of customers your 
boss is on your back… if you insult somebody by telling them they look fat then 
you’re going to lose that customer [laughs]” IndepCP2(2yrs). 
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Her belief that this would reflect on her employment status could lead to her not offering 
lifestyle advice, which conflicts with her health professional role. Other pharmacists 
expressed concern at company targets to perform a specified number of MUR consultations 
conflicting with the clinical need of patients: 
 
“…because I know colleagues....who are quite...they push it quite hard...but the 
problem is that I think the patient doesn’t get anything out of it because it’s just...I 
feel the patient’s being...cajoled into a room because you want to do 
something...” SuperCP1(8yrs). 
 
The company targets appear to be structuring the pharmacists’ behaviour and therefore 
potentially influencing clinical decisions, presenting a challenge to the pharmacists’ 
professional autonomy. 
 
Pharmacists’ perceptions of patients  
 
Categorising patients .The pharmacists had models of different ‘types’ of patients which 
they used to categorise the patients they encountered. One supermarket pharmacist 
described how staff identified patients whom they perceived would respond well to receiving 
lifestyle advice: 
 
“...so they know which ones who you can talk to and which ones ...won’t talk to 
you, which ones will follow through, which ones can provide advice for...” 
SuperCP1(8yrs).  
 
Within the context of a busy, pressured workplace environment and a legal responsibility to 
ensure that patients are dispensed the correct medication, it makes sense that pharmacists 
would develop cognitive ‘shortcuts’, also known as stereotypes, to interpret patients’ 
behaviour and be able to respond accordingly.(Haslam et al., 2002) The stereotypes created by 
pharmacists are important, as they are likely to influence the interactions the pharmacist has 
with patients and may influence the care patients receive. It follows that patients categorised 
as “ones” who “won’t talk” are less likely to be given lifestyle advice than patients the 
pharmacist perceived to be more open to receiving lifestyle advice.  
 
Beliefs about patients with CVD. Some pharmacists believed that patients with CVD lacked 
knowledge about their condition and appropriate self-management. Yet many pharmacists 
simultaneously believed that the majority or all patients (with CVD or otherwise) were aware 
of the direct association between health behaviours and poor health, citing this as a reason 
for not providing patients with uninvited lifestyle advice. 
 
“...in all honesty there’s nobody on this planet that doesn’t know that they need to 
lose weight or doesn’t know that they need to cut their drinking a bit and so on, 
they know that, I don’t believe there’s anybody that doesn’t know that maybe they 
could be healthier” IndepCP6(26yr . 
Whilst patients may be aware that they need to change their behaviour, pharmacists 
offering such patients behaviour change advice may act as means of facilitating 
patients to change behavioural intentions into behaviour change.  
 
DISCUSSION AND CONCLUSION 
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The pharmacists who participated in this study viewed providing lifestyle advice as important 
but identified many barriers to doing so.  A novel finding from the study concerns the 
pharmacists’ perceptions of patients. First, pharmacists appeared to categorise patients in 
terms of ‘types’ of patients who were open to receiving lifestyle advice and those who were 
not. Importantly, these stereotypes may influence whether some patients are given lifestyle 
advice by pharmacists. The pharmacists also appeared to believe that patients with CVD 
lacked awareness and knowledge of CVD, however simultaneously believed these patients 
were aware of the role health behaviours have in CVD development and management. This 
may lead pharmacists to believe that lifestyle advice will not benefit patients with CVD, and 
consequently such advice may not be a high priority activity in a busy pharmacy. Street, 
Gordon and Haidet (2007) (Street Jr et al., 2007) found physician communication behaviours to 
correlate with the physicians’ perceptions of patients, with physicians being more patient-
centred, less contentious and showing more positive emotions towards patients who they 
perceived to be better communicators, more actively involved in the consultation, more likely 
to adhere to treatment and more satisfied with treatment. It may be that patients who are not 
‘actively involved’ in consultations, or perceived to be of a ‘type’ not open to receiving advice 
may in fact need more assistance than patients who are able to actively engage in 
encounters with health professionals.  
 
Furthermore, pharmacists in the present study also believed that giving patients lifestyle 
advice may provoke a negative response, with some participants alluding to the potential of 
patients to become aggressive. This supports the findings of previous reviews which found 
that pharmacists feared ‘interfering’ with or offending patients.(Anderson et al., 2003; Eades et al., 2011) A 
recent qualitative study exploring pharmacists’ attitudes towards providing advice about 
alcohol consumption also found that having concerns about offending or alienating 
customers was a major barrier to offering the service.(Horsfield et al., 2011) Research conducted 
with Australian clinicians found the clinicians’ perceptions of how acceptable clients felt it was 
for them to offer lifestyle advice affected providing such advice, with ‘low implementers’ 
expressing concerns of appearing judgmental, receiving negative reactions from clients and 
damaging the clinician-client relationship.(Laws et al., 2008) It is also noteworthy that the 
pharmacists’ perceptions contrast with those in the literature exploring patients’ perceptions 
of pharmacists, which suggests that whilst most patients do not expect to receive lifestyle 
advice from a pharmacist, they are open to receiving it.(Eades et al., 2011) 
Professional identity emerged as a prominent theme in relation to the provision of lifestyle 
advice, appearing to underpin many of the perceived barriers to providing lifestyle advice. At 
the core of this appeared to be the retail environment in which community pharmacists 
practise, resulting in a dual role of health professional and business employee. In keeping 
with previous research, (Anderson et al., 2003; Eades et al., 2011) most of the pharmacists were positive 
about a role in public health (in this case providing lifestyle advice) but reported difficulties 
achieving this due to barriers such as time, high workload and pressure to meet targets. 
Remuneration appeared key to pharmacists’ provision of lifestyle advice for patients with 
CVD, with the pharmacists suggesting that current remuneration practices hindered their 
provision of lifestyle advice. Some pharmacists suggested that providing lifestyle advice was 
not in their best interests because they received no financial return for doing so. As a result, 
many pharmacists reported prioritising other activities (primarily dispensing) over providing 
lifestyle advice, again supporting the findings of previous studies.(Anderson et al., 2003; Eades et al., 2011; 
O'Loughlin et al., 1999)  
However, the way barriers to providing lifestyle advice were perceived by pharmacists 
employed by multiple and independent pharmacies varied. Despite reporting high workloads 
and time pressure, pharmacists employed by independent pharmacies appeared to be more 
comfortable spending time offering patients lifestyle advice, even if other patients were 
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waiting to be seen. In contrast, these barriers seemed more salient to pharmacists employed 
by multiple pharmacies, with the supermarket pharmacist and many multiple pharmacists 
reporting pressure to provide a quick service and not keep other patients waiting. This in turn 
appeared to be underpinned by pressure to meet company targets, causing potential conflict 
between the pharmacist’s health professional and business employee roles. This has 
implications for pharmacists providing lifestyle advice, and in the current study appeared to 
manifest in two ways: pharmacists conducting consultations to meet company targets rather 
than in response to clinical need and pharmacists not offering potentially unwelcome health 
behaviour advice to patients, fearing that this may have repercussions on their employment 
status if the patient reacted badly. This supports a previous research study by Bush et al. 
(2009)(Bush et al., 2009) which found that pharmacists working in multiple pharmacies experienced 
conflict with commercial interests as a significant barrier to providing the set public health 
agenda.  
 
The retail environment of the community pharmacy was perceived to affect perceptions of the 
pharmacists’ role, with participants inferring that patients did not recognise the community 
pharmacist as a health professional. Consequently lifestyle advice provision was reportedly 
affected, due to patients not fully recognising the pharmacists’ professional opinion. It may be 
that the ‘shop’ appearance of the community pharmacy results in patients having different 
expectations and perceptions of community pharmacists than they have of other health 
professionals. This may result in patients perhaps expecting the ‘customer service’ that they 
expect in a retail environment, resulting in less tolerance to wait to be seen by a community 
pharmacist than other health professionals operating in a more traditional clinical 
environment.  
 
Anderson et al. (2003) (Anderson et al., 2003) suggested that pharmacists have a reactive approach 
to public health provision and are most comfortable giving advice around medicines, which 
also appeared to be the case in the present study. The pharmacists seemed happy to 
provide lifestyle advice if the patient asked or if it related to medicine. The pharmacists 
primarily conceptualised lifestyle advice as part of MURs, pharmacy services which provide 
some patients with a yearly consultation with a pharmacist to assess the patient’s use of 
medicine, incorporating some questions about their lifestyle. However, importantly, other than 
in these consultations there appeared to be a dichotomy between dispensing and lifestyle 
advice, and the pharmacists did not report routinely integrating lifestyle advice with their 
regular dispensing practices. This appeared to relate to a lack of time, fear of a negative 
patient response and a lack of confidence in giving lifestyle advice. According to Bandura 
(1977) (A Bandura, 1977), self-efficacy (confidence in one’s ability to carry out a behaviour), is a key 
predictor of whether the behaviour is performed. Some pharmacists reported a lack of 
confidence in their abilities to initiate conversations about health behaviours with patients, 
with some pharmacists reporting that they had not received appropriate training to enable 
them to provide lifestyle advice. Interestingly, this was not restricted to pharmacists who had 
qualified before the introduction of the pharmacy contract; newly qualified pharmacists also 
reported a lack of self-efficacy to give patients lifestyle advice. This supports the findings of 
previous reviews which concluded that pharmacists - low levels of self-efficacy and required 
more training to increase their confidence in providing public health services.(Anderson et al., 2003; 
Eades et al., 2011) 
 
Strengths and Limitations 
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This was an in-depth qualitative study conducted with community pharmacists in a UK 
setting. To our knowledge, it is the first study to explore English community pharmacists’ 
experiences of providing lifestyle advice for patients with CVD. There are however limitations 
to this research. Firstly, in order to increase study participation, the method of interviewing 
participants differed, with seven pharmacists interviewed face-to-face and eight by telephone. 
This could have affected the quality of the data collected from the telephone interviews as the 
interviewer was not able pick up on the participants’ body language and any non-verbal cues 
which may have affected the quality of the rapport established between the interviewer and 
participant. Alternatively, the increased sense of anonymity may have enhanced the quality 
of the data collected. There is a paucity of in-depth qualitative research in this field of 
research. The sample was representative of those working in a variety of community 
pharmacy settings and this resulted in contrasting as well as complementary accounts.  The 
richness of the data collected and the internal validity of the analysis gives us confidence that 
the findings are transferable if not statistically generalizable. 
 
Conclusion 
 
In conclusion, many pharmacists saw the potential benefits of facilitating patient self-
management of CVD through providing lifestyle advice. However, in practice they perceived 
multiple barriers to doing so and it did not appear to be routine practice. Issues relating to 
professional identity appeared key barriers to the implementation of lifestyle advice, 
particularly concerning the way pharmacists are currently remunerated which appeared to 
result in lifestyle advice being a lower priority than other pharmacy activities. The extent to 
which pharmacists perceived barriers to providing lifestyle advice to patients with CVD 
differed, with pharmacists employed by multiple owned pharmacies in particular reporting 
pressure to provide a quick service and meet targets as preventing them providing lifestyle 
advice. The retail environment of the community pharmacy was associated with potential role 
conflict and perceived to result in patients and other health professionals not appreciating the 
competencies of the community pharmacist. Some of the pharmacists lacked confidence in 
their ability to give lifestyle advice - particularly concerning weight loss - and did not appear to 
integrate lifestyle advice with routine pharmacy practice. The way pharmacists perceived and 
categorised some patients may result in pharmacists not offering certain patients lifestyle 
advice. 
 
Practice Implications 
 
In order to implement government policy, contractual obligations and best practice 
guidelines, pharmacists may benefit from enhanced training to increase their self-efficacy to 
provide lifestyle advice to patients with CVD. Pharmacists may also benefit from education in 
integrating lifestyle advice with regular dispensing practice and capitalising on interactions 
with patients in a time-pressured environment. Challenging pharmacists’ perceptions of 
‘types’ of patients who may benefit from lifestyle advice and expectations of negative patient 
responses to such advice may also be beneficial. Changes to the way pharmacists are 
remunerated for providing lifestyle advice may increase pharmacists’ provision of lifestyle 
advice for patients. 
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9.2 Appendix 2 – Participant Information Sheet 
 
Participant Information Sheet 
  
Project Title: Community pharmacists' experiences of public health provision for non-diabetic 
patients with hypertension and hyperlipidaemia. 
 
 
You are being invited to take part in a research study. Before you decide whether or not to take 
part, it is important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully. 
 
What is the purpose of the study?  
 
In recent years, formalised by the pharmacy contract, pharmacists have become increasingly 
involved in activities relating to public health. A strong body of evidence consistently shows 
that interventions delivered by pharmacists have significant clinical benefits in relation to a 
number of cardiovascular disease risk factors. However research has found varying levels of 
pharmacist-led health promotion activity. A wide range of factors influence pharmacists’ health 
promotion activity therefore more research is needed to develop a greater understanding of 
community pharmacists’ experience, particularly in relation to cardiovascular health in the non-
diabetic population. 
 
Why have I been chosen? 
 
Community pharmacists working in chain and independently owned pharmacies at different 
geographical locations across the Midlands have been invited to take part in this study. 
 
What will happen to me if I take part? 
 
If you decide to take part in the study the researcher will arrange to meet with you at a 
convenient time and place. This could be at your home, workplace or at a meeting venue. 
Participation in the study involves a single interview which is expected to last between 45 and 
60 minutes. The researcher will ask you some questions about your experience, thoughts and 
opinions about providing public health services in the pharmacy, particularly in relation to 
cardiovascular health. The interview will be recorded using a digital recording device so the 
interviewer can transcribe it at a later date. At the end of the interview you will be asked to give 
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yourself a different name so that nobody will be able to identify you from the data. Anything 
you say will be kept completely confidential. 
 
Are there any potential risks in talking part in the study? 
 
It is not expected that you will experience any disadvantages as a result of participating in the 
study. You may have concerns about expressing opinions that your employer may disapprove 
of, given that an audio recording of the interview will be made. Anything that you chose to say 
will remain confidential. Nobody, including your employer, will be able to identify you or your 
place of work from the study results. 
 
 
Do I have to take part? 
 
No, you have no obligation to take part in this study. If you do decide to take part in the study 
you can still stop and withdraw at any point without having to provide an explanation.  
 
 
Will my taking part in this study be kept confidential? 
 
All of the information that you tell the researcher will be kept completely confidential. Only the 
researcher will know who you are. You will be asked to choose a different name for yourself, 
and you will be known under that name. The interview will be recorded on a password 
protected digital audio device which will be stored in a locked filing cabinet at Aston University. 
The recording will be downloaded onto a password protected computer at Aston University. 
The interview recording and transcript will be stored for up to 5 years after which it will be 
destroyed. 
 
 
What will happen to the results of the research study? 
 
The interviews will be analysed and the results will be published as part of a PhD thesis and 
potentially in an academic journal. The researcher’s academic supervisors may look at an 
anonymised version of the interview transcript. Direct quotations of what you have said in the 
interview may be used as part of the results. Nobody will be able to identify you from the 
quotations or results of the study. 
 
You will be given the opportunity to give the researcher your contact details if you would like to 
be sent a copy of the study findings. 
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Who is organising and funding the research? 
 
Kirsty Morton, a PhD student from the School of Life and Health Sciences at Aston University 
is organising and conducting the research. The research is supervised by Professor Helen 
Pattison, Dr Rachael Powell and Dr Chris Langley from the School of Life and Health Sciences 
at Aston University. The research is funded by the Economic and Social Research Council 
(ESRC) and the Medical Research Council (MRC). 
 
Who has reviewed the study? 
 
The study has been reviewed and approved by Aston University's Ethics Committee. 
 
 
Who do I Contact if Something Goes Wrong or I need Further Information?  
 
If you have any questions, concerns or would like further information about the study please feel free 
to contact the researcher, Kirsty Morton, at mortonk2@aston.ac.uk or 0121 204 4250. 
 
You can also contact the researcher’s supervisor, Professor Helen Pattison, on 
h.m.pattison@aston.ac.uk or telephone 0121 204 4073. 
 
Who do I contact if I wish to make a complaint about the way in which the research is conducted ? 
 
If you have any concerns about the way in which the study has been conducted you should contact 
the Secretary of Aston University Research Ethics Committee, John Walter, on 
j.g.walter@aston.ac.uk or telephone 0121 204 4665. 
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9.3 Appendix 3 – Volunteer Consent Form 
Volunteer Consent Form 
 
 
Title of Project: Community pharmacists’ experiences of public health provision for non-
diabetic patients with hypertension and hyperlipidaemia.  
 
Name of Chief Researcher: Kirsty Morton 
 
 
  Tick 
Box 
1 I confirm that I have read and understood the information sheet for the above study. I have 
had the opportunity to consider the information, ask questions and have had any questions 
answered satisfactorily. 
 
2 I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving any reason, without my legal rights being affected. 
 
3 I agree to the interview being digitally recorded and transcribed with my personal 
information removed. 
 
4. I understand that my interview responses will be looked at by the researcher’s  
academic supervisors. These responses will not contain any personal information that  
could identify me. 
 
 
5. I understand that I may be directly quoted under another name. The things I say may  
be published but any publication will not contain any personal information that could  
identify me. 
 
6. I agree to take part in the above study.  
 
 
 
_________________________ ________________ ___________________ 
Name of volunteer Date Signature 
 
 
_________________________ ________________ ___________________ 
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Researcher Date Signature 
 
 
 
7. I would like to be sent a summary of the study findings. 
 
 
 
 
 
Email/ Postal Address………………………………………………............................................... 
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9.4 Appendix 4 – Interview Schedule  
 
1. Talk me through your typical working day. 
 
2. What are the five activities which form the most important part of your working 
day? 
 
3. What role does a community pharmacist currently play in identifying patients at 
risk of experiencing a cardiovascular event/ future cardiovascular events? 
[Prompts: Screening, Identification process (prescription for particular medications, 
provision of self-monitoring devices, referral to other services, behaviour/lifestyle 
change advice.]   
 
4. What additional services or activities (if any) do you think community 
pharmacists could provide for cardiovascular patients in the future? 
[Prompts: provision of self-monitoring devices, advice on medication, screening, 
identification process, behavioural/lifestyle change advice] 
 
5. Talk me through a recent time you have given a cardiovascular patient lifestyle 
advice.  
[Prompts: Identification process, advice provided, confidence in ability to do so, was it 
successful, willingness of patient to receive advice]. 
 
6. How do you feel about initiating conversations with patients regarding health 
behaviours such as diet and exercise? 
[Prompts: Confident – if so why, not confident – if not, why not?]. 
 
7. Describe any challenges to promoting patient self-management of 
cardiovascular health in the community pharmacy. 
[Prompts: Time, workload, space, perception of patient’s reaction, company policy, 
lack of confidence in abilities, lack of training]. 
 
8. What (if anything) would make it easier to promote patient self-management of 
cardiovascular health in the community pharmacy? 
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[Prompts: Time, workload, space, perception of patient’s reaction, company policy, 
confidence in abilities, appropriate training] 
 
 
9. In an ideal world what do you think should be part of a community pharmacists’ 
role? 
 
10. What input do you think patients would like from their community pharmacist 
with regards to managing their cardiovascular health? 
[Prompts: medication advice, behaviour/lifestyle advice, advice re: self-monitoring 
devices, referral to other services]. 
 
11. Describe the role different staffing groups within the pharmacy play in the 
delivery of cardiovascular health promotion. 
[Dispensers’ role, healthcare assistants’ role, professional relationship with 
pharmacist]. 
 
12. What are your thoughts on the suitability of the community pharmacy to 
provide/deliver public health services in general? 
[geography, opening hours, ease of access, time pressures, privacy, space, 
pharmacist training] 
 
13. From your perspective, what role has the PCT played in cardiovascular health 
promotion and prevention of CVD? 
 
14. Describe your working relationship with other professionals involved in 
cardiovascular healthcare. 
[Referrals to and from GPs, any areas of conflict, professional identity, impact on 
service]. 
 
 
15. Is there anything I haven’t asked about that you feel is important/relevant? 
 Additional Information 
1.      Age 
2.      Gender 
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3.      Ethnicity 
4.      Number of years in practice 
5.      Independent/Multiple pharmacy: 
 Independent (5 branches or fewer) 
  Small Chain (more than 5, up to 20 branches),  
 Large Chain (more than 20, up to 200 branches),  
 Multiple (200 branches or above)  
  Supermarket. 
 
6.      Post code of pharmacy (used for deprivation score) 
7.      Services offered by participant’s pharmacy:   
•       Smoking cessation   
•       BP testing 
•       Blood glucose testing 
•       Cholesterol testing 
•       Weight Management 
•       Medicine Use Reviews 
 New Medicines Service 
  
 Are you happy (a) to be contacted regarding participation in future research 
studies including piloting questionnaires and (b) facilitating the recruitment of 
patients for another study through distributing leaflets and displaying posters 
in your pharmacy 
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9.5 Appendix 5 – Example analysis 
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9.6 Appendix 6 – Final Questionnaire 
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9.7 Appendix 6 – Invitation Letter 
 
Aston University 
Aston Triangle 
  Birmingham  
B4 7ET 
Tel + 44 0121 204 3000 
www.aston.ac.uk 
  
Dear Community 
Pharmacist(s) 
 
Project Title: Predicting community pharmacists' intentions to provide weight 
loss and medication adherence advice to patients with cardiovascular disease 
 
My name is Kirsty Morton and I am a PhD student from Aston University. I am interested in 
community pharmacists’ experiences of providing public health services for patients with 
cardiovascular disorders and would be grateful if you would consider taking part in the 
above study. 
 
Participation involves filling out a single questionnaire that will take up to 30 minutes. 
This can be filled in online via this link X or with a paper copy if you prefer. The 
research has received ethical approval from Aston University Ethics Committee, and is 
supervised by Professor Helen Pattison, Professor Chris Langley and Dr Rachael Powell. 
 
If you have any questions please do not hesitate to contact me on the details 
provided below. 
 
Yours 
faithfully 
 
Kirsty 
Morton 
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9.8 Appendix 8 – Participant Information sheet  
 
Participant Information 
Sheet 
 
Project Title: Predicting community pharmacists' intentions to provide weight loss 
and medication adherence advice to patients with cardiovascular disease 
 
You are being invited to take part in a research study. Before you decide whether or not 
to take part, it is important for you to understand why the research is being done and what 
it will involve. Please take time to read the following information carefully. 
 
What is the purpose of the 
study? 
 
In recent years, formalised by the pharmacy contract, pharmacists have become 
increasingly involved in activities relating to public health. A strong body of evidence 
consistently shows that interventions delivered by pharmacists have significant clinical 
benefits in relation to a number of cardiovascular disease risk factors. However research 
has found varying levels of pharmacist-led health promotion activity. A wide range of 
factors influence pharmacists’ health promotion activity therefore more research is needed 
to develop a greater understanding of community pharmacists’ experience. This study is 
investigating how pharmacists experience giving two different kinds of health promotion 
advice (weight loss and medication adherence advice) to patients with cardiovascular 
disease. 
 
Why have I been 
chosen? 
 
Community pharmacists working in England have been invited to take part in this 
study. 
 
What will happen to me if I take part? 
 
If you decide to take part in the study you will be asked to fill out a single questionnaire. 
This can either be filled in online or using a paper version. You will read information 
about the study, and then you will be asked to consent to taking part in the study. It is 
expected this will take around 30 minutes. 
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Are there any potential risks in talking part in the 
study? 
 
It is not expected that you will experience any disadvantages as a result of participating in 
the study. You may be concerned that this is a test of your practice or that your employer 
will be able to identify you or your place of work from the responses you give. All the 
information you give in the questionnaire will be kept strictly confidential and nobody will be 
able to identify you from the responses you give. This questionnaire is not designed to test 
you; we are interested in your experience of giving patients different kinds of advice. 
 
Do I have to take part? 
 
No, you have no obligation to take part in this study. If 
you do decide to take part in the study you can still 
stop and withdraw at any point up to submitting 
the completed questionnaire (after which the data 
becomes anonymised and can’t be traced) 
 Will my taking part in this study be kept 
confidential? 
 
Yes. All of the data generated from the questionnaire is anonymous. If you complete the 
questionnaire online, data is stored on a secure server at Aston University. If you complete 
a paper copy of the questionnaire it will be stored in a locked filing cabinet in a locked 
room.  In both cases, your data is completely anonymous – no identifying details will be 
stored with the data. 
 
What will happen to the results of the research study? 
 
The data will be analysed and the results will be published as part of a PhD thesis and 
potentially in an academic journal. 
 
You will be given the opportunity to give the researcher your contact details if you would 
like to be sent a copy of the study findings. 
 
Who is organising and funding the 
research? 
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Kirsty Morton, a PhD student from the School of Life and Health Sciences at Aston 
University is organising and conducting the research. The research is supervised by 
Professor Helen Pattison, Dr Rachael Powell and Professor Chris Langley. The research is 
funded by the Economic and Social Research Council (ESRC) and the Medical Research 
Council (MRC). 
 
Who has reviewed the study? 
 
The study has been reviewed and approved by Aston University's Ethics Committee. 
 
 
Who do I Contact if Something Goes Wrong or I need Further Information? 
 
If you have any questions, concerns or would like further information about the study 
please feel free to contact the researcher, Kirsty Morton, at mortonk2@aston.ac.uk or 
07973184217. 
 
You  can  also  contact  the  researcher’s  lead  supervisor,  Professor  Helen  Pattison,  
on h.m.pattison@aston.ac.uk or telephone 0121 204 4073. 
 
Who do I contact if I wish to make a complaint about the way in which the research 
is conducted ? 
 
If you have any concerns about the way in which the study has been conducted you should 
contact the Secretary of Aston University Research Ethics Committee, John Walter, on 
j.g.walter@aston.ac.uk or telephone 0121 204 4665
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9.9 Appendix 9 – List of excluded studies 
 Reason for exclusion  
Title Author, Year Not an 
interventio
n for target 
population 
Participants 
not 
pharmacists/
pharmacy 
staff/student
s. 
Interventio
n does not 
target 
relevant 
lifestyle 
behaviours 
Does not 
evaluate 
effect of 
interventio
n on 
behaviour 
Report 
not 
available 
General practitioners perceptions about the extended roles of the community pharmacists in the state of Karnataka: A 
study 
Adepu & Nagavi (2006)  x    
A national diabetes care and education programme: the Ghana model Amoah et al (2000)  x    
12th Annual International Joint Conference of the University-of-the-West-Indies Diabetes Outreach 
Program/Caribbean-Food-and-Nutrition-Institute 
Anon (2006) x     
Smoking-cessation services in Iowa community pharmacies Aquilino et al. (2003) x     
Evaluation of the Washington State National Pharmaceutical Stockpile dispensing exercise, part II--dispensary site 
worker findings 
Beaton et al. (2004)  x    
The pharmaceutical prescription Belton (2000)   x   
Training during practical pharmacology sessions for undergraduate medical students: An experience with a modified 
teaching programme 
Bhavsar et al. (1999)  x    
Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk 
factors for coronary heart disease 
Blenkinsopp et al. (2003) x     
A tailored intervention to support pharmacy-based counseling for smoking cessation Bock et al. (2001)    x  
Changes to supervision in community pharmacy: pharmacist and pharmacy support staff views Bradley et al. (2013)   x   
Assessment of the effectiveness of pharmacists' activities in treatment of tobacco-addicted patients in the context of 
pharmacists' counselling in Cracow's pharmacies 
Brandeys et al (2009)   x   
The making of a nutrition professional: the Association for Nutrition register Cade et al (2012) x     
A survey of parenteral therapy services provided to home patients by Australian hospital pharmacies Capes et al (1997) x     
Misoprostol for prevention of postpartum hemorrhage: An evidence-based review by US Pharmacopeia (USP) Carpenter (2001) x     
Tobacco use and cessation counseling--global health professionals survey pilot study, 10 countries, 2005 Centers for Disease 
(2005) 
 x    
Integrated Chronic Obstructive Pulmonary Disease Management in Primary Care Chavannes (2008)   x   
A Pharmacotherapy Capstone Course to Advance Pharmacy Students' Clinical Documentation Skills Conway & Ahmed (2012)   x   
Audit of nutritional supplements within three general practices Cooper (2007)   x x  
The implementation of the Counterweight Programme in Scotland, UK Counterweight Project 
(2012) 
x     
Assessment of healthcare professionals' knowledge about warfarin-vitamin K drug-nutrient interactions Couris et al. (2000)   x   
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 Reason for exclusion  
Title Author, Year Not an 
interventio
n for target 
population 
Participants 
not 
pharmacists/
pharmacy 
staff/student
s. 
Interventio
n does not 
target 
relevant 
lifestyle 
behaviours 
Does not 
evaluate 
effect of 
interventio
n on 
behaviour 
Report 
not 
available 
Options for action of a more environmentally acceptable use and handling of pharmaceuticals Deffner & Goetz (2008)   x   
A week long diabetes simulation for pharmacy students Delea et al. (2010)   x   
Randomized Trial Assessing the Effectiveness of a Pharmacist-Delivered Program for Smoking Cessation Dent et al. (2009) x     
Tobacco treatment practices of pharmacists in Montana Dent et al. (2010) x     
Active-Learning Strategies to Develop Health Literacy Knowledge and Skills Devraj et al. (2010)   x   
The impact of training and delivering alcohol brief intervention on the knowledge and attitudes of community 
pharmacists: A before and after study Dhital et al. (2013 
   x  
Effectiveness of alcohol brief intervention delivered by community pharmacists: study protocol of a two-arm 
randomised controlled trial 
Dhital et al. (2013)    x  
Improving Pharmacy Staff Knowledge and Practice on Childhood Diarrhea Management in Vietnam: Are Educational 
Interventions Effective? 
Duc Minh et al. (2013)   x   
Connecticut Competency-Based Point of Dispensing Worker Training Needs Assessment  Durante et al. (2014)   x   
Public health in community pharmacy: A systematic review of pharmacist and consumer views Eades et al. (2011) x     
Consensus statement on office-based treatment of opioid dependence using buprenorphine Fiellin et al. (2004)   x   
Developing and evaluating training for community pharmacists to deliver interventions on alcohol issues Fitzgerald et al. (2009)    x  
Virtual reality skills training for health care professionals in alcohol screening and brief intervention Fleming et al. (2009)  x    
The Evolving Role of the Community Pharmacist in Chronic Disease Management - A Literature Review George et al. (2010) x     
An assessment of emergency preparedness in western Wisconsin Gilmore et al. (2007)   x   
A motivational interviewing skills course for pharmacy students Goggin et al. (2010)   X   
Allied health professionals' use of online evidence: a survey of 790 staff working in the Australian public hospital system Gosling et al (2004)  x    
Prevention of HIV/AIDS and other blood-borne diseases among injection drug users - A national survey on the 
regulation of syringes and needles 
Gostin et al. (1997)  x    
Organization and results of student pharmacist bone mineral density screenings in women Harris et al. (2010)   x   
What do community pharmacists think about undertaking screening and brief interventions with problem drinkers? 
Results of a qualitative study in New Zealand and England 
Horsfield et al. (2010) x     
Nutrition and nurturing: A service-learning nutrition pharmacy course Jarvis et al. (2004)   x   
CLARION: A novel Interprofessional approach to health care education Johnson et al. (2006)  x    
An advanced diabetes care course as a component of a diabetes concentration Johnson et al (2003)   x   
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 Reason for exclusion  
Title Author, Year Not an 
interventio
n for target 
population 
Participants 
not 
pharmacists/
pharmacy 
staff/student
s. 
Interventio
n does not 
target 
relevant 
lifestyle 
behaviours 
Does not 
evaluate 
effect of 
interventio
n on 
behaviour 
Report 
not 
available 
Role of community pharmacists in the prevention and management of the metabolic syndrome in Kuwait Katoue et al. (2013)   x   
Certified diabetes expert nurse and nurse educators in Japan Kawaguchi. (2007)  x    
Alcohol brief intervention in community pharmacies; a feasilbity study of outcomes and customer experiences Khan et al. (2013)    x  
Community pharmacists' involvement in smoking cessation: familiarity and implementation of the National smoking 
cessation guideline in Finland 
Kurko (2010) x     
Recent trends on the future of graduate education in the pharmaceutical sciences and research Kushwaha et al. (2010) x     
Retail pharmacists and doping in sports: knowledge and attitudes. A national survey in France Laure et al. (2000)   x   
Therapeutic lifestyle changes and pharmaceutical care in the treatment of Dyslipidemias in adults Lenz (2005) x     
An elective course on lifestyle modifications in pharmacotherapy Lenz (2007)    x  
Therapeutic lifestyle strategies taught in U.S. Pharmacy Schools Lenz et al. (2009)    x  
First steps towards interprofessional health practice in Tanzania: An educational experiment in rural Bagamoyo district Leshabari et al. (2012)   x   
Weight management in primary care: how can it be made more effective? Maryon-Davis (2005) x     
A diabetes care team--role of diabetes specialists and certified diabetes educator Matsuoka (2001) x     
The Role of Academic Pharmacy in Tobacco Cessation and Control McBane et al. (2013) x     
Delphi survey of experts' opinions on strategies used by community pharmacists to reduce over-the-counter drug 
misuse 
McBride (2003)   x   
Provision of advice on alcohol use in community pharmacy: a cross-sectional survey of pharmacists' practice, 
knowledge, views and confidence 
McCraig et al. (2011) x     
Advancing patient care through innovative practice: The Clinical Partners Program Mehta et al. (2005)    x  
Student Confidence in Tobacco Cessation Counseling Melton et al. (2011)     x 
Smoking Cessation Counseling Practices of Texas Pharmacists Meshack et al (2009). x     
Involvement of Sudanese community pharmacists in public health activities Mohamed et al. (2013) x     
Public health and the pharmacist: a challenge of importance regarding training Momas (2009) x     
Atherothrombosis: epidemiology, pathophysiology, and prevention Munger (2004) x     
An Advanced Pharmacy Practice Experience in Public Health Patterson (2008)    x  
Ask, advise and refer: hypothesis generation to promote a brief tobacco-cessation intervention in community 
pharmacies 
Patwardhan & Chewning 
(2009) 
x     
An exercise prescription course to improve pharmacy students’ confidence in patient counselling Persky (2009)    x  
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 Reason for exclusion  
Title Author, Year Not an 
interventio
n for target 
population 
Participants 
not 
pharmacists/
pharmacy 
staff/student
s. 
Interventio
n does not 
target 
relevant 
lifestyle 
behaviours 
Does not 
evaluate 
effect of 
interventio
n on 
behaviour 
Report 
not 
available 
Drugs and professional interactions: the modern day pharmacist Petty (2003)   x   
Vaccination delivery by chain pharmacies in California: Results of a 2007 survey Pilisuk et al. (2010) x     
Subsidised nicotine replacement therapy in a community pharmacy setting Poder et al. (2005) x     
A Team-Based Learning Course on Nutrition and Lifestyle Modification Pogge (2013)    x  
An elective, interdisciplinary health care case studies course Popovich (2000)  x    
Diabetes care: Model for the future of primary care Posey & Tanzi (2010) x     
The community pharmacist and the problem of excessive drinkers Pouyet-Poulet et al. 
(2001) 
x     
Tobacco use and cessation counseling among health professional students: Lebanon Global Health Professions Student 
Survey 
Sadde et al. (2009) x     
Efficacy of continuing education in improving pharmacists' competencies for providing weight management service: 
Three-arm randomized controlled trial 
Sarayani et al. (2012)    x  
Quality of drug use in Swedish nursing homes - A follow-up study Schmidt & Fastbom 
(2000) 
  x   
Vaccine-related standard of care and willingness to respond to public health emergencies: A cross-sectional survey of 
California vaccine providers 
Seib et al. (2012) x     
Pharmacy-based needle exchange (PBNX) schemes in South East England: a survey of service providers Sheridan et al. (2000) x  x   
HIV prevention and drug treatment services for drug misusers: a national study of community pharmacists' attitudes 
and their involvement in service specific training 
Sheridan et al. (1997)   x   
Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community 
pharmacy practitioners 
Shigby & Pugh (1997)   x   
A Diabetes Self-Management Education Class Taught by Pharmacy Students Shrader et al. (2013)    X  
The long-term learning effect of training in stage of change for smoking cessation: a three-year follow up of community 
pharmacy staff's knowledge and attitudes 
Sinclair et al. (1999)    x  
Pharmacovigilance of over-the-counter products based in community pharmacy: A feasible option? Sinclair et al (1999)   x   
Community pharmacy personnel interventions for smoking cessation Sinclair et al (2004) x     
Linking India Global Health Professions Student Survey data to the World Health Organization Framework Convention 
on Tobacco Control 
Sinha et al (2010) x   x  
National survey of US health professionals' smoking prevalence, cessation practices, and beliefs Tong et al (2010) x     
Sleep disorders and hypnotic agents: medical, social and economical impact Touitou (2007)   x   
Weight management in community pharmacy: what do the experts think? Um et al (2013) X     
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 Reason for exclusion  
Title Author, Year Not an 
interventio
n for target 
population 
Participants 
not 
pharmacists/
pharmacy 
staff/student
s. 
Interventio
n does not 
target 
relevant 
lifestyle 
behaviours 
Does not 
evaluate 
effect of 
interventio
n on 
behaviour 
Report 
not 
available 
Practice-based buprenorphine maintenance treatment (BMT): how do French healthcare providers manage the opiate-
addicted patients? 
Vignau et al. (2001)   x   
Is level of knowledge, attitude and use of folic acid among pregnant women in Croatia a call for public health action? Vitale et al (2009)   x   
Need for weight management in Switzerland: findings from National Blood Pressure Week 2009 Volken et al.  (2011) x     
Tobacco use and cessation counselling: cross-country. Data from the Global Health Professions Student Survey (GHPSS), 
2005-7 
Warren et al. (2008) x     
Views of the Scottish general public on community pharmacy weight management services: international implications Weidmann et al. (2012) x     
Evaluation of the Swiss Society of Pharmacists' campaign "Future Non-Smoker" Wick et al. (2000) X     
Preparing pharmacy students and pharmacists to provide tobacco cessation counselling Williams (2009) x     
Community pharmacists and men's health in rural Victoria Wood et al. (2004)   x   
Call to action: Integrating student pharmacists, faculty, and pharmacy practitioners into emergency preparedness and 
response 
Woodard et al. (2010)   x   
Effectiveness of a pharmacist-based smoking-cessation program and its impact on quality of life  Zillich et al. (2002)      
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9.10 Appendix 10 – Example data collection form 
 
Data Extraction Form 
Study ID (surname first author & year published) Maguire et al 2001 
Notes  
  
 General Information 
Date form completed 9/2/14 
Name person extracting data Kirsty 
Report title (title of paper/report) A randomized controlled trial of a smoking 
cessation intervention based in community 
pharmacies 
Reference details  
Report author contact details  
Publication type (journal, report) Journal article 
Possible conflicts of interest (for study authors)  
 
 Eligibility 
Study Characteristics Review Inclusion Criteria 
(list here) 
Yes/No/Unclear Location in 
text  
Type of study Randomised  control trial 
(inc ppt randomisation to 
conditions, include control 
and intervention group, 
includes baseline and 
outcome measures) 
yes 325 
 Non-randomised  control 
trial  
  
Before and after study    
Intervention study (inc. 
outcome measures, no 
baseline measures) 
  
Other design (state)   
Participants Community pharmacists, 
patients. 
  
Types of intervention Educational (?) 
Follow up from researcher  
  
Types of outcome 
measures 
Self-reported smoking 
cessation 
  
Decision 
(Include/Exclude) 
INCLUDE 
Reason for exclusion  
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Notes  
 
DO NOT PROCEED IF STUDY IS EXCLUDED FROM REVIEW 
 
 Population and setting 
 Description (inc. comparative info for 
intervention and control group if available) 
Location in 
text (page no) 
Population description (where 
are ppts drawn from?) 
Pharmacists in London and northern Ireland  326 
Setting (inc. location & social 
context) 
No information  
Method(s) ppt recruitment mailing and via an advertisement in the 
pharmaceutical press” 
326 
Notes   
 
 Methods 
 Descriptions as stated in report/paper Location in 
text 
Aim of study No specific aim stated. State that paper “reports 
a randomized controlled 
trial, evaluating a specially structured 
intervention package, the Pharmacists’ Action 
on Smoking(PAS) developed and piloted in 
Belfast” 
326 
Design RCT  
Unit of allocation?   
Start/End date ?  
Duration of participation 
(recruitment to last follow up) 
2 years(?) last patient follow up.  
Notes   
 
 Risk of bias 
Domain Risk of bias 
Low/High/Unclear 
Support for judgement Location in 
text 
Random sequence 
generation (selection 
bias) 
High Pharmacists not randomly 
allocated to either condition – 
they delivered both 
‘intervention care’ and 
‘standard care’. 
326 
Allocation 
concealment 
(selection bias) 
High Pharmacists not randomly 
allocated to either condition – 
they delivered both 
‘intervention care’ and 
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‘standard care’. 
Blinding of 
participants and 
personnel 
(performance bias) 
High Outcome group: Smokers blind 
to condition? 
All/Pharmacists delivered both 
conditions 
 
 
Blinding of outcome 
assessment (detection 
bias) 
High Outcome group: 
All/ Pharmacists delivered both 
conditions so not blind. 
 
Incomplete outcome 
data (attrition bias) 
High Does not provide any 
information on drop outs 
 
Selective outcome 
reporting? (attrition 
bias) 
High Does not provide any 
information on drop outs 
 
Other bias Pharmacists paid £15 
for every smoker 
enrolled and followed 
up at 12 months 
  
Notes    
 
 
 Participants  
Provide overall data and, if available, comparative data for each intervention or comparison group 
 Descriptions as stated in report/paper Location in 
text 
Total number eligible Pharmacists (not stated) 
Patients – not stated 
 
Total number recruited Pharmacists – 124 
Patients - 484 
326, 328 
Withdrawals and exclusions Not stated  
Age (mean, range etc) Pharmacists – not stated 
Patients: Intervention:  42 (17-69) 
                Control: 38 (25-72)  
328 
Sex Pharmacists – not stated 
Patients: Intervention: F 107, M 158. 
                Control: F 96, M 123 
328 
Race/ethnicity Not stated  
Occupation (pharmacy 
undergraduate/qualified 
pharmacist/pharmacy staff) 
Community pharmacists  
Notes   
 
 Intervention groups 
Copy and paste table for each intervention and comparison group 
 Descriptions as stated in report/paper Location in 
text 
 Description (a) No information given  
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1. Theoretical basis of 
intervention: how was it 
developed, rationale, use 
of theory. 
(b) 3 hour workshop on smoking cessation 
(inc. detailed description of 
methodology).  Covered epidemiology, 
smoking stats, use of NRT, cycle of change 
model and PAS model (Maguire, 1995, 
1996, 1997). Followed up by one of two 
researchers to provide support re 
implementation of intervention. 
Pharmacists ‘trained to identify as many 
opportunities for promotion of the 
services as possible’ so study not limited 
to customers asking for NRT – ask clients 
about smoking when dispensing meds. 
 
 
 
 
 
2. Elements/components  of 
intervention 
326 
3. Use of BCTs within 
interventions aimed at 
changing pharmacists’ 
behaviour 
 
Duration of intervention (how 
long?) 
3 hour training session. Does not state how 
long follow up lasted, how many times or how 
long after initial training prog. 
326 
Timing (frequency, duration of 
each episode) 
As above  
Delivery (mechanism, medium 
intensity, fidelity) 
No information.  
Providers (number, profession, 
training) 
One of the authors provided training. He and 
another researcher provided follow up. No 
other information given. 
326 
Notes n.b. being paid for every smoker enrolled and 
followed up at 12 months. 
 
 
 Outcomes 
 
Copy and paste for each outcome 
 Descriptions as stated in report/paper Location in 
text 
Outcome name Smoking status  
Outcome definition used in 
study (for comparison to ours) 
Self-reported abstinence supported by negative 
urinary cotinine test at 12 months 
328 
How was outcome measured? 
(e.g. questionnaires,  exams, 
self -reflection, observation) 
Self-report and urine test  327 
Unit of measurement (if 
applicable) 
  
Is outcome tool validated? (if 
applicable) 
  
Notes   
 
 
 Descriptions as stated in report/paper Location in 
text 
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Outcome name Pharmacists’ experiences during study 328 
Outcome definition used in 
study (for comparison to ours) 
  
How was outcome measured? 
(e.g. questionnaires,  exams, 
self -reflection, observation) 
Semi structured interview and focus group 328 
Unit of measurement (if 
applicable) 
  
Is outcome tool validated? (if 
applicable) 
  
Notes   
 
 
 
 Results 
 Descriptions as stated in report/paper Location in 
text 
What analysis was used to 
determine outcome of data?  
Qual: clustering the data using the “Gestault 
method” (??) 
Chi square analysis and descriptive stats. 
 
If appropriate, state statistical 
analysis used.  What results 
were reported? (e.g. CIs, 
means, p values) 
44% of pharmacists had enrolled at least 1 
patient in study whilst only 24 pharmacists 
enrolled 12 or more patients in 1 year. 
In PAS group none of the pharmacists reported 
follow up consultations beyond 4 weeks other 
than for supply of NRT. 
 
Smoking cessation: PAS model 14.3% had 
abstained for 12 months compared with 2.7% of 
controls (chi squared= 16.2, p<0.001). At 3 
months 11% of non PAS reported not smoking 
compared with 27.5% of PAS group. 
 
Cotinine levels higher in intervention group 
than control group.* 
 
Reported that pharmacy type, size, pharmacist 
age or gender did not influence smoking 
cessation rates (but do not provide figs). 
328 
If applicable, reported qual. 
Findings 
NB. Not reported as themes, just summarised. 
Pharmacists believed PAS model was practical, 
useful and successful smoking cessation 
intervention. 
Felt knowledge of cycle of change (Bunton et al, 
1999) was valuable when trying to change 
clients smoking behaviour. 
 
Lack of time and insufficient remuneration main 
barriers. Some felt project lost them custom. 
Pharmacists felt need to improve relationships 
with GPs. Pharmacists also commented on need 
to improve pharmacists and counter assistants’ 
329 
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communication skills to facilitate clients 
becoming more receptive to health promo 
advice 
Notes Pharmacists who did not recruit any patients 
did not want to participate in interviews/focus 
groups. 
 
*Explained as either chance finding or because 
some ppts in intervention group said they were 
abstainers but abstained for day or two before 
urine test in order to pass it. 
 
 
 Applicability 
Does the study directly address 
the review question? 
(any issues of partial/indirect 
applicability?) 
Did not state review 
question/aim 
 
   
 
 Other Information 
 Descriptions as stated in report/paper Location in 
text 
Key conclusions of study 
authors 
  
References to other studies Maguire 1996  
Correspondence required for 
further study information 
(what and from whom?) 
PAS model can be effective method of providing 
smoking cessation support in the community 
pharmacy setting. 
Concluded that increased success in PAS 
condition compared to standard advice 
demonstrates that increased success was due to 
advice and support offered by community 
pharmacists. 
 
Minority of pharmacists who initially expressed 
interest were motivated to take part in study 
and many were not able to recruit patients at 
“desired rate”. Concluded enthusiastic 
pharmacists could volunteer for this rather than 
expecting all pharmacists to participate. 
 
Correspondence received 
(from whom, what and when?) 
  
Notes   
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Types of mixed methods 
study components or primary 
studies
M ethodological quality criteria (see tutorial for definitions and examples) Responses
Yes No Can't tell Comments
Screening questions •               Are there clear qualitative and quantitative research questions (or objectives*), or a clear mixed methods question (or objective*)?
(for all types) • Do the co llected data allow address the research question (objective)? E.g., consider whether the fo llow-up period is long enough for the
outcome to occur (for longitudinal studies or study components).
Further appraisal may be not feasible or appropriate when the answer is ‘No’  or ‘Can’ t tell’  to  one or both screening questions.
1. Qualitative 1.1. Are the sources of qualitative data (archives, documents, informants, observations) relevant to  address the research question
(objective)?
1.2. Is the process for analyzing qualitative data relevant to  address the research question (objective)?
1.3. Is appropriate consideration given to  how findings relate to  the context, e.g., the setting, in which the data were co llected?
1.4. Is appropriate consideration given to  how findings relate to  researchers’  influence, e.g., through their interactions with participants?
2. Quantitative 2.1. Is there a clear description of the randomization (or an appropriate sequence generation)?
randomized contro lled 2.2. Is there a clear description of the allocation concealment (or blinding when applicable)?
(trials) 2.3. Are there complete outcome data (80% or above)?
2.4. Is there low withdrawal/drop-out (below 20%)?
3. Quantitative 3.1. Are participants (organizations) recruited in a way that minimizes selection bias?
 non-randomized 3.2. Are measurements appropriate (clear origin, or validity known, or standard instrument; and absence of contamination between groups
when appropriate) regarding the exposure/intervention and outcomes?
3.3. In the groups being compared (exposed vs. non-exposed; with intervention vs. without; cases vs. contro ls), are the participants
comparable, or do researchers take into account (contro l for) the difference between these groups?
3.4. Are there complete outcome data (80% or above), and, when applicable, an acceptable response rate (60% or above), or an acceptable
fo llow-up rate for cohort studies (depending on the duration of fo llow-up)?
4. Quantitative 4.1. Is the sampling strategy relevant to  address the quantitative research question (quantitative aspect o f the mixed methods question)?
descriptive 4.2. Is the sample representative of the population understudy?
4.3. Are measurements appropriate (clear origin, or validity known, or standard instrument)?
4.4. Is there an acceptable response rate (60% or above)?
5. M ixed methods 5.1. Is the mixed methods research design relevant to  address the qualitative and quantitative research questions (or objectives), or the
qualitative and quantitative aspects of the mixed methods question (or objective)?
5.2. Is the integration of qualitative and quantitative data (or results*) relevant to  address the research question (objective)?
5.3. Is appropriate consideration given to  the limitations associated with this integration, e.g., the divergence of qualitative and quantitative
data (or results*) in a triangulation design?
Criteria for the qualitative component (1.1 to  1.4), and appropriate criteria for the quantitative component (2.1 to  2.4, or 3.1 to  3.4, or 4.1 to  4.4), must be also applied.
9.11 Appendix 11 MMAT 
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9.12 Appendix 12 Participant Information Sheet 
 
Participant Information Sheet 
  
Project Title: Community pharmacists' experiences of public health provision for non-diabetic 
patients with hypertension and hyperlipidaemia. 
 
 
You are being invited to take part in a research study. Before you decide whether or not to 
take part, it is important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully. 
 
What is the purpose of the study?  
 
In recent years, formalised by the pharmacy contract, pharmacists have become increasingly 
involved in activities relating to public health. A strong body of evidence consistently shows 
that interventions delivered by pharmacists have significant clinical benefits in relation to a 
number of cardiovascular disease risk factors. However research has found varying levels of 
pharmacist-led health promotion activity. A wide range of factors influence pharmacists’ health 
promotion activity therefore more research is needed to develop a greater understanding of 
community pharmacists’ experience, particularly in relation to cardiovascular health in the non-
diabetic population. 
 
Why have I been chosen? 
 
Community pharmacists working in chain and independently owned pharmacies at different 
geographical locations across the Midlands have been invited to take part in this study. 
 
What will happen to me if I take part? 
 
If you decide to take part in the study the researcher will arrange to meet with you at a 
convenient time and place. This could be at your home, workplace or at a meeting venue. 
Participation in the study involves a single interview which is expected to last between 45 and 
60 minutes. The researcher will ask you some questions about your experience, thoughts and 
opinions about providing public health services in the pharmacy, particularly in relation to 
cardiovascular health. The interview will be recorded using a digital recording device so the 
interviewer can transcribe it at a later date. At the end of the interview you will be asked to give 
yourself a different name so that nobody will be able to identify you from the data. Anything 
you say will be kept completely confidential. 
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Are there any potential risks in talking part in the study? 
 
It is not expected that you will experience any disadvantages as a result of participating in the 
study. You may have concerns about expressing opinions that your employer may disapprove 
of, given that an audio recording of the interview will be made. Anything that you chose to say 
will remain confidential. Nobody, including your employer, will be able to identify you or your 
place of work from the study results. 
 
 
Do I have to take part? 
 
No, you have no obligation to take part in this study. If you do decide to take part in the study 
you can still stop and withdraw at any point without having to provide an explanation.  
 
 
 
Will my taking part in this study be kept confidential? 
 
All of the information that you tell the researcher will be kept completely confidential. Only the 
researcher will know who you are. You will be asked to choose a different name for yourself, 
and you will be known under that name. The interview will be recorded on a password 
protected digital audio device which will be stored in a locked filing cabinet at Aston University. 
The recording will be downloaded onto a password protected computer at Aston University. 
The interview recording and transcript will be stored for up to 5 years after which it will be 
destroyed. 
 
 
What will happen to the results of the research study? 
 
The interviews will be analysed and the results will be published as part of a PhD thesis and 
potentially in an academic journal. The researcher’s academic supervisors may look at an 
anonymised version of the interview transcript. Direct quotations of what you have said in the 
interview may be used as part of the results. Nobody will be able to identify you from the 
quotations or results of the study. 
 
You will be given the opportunity to give the researcher your contact details if you would like to 
be sent a copy of the study findings. 
 
 
 
311 
 
Who is organising and funding the research? 
 
Kirsty Morton, a PhD student from the School of Life and Health Sciences at Aston University 
is organising and conducting the research. The research is supervised by Professor Helen 
Pattison, Dr Rachael Powell and Professor Chris Langley from the School of Life and Health 
Sciences at Aston University. The research is funded by the Economic and Social Research 
Council (ESRC) and the Medical Research Council (MRC). 
 
Who has reviewed the study? 
 
The study has been reviewed and approved by Aston University's Ethics Committee. 
 
 
Who do I Contact if Something Goes Wrong or I need Further Information?  
 
If you have any questions, concerns or would like further information about the study please 
feel free to contact the researcher, Kirsty Morton, at mortonk2@aston.ac.uk or 0121 204 4250. 
 
You can also contact the researcher’s supervisor, Professor Helen Pattison, on 
h.m.pattison@aston.ac.uk or telephone 0121 204 4073. 
 
Who do I contact if I wish to make a complaint about the way in which the research is 
conducted ? 
 
If you have any concerns about the way in which the study has been conducted you should 
contact the Secretary of Aston University Research Ethics Committee, John Walter, on 
j.g.walter@aston.ac.uk or telephone 0121 204 4665. 
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9.13 Appendix 13 – Consent form 
Volunteer Consent Form 
 
Title of Project: Community pharmacists’ experiences of public health provision for non-
diabetic patients with hypertension and hyperlipidaemia.  
 
Name of Chief Researcher: Kirsty Morton 
 
 
  Tick 
Box 
1 I confirm that I have read and understood the information sheet for the above study. I have 
had the opportunity to consider the information, ask questions and have had any questions 
answered satisfactorily. 
 
2 I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving any reason, without my legal rights being affected. 
 
3 I agree to the interview being digitally recorded and transcribed with my personal 
information removed. 
 
4. I understand that my interview responses will be looked at by the researcher’s  
academic supervisors. These responses will not contain any personal information that  
could identify me. 
 
 
5. I understand that I may be directly quoted under another name. The things I say may  
be published but any publication will not contain any personal information that could  
identify me. 
 
6. I agree to take part in the above study.  
 
 
 
_________________________ ________________ ___________________ 
Name of volunteer Date Signature 
 
 
_________________________ ___________________________________ 
Researcher Date Signature 
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9.14 Appendix 14 – Interview Schedule 
 
a) Tell me about your health. 
 
b) Tell me about your high blood pressure and/or high cholesterol. 
[Prompts: what condition is, how long patient has had it, whether they perceive any symptoms] 
 
c) What do you think caused your high blood pressure and/or high cholesterol? 
[Prompts: diet, age, exercise, smoking, familial, other] 
 
d) How were you diagnosed with high blood pressure and/or high cholesterol? 
[Prompts: visit to pharmacist, doctor or practice nurse, encouraged to see health professional 
by friend/relative] 
 
e) If you were having problems with your high blood pressure/cholesterol medication, 
who would you go to for advice? 
[Prompts: pharmacist, doctor, nurse, friend/relative] 
 
f) Tell me about the medicines you are taking. 
[Statins, water tablets, ] 
 
g) How do you monitor your high blood pressure and/or high cholesterol? 
[Prompts: self-testing, check-ups with health professionals (doctor, nurse, pharmacist)] 
 
h) Have you done anything differently since you were diagnosed with high blood pressure 
and/or high cholesterol? 
[Prompts: diet, weight loss, exercise, stopped smoking, adhere to prescribed medication] 
 
i) For diabetic + hyperlip/hyperten patients: Are there any differences in the way you manage 
the diabetes compared to your high blood pressure/cholesterol? 
[Prompts: relationship with doctor/pharmacist/nurse, response to symptoms, medication 
adherence, lifestyle] 
 
j) In your opinion, what is the role of the community pharmacist? 
[Prompts: dispense prescriptions, medication advice, health information, lifestyle advice, 
screening services, smoking cessation, weight reduction services] 
 
k) Does your community pharmacist help you manage your high blood pressure and/or 
high cholesterol?...Tell me more… 
[Prompts: medication advice (MURs/NMS), health information, lifestyle advice (diet, exercise, 
weight loss, smoking cessation)] 
 
l) Tell me about a recent time you’ve gone to a pharmacy to collect your blood 
pressure/cholesterol medication. 
[Prompts: interaction with pharmacist, advice offered by the pharmacist (if any), information 
patient required (if any), questions pharmacist asked (if any)] 
 
m) Has a community pharmacist discussed your diet or exercise habits with you? Tell me 
more. 
[Prompt: patient/pharmacist initiate the conversation, helpful/unhelpful] 
 
n) What are your thoughts on the suitability of the pharmacy as a place to receive advice 
about your diet and exercise? 
[Prompts: privacy, pharmacist qualifications, pharmacist’s role, appropriate location] 
 
o) What help or support would you like to receive from your pharmacist in relation to your 
condition? 
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[Prompts: dispensing of medication, medication advice and monitoring, lifestyle change 
advice, condition self-management support] 
 
p) Is there anything I haven’t asked about that you think is relevant or important? 
 
 
Demographics 
1. Age 
2. Gender 
3. Condition (hypertension/hyperlipidaemia/diabetes) 
4. Duration since patient was diagnosed. 
5. Postcode 
6. Occupation 
7. Have a regular pharmacy they visit? 
 
 
